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Recent clinical studies suggest that white matter pathology rather than grey matter 
abnormality is the major neurobiological substrate of age- related cognitive decline during 
“healthy” aging. According to this hypothesis, cerebrovascular (e.g. chronic cerebral 
hypoperfusion) and molecular (e.g. APOE, epigenetics) factors might contribute to age- 
related white matter pathology and cognitive decline. To test this, I used a new mouse 
model of chronic cerebral hypoperfusion and examined the following predictions:  
XXXIX 
1) hypoperfusion- induced white matter pathology might be associated with cognitive 
deficits, 2) APOE deficiency might be associated with white matter anomalies under 
normal physiological conditions and more severe hypoperfusion- induced white matter 
pathology, 3) chronic cerebral hypoperfusion might impact on hydroxymethylation (a 
newly discovered epigenetic marker) in white matter, via perturbations in associated 
epigenetic pathways, namely methylation and/ or TETs.   
I. Effects of chronic cerebral hypoperfusion on white matter integrity and cognitive 
abilities in mice 
To test the hypothesis suggesting that hypoperfusion- induced white matter pathology is 
associated with working memory and executive function impairment in mice, behavioural 
performance and neuropathology were systematically examined in two separate cohorts of 
sham and hypoperfused C57Bl6J mice. Spatial working memory, memory flexibility, 
learning capacity, short and long term memory recall were taxed using radial arm maze 
and water maze paradigms one month after surgery. At the completion of the behavioural 
testing white and grey matter integrity, inflammation were evaluated using standard 
immunohistochemistry with antibodies recognizing neuronal axons (APP), myelin sheath 
(MAG) and microglia (Iba1) as well as H&E histological staining to examine neuronal 
morphology and ischemic injury. In agreement with previous reports, the behavioral data 
indicated spatial working memory impairment in the absence of spatial memory 
flexibility, learning, short- and long- term memory recall deficits in hypoperfused mice 
However, in contrast to previous reports, a spectrum of white and grey matter 
abnormalities accompanied by an increased inflammation were observed in hypoperfused 
mice Although there was a significant association between hypoperfusion- induced 
inflammation in white matter and performance on a working memory radial arm maze task 
(p<0.05), the present pathological findings suggest that white matter abnormalities, 
neuronal ischemia and increased inflammation might be at the basis of hypoperfusion- 
induced cognitive impairment in mice. Further, chronic cerebral hypoperfusion might 
have affected alternative, non- examined brain processes (e.g. cerebral metabolism, 
neurotransmission) which might have contributed to the observed cognitive deficits in 
hypoperfused mice.  
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II. Effects of APOE on white matter integrity under normal physiological and 
chronically hypoperfused conditions in mice 
To test the hypothesis suggesting that mouse APOE deficiency might be associated with 
white matter anomalies under normal physiological conditions and the development of 
more severe white matter pathology following chronic cerebral hypoperfusion, white and 
grey matter integrity, inflammation were examined in APOE deficient mice on a C57Bl6J 
background (APOEKO) and C57Bl6J wild- type (WT) counterparts one month after 
chronic cerebral hypoperfusion or sham surgery. A combined neuroimaging (MRI- DTI)/ 
immunochemical approach was attempted in these mice as an additional step towards 
translation of this research to human subjects. The ex vivo MRI- DTI findings 
demonstrated APOE genotype effects on the development of white matter abnormalities 
following chronic cerebral hypoperfusion in mice. Significant reductions in MRI metrics 
(FA and MTR) of white matter integrity were observed in examined white matter areas of 
APOEKO hypoperfused mice compared with WT hypoperfused counterparts (p<0.05). 
However, the neuroimaigng findings were not supported by the pathological analysis 
where no significant APOE differences were observed in hypoperfusion- induced axonal 
(APP), myelin (MAG, dMBP) pathology and inflammation (Iba1) (p>0.05). No significant 
differences in MRI parameters and pathological grades of white matter integrity were 
evidenced between APOEKO and WT sham mice (p>0.05).  An absence of grey matter 
abnormalities was evidenced on T2- weighted scans and corresponding H&E stained brain 
sections in all experimental animals. However, significant reductions in MTR values and 
dMBP immunoreactivity (myelin pathology) (p<0.05) were observed in grey matter (the 
hippocampus) following chronic cerebral hypoperfusion in the absence of significant 
APOE genotype effect (p>0.05) suggesting the existence of both white and grey matter 
abnormalities in this animal model. Overall, the present neuroimaging data, but not 
pathological analysis, partially validated the main study hypothesis suggesting that APOE 
deficiency might be associated with the development of more severe white matter 
abnormalities in hypoperfused mice. 
 
XXLI 
III. Characterization of methylation and hydroxymethylation in white matter under 
normal physiological and chronically hypoperfused conditions in mice 
Lastly, I sought to test the hypothesis that chronic cerebral hypoperfusion might alter 
oxygen dependent DNA hydroxymethylation (5hmC) in white matter regions via 
perturbations in methylation (5mC) and/ or Ten- eleven translocation proteins (e.g. TET2) 
in mice. DNA methylation (5mC), hydroxymethylation (5hmC) and TET2 were 
immunochemically studied in white and grey matter of sham and chronically 
hypoperfused C57Bl6J mice a month after surgery. The immunochemical results 
demonstrated significant increases (p<0.05) in 5hmC in the hypoperfused corpus callosum 
(CC) in the absence of significant hypoperfusion- induced alterations in the distribution of 
5mC and TET2 (p>0.05) in white matter. Significant hypoperfusion- induced increases 
were evident for TET2 in the cerebral cortex (Cx) (p<0.05). These data partially validated 
the main study hypothesis suggesting hypoperfusion- induced alterations in 5hmC in white 
matter. However, in contrast to the study hypothesis, the observed hypoperfusion- induced 
alterations in 5hmC occurred in the absence of changes in 5mC and TET2 in white matter. 
A subsequent correlation analysis between hydroxymethylation and 5mC, TET2 in the CC 
failed to show significant associations (p>0.05). In search of the cellular determinants of 
5hmC in the CC, hydroxymethylation was examined in relation to some of the cell types 
in white matter- mature oligodendrocytes, oligodendrolial progenitors (OPC) and 
microglia both in vivo and in vitro. Specifically, a separate parametric correlation analysis 
between the proportion of 5hmC positive cells and the respective proportions of mature 
oligodendrocytes, OPC and microglia in the CC demonstrated that hydroxymethylation 
correlated significantly only with microglia in vivo (p<0.05). Following this, 5hmC 
immunochemical distribution was studied in vitro in oligodendroglia cells at different 
stages of maturation, and interferon γ/ lypopolisaccharide activated and nonactivated 
microglia. The in vitro analysis demonstrated that 5hmC is high in OPC, activated and 
nonactivated microglia, but it is low in mature oligodendrocytes. Taken together the in 
vivo and in vitro cellular analyses suggest that the processes of hydroxymethylation in 
white matter might be immunoregulated. However, it is possible that in vivo in addition to 
microglia, other cell types (e.g. astrocytes, OPC) contributed to the presently observed 
5hmC upregulation in the hypoperfused CC. 
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Conclusion 
The experimental work presented in this thesis further developed and characterized a new 
mouse model of chronic cerebral hypoperfusion by confirming previous behavioural 
findings (e.g. working memory deficits) and revealing previously undetected spectrum of 
white and grey matter pathology in this animal model. The thesis demonstrated for the 
first time by using a newly developed ex vivo MRI procedure that APOE might modulate 
hypoperfusion- induced white matter pathology in mice. Additional immunochemical 
analysis revealed important hypoperfusion- induced epigenetic alterations in white 
(5hmC) and grey (TET2) matter in this animal model. Future experiments on chronically 
hypoperfused mice would allow to get a better insight into the neurobiological 
determinants (e.g. white vs. grey matter) underlying the observed cognitive deficits in this 
animal model, the involved cellular and molecular pathways as well as the functional 
significance of genetic (APOE) and epigenetic (5hmC, TETs) alterations in the 
hypoperfused brain. Future experimental work on this animal model would potentially 
reveal new biological targets for the pre- clinical development of therapies for age- related 
cognitive decline. Further development and optimization of the newly developed ex vivo 
MRI procedure would allow its broader application in preclinical settings and would 


































1.1. Cerebral white matter 
The cerebral white matter is composed of bundles of myelinated and non- myelinated 
neuronal axons (tracts) connecting cortico- cortical and cortico- subcortical grey matter 
regions. The Renaissance anatomist Andreas Vesalius was the first to clearly distinguish 
brain white matter regions from grey matter structures in 1543 in his work De Humani 
Corporis Fabrica (Vesalius, 1543) (figure 1.1. A). Since this pioneering work, the 
neuroanatomy, function, cellular and molecular composition of the cerebral white matter 
have been described and studied under both normal and pathological conditions.  
 The cerebral white matter constitutes 40- 50% of the total volume of the adult human 
brain (~16% of the total volume of the adult mouse brain) (Zhang and Sejnowski, 2000) 
(figure 1.1. B- C). The corpus callosum (CC), the external capsule (EC), the internal 
capsule (IC), the fimbria fornix (Fx), and the optic tract (OT) are the major white matter 
regions.  The CC represents the main association fiber system connecting prefrontal, 
premotor and somatosensory areas between the two hemispheres and therefore supporting 
various cognitive, memory, and sensory- motor functions (Bloom and Hynd, 2005). The 
EC is a smaller white matter bundle primarily comprising cholinergic fibers from the basal 
forebrain to cortical areas (Selden et al., 1998). The IC is the major subcortical white 
matter tract separating the caudate nucleus and the thalamus from the lenticular nucleus 
(Sullivan et al., 2010). This white matter tract ensures cortico- subcortical connectivity 
and the associated cognitive, somatosensory and motor functions (Sullivan et al., 2010). 
The Fx is mainly involved in the support of hippocampal afferent and efferent 
connectivity and the structural integrity of this white matter region plays a critical role in 
cognition and memory (Adelmann et al., 1996). The OT mediates the transmission of 
visual impulses from the retinas to the occipital (visual) lobe (Andrews et al., 1997).  
Therefore, pathological damage to the cerebral white matter could lead to a multitude of 
functional deficits depending on the extent and the localization of the lesion. White matter 
abnormalities are evidenced in different neurological, neurodegenerative and psychiatric 
disorders (Fields, 2008).  
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Figure 1.1.: Cerebral white matter 
Different representations of the cerebral white matter (arrows in A, B, C) on horizontal 
brain sections. In (A) is shown the first neuranatomical schematic drawing of the cerebral 
white matter (black arrow) made by Vesalius in 1543 (image adapted from Vesalius, 
1543). In (B) is presented the cerebral white matter of a healthy young adult appearing as 
bright hyperintesities (blue arrow) on a modern noninvasive diffusion tensor imaging 
(DTI) scan (image adapted from Hedden and Gabrielli, 2004). In (C) is shown a post- 
mortem sample of a healthy human adult brain where the white matter appears as white 
regions (black arrow) surrounded by cortical and subcortical grey matter structures 
(image adapted from Wikipedia: http://en.wikipedia.org/wiki/Human_brain) 
 
2 
At the microscopic level the cerebral white matter is composed of the neuronal axons 
covered by the myelin sheath and the myelin- producing oligodendroglial cells (figure 
1.2.). The myelin sheath insulating the neuronal axons was first discovered by Rudolf 
Virchow in 1854 and since its structure has been characterized in details (Virchow, 1854). 
The myelin sheath is composed of myelin internodes interrupted by non- myelinated areas 
with a high sodium channels content called the nodes of Ranvier. The nodes of Ranvier 
support the evolutionary evolved phenomenon of saltatory conduction in vertebrates 
(Peters, 1966; Hartline and Colman, 2007). The saltatory axonal conduction accelerates 
the propagation of action potentials in myelinated fibers contributing to greater conduction 
velocity and speed of information processing in comparison with non- myelinated axons 
(Hartline and Colman, 2007). The myelin sheath is composed of ~ 40 % water with a dry 
mass constituted of ~70 - 85 % lipids and ~15 - 30 % proteins (de Vries and Hoekstra, 
2000). The primary myelin lipid components are cholesterol, galactocerebrosides, 
phospholipids sphingomyelin (composed of ceramides and their bioproduct sulfatides) 
which serve to strengthen the myelin sheath (O`Brien and Sampson, 1965; Han et al., 
2003; Dietschy et al., 2004; Marcus et al., 2006). For instance, mutation of the enzyme 
responsible for the production of galactocerebrosides- ceramide galactosyltransferase 
results in a thinner myelin sheath and the occurrence of hind limb ataxia and tremors in 
mice (Coetzee et al., 1996). Specific oligodendroglial- mutation of the squalene synthase, 
an enzyme catalyzing the first step in the production of sterols leads to abnormal myelin 
structure and motor deficits in mice (Saher et al., 2005). The myelin protein components 
are myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG), proteolipid 
protein (PLP), 2`,3`- cyclic nucleotide 3`- phosphodiesterase (CNP), and myelin- 
associated glycoprotein (MAG). Each of these proteins fulfills a distinct role in the 
maintenance of the myelin sheath (Jahn et al., 2009) and some examples are provided in 
Chapter 1, section 1.3.1. 
The myelin- producing oligodendrocyte is the major cell type of the cerebral white matter. 
The term oligodendrocyte was first introduced by Rio Hortega in 1928 who used metallic 
impregnation techniques to study the cellular phenotypes in the mammalian brain 
(Hortega, 1928). Morphologically, the mature oligodendrocyte is characterized by a small 
soma surrounded by multiple processes branching and ensheathing hundreds of  
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Figure 1.2.: Cellular composition of the cerebral white matter 
A schematic representation of the cellular composition of the cerebral white matter as 
observed near the walls of the ventricles bordered by the ependymal cells. The major 
cellular component of the cerebral white matter is the olgiodendrocyte producing the 
myelin sheath enwrapping hundreds of neuronal axons. Astrocytes are another cell type 
present in white matter regions composing the blood brain barrier, providing trophic 
and metabolic support to neurons and oligodendrocytes and participating in the 
endogenous processes of brain repair in concert with inflammatory microglia. The 




neuronal axons (Baumann and Pham- Dinh, 2001) (figure 1.2.). Only large diameter axons 
are myelinated by mature oligodendrocytes (Friede, 1972). The exact reasons for this 
selective myelination process during early neurodevelopment are unknown, but it is most 
likely the result of a complex cellular and molecular signaling orchestrating the interaction 
between immature oligodendroglial cells and neuronal axons (Sherman and Brophy, 
2005). In mammals, myelination is a gradual process. Depending on the species it starts 
either prior to (human) or after birth (mouse). In humans axonal myelination continues for 
more than two decades, whereas in mice this process is completed for a couple of weeks 
postpartum (Marret et al., 1995; Lebel et al., 2008).  
From a molecular perspective, the oligodendroglial cells are characterized by high 
metabolic- adenosine triphoshate (ATP) demands necessary for the production and 
maintenance of the myelin sheath (Ravera et al., 2009). Myelination requires iron and 
oligodendroglial cells at all stages of maturation are characterized by the highest 
intracellular iron content among neural cells which could under unfavourable extracellular 
conditions trigger free radicals production and lipid peroxidation (Braughler et al., 1986; 
Todorich et al., 2009). N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-
isoxazoleproprionic acid (AMPA) and kainite glutamatergic receptors are expressed by 
oligodendrocytes and they are the principal mediators of excitotoxic injury to these cells 
occurring during various pathological conditions such as hypoxic- ischemic events 
(Karadottir and Attwell, 2007; Bakiri et al., 2009). The oligodendrocytes are also 
characterized by low levels of natural antioxidative defenses such as gluthatione limiting 
their chances to fight damaging oxidative, excitotoxic and inflammatory agents 
(Thornburne and Juurlink, 1996). Taken together, the intrinsic biological characteristics of 
the oligodendroglia put them at a greater risk of damage under pathological conditions.  
Recent experimental data suggest that in addition to their basic myelination functions 
mature oligodendrocytes provide metabolic and trophic support to axons (Nave and Trapp, 
2008). For instance, genetic manipulation of the normal metabolic machinery in 
oligodendroglial cells by mutation of the Pex 5 gene leading to an absence of functional 
peroxisomes in these cells has been associated with a progressive axonal degeneration in 
adult mice (Kassmann et al., 2007). Oligodendrocytes also synthesize growth factors such 
as glial cell line- derived neurotrophic factor (GDNF) and brain- derived  
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neurotrophic factor (BDNF) providing trophic support to axons (Dougherty et al., 2000; 
Wilkins et al., 2003). 
In addition to mature oligodendrocytes, a small population of resident chondroitin sulfate 
proteoglycan (NG2) positive oligodendroglial progenitor cells (OPC) is also present in 
white matter tracts of the adult mammalian brain (Karadottir et al., 2008). The exact 
functional role of these progenitor cells remains not well understood, but they are likely to 
play a role in the endogenous processes of brain repair, namely by replacing injured and/ 
or apoptotic oligodendroglial cells and by remyelinating demyelinated axons (Chang et al., 
2000; Reynolds et al., 2002). Interestingly, in contrast to mature oligodendrocytes, 
immature oligodendroglia are able to fire action potentials similar to neurons (Karadottir 
et al., 2008).  Astrocytes are another glial cell type present in white matter regions. 
Morphologically, these cells are characterized by a stellar shape soma with multiple 
processes branching around neuronal axons, oligodendroglial cells and blood vessels 
composing the blood brain barrier (figure 1.2.). Functionally, astrocytes are involved in 
the formation of the blood brain barrier, maintenance of the extracellular homeostasis by 
glutamate buffering, provision of trophic and metabolic support (e.g. glycogen production) 
to the rest of the neural cells (Hertz and Zielke, 2004; Hawkins and Davis, 2005; 
Magistretti, 2006). Astrocytes also play a role in the endogenous brain repair mechanisms 
by secreting inflammatory agents and by actively participating in the formation of glial 
scars in the presence of neuropathology or brain injury (Volterra and Meldolesi, 2005). 
Microglia are inflammatory glial cells scattered throughout the brain which are usually 
quiescent (inactive) under normal physiological conditions, but become activated in the 
presence of neuropathology (figure 1.2.). Microglia secrete inflammatory agents and in 
concert with astrocytes and OPC, these inflammatory cells are active participants in the 
endogenous brain repair mechanisms (Parkhurst and Gan, 2010).  
 
1.2. Age- related white matter pathology and cognitive decline 
White matter abnormalities are a common neuropathological finding on magnetic 
resonance imaging (MRI) scans of both healthy* and demented elderly. These recent 
neuroimaging findings have revolutionized the long- lasting neurobiological concept of 
age- related cognitive decline as the functional outcome of grey matter volume loss. 
 
*In the present thesis the term “healthy elderly” refers to aged individuals who do not present 
dementia- like neuropathological changes (e.g. amyloid plaques) and cognitive deficits.  
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Although there are subtle neuronal morphological changes such as reductions in synapses 
and dendrites, the number of neuronal cells remains unchanged in the aged mammalian 
brain (Anderson et al., 1983; Duan et al., 2003). 
In 2001, O`Sullivan et al., suggested that cortical disconnections due to white matter 
pathology are the major neuropathological substrate of age- related cognitive deficits 
(O`Sullivan et al., 2001). These initial results have been subsequently repeated and 
extended by other groups and it is now largely accepted that widespread white matter 
abnormalities occur in the aging human brain and they are associated with cognitive 
decline (Salat et al., 2005; Bastin et al., 2009; Gunning- Dixon et al., 2009; Madden et al., 
2009; Penke et al., 2010). Significant reductions in MRI metrics of white matter integrity, 
namely fractional anisotropy (FA) and magnetization transfer ratio (MTR) values are 
observed with increasing age and these neuroimaging parameters negatively correlated 
with performance on cognitive tasks taxing executive function, working memory, and 
processing speed (O`Sullivan et al., 2001; Charlton et al., 2006; Cook et al., 2007; Grieve 
et al., 2007; Wright, et al., 2008; Kennedy and Raz, 2009). These cognitive functions rely 
on the rapid transmission of information between cortical and subcortical regions (Rolls, 
2000; Funahashi, 2001; Tekin and Cummings, 2002; Grieve et al., 2007). Specifically, a 
disruption of the prefrontal- hippocampal connectivity might be at the basis of the 
selective executive and working memory impairment observed in elderly people with 
white matter pathology (Grieve et al., 2007). Interestingly, general intelligence, semantic 
knowledge and episodic memory are relatively preserved in healthy elderly (Charlton et 
al., 2006; Kennedy and Raz, 2009). Further, white matter abnormalities are observed in 
individuals with mild cognitive impairment, vascular dementia and Alzheimer`s disease 
(Gootjes et al., 2004; Head et al., 2004). Neuroimaging data have demonstrated that there 
is a difference in the extent of the observed white matter alterations between healthy and 
demented elderly. In the healthy aging human brain white matter lesions affect primarily 
frontal association fibers, whereas in mild cognitive impairment, vascular dementia and 
Alzheimer` s disease patients white matter pathology is evidenced in both anterior and 
posterior brain regions suggesting that a more widespread white matter damage might 
contribute to the development and severity of senile dementia (Gootjes et al., 2004; Head 
et al., 2004). 
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At the microscopic level pathological postmortem analysis reveals that age- related white 
matter lesions are characterized by myelin loss, axonal injury and increased inflammation 
(Fernando et al., 2006; Gold et al., 2007; Ihara et al., 2010). Alterations in myelin lipid 
content are observed with increasing age. For instance, biochemical studies using post- 
mortem brain samples show a decrease in cholesterol, phospholipids, gangliosides, and 
sphingomyelin bioproducts- ceramides and sulfatides in the frontal and temporal cerebral 
white matter with advanced age (Svennerholm et al., 1994). Further, stereological 
comparisons of white matter integrity between healthy young and old adults show a 
significant decrease in the total length of the myelinated fibers accompanied by a 
significant increase in the mean axonal diameter in old adults in comparison with young 
controls indicating a substantial myelin loss with increasing age (Tang et al., 1997). 
Myelin pathology is also evidenced in aging rats and nonhuman primates (Knox et al., 
1989; Peters et al., 2000; Peters and Sethares, 2002). For instance, in the prefrontal cortex, 
CC, and primary visual cortex of the aged rhesus monkey pathological abnormalities in 
myelin integrity such as a loosening of its compaction, a formation of liquid- filled 
ballons, an increase in the paranodes length, an accumulation of oligodendroglia- derived 
cytoplasm within the myelin lamella are observed by means of electron microscopy 
(Peters et al., 2000; Peters and Sethares, 2002). Interestingly, aged monkeys present 
similar cognitive impairments to healthy elderly people such as executive function 
(memory flexibility), working memory and processing speed deficits (Herndon et al., 
1997; Luebke et al., 2004). Consequently, pathological disruption of the myelin integrity 
might lead to changes in the axonal conduction rates resulting in a loss of synchrony in 
cortico- subcortical neuronal circuits and a subsequent cognitive impairment. Indeed, in a 
study by Xi et al., 1999 comparing the conduction velocity of axons in the pyramidal 
tracts of aged cats with those in young cats it has been found that 51% of pyramidal tract 
neurons in young cats are fast conducting when compared with 26% in old cats. Aged cats 
exhibit an overall 43% decrease in median axonal conduction velocity compared with 




1.3. Mechanisms of damage to white matter 
1.3.1. Excitotoxicity and oxidative stress 
Excitotoxic and oxidative insults are common molecular mechanisms leading to white 
matter pathology in many neurological and neurodegenerative conditions (Volpe, 2001; 
Park et al., 2004; Yi and Hazell, 2006; Baltan et al., 2008). From a mechanistic point of 
view, the excitotoxic damage to white matter is mediated via the glutamatergic NMDA, 
AMPA/ kainite receptors present on oligodendroglial cells at all stages of maturation 
(Karadottir and Attwell, 2007; Bakiri et al., 2009). Specifically, exposure of 
oligodendrocytes to glutamate induces cystine depletion through the action of a glutamate- 
cystine exchange system, thereby depleting gluthatione and causing free radical mediated 
cell death (Yonezawa et al., 1996). Under excitotoxic conditions gluthatione scavenges 
hydrogen peroxide by an electron donor. However, if hydrogen peroxide is not scavenged 
it drives the conversion of lipid hydroperoxides to alkoxyl radicals and in the presence of 
increased iron leading to the formation of peroxyl radicals attacking cellular 
mitochondrias and provoking apoptotic cell death. Oligodendrocytes have been shown to 
have 23 fold more iron than astrocytes while having less than half of their gluthatione 
amount (Thornburne and Juurlink, 1996). Hypoxic- ischemic conditions are characterized 
by increased excitotoxicity and the development of white matter pathology (Matute et al., 
2001). For instance, using in situ model of adult brain slices transient oxygen and glucose 
deprivation has been found to result in white matter damage accompanied by widespread 
oligodendroglial cell death (Tekkok and Goldberg, 2001). However, application of 2,3-
dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX)- an AMPA/ 
kainate antagonist during oxygen and glucose deprivation in the same in situ model 
prevents oligodendroglial cell death as well as the development of white matter pathology. 
Further, in vivo in a mouse model of periventricular leukamalacia characterized by 
hypoxic- ischemic white matter injury, the application of AMPA antagonists has 
neuroprotective effects (Follet et al., 2004). Periventricular leukomalacia is a common 
neurological disorder in preterm babies. It is characterized by excitotoxic white matter 
injury due to hypoxic- ischemic events during premature birth associated with long- term 
motor and cognitive morbidities (Volpe, 2001). Excitotoxic and oxidative damage to 
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cerebral white matter is also evidenced in adults specifically in individuals with traumatic 
brain and spinal cord injury as well as in elderly people as a result of an age- related 
increase in brain excitotoxicity (Park et al., 2004; Yi and Hazell, 2006; Baltan et al., 
2008). 
1.3.2. Inflammation 
Increased inflammatory agents released by astrocytes and microglia under pathological 
conditions are known to cause demyelination, axonal injury and oligodendroglial cell 
death (Hu and Lucchinetti, 2009). The precise mechanisms via which inflammation affects 
white matter integrity are still not well understood. Oligodendrocytes express receptors for 
interleukins (IL) and cytokines such as IL- 2, IL- 1α/β, IL- 6 interferon γ (IFNγ), tumor 
necrosis factor α (TNFα) (Otero and Merrill, 1994; Dopp et al., 1997). These 
inflammatory agents are known to be important signaling cues governing oligodendroglial 
maturation, migration and myelination during neurodevelopment as well as in certain 
neuropathological conditions associated mainly with the processes of active remyeliantion 
(Diemel et al., 1998; Vela et al., 2002). However, in vitro experiments have demonstrated 
that elevated inflammatory levels such as an increase in IL- 2, IFNγ, TNFα are lethal to 
oligodendroglial cells (Otero and Merrill, 1994; McLaurin et al., 1995; Vartanian et al., 
1995). In vivo experiments using transgenic mice overexpressing TNFα have confirmed 
the in vitro studies demonstrating that the toxic effects of this cytokine are directly related 
to the function of activated microglia and macrophages (Corbin et al., 1996). Further, 
intraneuronal injection of TNFα into the sciatic nerve of the adult rat produces 
demyelination, axonal degeneration and vascular pathology several days after injection 
(Redford et al., 1995). In addition, TNFα affects myelin integrity by stimulating the 
activity of sphingomyelinase an enzyme converting sphigophospolipids to toxic ceramides 
and sulfatides under pathological conditions. In vitro treatment of bovine or rat 
oligodendrocytes with ceramide analogue (C2) induces oligodendroglial apoptosis 
showing that inflammatory agents such as TNFα could indirectly impact on myelin 
integrity and oligodendrocytes by stimulating alternative molecular pathways (Larocca et 
al., 1997). Impaired immune response followed by  increased inflammation, active 
demyelination, oligodendroglial apoptosis,  axonal damage are all observed in patients 
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with multiple sclerosis, encephalomyelitis and acquired immunodeficiency syndrome 
(Minagar et al., 2002; Hu and Lucchinetti, 2009). These patients present functional 
impairments such as motor, visual and cognitive deficits, depression with a different 
degree of severity depending on the disease stage (Calabrese, 2006). 
1.3.3. Gene mutations 
Mutation in genes coding for major myelin proteins is associated with impaired white 
matter integrity and functional deficits in both laboratory mice and human patients with 
congenital dysmyelinating disorders (leukodystrophies).  
PLP is one of the major myelin protein components playing an important role in myelin 
integrity and structural maintenance (Klugmann et al., 1997). A X- linked mutation in PLP 
gene occurs naturally in human patients with Pelizaeus- Merzbacher disease and spastic 
paraplegia as well as in mice presenting jimpy phenotype (Nave et al., 1986; Saugier- 
Veber et al., 1994). At the pathological level, naturally occurring PLP mutation in mice 
results in congenital dysmyelination with preserved axonal integrity and a very short life- 
span (~4 weeks) (Nave et al., 1986; Klugmann et al., 1997). However, experimental 
genetic deletion of the PLP gene leads to an increased life span (>12 months) allowing a 
better characterization of the functional importance of PLP (Griffiths et al., 1998). PLP 
null mice exhibit a late- onset neurodegeneration characterized by progressive axonal loss 
and swellings throughout the central nervous system affecting primarily the long spinal 
tracts. This neuropathological profile is associated with late onset ataxia in the absence of 
seizures and tremors and premature death similar to disease progression in human patients 
with Pelizaeus- Merzbacher disease and spastic paraplegia (Garbern et al., 2002). 
MBP in addition to PLP constitutes one of the most abundant protein members of the 
compact myelin and it has similar to PLP function (Dupouey et al., 1979; Klugmann et al., 
1997). In mice, mutation in MBP gene results in a shiverer phenotype characterized by 
hypomyelination with abnormal myelin structure (an impaired myelin compaction), subtle 
changes in axonal cytoarchitecture in the absence of swellings or salient axonopathy,  
motor  (gait) disturbances, convulsions, and very short lifespan (between 50- 100 days) 
(Dupouey et al., 1979; Readhead and Hood; 1990; Kirkpatrick et al., 2001). In humans, 
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MBP protein is pathologically damaged in patients with multiple sclerosis and most likely 
contributes to the observed neuropathological features and functional deficits (Allegretta 
et al., 1990). 
MAG is a transmembrane glycoprotein localized at the periaxonal space. It is functionally 
involved in the maintenance of the structural integrity and survival of both the neuronal 
axons and oligodendroglia (Quarles, 2007). MAG is also a molecular factor known to 
inhibit axonal regeneration and neurite outgrowth acting through the NOGO receptor 
pathway (Liu et al., 2002). This myelin protein is particularly vulnerable to hypoxic- 
ischemic insults (Aboul- Enein et al., 2003). Interestingly, MAG null mutation in mice 
does not impact significantly on the overall myelin structure (at the exception of some 
multiple ensheathed axons) (Schachner, 1994). The phenotype of MAG mutants is normal 
and no severe functional (motor and/ or cognitive) deficits are observed (Montag et al., 
1994). 
Additionally, mutation in the glial fibrillary acid protein (GFAP) present in astrocytes and 
radial glia indirectly impacts on myelin integrity (Song et al., 2002). Absence of 
endogenous astrocytes in both humans with Alexander disease and in genetically modified 
GFAP null mice results in a substantial dysmyelination associated with an impaired 
oligodendroglial function and short survival. In humans, GFAP mutation is associated 
with sever functional deficits such as seizures, muscle spasticity, cognitive deficits and a 
very short lifespan (~10 years after disease onset) (Johnson, 2002).  
1.4. Methods for detection of white matter integrity 
1.4.1. Magnetic resonance imaging (MRI) 
Magnetic resonance imaging (MRI) is a neuroimaging technique used in both clinical and 
preclinical settings. It was initially developed about 40 years ago (Lauterber, 1973) and its 
principle relies on the physical properties of water molecules composing the body organs. 
The MRI scanner applies strong magnetic fields to the person/ animal/ biological sample 
resulting in an excitation of the water hydrogen atoms (protons) which align their own 
magnetic fields (spins) in the direction to the scanner magnetic field. Subsequently, the 
application of a brief radio frequency (RF) produces an electromagnetic field. The 
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generated RF is absorbed by the aligned protons and flips their own spin. The frequency at 
which the protons resonate depends on the strength of the applied magnetic field. Once the 
RF is turned off, the spin of the protons will return progressively to baseline. The time 
taken for the protons (the relaxation time) to return to their initial spin is measured by the 
MRI scanner. The protons from the different body tissues have different relaxation 
properties allowing the generation of MRI image contrast. The generation of high quality 
MRI images with a good spatial resolution depends on the strength of the applied magnet, 
the total imaging time and physiological artifacts (movement, respiration, blood 
circulation etc). MRI provides a good regional contrast between the different soft tissues 
of the body and unlike computer tomography (CT) scans or traditional X-rays, MRI does 
not apply ionizing radiation making this neuroimaging technique safer for clinical use. 
1.4.1.1. Diffusion tensor imaging (DTI) 
Diffusion tensor imaging (DTI) is a newly developed MRI approach first described by 
Moseley et al., in 1990 measuring the temperature driven directional diffusivity of water 
molecules in organized biological systems such as white matter tracts (Moseley et al., 
1990). Specifically, DTI provides a quantitative evaluation of white matter structural 
integrity relying on the physical phenomenon of fractional anisotropy (FA). FA is defined 
by the axial diffusivity (λ‖) determined by the diffusion of water molecules along the 
neuronal axons and the radial diffusivity (λ ) characterized by the water diffusivity 
perpendicular to the neuronal axons (through the myelin sheath and the axonal 
cytoarchitecture). Under normal physiological conditions, the diffusion of water molecules 
in white matter tracts is mainly along the neuronal axons and it is highly anisotropic 
(~1.0). FA decreases in the presence of pathology due to a disruption of the myelin 
membranes, axonal injury and the occurrence of an isotropic (in all direction) water 
diffusivity (Basser, 1995; Beaulieu, 2002). FA is shown to be a sensitive noninvasive 
biomarker for white matter integrity and it is currently used in both clinical and preclinical 
settings. Recent neuroimaging studies have established that DTI is sensitive to changes in 
white matter integrity when applied on ex vivo samples (Filippi et al., 2001; Bozzali et al., 
2002; Deary et al., 2003; Song et al., 2003; Song et al., 2005; Dhenain et al., 2006; Harms 
et al., 2006; Harsan et al., 2006;  Sun et al., 2006a; Gouw et al., 2008; Bastin et al., 2009; 
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Penke et al., 2010; Holland et al., 2011). Although, postmortem brain tissue is 
characterized by a lower temperature and reduced overall water diffusivity due to the 
application of fixatives and the absence of active blood circulation, FA is relatively 
preserved (Guilfoyle et al., 2003; Sun et al., 2003; Sun et al., 2005). The advantage of ex 
vivo DTI application to biological samples is that it allows longer imaging time in the 
absence of physiological artifacts and therefore the generation of MRI images with a 
better spatial resolution. Ex vivo DTI provides a more detailed histological white matter 
analysis when combined with basic immunohistochemical/ biochemical techniques 
allowing the simultaneous examination of microstructural (axons and myelin integrity, 
inflammatory cells) and molecular (myelin gene expression, protein and lipid levels) basis 
of white matter pathology observed on MRI scans. 
1.4.1.2. Magnetization transfer ratio (MTR) 
Magnetization transfer ratio (MTR) is a new MRI technique first developed by Wolff and 
Balaban in 1989 providing information on white matter integrity by calculating a ratio 
between the free water protons and the macromolecular (myelin) bound water pool in the 
brain (Wolff and Balaban, 1989; Grossman et al., 1994). A decrease in MTR is usually 
associated with an increase in the free brain water pool due to white matter (primarily 
myelin) damage (McGowan et al., 1999; Schmierer et al., 2004; Blezer et al., 2007; Bastin 
et al., 2009; Ou et al., 2009; Holland et al., 2011). Similar to DTI, MTR is also 
successfully applied for the detection of white matter integrity both in vivo and ex vivo 
(McGowan et al., 1999; Schmierer et al., 2004; Blezer et al., 2007; Bastin et al., 2009; Ou 
et al., 2009; Holland et al., 2011).  
1.4.2. Ex vivo (postmortem) histopathological evaluation of white matter integrity 
Microstructural white matter axonal and myelin integrity are studied on postmortem brain 
samples by means of standard histological and immunohistochemical techniques. The 
most common histological stainings applied for the study of white matter integrity are 
Kluver Barrera allowing the visualization of gross white matter fiber disorganizations and 
Luxol fast blue allowing the differentiation of white matter abnormalities (pale areas) 
from normal appearing white matter (intensely stained in blue) (Kluver and Barrera, 1953; 
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Goto, 1987). These techniques are good indicators of the overall white matter integrity, 
however they lack a sufficient sensitivity as to the different cellular components of the 
cerebral white matter such as the neuronal axons and the myelin sheath, therefore they are 
not good biomarkers for subtle pathological changes in white matter integrity. Standard 
immunohistochemical techniques employing antibodies to the neuronal axons and the 
myelin proteins are much more sensitive to mild changes in the microstructural integrity 
of the cerebral white matter. 
1.5. Chronic cerebral hypoperfusion 
Chronic cerebral hypoperfusion is associated with age- related changes in the 
cerebrovasculature leading to subtle reductions in the cerebral blood supply and 
metabolism. Arteriosclerosis (affecting the arteries) and atherosclerosis (affecting the 
small blood vessels) are characterized by the accumulation of lipids, cholesterol, 
inflammatory macrophages in the walls of the cerebral blood vessel leading to their partial 
occlusion and the occurrence of a forebrain hypoperfusion (Kalback et al., 2004; Moore 
and Tabas, 2011) (figure 1.3. A). One of the major risk factors for the development of 
atherosclerotic lesions in elderly is an existing polymorphism in the human apolipoprotein 
E (APOE) gene (Chapter 1, section 1.6.) (Elosua et al., 2004). A detectable carotid 
stenosis is present in 75% of men and 62% of women aged ≥ 65 years and the prevalence 
of a  ≥ 50% stenosis in this population being 7% in men and 5% in women (O`Leary et al., 
1992). Peripheral carotid stenosis has been shown to impact on the cerebral 
microvasculature leading to thickening of the basement membrane, reductions in vascular 
smooth muscle content, and loss of vessels elasticity (de Leeuw et al., 2000; Farkas et al., 
2006). All these morphological changes in the macro and micro cerebrovasculature impact 
on the overall vascular tone and could lead to impaired neural metabolism. Carotid 
occlusive disease is responsible for 15- 20% of all ischemic stroke (Chaturvedi et al., 
2005). Whereas, stroke is a well- known cause for dementia, carotid stenosis itself is less 
well- established independent risk factor for a cognitive impairment. The mechanisms of 
cognitive impairment occurring in patients with carotid stenosis are poorly understood. 
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1.5.1. Chronic cerebral hypoperfusion, age- related white matter pathology and 
cognitive decline  
Human studies have suggested that chronic cerebral hypoperfusion is the major 
pathophysioloigcal mechanism leading to the occurrence of age- related white matter 
pathology and cognitive decline (Fernando et al., 2006). Specifically, MRI evidenced 
white matter lesions coincided with pathologically observed increases in hypoxia- 
inducible factors (HIF) HIF1α and HIF2α suggesting that white matter lesions in elderly 
are most likely due to hypoxic environment. Furthermore, the increase in HIFs is also 
associated with an increase in inflammatory levels showing that complex cellular and 
molecular events following hypoperfusion contribute to the development of white matter 
pathology in elderly. In patients with small vessel disease a decreased cerebral blood flow 
in subcortical regions (putamen and thalamus) is negatively associated with the burden of 
white matter pathology in these brain areas (Kawamura et al., 1991). These data suggest 
that chronic cerebral hypoperfusion in cerebral regions supplied by the deep penetrating 
arteries most likely contributes to the occurrence of white matter lesions in periventricular 
and deep subcortical areas. Ischemic white matter lesions in Alzheimer`s patients exhibit 
oligodendroglial loss and microvessels pathology such as abnormal collagen deposition in 
the vessels wall indicating that cerebrovascular disease leading to hypoxic- ischemic 
events contributes to the development of neuropathology and dementia in elderly (Brown 
et al., 2000). 
 Although it is methodologically extremely challenging to study in isolation the effects of 
chronic cerebral hypoperfusion on cognitive function in elderly humans presenting very 
often additional neuropathological conditions (e.g. Alzheimer`s disease), several published 
reports have tried to address the impact of reduced cerebral blood flow on cognitive 
performance in the healthy aging population. A recent study (the Tromso study) applying 
MRI for the detection of white matter integrity, ultrasonography for the measurement of 
carotid stenosis and a battery of neuropsychological tests has demonstrated that subjects 
with carotid stenosis have significantly impaired attention, psychomotor speed, memory, 
and motor functioning, independent of MRI lesions (Mathiesen et al., 2004). Furthermore, 
a decreased cerebral blood flow due to hypoperfusion measured by transcranial Doppler 
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has been associated with a poorer performance on a battery of cognitive tests (Mini 
Mental State Examination) in both healthy and demented elderly (Ruitenberg et al., 2005). 
The results from a postmortem neuropathological study suggest that chronic reduction of 
the cerebral blood supply observed in Alzheimer`s patients contributes to the development 
of white matter lesions and the progression of dementia, especially in APOE4 carriers 
(Alafuzoff et al., 2000). Similar findings have been reported in vivo. Reductions in 
cerebral brain metabolism are usually observed with increasing age in both grey and white 
matter regions and they are associated with cognitive decline and dementia (Ogawa et al., 
1996; Pardo et al., 2007). Alzheimer`s disease and vascular dementia patients present a 
significantly decreased cerebral blood flow in comparison with normal elderly (Schuff et 
al., 2009a). However, little is known about the exact contribution of chronic cerebral 
hypoperfusion to the occurrence of age- related changes in the cerebral metabolism. 
Derdeyn et al., 1999 have demonstrated that chronic cerebral hypoperfusion in patients 
with carotid stenosis leads to a reduced rate of cerebral metabolism (Derdeyn et al., 1999). 
However, the ratio between the oxygen extraction fraction and the rate of cerebral 
metabolism is normal in hypoperfused patients suggesting that collateral blood flow could 
compensate for normal cerebral metabolism. 
From a mechanistic point of view, the cerebral white matter is particularly vulnerable to 
such changes in the cerebral blood supply due to its limited vascular irrigation. At the 
difference from the highly vascularized cerebral grey matter, the cerebral white matter is 
defined as an arterial end and border zone with a very low blood supply even under 
normal physiological conditions rendering this neuroanatomical structure particularly 
vulnerable to hypoxic- ischemic events (Nonaka et al., 2003). Chronic cerebral 
hypoperfusion is characterized by subtle blood flow reductions (<50% of baseline) which 
are usually compensated by the cerebral anastomosis provided by the cerebral arteries 
composing the Circle of Willis. This compensation could explain the relative absence of 
neuropathological changes after chronic cerebral hypoperfusion in the highly vascularized 
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Figure 1.3.: Hypoperfusion- induced white matter pathology  
In humans, age-related cerebrovascular changes (e.g. atherosclerosis) (A) lead to chronic 
cerebral hypoperfusion and the occurrence of white matter pathology (B). To model age- 
related neuropathology in preclinical settings, 0.18mm diameter piano microcoils (D) are 
bilaterally applied to the common carotid of mice (C) leading to chronic cererbral 
hypoperfusion and the development of white matter pathology. The cerebral white matter 
is defined as an arterial border end zone with a poor vascular irrigation rendering these 
neuroanatomical regions particularly vulnerable to subtle metabolic changes (E). (images 
adapted from ADAM Medical images http://adameducation.com/adam_images.aspx) 
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al., 2007; Coltman et al., 2011; Holland et al., 2011). However, this cerebrovascular 
compensation might be inefficient in sustaining a normal flow to the cerebral white matter 
which is mainly irrigated by small arterioles and veins emanating from the anterior 
cerebral artery (for the frontal white matter- CC, EC), the posterior and basilar cerebral 
arteries (for the subcortical white matter- IC, Fx, OT) (figure 1.3.B, E). Further, it is also 
possible that the reduced levels of glucose affect oligodendroglial metabolism. 
Oligodendrocytes are known to be the biggest consumers of lactate and glucose in the 
brain (Sanchez- Abarca et al., 2001; Rinholm et al., 2011). Pathological disruption of the 
oligodendroglial metabolism could affect their molecular and cellular machinery leading 
to impaired myelin production and maintenance promoting the subsequent development of 
white matter pathology. Furthermore, increased levels of excitotoxic and oxidative agents 
due to hypoperfusion might be harmful to the oligodendroglial cells (van Reempts et al., 
1986; Siesjo et al., 1995; Matute et al., 2001).  
1.5.2. Animal models of chronic cerebral hypoperfusion 
In elderly people it is extremely difficult to study in isolation the effects of single 
etiological factors on neuropathology and cognition due to the presence of comorbidities 
such as diabetes, cardiac disease, hypertension, neurodegeneration (e.g. Alzheimer`s 
disease) (Van Swieten et al.; 1991; Lindgren et al., 1994; Ruitenberg et a., 2005; Verdelho 
et al., 2010).  Therefore, animal models have been developed in order to study the cellular 
and molecular events following chronic cerebral hypoperfusion leading to the 
development of white matter pathology and cognitive deficits. 
1.5.2.1. Rat model of chronic cerebral hypoperfusion 
Chronic cerebral hypoperfusion was first experimentally modeled in rats due to the low 
experimental cost, the complete Circle of Willis in this rodent species, the relatively low 
mortality rate and the high reproducibility of both the neuropathological and behavioural 
outcome. To induce chronic cerebral hypoperfusion in the rat, the common carotid artery 
is bilaterally permanently ligated. This leads to ~30- 60% (of baseline level) initial 
reductions of the cerebral blood supply with a gradual flow recovery by 4 weeks post- 
surgery (Otori et al., 2003). The observed recovery of the cerebral blood flow is explained 
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by compensatory mechanisms such as enlargement of the arteries at the base of the brain. 
The posterior vessels constituting the Circle of Willis (the posterior cerebral artery, the 
posterior communicating artery, and the basilar artery) are considerably enlarged between 
3- 6 months after the induction of chronic cerebral hypoperfusion (Olendorf, 1989; Choy 
et al., 2006). The blood- brain barrier integrity is also impaired in hypoperfused rats as 
measured by the presence of venously administered horseradish peroxidase in the CC. The 
blood- brain barrier permeability increases progressively from 3 hours after bilateral 
carotid ligation reaching maximum permeability by day 3 post- surgery. The blood brain 
barrier integrity shows progressive recovery from day 7 post- surgery (Ueno et al., 2001). 
These cerebrovascular alterations are accompanied by an impaired cerebral metabolism 
mainly observed as ATP depletion immediately after the artery ligations followed by 
hypoxia and hypoglycemia (Plaschke et al., 2005). Reduced intracellular concentrations of 
ATP as well as the increased levels of excitotoxicity and oxidation are the most likely 
molecular mechanisms leading to neuropathological changes in chronically hypoperfused 
rats. Neuronal ischemic damage in grey matter regions (mainly in the CA1 region of the 
hippocampus evidenced by 1 week post- surgery) accompanies the development of white 
matter abnormalities such as white matter rarefication, vacuoles formation, myelin 
disintegration, oligodendroglial apoptosis, amyloid precursor protein (APP) accumulation 
in bulbous axons, early microglial activation (20 min post- surgery) and long- term 
astrocytic response (6 months post- surgery) (Pappas et al., 1996; Abraham and Lazar, 
2000; Farkas et al., 2004; Farkas et al., 2007; Otori et al., 2003; Tomimoto et al., 2003). 
White matter pathology in hypoperfused rats develops progressively over time and the 
very first abnormalities such as fibers disorganization are evidenced 3 days post- surgery 
(Wakita et al., 2002; Otori et al., 2003). Further, white matter pathology is accompanied 
by subtle changes in neuronal morphology demonstrated by alterations in mRNA and 
protein expression of synaptic (synaptophysin) and dendritic (microtubule- associated 
protein 2 (MAP2)) proteins (Liu et al., 2005). Chronically hypoperfused rats exhibit an 
early spatial reference memory impairment on a water maze task (7 days post- surgery) 
followed by a long- term spatial working and reference memory deficit on a radial arm 
maze task (63 days post- surgery) (Pappas et al., 1996; Sopala and Danysz, 2001). These 
results suggest that the observed learning and memory deficits in hypoperfused rats are 
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cumulative corresponding to the chronic nature of the cerebrovascular challenge and the 
progressive development of white matter pathology in this model. Further, in the rat, 
chronic cerebral hypoperfusion does not affect the locomotor and exploratory activity as 
well as the overall anxiety on an open- field test (de Bortoli et al., 2005). However, 
hypoperfused rats show increased anxiety levels on an open- arms T- maze task (de 
Bortoli et al., 2005). Overall, the rat model of chronic cerebral hypoperfusion reproduces 
most of the pathological and cognitive features associated with chronic cerebral 
hypoperfusion in humans, but the concomitant grey matter pathology renders difficult the 
evaluation of the effects of selective white matter pathology on cognition in hypoperfused 
rats. 
1.5.2.2. Gerbil model of chronic cerebral hypoperfusion 
The gerbil is another rodent species that has been used to model human age- related 
chronic cerebral hypoperfusion. In the gerbil, coiled stainless steel wire clips are applied 
to both common carotids leading to 24- 27% (of control baseline) chronic reduction of the 
cerebral blood flow observed up- to 8 weeks post- surgery (Kudo et al., 1990). At the 
neuropathological level hypoperfused gerbils exhibit varying degree of cortical atrophy, 
ventricular dilation, astroglial activation and white matter fibers rarefication occurring not 
earlier than 4 weeks post- surgery with increasing frequency and severity by 12 weeks 
post- surgery (Hattori et al., 1992; Kudo et al., 1993; Kurumatani et al., 1998). White 
matter pathology in hypoperfused gerbils is accompanied by neuronal ischemic loss in 
cortical and subcrotical (hippocampus) regions (Kudo et al., 1993). Further, in 
hypoperfused gerbils, Western blot analysis demonstrated significant decreases in MBP 
protein levels prior to changes in neuronal cytoarchitecture associated with reductions in 
neurofilament H and MAP2 two months after surgery. These results suggest that myelin 
pathology occurs prior to axonal damage in this model (Kurumatani et al., 1998). 
Additional immunohistochemical analysis demonstrated that MAP2 is significantly 
reduced in grey matter regions accompanied by an increased neurofilament 
phosphorylation 12 weeks post- surgery (Kudo et al., 1993). Learning and memory 
abilities in gerbils are studied by passive avoidance paradigms and hypoperfused gerbils 
show learning and memory deficits on this task 12 weeks post- surgery (Kudo et al., 
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1990). The gerbil model of chronic cerebral hypoperfusion is a low experimental cost in 
vivo tool reproducing correctly some of the neuropathological features and functional 
impairments observed in human patients with carotid stenosis. However, the gerbil model 
shows some limitations that could be overcome by using rats or mice. First, it is more 
difficult to train gerbils on behavioural paradigms which is not the case for rats and mice. 
Although, similar to gerbils mice have underdeveloped Circle of Willis (at the difference 
from rats where this cerebrovascular structure is complete and similar to humans) the 
development of genetically modified mice makes this rodent species a preferred in vivo 
tool for the evaluation of cerebrovascular pathology in preclinical settings. 
1.5.2.3. Mouse model of chronic cerebral hypoperfusion 
The large preclinical use of genetically modified mice has prompted the recent 
development and characterization of a new mouse model of chronic cerebral 
hypoperfusion by our and other groups (Shibata et al., 2004; Shibata et al., 2007; Nishio et 
al., 2010; Coltman et al., 2011; Holland et al., 2011). This model consists of the bilateral 
application of piano wire coils around the common carotid artery (figure 1.3. C, D). The 
use of coils with different internal diameter allows experimental regulation of the cerebral 
blood flow reductions. In an initial work it has been demonstrated that using microcoils 
with an internal diameter of 0.18 mm leads to a 20- 30% (of baseline levels) reductions of 
the cerebral blood supply and the development of a predominant white matter pathology 
1- 2 month(s) post- surgery (Shibata et al., 2004). The first white matter changes in this 
model are observed as soon as 2 weeks post- surgery (unpublished observations from Dr 
Horsburgh`s laboratory). Application of microcoils with a smaller internal diameter (0.16 
mm) induces mixed grey and white matter pathology one month post- surgery (Shibata et 
al., 2004). Therefore, the 0.18 mm diameter is preferentially used by the groups working 
on this model because of the development of white matter pathology in the absence of 
neuronal ischemia. In chronically hypoperfused mice, white matter abnormalities are 
characterized by fibers rarefication, vacuolation, MAG debris, degraded MBP (dMBP) 
accumulations, and increased inflammatory levels in white matter tracts (Shibata et al., 
2004; Shibata et al., 2007; Coltman et al., 2011; Holland et al., 2011). Myelin pathology in 
chronically hypoperfused mice is accompanied by mild to moderate axonal injury 
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(Coltman et al., 2011). These pathological observations have been confirmed by a recent 
in vivo MRI- DTI study reporting significant reductions in FA and MTR values in white 
matter tracts one month after chronic cerebral hypoperfusion (Holland et al., 2011). Long- 
term studies on this model have demonstrated accumulative pathological changes in the 
brains of hypoperfused mice. Specifically, hippocampal neuronal loss occurs at 8 months 
after surgery (Nishio et al., 2010). Furthermore, cerebral blood flow reductions in 
chronically hypoperfused mice are associated with late- occurring reductions in cerebral 
metabolism in grey matter regions (striatum, hippocampus and cortex) 6 months after 
microcoils application (Nishio et al., 2010). At the functional level, one month after 
surgery chronically hypoperfused mice perform as well as sham on a comprehensive 
battery of tests such as a startle prepulse inhibition test, hot plate test, rotarod and grip 
strength motor tests, open field test, light/ dark transition test, porsolt forced swim test, 
cue and fear conditioning (Shibata et al., 2007). At the same post- surgery time point, 
chronically hypoperfused mice exhibit deficits on a radial arm maze spatial working 
memory task in the absence of learning and memory deficits on radial arm maze and water 
maze reference memory tasks (Shibata et al., 2007; Coltman et al., 2011). Interestingly, 8 
months after surgery hypoperfused mice show an impaired reference memory on a radial 
arm maze paradigm most likely due to grey matter structural abnormalities (Nishio et al., 
2010).  
Due to its recent development in 2004, this new mouse model of chronic cerebral 
hypoperfusion has not been fully characterized and more work needs to be done in order 
to get a better insight into the molecular and cellular events underlying the occurrence of 
white matter pathology and functional deficits in chronically hypoperfused mice. Since 
most of the currently available genetically modified mice used in research settings are on a 
C57Bl6J background the microcoil surgery has been specifically optimized for 
experimental application in C57Bl6J mice. 
1.6. Apolipoprotein E (APOE) 
Apolipoproteins are formed by the binding of an apoprotein to a lipoprotein. Lipoproteins 
are biochemical assemblies composed of a core of triglycerides and cholesterol esters 
surrounded by a layer of phospholipids allowing the transport of insoluble lipids 
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throughout the body. Apoproteins support the stability of the lipopoprotein allowing its 
targeted transport and receptor binding.  Apopoprotein E binds specifically to high density 
lipoproteins (HDL) involved in the peripheral metabolism of cholesterol, mainly by 
collecting cholesterol from the different body organs and delivering it back to the liver; to 
very low density lipoproteins (VLDL) distributing newly synthesized cholesterol from the 
liver to the rest of the body organs; and to chylomicrons transporting triglycerides from 
the intestine to the liver, skeletal muscle, and the adipose tissue) (figure 1.4. A).  
Apolipoprotein E (APOE) is a glycoprotein of 299 amino acids with a molecular weight of 
~34- kDa first discovered by Shore and Shore in 1973. APOE is found in both the 
periphery (spleen, liver, macrophages) as well as in the central nervous system.  
In the periphery APOE is synthesized predominantly by the liver which is the integral 
organ of lipid metabolism (Elshourbagy et al., 1985).  
In the brain, APOE is found in the parenchyma as well as in the cerebrospinal fluid (CSF). 
APOE mRNA is detected in the cerebral cortex, the cerebellum, the brain stem, the 
choroid plexus, the thalamus, the hypothalamus and the hippocampus (Elshourbagy et al., 
1985; Lorent et al., 1995). Astrocytes are the neural cells expressing APOE under normal 
physiological conditions (Boyles et al., 1985). Low APOE levels are also detected in 
microglia, oligodendrocytes, ependymal cells. In primates and humans, APOE is present 
at lower levels in neurons under normal physiological conditions (Han et al., 1994; 
Metzger et al., 1996). In rodents, neuronal APOE expression is evidenced only in the 
presence of ongoing neuropathology (Horsburgh et al., 1996; Horsburgh et al., 1997).  
APOE mediates its effects via the low density lipoprotein receptor (LDL- R) family- a 
class of single transmembrane glycoproteins containing large extracellular and relatively 
short intracellular domains, generally recognized as cell surface endocytic receptors, 
which bind and internalize extracellular ligands for lysosomal degradation. The LDL- R 
consists of more than 10 members of receptors, but the most important ones for APOE 
function are the low density lipoprotein receptor (LDLR), the very low density lipoprotein 
receptor (VLDLR), the low density lipoprotein receptor- related protein  
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Figure 1.4.: APOE structure and potential APOE effects on white matter integrity 
A schematic representation of a lipoprotein particle composed of triacyglycerol and 
cholesterol esters surrounded by a layer of phospholipids allowing the transport of 
insoluble lipids through the body. Apoproteins are attached to lipoproteins resulting in 
apolipoprotein complexes (A). APOE might impact on the integrity of the cerebral white 
matter under both normal and pathological conditions either directly via the regulation of 
the homeostasis of the lipid component of the myelin sheath or via APOE- modulated 
mechanisms such as excitotoxicity, oxidation and immune response (B). The electron 
microscopy image of myelin sheath in (B) is adapted from Wikipedia 
http://en.wikipedia.org/wiki/Myelin. 
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(LRP1). The LDL- R family members are involved in multiple signaling pathways playing 
an important role during early neurodevelopment as well as in the adult mammalian brain 
(Cooper and Howell, 1999).  
1.6.1. Differences between human and mouse APOE  
In humans, the APOE gene is located on chromosome 19q13.2. It is composed of 5 exons 
and 4 introns. Human APOE exists in three different isoforms- APOE2, APOE3, and 
APOE4 coded by three different alleles- ԑ2, ԑ3, and ԑ4 respectively (Utermann et al., 1977; 
Zannis et al., 1981). The resulting three human APOE proteins differ in their amino acid 
composition at residues 112 and 158 leading to differences in their functionality.  APOE3 
has a cysteine at residue 112 and an arginine at residue 158, APOE2 has cysteine at both 
positions, and APOE4 contains arginine at both positions. In APOE4, arginine-112 (Arg- 
112) impairs domains interaction between Arg- 61 (N terminal domain) and glutamate- 
255 (Glu- 255) (C terminal domain) and reduces the stability of the protein leading to a 
so- called molten globule state (Weisgraber, 1994). The APOE4 structural conformation 
has been shown to mediate its negative effects on neurobiology such as increase in beta 
amyloid (Aβ) production, potentiation of Aβ induced leakage and apoptosis, and its 
enhanced proteolytic cleavage in neurons (Mahley et al., 2006).  
In other mammalian species, including the great apes, APOE gene does not present 
multiple isoforms and the resulting protein is molecularly similar to APOE4, but 
functionally behaves like human APOE3 (Hanlon and Rubinsztein, 1995).  
In the mouse, the APOE gene is situated on chromosome 7 and its amino acid sequence 
homology to the human APOE gene is >90% (Maloney et al., 2007). However, the 
homology between the human and the mouse APOE gene promoter is <40% which might 
account partially for the observed species differences in the APOE cell distribution. From 
a structural point of view, similar to human APOE4, mouse APOE contains arginine at 
residue 112, but arginine at residue 61 is replaced by thryonine (Thr- 61) thus abolishing 
the human APOE4- specific domain interaction between Arg- 112 and Glu- 255. 
Replacing Thr- 61 with arginine introduces domain interaction and allows mouse APOE 
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to behave like human APOE4 (Raffai et al., 2001). Functionally, similar to other 
mammalian species, mouse APOE preferentially binds to HDL, but not VLDL. 
1.6.2. APOE deficient mice 
To experimentally address APOE function in the central nervous system under normal 
physiological and pathological conditions, APOE deficient (APOEKO) mice have been 
created as described in Chapter 2, section 2.1.2. These animals are characterized by 
increased plasma cholesterol levels (Van Ree et al., 1994), early development of 
atherosclerosis (Piedrihta et al., 1992; Van Ree et al., 1994), impaired immune response 
(Laskowitz et al., 2000), blood brain barrier anomalies (Fullerton et al., 2001; Methia et 
al., 2001; Hafezi- Moghadam et al., 2006), increased lipid peroxidation in the plasma 
(Witting et al., 2000) and in the central nervous system (Lomnitski et al., 1999; 
Ramassamy et al., 2001; Pratico et al., 2002; Choi et al., 2004), and early onset of 
neurodegeneration (Masliah et al, 1995; Masliah et al., 1997). At the functional level, 
APOEKO mice exhibit learning and memory deficits when compared with wild- type 
(WT) counterparts (Gordon et al., 1995; Masliah et al., 1997). After experimentally 
induced brain injury APOEKO animals present a poor neuropathological and functional 
recovery as shown in models of traumatic brain injury (Chen et al., 1997; Lomnitski et al., 
1997; Lomnitski et al., 1999; Lynch et al., 2002), global ischemia (Hosrburgh et al., 1999; 
Sheng et al., 1999; Kitagawa et al., 2002), focal ischemia (Laskowitz et al., 1997a), 
entorhinal cortex lesion (Champagne et al., 2005). Intraventricular infusion of human 
recombinant apolipoprotein E rescues the pathological and the functional deficits 
associated with APOE deficiency after global ischemia (Horsburgh et al., 2000a), during 
normal aging (Masliah et al., 1995), after kainic acid induced lesion (Buttini et al., 1999). 
These results suggest that APOE is an important molecular factor in the endogenous 
neuroregenerative processes.  
1.6.3. APOE, age- related white matter pathology and cognitive decline 
APOE and its human isoforms have been primarily studied in the context of Alzheimer`s 
disease and senile dementia, due to the increased risk of Alzheimer`s disease in APOE4 
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carriers. Therefore, so far, the major research focus on APOE has been primarily on its 
effects on grey matter structural integrity (Saunders et al., 1993; Mahley et al., 2006).  
Little attention has been paid to APOE and its effects on white matter integrity during 
healthy aging. Recent combined functional MRI (fMRI) and neuropsychological studies 
have demonstrated that non demented APOE4 adults activate a significantly higher 
number of cerebral regions during the performance of a working memory task suggesting 
the existence of compensatory mechanisms (e.g. a recruitment of larger neuronal 
networks) allowing these individuals to perform the cognitive task at the same level as 
APOE3 carriers (Bookheimer et al., 2000; Wishart et al., 2006). In regards to APOE 
involvement in the turnover of myelin lipids and cholesterol one could suspect that this 
apolipoprotein and its different human isoforms impact differentially on white matter 
integrity. Indeed, recent neuroimaging studies discovered that cognitively intact middle 
aged APOE4 individuals exhibit white matter abnormalities compared with age and 
cognitive status- matched APOE3 carriers (Filippini et al., 2009; Heise et al., 2010; Ryan 
et al., 2011). Specifically, in cognitively intact APOE4 adults, white matter abnormalities 
have been detected in prefrontal transcollosal tracts, the genu and the splenium of the CC 
years prior to the onset of dementia. By calculating MRI transversal relaxation rates (an 
indirect measure of myelin integrity) it has been established that the APOE4 genotype is 
directly related to myelin integrity in white matter regions (Bartzokis et al., 2007). On the 
basis of these results it has been proposed that APOE initially mediates its effects on 
cognition via its decreased functionality leading to impaired myelin metabolism and white 
matter pathology. Further, the observed human APOE isoform differences in white matter 
integrity among healthy APOE3 and APOE4 carries is most likely due to isoform- related 
functional and/ or quantity (brain APOE4 levels are estimated to be 12- 20% lower than 
APOE3 levels) differences (Bartzokis et al., 2006). Therefore, the inability of APOE4 to 
sustain normal myelin lipid and cholesterol metabolism or the reduced brain levels of this 
apolipoprotein might be at the basis of the observed white matter abnormalities in 
cognitively intact APOE4 carriers. Interestingly, positron emission tomography (PET) 
neuroimaging studies have revealed that young and middle aged cognitively intact APOE4 
adults present reduced cerebral metabolism in the same brain regions which are 
subsequently affected in Alzheimer`s patients, namely parietal, temporal, prefrontal and 
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posterior cingulated regions (Reiman et al., 1996; Reiman et al., 2004). These results 
suggest the existence of asymptomatic cerebrovascular abnormalities in cognitively 
normal APOE4 carriers. Further it has been established using fMRI that MRI signal 
intensity is significantly increased in the anterior cingulated and dorsal prefrontal cortex of 
cognitively intact APOE4 adults during the recall phase of a working memory task 
(Bookheimer et al., 2000). Overall, these results suggest that subjects at genetic risk for 
Alzheimer`s disease show white matter abnormalities accompanied by a reduced cerebral 
metabolism and a widespread brain activation during cognitive effort years prior to the 
occurrence of dementia. However, future clinical and preclinical studies should elucidate 
the exact cellular and molecular events via which APOE and its isoforms impact on white 
matter integrity, cerebral metabolism and cognitive function.  
1.6.4. APOE- related mechanisms impacting on white matter integrity 
APOE could impact on white matter integrity under both normal physiological and 
pathological (e.g. chronic cerebral hypoperfusion) conditions due to its role in the 
maintenance of the myelin lipid and cholesterol homeostasis as well as its involvement in 
the endogenous brain repair mechanism via its anti- excitotoxic, anti- oxidative and 
immunomdulatory functions (figure 1.4. B). 
1.6.4.1. Role of APOE in the transport and metabolism of brain lipids and cholesterol 
APOE plays an important role in the turnover of lipid and cholesterol content in the 
central nervous system. The brain cholesterol is synthesized locally primarily by glia and 
it is delivered to neurons by APOE (Boyles et al., 1985; Elshourbagy et al., 1985). The 
brain is the body organ with the highest cholesterol content mainly present in white matter 
regions (Dietschy et al., 2001). Cholesterol is found in myelin, glial and neuronal cell 
membranes and it is essential for neuronal plasticity (Goritz et al., 2002), synaptogenesis 
(Mauch et al., 2001), neuroregeneration and remyelination (Poirier et al., 1993). 
Cholesterol is cleared from the brain by its neuronal conversion to 24S- 
hydroxycholesterol which passes through the blood- brain barrier (Bjorkhem et al., 2006). 
With age, brain cholesterol levels decrease (Thelen et al., 2006) and 24S- 
hydroxycholesterol levels increase (Lutjohann et al., 1996) and this is more pronounced in 
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the presence of neuropathology such as Alzheimer` s disease (Lutjohann et al., 2000; 
Yanagisawa et al., 2002). Further, during neuroregeneration of experimentally injured 
sciatic nerve APOE levels increase significantly with a peak at the time of active 
remyelination (Boyles et al., 1989). It has been shown that APOE plays an important role 
in the delivery of newly synthesized cholesterol to damaged cells and to actively 
participate in the clearance of cellular debris promoting neuroregeneration and 
remyelination.  
APOE is also involved in the transport and metabolism of other brain lipids such as 
phospholipids. Phospholipids are integral constituents of cell membranes and myelin. 
APOE deficient mice show a significant reduction in cortical phospholipids and their 
constituent fatty acids in comparison to WT littermates (Montine et al., 1999).  
Furthermore, oxidized phospholipids have been shown to participate in concert with 
cholesterol in the formation of atherosclerotic plaques occurring with increasing age in the 
majority of APOE4 human carriers and in APOE deficient mice due to an inefficient lipid 
and cholesterol turnover and the pathological accumulation of the latter in the walls of the 
blood vessels followed by the occurrence of brain hypoperfusion (Piedrihta et al., 1992; 
Van Ree et al., 1994; Elosua et al., 2004).   
APOE is involved in the metabolism of sulfatides which are exclusively synthesized by 
oligodendrocytes (Poduslo and Miller, 1985). Sulfatides are part of the myelin lipid 
component, but they also participate in the regulation of cell growth, protein trafficking, 
cell adhesion, and neural plasticity (Marcus et al., 2006). The hippocampal and cortical 
sulfatide mass is higher in the brains of APOE deficient mice than in WT counterparts 
(Han et al., 2003). Similarly human APOE4 carriers have increased sulfatide content 
compared to APOE3 carriers. Although sulfatides are important for myelin maintenance 
(Marcus et al., 2006), when the level of these lipids increases excessively as in the case of 
metachromatic leukodystrophies, they exert a toxic effect on the myelin- producing 
oligodendroglia and by consequence contribute to the appearance of substantial 
demyelination and functional deficits such as motor and gait disturbances as well as 
cognitive and memory dysfunction (Ramakrishnan et al., 2007).   
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1.6.4.2. Anti- excitotoxic function of APOE 
In vitro and in vivo studies have shown that APOE is involved in the modulation of 
excitotoxicity and this in an isoform- dependent manner. For instance, an excitotoxic 
kainic acid intra- amygdalar administration in rats induces APOE mRNA and protein up- 
regulation in neurons as evidenced 7 days post- injury (Montpied et al., 1999; Boschert et 
al., 1999). These results have been confirmed in vitro using organotypic cultures, where 
kainite acid treatment is found to increase APOE mRNA expressions by 72% (Montpied 
et al., 1999). In vitro exposure of primary neural culture and a neuronal cell line to a 
human recombinant APOE prior to NMDA- induced excitotoxic challenge partially 
reduces cell death (Aono et al., 2002). Subsequent in vitro experiments have determined 
that APOE modulates excitotoxicity by its direct binding to LDL- R receptors modulating 
Ca
2+
 influx through the NMDA receptors (Bacskai et al., 2000, Qiu et al., 2002). These 
preclinical findings have been confirmed by preclinical and clinical studies. After 
intracerebral kainite injection, human APOE3 transgenic animals show significantly 
reduced lesion size in comparison with human APOE4 transgenic mice (Buttini et al., 
1999).  In humans, APOE4 carriers show poorer functional and pathological outcome after 
traumatic brain injury- a neurological disorder characterized by increased levels of 
excitotoxicity (Chiang et al., 2003; Yi and Hazell, 2006). APOE4 traumatic brain injury 
patients also develop more severe white matter pathology and cognitive deficits in 
comparison with APOE2 and APOE3 carriers (Ariza et al., 2006).  
1.6.4.3. Anti- oxidative function of APOE 
APOE has been associated with oxidative stress mainly because of its effects on 
neuropathology and functional outcome in different neurological and neurodegenerative 
conditions. Young APOEKO mice (6 months old) have been found to have 2 fold greater 
total protein oxidation in the hippocampus in comparison with age- matched WT controls 
and this level of protein oxidation is similar to the one observed in aged WT and 
APOEKO deficient mice (18 months). Absence of significant differences in protein 
oxidation has been observed between the old APOE deficient and age- matched WT mice 
(Choi et al., 2004). These results demonstrate an impaired oxidative modulation in young 
APOE deficient mice which might impact on their neuropathological and functional 
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outcome after injury to the central nervous system. Indeed, APOE deficient mice show an 
inadequate oxidative response after experimental head trauma associated with a poor 
neurological outcome (Lomnitski et al., 1999). Further in the same study, using an in vitro 
system it has been found that human recombinant APOE3 is able to modulate the 
oxidative effects of Cu
2+
 - induced lipid peroxidation. Additionally, pretreatment of APOE 
deficient mice with the anti- oxidant vitamin E significantly reduces ischemic damage 
after experimental infarction (Kitagawa et al., 2002). Infusion of recombinant APOE in 
APOE deficient mice significantly reduces free radical levels following global ischemia 
(Horsburgh et al., 2000a). These in vivo results have been confirmed in vitro. Specifically, 
recombinant APOE and APOE conditioned media prevent peroxide free radical induced 
cytotoxicity in vitro in an isoform- dependent manner APOE2> APOE3> APOE4 (Miyata 
and Smith, 1996). Interestingly, similar results have been reported in a postmortem study 
on brain tissue samples from Alzheimer`s patients showing the same gradient of APOE- 
isoform susceptibility to oxidation (APOE2> APOE3> APOE4) (Jolivalt et al., 2000). The 
in vivo and in vitro data on APOE demonstrates that this apolipoprotein has anti- 
oxidative properties and APOE deficiency can impact on neuropathology via impaired 
anti- oxidative defenses. 
1.6.4.4. Immunomodulatory function of APOE 
APOE has also been studied in relation to its immunomodulatory properties due to its 
implication in various neurological and neuropathological disorders (Laskowitz et al., 
1998). In vivo studies have demonstrated that APOEKO mice exhibit increased TNFα and 
IL6 mRNA levels after lipopolysaccaride (LPS) venous injection compared to WT 
controls. These results have been confirmed in vitro where mixed glial cultures prepared 
from APOE deficient mouse pups express higher TNFα, IL1-β, and IL6 mRNA levels 
after LPS treatment (Lynch et al., 2001). Pretreatment of APOE deficient mixed neuronal-
glial cultures with human recombinant APOE blocks glial secretion of TNFα after LPS 
stimulation (Lynch et al., 2001). APOE has also been shown to modulate microglial nitric 
oxide (NO) synthesis and this in an isoform- specific manner. In vitro studies using 
peritoneal and brain macrophage (microglia) from human APOE3 and human APOE4 
transgenic mice show that significantly higher NO levels are produced by APOE4 
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microglia in comparison with APOE3 cultures (Colton et al., 2002). Similar results have 
been observed in monocyte- derived macrophages from human APOE3 and human 
APOE4 carriers. Human APOE4 macrophages produce significantly more NO than human 
APOE3 macrophages (Colton et al., 2002). Increased inflammatory levels are observed in 
many brain disorders such as multiple sclerosis and Alzheimer` s disease and for these 
conditions a significantly increased inflammatory levels are evidenced for APOE4 carriers 
corresponding with the accelerated disease progression in these individuals (Fazekas et al., 
2005). 
1.7. Epigenetics 
Epigenetics (from Greek επί- above genetics) is defined as changes in gene expression in 
the absence of alterations in the underlying DNA sequence. The term epigenetics was first 
introduced by Waddington in 1942 in an attempt to describe the evolutionary perspective 
of gene- environment interactions, but he had no scientific idea of the molecular aspects of 
the phenomenon (Waddington, 1942). Over the last decades a substantial insight has been 
gained in epigenetic mechanisms, namely methylation, hydroxymethylation, histone 
acetylation, histone deacetylation, microRNAs. These epigenetic marks have been shown 
to regulate gene expression during early mammalian development as well as in adults 
(Bird, 2002; Hernandez et al., 2011). Epigenetic changes have been associated with many 
neurodevelopmental, neurodegenerative, cerebrovascular, and psychiatric conditions 
(Mehler, 2008).  
1.7.1. DNA methylation 
DNA methylation is one of the major epigenetic mechanisms in eukaryotic cells 
associated with transcriptional repression (gene silencing) (Bird, 2002). Inversely, 
hypomethylation of regulatory elements correlates with transcriptional activity (gene 
expression). Methylation was first discovered in calf thymus in 1948 by Hotchkiss 
(Hotchkiss, 1948) and confirmed two years later by Wyatt (Wyatt, 1951). However, 5- 
methylcytosine (5mC) role in gene regulation was first proposed in 1975 (Holliday and 
Pugh, 1975; Riggs, 1975) and accumulative supporting evidence has been gathered over 
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Figure 1.5.: Methylation and hydrohyxmethylation 
5mC is an epigenetic mark resulting from the transfer of a methyl group (CH3) from S- 
adenosylmethionine (SAM) to C- a reaction dependent on the activity of DNMT1, 
DNMT3a, DNMT3b. 5mC is primarily associated with transcriptional repression. 5hmC is 
a newly discovered epigenetic mark resulting from the oxidation of 5mC- a reaction 
catalyzed by the TETs. The exact gene regulatory role of 5hmC is still unclear. Although 
both methylation and hydroxymethylation have been associated with age- related 
neurodegeneration, nothing is known about the effects of these two epigenetic marks on 
white matter integrity under both normal physiological and chronically hypoperfused 
conditions. 
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of a methyl group (CH3) from S- adenosylmethionine (SAM) to cytosine (C) producing 
5mC (figure 1.5.). In the mammalian genome approximately 4% of C is methylated and it 
is predominantly found in the context of 5`- cytosine phosphate guanine- 3` (CpG) 
dinuclotides. Between 60- 90% of all CpG in the mammalian genome are methylated and 
they are transcriptionally inactive. However, the rest of the CpG (called CpG islands) 
remain non- methylated and they are closely associated with active transcriptional activity. 
In mammals methylation patterns are maintained by the enzymatic activity of DNA 
methyltransferase (DNMT). Absence of DNMT will result into two non- methylated 
daughter strands during replication and this would be associated with passive 
demethylation. Three DNMTs with a different functional activity have been identified in 
mammals: DNMT1, DNMT2, DNMT3a and 3b. DNMT1 is involved in the maintenance 
of methyltransferase activity during the S phase of cellular replication because of its 
preference for hemimethylated DNA as compared with non- methylated DNA (Yoder et 
al., 1997). DNMT2 has no detectable methyltransferase activity (Okano et al., 1998). 
DNMT3a and 3b are methyltransferases regulating the set up of de novo DNA methylation 
patterns during early mammalian development (Okano et al., 1999). Methylation can 
impact on gene transcription by 1) impeding transcription factors from binding to their 
promoters or 2) binding of specific transcriptional inhibitory proteins to methylated DNA 
such as methyl-CpG-binding domain proteins (MBDs) and methyl-CpG-binding protein 2 
(MeCP2). Additionally, chromatin modifiers such as histone deacetylases (HDACs) are 
recruited by MBDs leading to complex methylation- deacetylation process, compact 
chromatin structure and transcriptional repression at heterochromatic genomic regions 
(Nan et al., 1998). Mutation in MeCP2 gene is the major cause of Rett syndrome- the most 
common form of mental retardation in females showing a role of methylation during 
neurodevelopment (Amir et al., 1999). Further, methylation of neural specific genes 
governs neuronal vs. glial fate specification during early neurodevelopment. Specifically, 
hypermethylation of the GFAP promoter is associated with predominantly neuronal cell 
fate, whereas hypomethyaltion of the GFAP promoter triggers glial differentiation (Okada 
et al., 2008). 
DNA demethylation also occurs and it involves at least two established mechanisms (Wu 
and Zhang, 2010). Demethylation is associated with a functional deficiency of one or 
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more DNMTs leading to an absence of newly methylated DNA during replication or 
inefficient maintenance of established methylation patterns (Yoder et al., 1997; Okano et 
al., 1999). The second mechanism involves DNA demethylases such as 5mC DNA 
glycosylase (5-MCDG) and requires RNA for its demethylation function (Zhu, 2009). 
Further, one of the MBDs- MBD4 has also been shown to act as a demethylase similar to 
5- MCDG (Zhu et al., 2000). Recent reports suggest that the newly discovered epigenetic 
mark 5 hydroxymethylcytosine (5hmC) (Chapter 1, section 1.7.2.) might also participate 
in DNA demethylation machinery by its DNA glycosylase function leading to replacement 
of 5mC with C (Cannon et al., 1988).  
1.7.1.1. DNA methylation, age- related neuropathology and cerebrovascular disease 
DNA methylation patterns are not fixed and they change with aging in a complex fashion 
due to the specific cellular and molecular environment of the aging mammalian organism. 
A recent study has demonstrated that 5mC distribution on CpG islands in frontal and 
temporal cortex, cerebellum, and pons from neurologically intact humans (from 1 to 102 
years of age) increases significantly with chronological age and it is most likely associated 
with a transcriptional repression (Hernandez et al., 2011). However, results from other 
published work suggest that age- related changes in brain methylation are disease- and 
gene- specific (Tohgi et al., 1999; Wang et al., 2008; Mastroeni et al., 2009; Mastroeni et 
al., 2010). Data from studies on homozygote twins with discordant Alzheimer`s disease 
have shown that the twin suffering from Alzheimer`s disease exhibited significantly 
decreased 5mC immunoreactivity in the temporal cortex than his cognitively intact twin 
brother (Mastroeni et al., 2009). Further global DNA hypomethylation was observed in the 
enthorhinal cortex of Alzheimer`s patients (the cerebral region where the first signs of 
neurodegeneration are observed) in comparisons with controls (Mastroeni et al., 2010). 
There is increasing evidence that the promoter region of the APP gene is significantly 
demethylated after the age of 70 which might be associated with the deposition of Aβ in 
the aging brain (Tohgi et al., 1999). Interestingly, the APOE regulatory sequence in the 
prefrontal brain tissue and in the peripheral lymphocytes was significantly 
hypermethylated in Alzeheimer`s patients (Wang et al., 2008). Several mechanisms have 
been proposed to impact on DNA methylation in the aging brain such as altered DNMTs 
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expression or function, increased oxidative stress and free radical species as well as 
environmental factors such as diet and drugs. For instance, comparison of DNMTs and 
MeCP2 protein mRNA expression with aging in the brains of control and DNMT1 
heterozygous KO mice an age- dependent decrease in MeCP2 in the control but not the 
KO brain was observed suggesting that a decrease in MeCP2 associated with histone 
deacetylation might be parallel to changes in 5mC genomic content in the aging brain 
(Bird and Wolffe, 1999). Further, an increase in 8- hydroxyguanine free radical levels 
induces not only DNA damage, but it is also associated with impaired methylation as 8- 
hydroxyguanine profoundly alters the methylation of adjacent C (Cerda and Weitzan, 
1997). A diet deficient in vitamin B is associated with increased methylation and 
accelerated neurodegeneration in Alzheimer` s and Parkinson` s disease (Duan et al., 
2002; Kruman et al., 2002). Altered methylation has been reported to occur in age- related 
cerebrovascular conditions such as atherosclerosis and stroke (Post et al., 1999; Endres et 
al., 2000; Endres et a., 2001; Westberry et al., 2008). For instance, a hypermethylation of 
the estrogen receptor α (ERα) has been evidenced in vascular tissue (arteries and veins) of 
human patients with clinically diagnosed atherosclerosis (Post et al., 1999). These results 
suggest that methylation plays a role in the development of age- related cerebrovacular 
changes. Further, stroke is a common neurological condition occurring in middle- aged 
and aged patients. Severe oxygen and glucose reductions to the brain are associated with 
global genomic hypermethylation and an increase in DNA methylation results in a more 
severe ischemic injury (Enders et al., 2000). This data is confirmed by preclinical studies 
where DNMT heterozygous mutants have reduced ischemic damage in the cortex and the 
striatum after transient middle carotid occlusion (a model of focal ischemia) (Enders et al., 
2000; Enders et al., 2001). Interestingly, in a rat model of stroke, a sex- specific alteration 
in ERα methylation patterns are observed, specifically ERα gene promoter was 
hypomethylated in female, but not in male rats (Westberry et al., 2008). However, in this 
particular study the authors did not provide information on the association between ERα 
methylation patterns and the pathological/ functional outcome after stroke. So far, nothing 
is known about the role of methylation in the development of age- related white matter 
pathology and how changes in methylation could impact on cognition in elderly. 
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1.7.2. DNA hydroxymethylation 
5- Hydroxymethylcytosine (5hmC) was first discovered in 1952 in bacteriophages (Wyatt 
and Cohen, 1952). In the mammalian genome 5hmC was described for the first time in 
1972 when Penn et al. reported that 5hmC constitutes about 15% of total C in DNA in 
brains of adult rats, mice and frogs (Penn et al., 1972). However, as this finding could not 
be reproduced by others (Kothari et al., 1976), 5hmC received only limited attention over 
the next 30 years until 2009 when Kriaucious and Heintz rediscovered 5hmC in Purkinje 
neurons and granule cells of the adult mouse cerebellum (Kriaucious and Heintz, 2009) 
(figure 1.5.). 5hmC is produced by oxygenation of 5mC- an oxygen- dependent reaction 
catalyzed by the Ten- Eleven Translocation protein family (TET1, TET2, TET3) 
(Tahiliani et al., 2009; Ito et al., 2010) (Chapter 1, section 1.7.3.). At the difference from 
5mC which is equally distributed in differentiated and undifferentiated cells, 5hmC shows 
lineage specific genomic distribution (Kinney et al., 2011; Ruzov et al., 2011). 
Specifically, 5hmC is high in embryonic stem cells, but it decreases with cell maturation 
(Globish et al., 2010; Ito et al., 2010; Ficz et al., 2011; Kinney et al., 2011; Ruzov et al., 
2011). In adult mammalian organisms 5hmC is low or absent in most somatic tissues 
(kidney, heart, spleen, muscle, liver, intestine), but it is highly enriched in brain where it 
constitutes about 0.6% and 0.4% of the total DNA nucleotides in Purkinje neurons and 
granule cells respectively (Kriaucious and Heintz, 2009; Globish et al., 2010; Li and Liu, 
2011; Kinney et al., 2011; Ruzov et al., 2011). So far, nothing is known about 5hmC 
content in other neural cell types (e.g. glia). Using a selective genome- wide labeling of 
5hmC in mouse cerebellum at different stages of neurodevelopment it has been found that 
brain hydroxymethylation gradually increases from postnatal day 7 (~0.1% of total 
nucleotides in the genome) to adult stage (~ 0.4% of total nucleotides) (Song et al., 2010). 
These results suggest that this new epigenetic mark might play an important role during 
neurodevelopment. A further comparison of 5hmC content in adult cerebellum of 10 
months old male and female mice has revealed an absence of sex differences in its 
genomic distribution (Song et al., 2010). Little is known about the functional role of 5hmC 
in the central nervous system. Recent studies on human frontal lobe tissue using deep 
genome sequencing as well as studies on mouse embryonic stem cells have demonstrated 
that 5hmC is particularly enriched at euchromatin rich genomic regions and it is most 
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likely to be involved in facilitation of gene expression (Ficz et al., 2010; Jin et al., 2011). 
Other reports suggest a role of 5hmC in active DNA demethylation and base excision 
mechanisms, but none of these has been fully proven yet (Surani and Hajkova, 2010). 
These hypotheses are based on findings showing that 5hmC prevents DNMT1- mediated 
methylation of the target C which will interfere with the methylation maintenance during 
cell replication and may lead to passive demethylation (Tahiliani et al., 2009). Further, on 
the basis of a previous identification of 5hmC- specific glycosylase activity it has been 
suggested that 5hmC might be a key intermediate of active demethylation involving DNA 
repair mechanisms (Cannon et al., 1988). Interestingly, methyl- CpG- binding proteins 
including MBD1, MBD2, MBD4 and MeCP2 have reduced affinity for 5hmC which 
might have a direct impact on the transcription of genes with enriched 5hmC content at 
their regulatory sequences (Valinluck et al., 2004; Jin et al., 2010). Our group and others 
have recently discovered that the process of active demethylation of the paternal pronuclei 
in the zygote coincides with high hydroxymethylation (Iqbal et al., 2011; Ruzov et al., 
2011; Wossidlo et al., 2011). 
1.7.2.1. DNA hydroxymethylation and age- related neuropathology 
The initial study reporting the presence of 5hmC in adult brain failed to show changes in 
5hmC cerebellar content with age (Kriaucious and Heintz, 2009). However, applying a 
new 5hmC genome- wide labeling approach it has been found that intragenic 5hmC 
genomic content increases in adult mouse cerebellum with age and it is associated with an 
increased expression of genes related to neuropathology (Song et al., 2010). Specifically, 
5hmC intragenic increase is associated with genes involved in Alzheimer`s, Huntington`s, 
Parkinson`s disease as well as with angiogenesis and hypoxia. However, nothing is known 
about the functional importance of 5hmC increase with neurdegeneration and future 






1.7.3. Ten- Eleven- Translocation proteins (TETs) 
The Ten- Eleven Translocation protein family includes three members (TET1, TET2, 
TET3) all having the capacity to catalyze the conversion of 5mC to 5hmC in a 2-
oxoglutarate- and Fe(II)- dependent manner (Tahiliani et al., 2009; Ito et al., 2010) (figure 
1.5.).  So far, all three TETs have been extensively studied in mouse and human 
embryonic stem cells as well as in different types of myeloid cancers, but little is known 
about the distribution and functional significance of these proteins in the central nervous 
system (Tahiliani et al., 2009; Ito et al., 2010; Ko et al., 2010; Ficz et al., 2011; Ruzov et 
al., 2011). In consistency with 5hmC high genomic content, all three TETs have been 
shown to be expressed in mouse embryonic stem cells as well as in human embryonic 
stem cells- derived neural stem cells (Ruzov et al., 2011). However, at the difference from 
mouse embryonic stem cells, human embryonic stem cells express only TET1 and TET3 
at least at the mRNA level (Ruzov et al., 2011). These data suggest important species 
differences in the expression of these proteins implicating potential functional differences. 
TET family members are differentially expressed in mouse tissues with TET2 being the 
most widely expressed (including brain). At the functional level, both TET1 and TET2 are 
important regulators of mouse embryonic stem cells self- renewal and pluripotency (Ficz 
et al., 2011; Ito et al., 2010). Double knockdown of TET1 and TET2 is associated with a 
down- regulation of pluripotency genes and an increase in methylaiton of their promoters 
in mouse embryonic stem cells (Ficz et al., 2011). Most of the mutant embryonic stem 
cells differentiate predominantly into extraembryonic tissue (trophectoderm) (Ficz et al., 
2011). Under normal conditions, a decrease of hydroxymethylation is evidenced at the 
level of pluripotency genes during mouse embryonic stem cells differentiation. Natural 
TET2 mutation is observed in some human patients with myeloid cancers (Ko et al., 
2010). In these individuals, low 5hmC content accompanied by hypomethylation is 
evidenced in bone marrow suggesting that TET2 is involved in DNA demethylation 
potentially via hydroxymethylation- dependent mechanism. Nothing is known about TETs 




1.8. Thesis aims 
The major aim of the present thesis was to experimentally study the effects of single 
etiological factors as well as their interactive effects on white matter integrity and 
cognitive abilities in mice. An attempt was made to translate the findings to humans and a 
specific focus was given to cerebrovascular (chronic cerebral hypoperfusion), genetic 
(APOE) and epigenetic (methylation and hydroxymethylation) mechanisms with known or 
suspected impact on white matter integrity and cognition in elderly people. 
 
The specific aims of the present thesis were to: 
 
 Determine the effects of hypoperfusion- induced white matter pathology on 
cognitive and memory abilities in mice. 
 
 Investigate the effects of APOE on white matter integrity under normal 
physiological and chronically hypoperfused conditions in mice. 
 
 Characterize methylation and hydroxymethylation in white matter under normal 











Materials and methods 
2.1. Animals 
All animal procedures were carried out in accordance with the United Kingdom Animals 
(Scientific Procedures) Act 1986. 
All mice were group- housed in transparent Plexiglas cages (20 x 30 x 20 x 30 cm) and 
kept at the laboratory animal facilities under standard laboratory conditions. The humidity, 
the ambient temperature (22ºC) as well as the light/ dark cycle (14h light/ 10h dark) in the 
animal facility were maintained constant during the entire experimental period. Food and 
water were provided ad libitum. After chronic cerebral hypoperfusion, all animals were 
fed with a mashed chow during the first post- surgery week composed of normal mouse 
chow dissolved in water to facilitate food intake and prevent weight loss. Food restriction 
was applied for the purposes of the radial arm maze experiment (Chapter 3). The food 
restriction procedure started one week prior to the behavioural testing and was maintained 
until the end of the experiment in order to reduce the weight of the animals to 85- 90% 
from their original one. During the first week of food deprivation the animals were 
introduced to the flavour of the reward pellets (Bio- Serve, UK) used for the radial arm 
maze task.  
2.1.1. C57Bl6J mice 
Male adult C57Bl6J mice (Charles River, UK) were used for the purposes of this thesis. 
The C57Bl6J is the most commonly used inbred mouse strain in research. It is also a 
background strain for the majority of the existing genetically modified mouse lines.   
2.1.2. APOEKO mice 
The APOEKO mice used for the purposes of this thesis were purchased from Charles 
River, UK. The APOE deficient mice were generated as described in Piedrahita et al., 
1992. The targeted deletion of the APOE gene was achieved by a targeting plasmid via 
homologous recombination in 129J embryonic stem cells. The selected APOE deficient 
embryonic stem cells were subsequently microinjected into blastocysts reintroduced into 
the uteri of pseudopregnant C57Bl6J mice. Heterozygous and homozygous F1 chimeric 
mice were born at the expected Mendelian frequency. Using immunodiffusion test, it was 
confirmed that the generated homozygous animals were unable to synthesize APOE. The 
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F1 APOEKO homozygous mice were backcrossed for six generation to C57Bl6J mice in 
order to derive the APOEKO line used for this study (Piedrahita et al., 1992). 
2.2. Chronic cerebral hypoperfusion 
Mice were anaesthetized with 5% isofluorane in 95% O2 and anesthesia was maintained 
during the entire surgical procedure. Chronic cerebral hypoperfusion was induced by the 
bilateral application of piano microcoils (0.18mm internal diameter; Sawane Spring Co.) 
to the common carotid artery (Coltman et al., 2011; Holland et al., 2011). During surgery, 
body temperature was maintained between 36.5°C - 37°C. To prevent an acute reduction 
of the cerebral blood flow due to the simultaneous application of microcoils to both 
common carotids, a 30min period was left between the application of each microcoil 
during which the animal was placed in an incubator at 32°C in order to prevent 
hypothermia. Sham-operated mice underwent exactly the same surgical procedure except 
that microcoils were not applied to the common carotid arteries. The post- surgery 
recovery of the mice was closely monitored. Their eating and drinking activities as well as 
signs of overt neurological dysfunction (eg. circling, rolling, hunching, seizures) were 
recorded. Any mouse which exhibited a poor recovery including ≥ 20% loss of the pre- 
surgery body weight was culled. The animals which did not survive the entire prescribed 
experimental period were excluded from the subsequent data analysis. The surgeries for 
the experiments described in my thesis were kindly performed by Dr. Karen Horsburgh 
(the first radial arm maze and the water maze experiments, Chapter 3), Dr. Catherine 
Gliddon (experiments, Chapter 4, Chapter 5), and Dr. Phillip Holland (the second radial 
arm maze experiment, Chapter 3). 
2.3. Behavioural tests 
Prior to all behavioural procedures, the animals were handled by an experimenter for 5 
days. During the training period the mice were transported every day to the experimental 
room 30min before the actual start of the behavioural test. Due to the large experimental 
numbers, the behavioural experiments described in my thesis were performed with the 
help of Jessica Smith (all tests), Aisling Spain (the first radial arm maze experiment; the 
water maze experiment), Robin Coltman (the first radial arm maze experiment), Dr Gillian 
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Scullion (the second radial arm maze experiment). All behavioural tests were performed 
blindly to the treatment (sham vs. hypoperfusion) of the animals. 
2.3.1. Vision test 
Preliminary studies in our laboratory showed that chronic cerebral hypoperfusion induces 
pathological damage to the myelin sheath and neuronal axons in the optic tract. Therefore, 
the visual abilities of the animals from the first radial arm maze experiment were tested at 
three different time points: 1) 3 days prior to surgery (control baseline level), 2) 6 days 
before the behavioural testing (24 days after surgery), and 3) at the end of the behavioural 
testing (50 days after surgery). 
2.3.1.1. Principle and apparatus 
The vision test is based on the principle that a mouse with an intact vision will move its 
entire head into the direction of a moving visual stimulus (figure 2.1. A).  
The apparatus was the same as the one described in Thaung et al., 2002 and it was placed 
in an experimental room with ambient lighting.  The apparatus consisted of a motorized 
drum, 30.5 cm in diameter and 54.5 cm in height, which could rotate at 2 revolutions per 
minute (rpm) clockwise and counterclockwise. A stationary circular metal platform (8.0 
cm in diameter, situated at 20 cm above the bottom of the drum) was located at the interior 
of the drum. A black and white stripe card (2 degrees, 5.3 mm wide) was used as a pattern 
to test the visual acuity of the mice. The behavioral procedure was recorded by a camera 
fixed above the drum and connected to a video recorder. 
2.3.1.2. Procedure 
At the beginning of the test the mouse was left on the central platform for 5min to 
habituate to the apparatus. Afterwards, the drum was rotated for 60 sec clockwise, stopped 
for 30 sec (pause) and again rotated counterclockwise for another 60 sec. The head 
movement in the direction of the rotating stripes was considered a visual response. If an 
animal did not show a directional (head) response to the moving stripe pattern, it was 







Figure 2.1.: Behavioral paradigms 
A schematic representation of the applied behavioural paradigms.  
The visual abilities of sham and hypoperfused mice were tested using a circular visual 
drum with automatically rotated visual pattern and a central circular platform on 
which the animal was placed during testing. The head movement into the direction of 
the moving visual pattern was considered a visual response (A). Spatial working 
memory was tested using an 8- arm radial arm maze paradigm where the animal had to 
learn to retrieve a food reward situated at the end of each of the 8-arms without 
revisiting previously visited arms (B). Spatial memory flexibility was challenged using 
a water maze apparatus (C) where the animal had to learn and remember 5 different 
spatial locations of a hidden escape platform for a set criterion (<20sec swimming 
latency to platform over 3 consecutive trials) when released from a different start point 
(S, N, E, W) on each trail. The spatial location of the hidden platform varied on virtual 
inner and outer ring in the water maze (D).  
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2.3.2. Spatial working memory task on a radial arm maze paradigm 
2.3.2.1. Principle and apparatus 
In the radial arm maze, a food deprived rodent (a mouse or a rat) has to learn and 
remember the spatial location (usually the end of one or all of the 8 maze arms) of a food 
pellet using intra and/ or extramaze environmental cues. Depending on the experimental 
protocol and the type of the cognitive function that is challenged, the number of pellets, 
the presence/ the absence of environmental spatial cues could vary. An indication of a 
successful learning and memory process on this behavioural paradigm is the rapid 
retrieval of all reward pellets in the absence of revisiting errors, the higher number of the 
new entries in the first 8 arm choices, the lower total number of arm entries and the shorter 
latency to complete the task. 
The apparatus used for this study was a mouse version of the 8- arm radial maze which 
was first described by Olton and Samuelson, 1976 (figure 2.1. B). It was made of white 
plastic with Plexiglas arm walls. The diameter of the maze central platform was 20 cm. 
The dimensions of each of the 8 arms were 47 cm length/ 7 cm width/ 20 cm height. At 
the end of each arm was placed a white plastic well 3.5 cm in diameter and 2 cm deep. 
The maze was elevated 1m from the floor of the experimental room. A recording camera 
connected to a computer was fixed on the ceiling just above the central platform of the 
maze. The ongoing behavior of the animal during testing was distantly monitored by an 
experimenter using ANY- maze tracking software (Stoelting Co.). All experimental 
procedures were conducted in a dim- lit room provided with salient extra maze cues. 
2.3.2.2. Procedures 
2.3.2.2.1. Pretraining 
Two pretraining days were scheduled before the real training procedure in order to 
familiarize the animals with the experimental environment, the apparatus and the task 
itself. On pretraining day 1, food pellets were scattered all around the maze and each 
animal was left to explore freely the maze for 5 min. On pretraining day 2, a food pellet 
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was placed at the end of each of the 8 arms. The mouse was placed at the distal end of 
each of the 8 arms of the maze and left to retrieve and consume the food pellet.  
2.3.2.2.2. Training 
During the training procedure, a food pellet was located at the end of all 8 arms. At the 
beginning of every trial (one trial/ training day) the animal was placed on the central 
platform. Once it had entered one of the 8 arms, the other 7 arms were closed 
automatically. When the animal exited the visited arm it was confined on the central 
platform for 5 sec. After the 5 sec delay the mouse was allowed to make a new arm 
choice. A trial was ended when the animal had retrieved all 8 pellets or 25 min had 
elapsed. For each trial, the number of novel arm entries within the first 8 arm visits, the 
total number of arm entries, the number of arm re- entries (the revisiting errors), and the 
trial latency were recorded.  
2.3.3. Serial spatial learning and memory task an a water maze paradigm 
2.3.3.1. Principle and apparatus 
In the water maze, a rodent (a mouse or a rat) has to learn and remember the spatial 
location of a hidden escape platform using intra and/ or extramaze environmental cues 
(figure 2.1. C). The training procedure as well as the nature of the surrounding spatial 
environment could vary depending on the type of the cognitive function that is challenged. 
An indication of intact learning and memory processes on this behavioural paradigm is the 
rapid acquisition of the task (the platform location) and it is usually translated by a 
reduction of the swimming latency and the trajectory to the platform as well as a longer 
time spent swimming in the platform quadrant during probe trials (performed in the 
absence of the escape platform). 
 For this experiment, an open field water maze was used (Morris, 1984). The apparatus 
was a white metal tank (2.0 m diameter) filled with water (0.5 m depth, temperature 25 ± 
1ºC) rendered opaque by the addition of 400mL liquid latex. A hidden escape platform (20 
cm in diameter for the cue task; 13 cm in diameter for the serial spatial memory task) was 
positioned 1.5 cm below the water surface in one of the four virtual quadrants of the water 
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maze ((northeast (NE), northwest (NW), southeast (SE), southwest (SW)). All behavioural 
testing was conducted in the same experimental room provided with prominent extra maze 
cues and an appropriate level of diffuse lighting. For the cue task, white curtains were 
drawn around the pool to prevent the animals to use any distal cues during spatial 
navigation. A red plastic ball (10 cm in diameter) situated 20 cm above the platform was 
the only available landmark. The swimming behaviour of the animals was monitored by 
an automated tracking system (Watermaze) connected to a recording camera fixed in a 
position that allowed the viewing of the entire water surface. The animals were carried 
manually to the apparatus and placed in the water facing the tank wall. On each trial, the 
mouse was released from a randomly allocated start point ((north (N), south (S), east (E), 
west (W)) and allowed 90 sec to find the hidden platform. When on the platform, the 
mouse was left there for additional 30 sec. If the mouse had not found the escape platform 
within the allocated 90 sec it was guided to it by a paint roller moved on the water surface. 
The mouse was taken out of the water by allowing it to mount on the paint roller and then 
it was transferred to a standard cage placed under a heating lamp to avoid hypothermia. 
2.3.3.2. Procedures 
2.3.3.2.1. Cue task 
As mice are not natural swimmers, their ability and motivation to swim were tested a day 
prior to surgery by using a cue task protocol in the water maze. Mice showing difficulties 
to swim or a floating behaviour were not included in the study. A month post- surgery, all 
experimental mice were trained again on the same task for 4 days prior to the beginning of 
the serial spatial learning and memory task in order to exclude any potential surgery 
effects on the swimming behaviour of the animals. For the correct performance of the cue 
task, the mice had to find a hidden escape platform in the absence of extra maze cues by 
navigating to a local landmark (a red ball) that was consistently associated with the hidden 
escape platform. The platform location was moved systematically from one trial to 
another. There were 4 trials per training day. The animal was released from a different 
start point (N, S, E, W) on each trial. The duration of an individual trial was 90 sec, but it 
was terminated as soon as the mouse had climbed on the platform. When on the platform, 
the animal was left there for 30 sec. If the mouse could not find the platform within the 
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allocated 90 sec it was guided to it by a paint roller and again left on the platform for 30 
sec. On each training day, all four quadrants and all four start points were used. 
2.3.3.2.2. Serial spatial learning and memory task 
2.3.3.2.2.1. Training 
The animals were trained on a serial spatial learning and memory task as described by 
Chen et al., 2000. This behavioural procedure consisted of 5 spatial reference memory 
tasks, each of them constituting a separate spatial problem. All tasks were performed in 
the same experimental environment (figure 2.1.D). 
The mice had to learn the 5 separate spatial tasks for a period of 10 training days with a 
maximum of 32 trials per task (except task 1 for which the number of trials was 40). The 
platform location varied from one task to another on virtual inner (1m diameter) and outer 
(1.5m diameter) rings. For each task, there were 8 trials per day with 10 min intertrial 
interval. Each trial lasted 90 sec. An animal had learned one of the 5 spatial problems, 
when it reached a preliminary established criterion of an average escape latency of less 
than 20 sec over 3 consecutive trials. After this criterion had been reached, on the 
following experimental day, the animal was trained on the next spatial task. All animals 
were trained until they learned a minimum of 5 spatial tasks. The animals that learned 
easily the first 5 spatial tasks were trained up to 10 tasks.  
2.3.3.2.2.2. Probe trials 
Two probe trials (PT) were conducted in order to test the strength of the established 
memory for task 1 to task 5. The first PT was conducted 10 min (short- term recall) after 
the criterion had been reached, the second PT was 3h later (long- term recall). For the PTs, 
an automatically raised (Atlantis) platform was used (Spooner et al., 1994). The start 
points for the probe trials were counterbalanced among the mice. The platform was placed 
in the training quadrant and was unavailable for the animal during the first 60 sec of the 
trial. After 60 sec had elapsed, the platform was automatically raised and the animal was 
given additionally 30 sec to find it. If the mouse had not found the platform within 90 sec, 
it was guided to it and after 30 sec removed from the pool. For each PT, the percentage of 
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time the animal spent searching for the hidden platform in the training quadrant (during 
the first 60 sec of each PT), the swimming speed, the number of platform crossings, the 
percentage of time spent swimming near the pool walls (thigmotaxis) and the latency to 
the platform when it reappeared (during the last 30 sec of each PT) were recorded. 
2.4. Transcardiac perfusion- fixation 
At the end of each of the experiments included in this thesis, the animals were perfusion 
fixed. Prior to the perfusion- fixation procedure, the mice were deeply anesthetized with 
5% isoflurane. An absence of a reflex response to a pinch on the hind limb was considered 
as a deeply anesthetized state. The anesthesia was maintained using a face mask during the 
procedure. The thoracic cage was widely open with surgical scissors in order to provide an 
access to the heart. Twenty ml 0.9% heparanized saline (NaCl) solution was infused at a 
speed of 2.1 ml/ min through the left cardiac ventricle and flushed with the vascular blood 
through the right cardiac atrium. Liver and spleen pallor was considered an indication of a 
successful removal of the blood from the body. Following this, a 20 ml 4% 
paraformaldehyde buffer (PFA) solution was infused through the vasculature at the same 
speed. The fixation was considered successful when the body was rigid at the end of the 
procedure. The brains were taken immediately out of the skull and immersed in 4% PFA 
for additional 24h fixation at 4°C prior to transfer in 0.1% phosphate buffer saline (PBS) 
where they were kept until paraffin embedding. For the ex vivo MRI experiments 
(Chapter 4), the whole mouse head was immersed in 4% PFA for two hours at room 
temperature (RT) before the brain was taken out of skull and left in 4% PFA overnight at 
4°C prior to imaging. 
2.5. Histology 
2.5.1. Paraffin embedding  
Brains were paraffin embedded manually as 3 mm thick coronal brain slices (Chapter 3) 
or automatically with a processor as whole brains (Chapter 4, Chapter 5). The 3 mm brain 
slices were cut using a mouse metal brain mould and sharp histological knives.  
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2.5.1.1. Processing of brain slices 
The manually cut coronal brain slices were placed in individual plastic embedding 
cassettes labeled with the experimental number of the animal, washed under running water 
for 15min, dehydrated in increasing grades of ethanol (70% ethanol (2 x 30min), 90% 
ethanol (2 x 30min), 100% ethanol (2 x 30min)) and xylene (2 x 30min). Subsequently, 
the brain slices were processed in paraffin (3 x 30 min) at 60°C and left there overnight. 
On the following day, the brain slices were placed in metal moulds, embedded in fresh 
paraffin, left for 2h at RT and transferred to 4°C for 24h. Following this, the paraffin 
embedded tissue was stored at RT until requested for microtome cutting. 
2.5.1.2. Processing of whole brains 
The whole brains were placed in individual plastic embedding cassettes labeled with the 
experimental number of the animal and paraffin embedded using an automatic processor 
with 16h cycle programme: the tissue was dehydrated in increasing grades of ethanol 
baths (70% ethanol (1h); 85% ethanol (1h); 90% ethanol (1h); 100% ethanol (4 x 1h)) and 
xylene (3 x 1h). Brains were left in paraffin (3 x 3h) and finally automatically embedded 
in fresh paraffin. The paraffin tissue blocks were stored at RT prior to microtome cutting. 
2.5.2. Microtome cutting 
Six µm coronal brain sections were cut on a microtome from paraffin- embedded blocks. 
The neuroanatomical levels of interest were: 0.38 mm bregma, -2.12mm bregma (Chapter 
3); 0.74 mm bregma, 0.38 mm bregma, -0.94 mm bregma, -2.12 mm bregma (Chapter 4) 
(Franklin and Paxinos, 1997) (figure 2.2. A-D). Special care was taken to preserve the 
intrahemispheric symmetry using a mouse brain atlas (Franklin and Paxinos, 1997) and 
major neuroanatomical landmarks. The brain sections were stretched in water (~ 40⁰C), 
mounted on poly- L- lysine coated glass slides and left to dry on a hot plate. The slides 






Figure 2.2.: Neuroanatomical levels at which the brains were microtome cut 
A schematic representation of coronal brain sections from the neuroanatomical levels 
(Franklin and Paxinos, 1997) at which the brains were serially microtome cut.  
For Chapter 3 the brains were microtome cut at levels 0.38mm bregma and -2.12mm 
bregma (B, D). For Chapter 4 the brains were microtome cut at levels 0.74mm bregma, 
0.38mm bregma, -0.94mm bregma, -2.12mm bregma (A- D). 
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2.5.3. Haemotxylin and eosin (H&E)  
Haemotxylin and eosin (H&E) histological staining was used for the examination of the 
overall brain morphology and the presence of neuronal ischemic damage. Haemotoxylin is 
a nuclear staining that stains in blue nucleic acids such as RNA. Eosin is a cytoplasmic 
staining that stains in light purple acidophilic elements such as the cytosol. 
Brain sections were deparaffinized at 60⁰C for 30 min, cleaned in 2 x xylene (10 min; 5 
min), rehydrated in decreasing grades of ethanol baths (100% ethanol (2 x 5 min); 90% 
ethanol (2 min); 70% ethanol (2 min)), washed under running water (2 min) and stained 
with haemotoxylin  for 2 min (for 30 sec when haemotoxylin was applied for an 
immunohistochemical counterstain, Chapter 2, section 2.6.1.1.). Subsequently, the 
sections were washed under running water (2min), immersed in acidic alchohol (10 sec), 
washed under running water (2 min), immersed in Scots tap water solution (2 min), 
washed under running water (2 min), and stained with eosin (2 min). Brain sections were 
washed under running water (2 min), dehydrated in increasing grades of ethanol baths 
(70% ethanol (10 sec); 90% ethanol (2 min), 100% ethanol (2 x 5min) and xylene (15 
min), and mounted on coverslips with DPX. 
2.6. Immunohistochemistry 
2.6.1. Avidin- biotin immunohistochemistry  
The avidin- biotin based immunohistochemical approach developed by Hsu et al, in 1981 
was used for the purposes of this thesis. The avidin- biotin method relies on the strong 
affinity (four binding sites) of avidin (a tetrameric protein derived from the white of avian, 
amphibian and reptile eggs) to the vitamin biotin (vitamin B7). The biotin molecule is 
easily conjugated to antibodies and enzymes. In the avidin- biotin immunohistochemical 
method, secondary antibody is conjugated to biotin and binds to the primary tissue 
antigen- bound antibody. The species in which the secondary antibody is raised 
determines the species of the serum used for blocking of the nonspecific binding sites 
performed prior to primary antibody application. During the primary- secondary antibody 
reaction, a biotinylated enzyme (horseradish peroxidase or alkaline phosphatase) binds to 
avidin and forms the avidin- biotin complex (ABC). The ABC  
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Figure 2.3.: Principles of immunohistochemistry 
A schematic representation of the basic principle of a standard immunohistochemical 
procedure.  
The primary antibody binds to its specific antigen (A). The biotinylated secondary 
antibody binds to the primary antibody (B). In the case of the peroxidase- based 
immunohistochemical procedure, the ABC diaminobenzidine complex binds to the 
secondary antibody allowing the visualization of the primary- secondary antibody 
reaction (C). In the case of the fluorescent immunohisto(cyto)chemistry, the secondary 
antibody is conjugated to a fluorochrome resulting in a fluorescent visualization of the 
primarimary- secondary antibody reaction (D). 
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reaction and by consequence the antigen of interest is revealed by the application of 33-
diaminobenzidine, tyramide or fluorochromes (figure 2.3.A-D). 
For the experimental purposes of the present thesis, a negative control for all 
immunohistochemical staining was an omission of the primary antibody on a subset of 
samples. 
The details of all primary and their respective secondary antibodies are given in table 2.1. 
2.6.1.1. Peroxidase ABC based immunohistochenistry 
Day1: Brain sections were deparaffinized at 60⁰C for 30 min, cleaned in 2 x xylene (10 
min; 5 min) and dehydrated in 2 x 100% ethanol (10 min; 5 min). Endogenous peroxidase 
activity was blocked by incubation with 0.5% H2O2 in methanol at RT for 30 min. 
Sections were washed under running water for 15min. An antigen retrieval step consisting 
of microwaving the sections at high temperature with citric acid (pH6.0) for 10 min was 
applied for some of the antibodies. The sections were washed in PBS for 5min to 
normalize the pH. After the antigen retrieval a blocking step consisting of sample 
incubation with 10% normal serum was performed for an hour at RT in humidified 
chambers. All primary antibodies were diluted in 10% normal serum at their specific 
optimal dilution (table 2.1.). The brain sections were incubated with primary antibody in 
humidified chambers overnight at 4⁰C. 
Day 2: Primary antibody was washed 3 x PBS (5 min/ each). Secondary antibody diluted 
(1:100) in PBS was applied on the sections for an hour at RT in humidified chambers. 
After 3 x PBS washes (5 min/ each) the sections were incubated in an avidin- biotin 
complex enzyme solution (ABC kit, Vector laboratories, UK) for an hour at RT in 
humidified chambers. After 3 x PBS washes (5 min/ each) an incubation with 3, 3- 
diaminobenzide tetrachloride solution (DAB) (Vector laboratories, UK) was performed 
for 2 min in order to visualize the antigen of interest (in brown colour). Subsequently, the 
sections were washed under running water for 10 min. A haemotxylin counterstain was 
performed for some stainings (Iba1; MAG) as described in Chapter 2, section 2.5.3. At the 
end of the procedure the sections were dehydrated into increasing grades of ethanol baths 
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(70% (2 min), 90% (5 min), 100% (2 x 5 min)), washed in xylene for 15 min and mounted 
on glass coverslips with DPX. 
2.6.1.2. Fluorescent immunohistochemstry 
Day 1: The procedure was exactly the same as for the peroxidase ABC based 
immunohistochemistry day 1 described in Chapter 2, section 2.6.1.1. 
Day 2: Primary antibody was washed 3 x PBS (5 min/ each). The sections were incubated 
with secondary antibody (1:200) diluted in 10% normal serum for an hour at RT in 
humidified chamber. After 3 x PBS washes (5 min/ each), the sections were incubated 
with DAPI (1:1000) in 0.1% PBS for 10 min at RT in humidified. The DAPI was washed 
3 x PBS (5 min/ each) and the sections were covesliped with Fluoromount solution 
(Sigma, UK). Immunofluorescent samples were covered with aluminum folio to prevent 
bleaching and stored at 4⁰C until imaging. 
2.6.1.3. DNA fluorescent immunohistochemistry  
Day 1: Brain sections were deparaffinized at 60⁰C for 30 min, cleaned in 2 x xylene (10 
min; 5 min) and dehydrated in 2 x 100% ethanol (10 min; 5 min). Endogenous peroxidase 
activity was blocked by incubation with 0.5% H2O2 in methanol at RT for 30 min. 
Sections were washed under running water for 15 min. Cell membranes were 
permeabilized by incubation in 1% Tryton- X in 0.1% PBS solution for 30 min at RT (for 
immunocytochemistry this was the first step of this protocol). Subsequently, the DNA was 
denaturated by 4M hydrochloric acid (HCL) treatment at 37⁰C for an hour. After 5 x 0.1% 
Tween washes (5 min/ each), a blocking step was performed by sample incubation with 
10% fetal calf serum (FCS) for an hour at RT in humidified chambers. Following this, the 
primary antibodies ssDNA, 5mC or 5hmC were diluted in 10% FCS at their optimal 
dilution (table 2.1.) and the tissue/ cell samples were incubated at 4⁰C overnight in 
humidified chambers. 
Day 2: Primary antibodies were washed in 5 x 0.1% Tween solution (5 min/ each) and the 
corresponding secondary antibodies (1:200) (table 2.1.) diluted in 10% FCS were  
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Primary antibody Target Dilution Secondary antibody Dilution Hydrochloric Citric Chromogen
manufacturer manufacturer acid acid manufacturer
Mouse monoclonal APP axons Horse anti- mouse no yes Peroxidase 
Millipore Invitrogen ABC kit
Vector laboratories
Goat polyclonal MAG myelin Horse anti- goat no no Peroxidase 
Santa Cruz Invitrogen ABC kit
Vector laboratories
Rabbit polyclonal dMBP degraded myelin Goat anti-rabbit no yes Peroxidase 
Millipore Invitrogen ABC kit
Vector laboratories
Rabbit polyclonal Iba1 microglia Horse anti- rabbit no yes Peroxidase 
Biocare medical Invitrogen ABC kit
Vector laboratories
Rat monoclonal 5hmC 5hmC Chicken anti- mouse yes no Tyramide
Diagenode DAKO Perkin Elmer
Mouse monoclonal 5mC 5mC Chicken anti- mouse yes no Tyramide
Eurogentec DAKO Perkin Elmer
 Rabbit polyclonal ssDNA ssDNA Donkey anti- rabbit yes no
Zymo research Alexa 555
Invitrogen
Rabbit polyclonal TET2 TET2 Donkey anti- rabbit no no
Santa Cruz Alexa 555
Invitrogen
Mouse monoclonal CC1 mature Chicken anti- mouse no yes Tyramide
Calbiochem oligodendrocytes DAKO Perkin Elmer














Table 2.1.: Primary and secondary antibodies, their manufacturer, cellular target, 
optimal dilution and specifics of the immuno(cyto)histochemical procedure 
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applied for an hour at RT in humidified chambers. After 5 x 0.1% Tween washes (5 min/ 
each) the samples were incubated with tyramide solution (Perkin Elmer, USA) for 15 min 
at RT in humidified chambers. The tyramide was washed 5 x 0.1% Tween solution (5 min/ 
each) and the samples were mounted on glass coverslips with Fluoromount solution 
(Sigma, UK). Immunofluorescent samples were covered with aluminum folio to prevent 
bleaching and stored at 4⁰C until imaging. 
For DNA immunocytochemical staining of oligodendroglia (Chapter 2, section 2.10.) and 
microglia (Chapter 2, section 2.11.) cells exactly the same staining procedure was applied 
at the exception of the tissue specific deparaffinization, dehydration and blocking of 
endogenous peroxidase activity. For immunocytochemistry, the 5hmC immunostaining 
protocol begins with an immediate cell membrane permeabilization with 0.1% Triton X 
solution of 4%PFA fixed cells. 
2.7. Pathology assessment 
2.7.1. Light microscopy 
Neuronal perikarya ischemic damage, white matter pathology (myelin and axonal 
integrity) as well as inflammatory activity were examined using an inverted light 
microscope (Leica). Images of the corresponding pathology were taken using Quick 
capture software and a camera connected to a computer. 
2.7.2. Neuroanatomical regions of interest 
The neuroanatomical regions of interest (ROIs) examined in this thesis were major white 
matter tracts (the CC, EC, and IC). The Fx and OT were also examined in the studies 
presented in Chapter 3 and Chapter 4 (figure 2.4.B) Grey matter ROIs were the 
hippocampus, the striatum and the cortex (Cx) (figure 2.4.A, B).   
2.7.3. Grey matter integrity and neuronal perikarya ischemic damage 
The overall tissue morphology and neuronal perikarya ischemic damage were assessed on 
H&E stained brain sections in cortical and subcortical grey matter regions. Ischemic and 
non ischemic neurons were identified on the basis of their cellular morphology (figure  
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Figure 2.4.: Neuroanatomical regions of interest (ROI) 
A schematic representation of the neuroanatomical regions of interest.  
The neuroanatomical levels of interest were 0.38mm bregma (A) and -2.12mm bregma 
(B). The regions of interest (ROIs) used for the pathological evaluation of grey and 
white matter microstructural integrity as well as the characterization of epigenetic and 
glial biomerkers were cortical (Cx) (B) and subcortical (striatum hippocampus) (A-B) 
grey matter regions as well s major white matter tracts (CC, EC, Fx, IC, OT) (B).  
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  Figure 2.5.1.: H&E staining 
 Representative images of H&E stained healthy (A) and ischemic (B) neurons in the CA1 
region of the hippocampus. Healthy neurons are characterized with light blue stained 
nuclei are shown in (A). Ischemic neurons are identified by their shrunken, dark nuclei 
and eosinphilic cytoplasm are indicated with black arrows in (A1).  A typical “ghost” 
neuron is indicated with a white arrow in (A1). 
Scale bar represents 15µm (magnification x60). 
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2.5.1.A, A1). Ischemic neurons present small pyknotic dark blue shrunken nuclei 
compared with the morphologically normal big light blue nuclei of healthy neurons. The 
cytoplasm of ischemic neurons is intensely eosinophilic. With long survival times after 
injury, damaged neurons are difficult to detect often become “ghost neurons” and engulfed 
by macrophages (figure 2.5.1. A1). Thus, due to the relatively long survival times after the 
initial induction of chronic cerebral hypoperfusion (2 month for the experiments in 
Chapter 3; 1 month for the experiments in Chapter 4, Chapter 5) and the formation of glial 
scars in ischemic brain regions it was difficult to quantify the exact number of ischemic 
cells in the different ROIs. Therefore, the neuronal perikarya ischemic damage was 
reported as present or absent, but was not quantified. 
2.7.4. White matter integrity and inflammation 
White matter structural integrity and inflammatory activity were examined by means of 
standard immunohistochemistry (Chapter 2, section 2.6.1.1.). The pathology was 
evaluated by means of a semi- quantitative pathological grading scale shown to be 
sensitive to white matter pathology in chronically hypoperfused mice (Coltman et al., 
2011; Holland et al., 2011). Using this system the severity and the extent (relative 
percentage of affected area) of the observed pathology were numerically categorized: 
grade 0 (normal), grade 1 (mild pathology), grade 2 (moderate pathology), grade 3 (severe 
pathology). A pathological grade was attributed to all ROIs for all biomarkers. For the 
experimental purposes of chapter 3, a global score of axonal (APP), myelin (MAG) 
integrity, inflammation (Iba1) in each experimental animal was calculated by a separate 
summation of the pathological grades in the examined white matter areas (Coltman et al., 
2011; Holland et al., 2011).  The total biomarker score is considered to be a representative 
nonquantitative measure of the overall extent and severity of the observed pathology.  
 
2.7.4.1. Evaluation of axonal integrity by means of amyloid precursor protein (APP) 
immunoreactivity 
Axonal integrity was examined using an antibody targeted to amyloid precursor protein 
(APP), an integral membrane protein transported from the cell body along the neuronal 
axons. Under normal physiological conditions APP is immunodetected in neuronal 
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synapses and soma as well as in glial cell bodies (Forloni et al., 1992; Palacios et al., 
1992). Axonal pathology disturbs normal axonal transport resulting in abnormal APP 
accumulation in swollen and/ or bulbous axons. Axonal integrity was examined in both 
white and grey matter ROIs. 
The axonal integrity was estimated by analyzing the presence or absence of 
immunodetectable axonal APP aggregations in one or more of the examined ROIs (figure 
2.5.2.A, A1). Normal axonal integrity (grade 0) was associated with the absence of 
immunodetectable axonal APP aggregations with localization of the protein solely in 
neuronal and glial cell bodies. A mild axonal injury (grade 1) corresponded to a minimal 
immunodetection of amyloid clumps within the neuronal axons covering less than 30% of 
the total surface of the examined ROI. A moderate axonal injury (grade 2) was associated 
with axonal APP aggregations covering between 30- 60% of the total surface of the ROI. 
A severe axonal injury (grade 3) corresponded to a substantial distribution of axonal APP 
aggregations affecting more than 60% of the total surface of the ROI. 
2.7.4.2. Evaluation of myelin structural integrity by means of myelin associated 
glycoprotein (MAG) immunoreactivity 
Myelin structural integrity was examined on MAG immunostained brain sections. MAG is 
a minor myelin protein (~2% of myelin protein content) and details on this protein 
function are given in Chapter 1, section 1.3.3. Myelin pathology with a different degree of 
severity was reported when disorganization of myelin fibers, vacuole formation and 
myelin debris with a different extent were observed in one or more of the white matter 
ROIs (figure 2.5.2.B, B1). 
Normal appearing myelin (grade 0) was characterized by tightly organized myelin fibers, a 
lack of vacuole formation and an absence of myelin debris. A slight disorganization of the 
myelin fibers translated by the formation of small vacuoles and the accumulation of 
myelin debris covering relatively less than 30% of the total surface of the examined white 
matter ROI was considered as mild myelin pathology (grade 1). A moderate myelin 


























Figure 2.5.2.: APP, MAG, dMBP, Iba1 immunohistochemistry 
Axonal (A-A1), myelin (B-B1, C-C1) integrity and inflammation (D-D1) in health (A-D) 
and disease (A1-D1). Axonal injury is revealed by APP immunoreactivity in bulbous/ 
swollen axons (arrow in A1). Myelin structural abnormalities are detected by MAG 
immunoreactivity as disorganized fibers, myelin debris, vacuoles (arrow in B1). Additional 
indication of myelin pathology is the presence of dMBP immunoreactivity (arrow in C1). 
Inflammatory levels are evaluated by Iba1 immunoreactive microglial cells (arrow in D1). 
All images are from the OT.  Scale bar represents 15µm (magnification x60). 
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pathology (grade 2) was associated with a higher degree of myelin fiber disorganization 
with an extent reaching between 30- 40% of the total surface of the examined white matter 
area. The myelin pathology was considered severe (grade 3) when the structure and the 
organization of the myelin sheath were compromised by  extensive vacuole formations 
and substantial aggregations of myelin debris scattered over relatively more than 60% of 
the total surface of the examined white matter area. 
2.7.4.3. Evaluation of degraded myelin by means of degraded myelin basic protein 
(dMBP) immunoreactivity 
Degraded myelin was detected by degraded myelin basic protein (dMBP) 
immunoreactivity- dMBP is a MBP isoform expressed only in pathological conditions 
(Matsuo et al., 1997). Myelin pathology with a different degree of severity was reported 
when immunodetectable dMBP was observed in one or more of the examined ROIs 
(figure 2.5.2.C, C1). 
The myelin sheath was considered normal (grade 0) in the absence of immunodetetable 
dMBP levels in the examined white matter ROI. A minimal myelin pathology (grade 1) 
was attributed to small circular dMBP aggregations covering relatively less than 30% of 
the total surface of the ROI. A moderate myelin pathology (grade 2) was associated with 
dMBP aggregations covering between 30 and 60% of the total surface of the ROI. A 
severe myelin pathology (grade 3) corresponded to an extensive distribution of dMBP 
aggregations in more than 60% of the total area of the examined ROI. 
2.7.4.4. Evaluation of inflammatory activity by means of ionized calcium binding 
antigen 1 (Iba1) immunoreactivity 
Inflammatory levels were assessed on immunostained sections with an antibody targeted 
to ionized calcium binding antigen- 1 (Iba1) expressed by microglia and macrophages (Ito 
et al., 1998). Under normal physiological conditions the brain inflammatory levels are 
low, but they increase in the presence of neuropathological events (figure 2.5.2.D, D1). 
Inflammation was examined in both white and grey matter ROIs. 
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Inflammatory activity was evaluated on the basis of the relative microglia/ macrophages 
activation (relative distribution of Iba1 positive cells in a given area). Normal microglial 
activation (grade 0) was associated with a minimal number (0- 3) of Iba1 positive cells 
evidenced within the ROI. A minimal inflammatory activity (grade 1) was characterized 
by a slight increase in the distribution of Iba1 positive cells affecting less than 30% of the 
total surface of the examined ROI. A moderate inflammatory activity (grade 2) was 
attributed to a higher degree of inflammatory activity related to an increase in the number 
and reactivity of Iba1 positive cells evidenced in between 30- 60% of the total surface of 
the ROI. A severe inflammatory activity (grade 3) corresponded to the presence of 
reactive Iba1 positive cells in more than 60% of the total surface of the examined ROI.  
For the purposes of the last experimental chapter (Chapter 5) presented in this thesis, the 
inflammatory levels were quantified by counting Iba1 positive cells on five random 
imaged fields taken from each ROI (Chapter 2, sections 2.8.).  
2.7.5. Other immunomarkers  
For the experimental purposes of Chapter 5, additional biomarkers were used for the 
immunodetection of cellular DNA components (5mC, 5hmC, single- stranded DNA), 
TET2 protein, mature (CC1) and precursor (NG2) oligodendroglial cells. 
2.7.5.1. 5- Methylcytosine (5mC) 
5mC is an epigenetic mark constituting ~1% of the total nucleotides of the mammalian 
DNA (Chapter 1, section 1.7.1.). It is immunodetected in cellular nuclei (figure 2.6. A- 
A2). 5mC immunoreactivity was quantified as explained in Chapter 2, section 2.8. 
2.7.5.2. 5- Hydroxymethylcytosine (5hmC) 
5hmC is a newly discovered epigentic mark resulting from the oxidation of 5mC (Chapter 
1, section 1.7.2.). Similar to 5mC, 5hmC is immunodetected in cellular nuclei (figure 2.6. 
B- B2). 5hmC immunoreactivity was quantified as explained in Chapter 2, section 2.8. 
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Figure 2.6.: 5mC, 5hmC, ssDNA, TET2, CC1, NG2  immunoreactivity 
Representative images from the healthy mouse brain of 5mC (A-A2) 5hmC (B-B2), 
TET2 (C-C2), CC1 (D-D2), NG2 (E-E2) immunoreactivity with the corresponding 
counterstaining ssDNA (for 5mC and 5hmC) (A1, B1) or DAPI (for TET2, CC1, 
NG2) (C1-E1). Merged images of the biomarker of interest and the counterstain are 
presented in A2-E2. 5mC, 5hmC, and TET2 images are taken from the CA1 region of 




2.7.5.3. Single stranded DNA (ssDNA) 
ssDNA is a biomarker for cellular DNA and is immunodetected in cellular nuclei (figure 
2.6. A1- B1). ssDNA was quantified as explained in Chapter 2, section 2.8. 
2.7.5.4. Ten- eleven translocation protein 2 (TET2) 
Ten- eleven translocation protein 2 (TET2) catalyzes the oxidative reaction leading to the 
production of 5hmC (Chapter 1, section 1.7.3.). TET2 brain distribution was studied using 
an immunohistochemical approach for the first time in the present thesis and a 
representative image of TET2 immunostaining is given in figure 2.6. C- C2. TET2 was 
quantified as explained in Chapter 2, section 2.8. 
2.7.5.5. CC1 or also called adenomatous polyposis coli (APC)  
Adenomatous polyposis coli (APC) (CC1) is a protein detected in mature 
oligodendrocytes (figure 2.6. D- D2) (Armstrong et al., 2002). CC1 was quantified as 
explained in Chapter 2, section 2.8. 
2.7.5.6. Chondroitin sulfate proteoglycan (NG2) 
NG2 is a membrane proteoglycan found in OPC in the central nervous system (figure 2.6. 
E- E2) (Chang et al., 2000; Reynolds et al., 2002). NG2 immunoreactivity was quantified 















Table 2.2.: Fluorochromes with their detection wavelengths 
(nm) used for the visualization of immunofluorescence- stained 
biomarkers. 
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2.8. Quantification of 5mC, 5hmC, TET2, CC1, NG2, and Iba1 positive cells 
2.8.1. Fluorescent microscopy and imaging 
Immunofluorescent brain samples were examined on an Axiovert (Carl Zeiss) 
fluorescence- detecting microscope. Each fluorochrome was detected at its corresponding 
excitation wave length (table 2.2.). Fluorescent images were generated using a lens 
magnification x40 and Axiovison software (Carl Zeiss) installed on a computer connected 
to the microscope camera. Five random fields were taken from each ROI and for each 
biormarker. Three separate images were generated from each of the five regional fields: 
one corresponding to the biomarker of interest, one corresponding to the ssDNA or DAPI 
staining, and a merged image of the biomarker of interest and ssDNA or DAPI (figure 
2.6.). For the Iba1 immunostained samples a light microscopy (Chapter 2, section 2.7.1.) 
was applied using the same microscope and imaging system. 
2.8.2. Cell counting 
Cell counts were performed manually on images generated as described in Chapter 2, 
section 2.8.1. Cells positive for the biomarker of interest (5hmC, 5mC, CC1, NG2, TET2, 
Iba1) were counted on each of the five random images taken from a given ROI and their 
number was averaged across the five imaging fields in order to obtain a regional average 
number of biomarker positive cells.  Subsequently, the number of ssDNA, DAPI or 
haemotoxylin positive cells was counted on the same five imaging ROI fields where the 
cells positive for the corresponding biomarker of interest were previously counted and 
their number was averaged across the five imaging fields in order to obtain a regional 
average number of total cells.  A proportion of cells positive for each of the biomarkers 
was calculated for each of the ROIs using the following formula: 
Biomarker positive cells= Average number of biomarker positive cells in ROI 
                                         Average number of total number of cells in ROI 
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During cell counting a special care was taken to avoid counting cells in neighbouring 
neuroanatomical regions which sometimes were also partially observed on the images and 
distinguished by their specific morphological and cellular landmarks. 
2.9. Ex vivo MRI- DTI 
MRI- DTI was applied on perfusion- fixed whole brain sample for the experimental 
purposes of Chapter 4. The aim was to achieve a better image resolution by using a longer 
imaging time in the absence of physiological artifacts allowing the detection of potentially 
subtle genotype differences in white matter integrity. Further, the experimental costs were 
reduced as more than 1 (3 to 4) brain samples were scanned by imaging session.  
 
2.9.1. Small rodent MRI scanner 
A small rodent 7T (T for tesla) Direct Drive MRI scanner (Varian Inc., Oxford, UK) was 
used for the ex vivo MRI experiment presented in this thesis. The apparatus consisted of a 
covering shield and a sliding table where the samples were positioned for imaging. The 
scanner was equipped with a 60 mm inner diameter gradient coil (1000 mT/ m) and a 
radiofrequency (RF) bird cage coil with an inner diameter of 26 mm (Rapid Biomedical, 
Wurzburg, Germany). The MRI system was controlled by a computer and the generated 
data was acquired using in- house software. The composing elements of a MRI scanner 
are schematically represented in figure 2.7. 
2.9.2. Brain preparation prior to ex vivo MRI scanning 
Within the 24h following transcardiac perfusion, 1- 2 brain(s) from the different 
experimental groups were placed and immobilized with a small piece of foam in a 2 ml 
plastic tube filled with 4% PFA to prevent tissue dehydration during imaging. Special care 
was taken to remove air bubbles from the tubes as they might impact on the image quality. 
The tubes were labeled tube 1 and 2 and each brain was given a number 1, 2, (tube 1) 3, 4 
(tube 2) which allowed the subsequent identification of the samples. Three- four brains 




Figure 2.7.: Composing elements of a MRI scanner 
A schematic representation of the composing elements of a MRI scanner.  
The MRI scanner is equipped with a magnet producing the magnetic field for the 
imaging procedure. Within the magnet are the gradient coils (controlled/ recorded by 
a computer through a gradient pulse program/ amplifier) for producing a gradient in 
the generated magnetic field in the X, Y, and Z directions. Within the gradient coils 
is the RF coil. The RF coil (controlled by a computer through RF source/ amplifier) 





any other value selected by the pulse sequence. The RF coil also detects (the signal is 
recorded by a computer through RF amplifier/ detector) the signal from the spins 
within the body. The patient/ biological sample is positioned within the magnet by a 
computer controlled MRI table. The scan room is surrounded by an RF shield 
preventing the high power RF pulses from radiating out through the facilities 
building. It also prevents the various RF signals from television and radio stations 
















Figure 2.8.: Brains set up for ex vivo MRI- DTI procedure 
An example image of the brains set up for ex vivo MRI- DTI scanning.  
The brains were put into plastic tubes filled with 4% PFA and labeled tube 1 
and tube 2. The brains in tube 1 were consistently labeled 1 and 2. The brains in 
tube 2 were consistently labeled brain 3 and 4. This was done for experimental 
“blinding” of the researcher and the subsequent identification of the samples. 
The animals from the four experimental groups were equally distributed among 
each batch/ imaging session. 
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2.9.3. Ex vivo MRI- DTI procedure 
Three to four brains were scanned simultaneously per overnight imaging session at RT. 
The tubes containing the brains were securely positioned in the centre of the  RF birdcage 
coil prior to each imaging session. Contiguous coronal T2- weighted, MTI, and DTI 
images were all acquired with spin-echo sequences with the following parameters: matrix 
size 256x128, field of view 24 x 12 mm, slice thickness 0.5 mm, number of slices 52. The 
repetition time/echo time was 3500/48 ms for the T2-weighted sequence and 2500/30 ms 
for both the MTI and DTI sequences. For DTI, diffusion-weighted (b = 1800 s/mm
2
) 
volumes were acquired with diffusion gradients (amplitude 25.6 G/cm, duration 4 ms, 
separation 13 ms) applied in 12 noncollinear directions and 2 volumes without the 
diffusion gradient applied. The MTI protocol employed two sequences; one acquired with 
a magnetization transfer pulse applied 3 kHz off resonance (flip angle 900°, duration 8.19 
ms). The imaging time was ~12h per session. The ex vivo MRI procedure was developed 
and performed by Dr Marits Jansen (Medical Physics, University of Edinburgh) and Gavin 
Merrifield (Medical Physics, University of Edinburgh). 
At the completion of the MRI procedure, the brains were transferred into individual 50 ml 
tubes filled with 0.1% PBS and kept at 4°C for additional 7 days prior to paraffin 
embedding. 
2.9.4. MRI image analysis 
The MRI images were analyzed using Image J 1.43o (NIH) software.  ROIs were 
manually delineated on the T2- weighted images in a manner blinded to the experimental 
treatment and the genotype of the animals using a placement procedure that relied on atlas 
based reference maps (Franklin and Paxinos, 1997) with morphological landmarks. 
Special care was taken to avoid any possible contamination by neuroanatomical regions 
adjacent to the delineated ROI. FA and MTR were measured in areas with known 
susceptibility to blood flow alterations: the CC (body and horns), EC, IC, and OT as well 
as in the hippocampus which was selected as a control grey matter ROI. The ROIs 
delineated on the T2- weighted scans of each mouse were automatically applied to the FA, 
MTR. The MTR maps were constsructed from the MTI scans with and without the off 
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resonance pulse allowing the estimation of the magnetization transfer ratio between the 
free and bound protons in the brain. The generated raw MRI data resulted from the 
bilateral evaluation of the FA and the MTR on a fixed n number of consecutive scans on 
which a given ROI could be detected: CC (8 scans), EC (7 scans), IC (3 scans), OT (2 
scans), hippocampus (2 scans). 
2.10. In vitro culture and maturation of oligodendroglial cells 
Oligodendroglial progenitor cells (OPCs) were isolated from the cerebral cortices of mice 
pups (post- natal day 0- 2). Cortices were separated from the rest of the brain under a 
dissecting microscope and subsequently digested with papain solution (1 ml DMEM 
(Invitrogen); 40l papain (Worthington Biochemical); 25l L-cysteine solution (Sigma); 
25l DNaseI type IV (Sigma) at 37°C for 10min. Following this, cells were further 
mechanically isolated from the surrounding epithelia by means of a sterile filter.  Cell 
pellets were collected by a centrifugation at 1000 rpm for 5 min (this step was repeated 
three times and after each centrifugation cells were resuspended into a fresh 10% DMEM 
solution).  Cell pellets were finally resuspended  onto a poly- D- lysine coated flasks and 
cultured into a SATO medium composed of DMEM supplemented with glutamine 
(Sigma), penicillin and streptomycin (Invitrogen), 10% horse serum (Invitrogen), insulin 
(Sigma) and transferrin (Sigma), 10ng/ ml fibroblast growth factor (FGF2) (Peprotech), 
10ng/ ml platelet derived growth factor (PDGF) (Peprotech). Cells were incubated at 
37°C, 7.5% CO2 for 3 days prior to the first media change. Subsequently, the media was 
changed every other day. Differentiation was achieved by removal of the growth factors 
(FGF2 and PDGF) from the SATO media and the cells were cultured for additional 0, 2, 6 
DIV to reach a certain maturational stage prior to fixation with 4% PFA (Chapter 2, 
section 2.12.). 
The oligodendroglial cell preparations were kindly provided by Dr Anna Williams and Mr 





2.11. In vitro culture of activated and nonactivated microglial cell  
Microglia cells were isolated from the cerebral cortices of postnatal day 0- 2 Sprague 
Dawley rat pups. Following removal of meninges, cortices were mechanically minced 
then enzymatically digested for 45 min at 37°C in 30u/ml papain (Worthington 
Biochemical Corporation, USA), 24mg/ml cysteine (Sigma), 4mg/ml DNaseI type IV 
(Sigma). The cell suspension was incubated with 10% DMEM (with 4.5g/L glucose, L-
glutamine, and pyruvate (all purchased from GIBCO) supplemented with 10% FCS 
(Invitrogen), and 1% penicillin/streptomycin (Sigma)) and centrifuged at 1000 rpm for 5 
min. Supernatant was discarded, and the cell suspension was resuspended in 10% DMEM 
and triturated with 19 and 23 guage syringe needles. Cells were plated on poly-D-lysine 
(Sigma) coated plastic flasks and grown as mixed glial cultures for 10 days in 10% 
DMEM with media changed every 2-3 days. Microglia were isolated by collecting the 
floating fraction in the flasks following 1h on a rotary shaker at 37⁰C at 250 rpm. Cells 
were plated on poly-D-lysine coated 16-well glass chamberslides (Lab-TEK, USA) at 50 
000 cells per well in 10% DMEM. Microglia were either left untreated or activated by 
overnight treatment with 20ng/ml IFNγ (Sigma) and 100ng/ml LPS (Sigma). Prior to 
5hmC immunocytochemistry, the microglial cells were fixed with 4% PFA as described in 
Chapter 2, section 2.12. 
The microglial cell preparations were kindly provided by Dr Veronique Miron (MRC 
Scottish Centre for Regenerative Medicine, University of Edinburgh). 
2.12. Fixation of oligodendroglial and microglial cells 
Prior to fixation with 4% PFA, the culture media was aspirate and the cells were washed 2 
x PBS (2min). Subsequently, 4% PFA solution was added to the wells and the cells were 
left in the fixative for 15min. After 3 x PBS washes (2min/ each), a fresh PBS solution 
was added to the wells, the plate was covered with parafilm and the cells were stored at 
4⁰C until required for immunocytochemistry. 
2.13. Statistics 




























Effects of chronic cerebral hypoperfusion on 
white matter integrity and cognitive abilities in 
mice 
3.1. Introduction and aims 
Grey matter abnormalities such as synaptic/ dendritic loss and dysfunction are often 
considered to be the main contributors of cognitive decline during “healthy aging” (Roman 
and Kalaria, 2006; Esiri, 2007). However, increasing evidence from combined 
neuroimaging and neuropsychological studies, suggest that white matter disruption or loss 
of the brains ‘connectivity’ might be the major neuropathological substrate associated with 
age- related cognitive decline in “healthy” elderly (O`Sullivan et al., 2001; Deary et al., 
2003; Charlton et al., 2006; Grieve et al., 2007; Kennedy and Raz, 2009; Penke et al., 
2010). At the microscopic level age- related white matter lesions are characterized by 
myelin rarefaction, vacuole formation, axonal damage, oligodendroglial apoptosis, 
increased inflammation, and small vessel pathology (Farkas et al., 2006; Fernando et al., 
2006; Ihara et al., 2010). These lesions were initially thought to be ‘silent’, but a number of 
studies have since shown that white matter abnormalities contribute to  impaired working 
memory and executive function in “healthy” elderly (O`Sullivan et al., 2001; Charlton et 
al., 2006; Cook et al., 2007; Grieve et al., 2007; Wright, et al., 2008; Kennedy and Raz, 
2009). Working memory is the cognitive ability mediating the learning, memory and 
recollection of newly learned information over relatively short periods of time, whereas 
executive function refers to the cognitive ability associated with planning, organization and 
rapid switching of strategies allowing an adequate behavioural adaptation to the imminent 
requirements of a constantly changing environment (Baddeley, 1992; Jurado and Rosselli, 
2007). Both working memory and executive function are cognitive mechanisms relying on 
the fast neuronal communication between cortico- cortical and cortico- subcortical regions 
(Rolls, 2000; Funahashi, 2001; Tekin and Cummings, 2002; Grieve et al., 2007). 
Therefore, pathological damage to white matter tracts might impact on neuronal 
connectivity leading to the occurrence of cognitive deficits in the elderly.  
The exact etiological causes underlying the development of age- related white matter 
abnormalities are not well understood mostly due to the existence of comorbidities in 
elderly such as diabetes, hypertension, cardiac disease, neurodegeneration (Verdelho et al., 
2010; Van Swieten et al.; 1991; Lindgren et al., 1994; Ruitenberg et al., 2005). However, 
age- related changes in the cerebrovasculature are believed to be one of the major 
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pathophysiological mechanisms associated with white matter lesions in the aging brain. 
Specifically, chronic cerebral hypoperfusion due to changes in the morphology of the 
cerebral blood vessels such atherosclerosis, fibrohylinosis, basement membrane thickening 
and increased vascular inflammation have been related to white matter pathology and 
cognitive deficits in “healthy” elderly (Kalaria, 1996; Tang et al., 1997; de Leeuw et al., 
2000; Farkas et al., 2006; Gold et al., 2007). Chronic cerebral hypoperfusion may be 
particularly harmful to white matter regions which neuroanatomically are characterized by 
arterial end and border zones with very limited blood irrigation even under normal 
physiological conditions (Nonaka et al., 2003) . 
In order to study in isolation the effects of chronic cerebral hypoperfusion on the cellular 
and molecular events leading to the development of age- related white matter 
abnormalities and cognitive decline in humans, animal models of chronic cerebral 
hypoperfusion have been initially developed in rats and gerbils (Kudo et al., 1990; Hattori 
et al., 1992; Kudo et al., 1993; Pappas et al., 1996; de Jong, et al., 1999; Tomimoto et al., 
2003; Kim et al., 2008). These two in vivo models consist of the permanent bilateral 
occlusion of the common carotid artery leading to chronic cerebral hypoperfusion and the 
development of predominant white matter pathology with concomitant grey matter 
ischemic injury and increased inflammation (Kudo et al., 1993; Pappas et al., 1996; Kim 
et al., 2008). At the functional level both chronically hypoperfused rats and gerbils exhibit 
impaired learning and memory (Kudo et al., 1990; Pappas et al., 1996; Sopala and Danysz, 
2001; Kumaran et al., 2008). However, the evaluation of cognitive deficits related to white 
matter pathology in these two animal models is hampered by the presence of grey matter 
damage.  
Recently, our group and others developed and characterized a new mouse model of 
chronic cerebral hypoperfusion where piano microcoils are surgically applied to the 
common carotid arteries leading to mild chronic reductions of the cerebral blood flow, 
akin to those occurring in the ageing brain where modest reductions in cerebral blood flow 
occur over many years (Kawamura et al., 1991; Ogawa et al., 1996; Brown et al., 2000; 
Mathiesen et al., 2004; Fernando et al., 2006; Pardo et al., 2007). The initial 
characterization of this new animal model has suggested that cerebral hypoperfusion leads 
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to  the development of predominant white matter pathology including increased 
inflammation in the absence of ischemic neuronal damage (Shibata et al., 2004; Shibata et 
al., 2007; Nishio et al., 2010; Coltman et al., 2011; Holland et al., 2011). Therefore, this 
new mouse model seemed to be a suitable in vivo tool for the investigation of functional 
impairments and associated pathology related to chronic cerebral hypoperfusion relevant 
to aging. Chronically hypoperfused mice have been previously shown to exhibit a spatial 
working memory deficit on a radial arm maze task in the absence of spatial reference 
memory, contextual and fear conditioning deficits (Shibata et al., 2007). However, so far, 
there has not been a systematic pathological evaluation of behaviourally tested chronically 
hypoperfused mice, thus rendering difficult any firm conclusions on the effects of 
hypoperfusion- induced neuropathology on cognitive function in mice. 
Building on previous work, the present study tested the hypothesis that hypoperfusion- 
induced white matter pathology might be associated with the occurrence of working 
memory and executive function deficits in mice. 
On the basis of previous findings on the mouse model of chronic cerebral hypoperfusion, 
the initial study predictions were that chronic cerebral hypoperfusion would lead to the 
development of predominant white matter pathology  and spatial working memory 
impairment in mice. 
The present study hypothesis challenged the long- lasting dogma (the standard theory) 
suggesting that grey matter abnormalities are the major neurobiological substrate of age- 
related cognitive decline  
In order to address the study hypothesis, spatial working memory was examined in sham 
compared with hypoperfused mice one month after surgery using the same radial arm 
maze paradigm as Shibata et al., 2007. On the basis of previous human findings showing 
an association between age- related white matter pathology and executive function (Grieve 
et al., 2007; Kennedy and Raz, 2009), in the present experiment, spatial memory 
flexibility (executive function) was also examined in a separate cohort of sham and 
chronically hypoperfused mice using a water maze paradigm one month after surgery. In 
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this experimental cohort spatial learning capacity, short and long- term recall were 
simultaneously tested.  
Since grey matter abnormalities (e.g. dendritic and synaptic loss) and increased 
inflammation accompany the development of white matter pathology in alternative animal 
models of chronic cerebral hypoperfusion as well as in elderly people (Anderson et al., 
1983; Kudo et al., 1993; Pappas et al., 1996; Kurumatani et al., 1998;  Duan et al., 2003; 
Tomimoto et al., 2003; Liu et al., 2005; Fernando et al., 2006; Roman and Kalaria, 2006; 
Esiri, 2007; Kim et al., 2008) in addition to white matter, grey matter integrity and 
inflammatory levels were also examined in behaviourally tested sham and hypoperfused 
animals using a standard histological/ immunohistochemichal approach at the completion 















The major aims of the present Chapter 3 were to: 
 
 Examine spatial working memory, memory flexibility, learning capacity, short and 
long term memory recall in sham compared with chronically hypoperfused mice. 
 
 In the same sham and hypoperfused mice which had undergone behavioural testing 
to examine and compare white and grey matter integrity, inflammation. 
 
 Determine potential associations between white matter integrity and behavioural 















3.2. Materials and methods 
3.2.1. Animals and surgery 
Three- month old male C57Bl6J mice weighting 25 ± 5gr were used for the experiments 
presented in Chapter 3 (Chapter 2, section 2.1.1.). The animals were randomly allocated to 
sham and hypoperfused groups. Initially, 10 sham and 20 hypoperfused mice were 
included in the radial arm maze experiment. The initial experimental numbers for the 
water maze experiment were 11 sham and 18 hypoperfused mice. Chronic cerebral 
hypoperfusion was induced as described in materials and methods (Chapter 2, section 
2.2.). Food and water were provided ad libitum for the animals tested on the serial spatial 
water maze task during the whole experimental period. The animals that underwent testing 
on the radial arm maze task were food- deprived in order to reduce their body weight up to 
85-90% from their original one. Only the animals surviving the whole experimental period 
were included in the final behavioural and pathological analysis.   
3.2.1. Behavioural tests 
Spatial working memory was challenged on a radial arm maze paradigm in sham and 
chronically hypoperfused mice (Chapter 2, section 2.3.2.). Additionally, the visual 
abilities of the animals included in this experiment were examined at three different time 
points (S.3.1- appendices I; Chapter 2, section 2.3.1.). 
Spatial memory flexibility, spatial learning capacity, short and long term memory recall 
were studied in a separate cohort of sham and chronically hypoperfused mice using a 
serial spatial learning and memory water maze task (Chapter 2, section 2.3.3.). In addition, 
as mice are not natural swimmers their ability to swim and perform a water maze task 
were tested on a cue task paradigm a day prior to surgery and a week prior to the serial 
spatial and learning task (three weeks post- surgery) (S.3.3- appendices I.; Chapter 2, point 
2.3.3.2.1.). 
The behavioural training on both the radial arm maze and the water maze tasks was 
performed one month post- surgery. At the completion of each of the behavioural 
procedures (~2 months post- surgery) the animals were perfusion- fixed (Chapter 2, 
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section 2.4.) and their brains were processed for histology and immunohistochemistry 
(Chapter 2, section 2.5.). 
3.2.2. Pathological assessment  
The pathological evaluation of white and grey matter structural integrity was performed at 
the completion of the behavioural training (~ 2 months after surgery) on each of the two 
behavioural paradigms. 
White matter structural integrity and inflammatory activity were examined at -2.12mm 
bregma neuroanatomical level (Franklin and Paxinos, 1997) as all white matter tracts of 
interest could be simultaneously studied on the same brain section. A standard 
immunohistochemical procedure (Chapter 2, section 2.6.1.1.) was applied using antibodies 
targeted to the neuronal axons (APP), myelin sheath (MAG), and microglia (Iba1). The 
pathology was assessed by means of a semi- quantitative grading scale (0- normal, 1- 
mild, 2- moderate, 3- severe pathology) (Chapter 2, section 2.7.4.; Coltman et al., 2011; 
Holland et al., 2011). A global score of axonal (APP), myelin (MAG) integrity, 
inflammation (Iba1) in each experimental animal was calculated by a separate summation 
of the pathological grades across the examined white matter areas (Coltman et al., 2011; 
Holland et al., 2011).  The total biomarker score in white matter areas was considered to 
be a representative nonquantitative measure of the overall extent and severity of the 
observed pathological changes (the data and analysis are given in tables S.3.3.1, S.3.3.2., 
S.3.3.3.- appendices I) and it was used for the correlation analysis with behavioural 
measures in chronically hypoperfused mice (section 3.2.3.3.). 
Grey matter structural integrity and neuronal ischemic damage were evaluated on H&E 
stained (Chapter 2, section 2.5.3.) coronal brain sections from 0.38mm bregma and -
2.12mm bregma neuroanatomical levels (Franklin and Paxinos, 1997) and reported to be 
present or absent in cortical (the Cx) and subcortical (the striatum and the hippocampus) 





3.2.3.1. Statistical analysis of the behavioural data 
3.2.3.1.1. Statistical analysis of the radial arm maze behavioural data 
For the radial arm maze behavioural data, statistical comparisons were performed on 
blocks of data for each animal in which each block comprised the average of two trials 
conducted on consecutive days of training for each behavioural measure  (Shibata et al., 
2007, Nishio et al., 2010, Coltman et al., 2011). The experimental group (n) numbers 
included in the statistical analysis were 10 sham and 10 hypoperfused mice. Two-way 
repeated measures analysis of variance (ANOVA) was applied to statistically compare the 
average number of revisiting errors and number of novel entries in the first 8 arm choices 
between sham and hypoperfused groups (Shibata et al., 2007, Nishio et al., 2010 Coltman 
et al., 2011). A separate two- way ANOVA was performed for each behavioural measure. 
The same statistical analysis was applied to compare the group average number of total 
arm entries and trial duration (analysis and data presented in appendices I, S.3.1.2.). When 
significant main effects of trial block of group x block interactions (p<0.05) were 
indicated by ANOVA, a Tukey`s post- hoc analysis was applied to determine the exact 
training day(s) when significant group differences in the behavioural performance 
between sham and hypoperfused mice occurred.  
Significant group differences were reported for p<0.05. 
3.2.3.1.2. Statistical analysis of the water maze behavioural data 
Similar to the radial arm maze study, two- way repeated measures ANOVA was applied 
for the statistical comparisons of the performance on a serial spatial learning and memory 
water maze task (Chen et al., 2000; Coltman et al., 2011). The experimental group (n) 
numbers included in the statistical analysis were 11 sham and 10 hypoperfused mice. In 
this particular experiment, the statistical analysis aimed at determining the effects of group 
(between subjects factor) and task number (platform locations 1-5 – repeated measures 
factor), and group x task interactions on the following dependent variables: the number of 
trials to criterion (memory flexibility), percentage of time spent swimming in the training 
83 
quadrant during the first 60 sec of the 10min and 3h probe trials (PT) (short and long- term 
memory recall), and the number of virtual platform crossings, latency to the first platform 
crossing, and swimming speed to platform for the 10 min and 3h PT data (the analysis is 
presented in appendices I, table S.3.1.). One-way ANOVA was applied to statistically 
compare the group average percentage of time spent in the training quadrant during the 
10min and 3h probe trials (PTs) with a chance level of performance (determined to be 
equal to 25% => 100% divided by 4 as the water maze has 4 training quadrants) for each 
group across the five tasks (Coltman et al., 2011). The average group number of spatial 
tasks learned in 10 days was statistically analyzed using an unpaired t- test (Coltman et al., 
2011).  
Significant group differences were reported for p<0.05.  
3.2.3.2. Statistical analysis of the pathological data 
The regional group median pathological grades of axonal and myelin integrity as well as 
inflammatory activity were compared using Mann- Whitney non- parametric statistics. 
Only the pathological data from the animals included in the final behavioural analysis of 
the radial arm maze and the water maze experiments were subjected to a Mann- Whitney 
statistical analysis. The total group median pathological scores of myelin integrity were 
also analyzed using Man- Whitney statistics (table S.3.3.3.- appendices I). 
Significant group differences were reported for p<0.05. 
3.2.3.3. Correlation analysis 
In an attempt to account for potential associations between white matter integrity and 
behavioural parameters in hypoperfused mice (the main study hypothesis), a non-
parametric Spearman`s correlation analysis was performed between white matter cellular 
components and behavioural measures of spatial working memory and executive function. 
The analysis was focused on co- variates relevant to the main study hypothesis in order to 
avoid performing multiple associations between biomarkers across brain areas and various 
behavioural parameters inevitably leading to meeting the set criterion of significance 
(p<0.05) purely by chance. Specifically, the correlations between the total pathological 
scores of axonal (APP), myelin (MAG) integrity and inflammation (tables S.3.3.1, 
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S.3.3.2.- appendices I) and both the average number of revisiting errors across the 8 
training sessions of the radial arm maze task (working memory), and the average number 
of trials to criterion across the 5 spatial water maze task (executive function) were 
calculated. The number of revisiting errors and the trials to criterion were selected for 
behavioural co- variates as these parameters are considered to be robust measures of 
working memory and memory flexibility (executive function) on a radial arm maze and 
water maze paradigm, respectively (Olton and Samuelson, 1976; Morris, 1984; Chen et 
al., 2000; D`Hooge and De Deyn, 2001; Shibata et al., 2007; Nishio et al., 2010; Coltman 
et al., 2011). A separate Pearson`s analysis was performed between each biomarker and 
behavioural parameter. In regards to the main study hypothesis suggesting associations 
between hypoperfusion- induced white matter pathology and spatial working memory and 
executive function in mice, only the pathological and behavioural data from the 
hypoperfused animals were used for the correlational analysis with a risk of underpowered 
statistics (Pappas et al., 1996; Liu et al., 2005).  Furthermore, due to the absence of 
numerical scale for pathological variations (pathological grades equal 0) necessary for the 
associations between pathology and behaviour, the data from the sham animals could not 
be used for the correlation analyses. 












3.3.1. Post- surgery recovery and physiological status  
Five of the initially 20 hypoperfused mice (25%) included in the radial arm maze 
experiment had a poor post- surgery recovery and were procedure terminated. 
Unexpectedly, prior to and during the behavioural procedure another 25% (5/20) of the 
hypoperfused mice exhibited a seizure- like activity consisting of brief (a couple of 
minutes) uncoordinated body convulsions. These animals were excluded from all 
subsequent analysis. The remaining 50% (10/20) of the hypoperfused animals and all 
sham mice (10/10) recovered well after surgery and showed no overt signs of neurological 
and/or physiological dysfunction for the entire experimental period (figure S.3.1.2. A- 
appendices I). 
From the hypoperfused animals tested on the water maze paradigm, 22.2% (4/18) of the 
initially included mice had to be procedure terminated prior to or during the behavioural 
testing due to a poor recovery. The remaining 77.8% (14/18) of the hypoperfused mice 
survived the entire experimental procedure in the absence of any neurological or 
physiological dysfunction. Only one of the 14 hypoperfused mice (0.07%) showed 
seizure- like activity during behavioural testing. This animal was excluded from further 
analysis. All sham mice (11/11) recovered well after surgery and survived the whole 
experimental period in the absence of any overt neurological and/ or physiological 
dysfunction (figure S.3.1.2.B- appendices I) 
3.3.2. Effects of chronic cerebral hypoperfusion on spatial working memory, memory 
flexibility, learning capacity, short- and long- term memory recall in mice 
3.3.2.1. Chronic cerebral hypoperfusion leads to spatial working memory 
impairment  
 
Spatial working memory was tested in food deprived sham and chronically hypoperfused 
mice using a radial arm maze paradigm in which, on each daily trial, one piece of food 
reward was available at the end of each arm (Chapter 2, section 2.3.2.). Indications of an 
intact spatial working memory were considered to be: the absence (or the low number) of 
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revisiting errors and the high number of novel entries in the first 8 arm choices. The 
statistical analysis was performed using two- way repeated measures ANOVA (Chapter 3, 
section 3.2.3.1.1.;  Shibata et al., 2007, Nishio et al., 2010, Coltman et al., 2011). The 
statistical analysis showed that hypoperfused animals (n=10) committed significantly 
more revisiting errors (F(1, 18)= 22.457, p<0.0001) and visited significantly fewer new arms 
in the first 8 arm choice (F(1, 18)= 7.897, p= 0.012) than sham mice (n= 10) (figure 3.1. A, 
B). There was a significant effect of the training day for both the number of revisiting 
errors (F(1,18)= 25.346, p<0.0001) and the number of novel entries in the first 8 arm 
choices (F(1,18)= 26.136, p<0.0001). Similar significant group differences were observed 
for the total number of arm entries and the trial duration (S.3.1.3.- appendices I). No 
significant training day x group interaction was found for any behavioural measure 
suggesting that the performance of both hypoperfused and sham mice improved with 
training (overtime): the number of revisiting errors (F(1,18)=  1.348, p= 0.288) and the 
number of novel entries in the first 8 arm choices (F(1,18)=  1.981, p=0.176) (the total 
number of arm entries and the trial duration- S.3.1.3.- appendices I). The post- hoc 
Tukey`s analysis demonstrated that hypoperfused mice committed significantly more 
revisiting errors on training day 2 (p= 0.001), day 6 (p=0.011), day 7 (p= 0.003), and day 
8 (p=0.031) (figure 3.1. A). They also visited significantly fewer novel arms on training 
day 4 (p=0.007), day 7 (p=0.043), and day 8 (p=0.019) (figure 3.1. B). 
These behavioural results were confirmed by our group in an additional cohort of 
hypoperfused animals tested on the same radial arm maze spatial working memory task 
(S.3.2.- appendices I; Coltman et al., 2011) as well as independently by others (Shibata et 






  Figure 3.1.: Group performance on a spatial working memory radial arm maze task 
(group mean ± SE) 
Spatial working memory was significantly impaired in chronically hypoperfused mice. 
Two- way repeated measures ANOVA demonstrated that chronically hypoperfused mice 
(n=10) committed significantly more revisiting errors (A) and entered significantly fewer 
new arms in the first 8 arm choices (B), than sham mice (n=10) on a radial arm maze 
paradigm (p<0.05). 





3.3.2.2. Chronic cerebral hypoperfusion does not affect spatial memory flexibility  
 
Spatial memory flexibility was tested in sham and hypoperfused mice using a water maze 
protocol where each animal had to learn five separate spatial problems with a set criterion 
of performance in 10 days (Chapter 2, section 2.3.3.2.2.; Chen et al., 2000; Coltman et al., 
2011). Spatial memory flexibility was considered intact when the animals were able to 
rapidly acquire new spatial problems in a few trials to criterion. The statistical analysis 
was performed using two- way repeated measures ANOVA (Chapter 3, section 3.2.3.1.2; 
Chen et al., 2000, Coltman et al., 2011). No significant main effects of task (F(4, 76) = 
1.566, p = 0.19), or group (F(1, 19) = 0.035, p = 0.85) and no significant group x task 
interaction (F(4, 76) = 0.524, p = 0.72) for the number of trials to criterion were evident 
(figure 3.2. A).  
 
3.3.2.3. Chronic cerebral hypoperfusion does not affect spatial learning capacity  
 
Spatial learning capacity was evaluated by statistically comparing the average number of 
spatial problems sham and hypoperfused mice managed to learn on the serial spatial 
learning and memory task in 10 days using an unpaired t- test (Chapter 3, section 
3.2.3.1.2; Coltman et al., 2011). This analysis revealed no significant differences between 
the two experimental groups in the number of spatial tasks learned in 10 days  
(t= 0.756, p = 0.459) (figure 3.2.B). 
 
3.3.2.4. Chronic cerebral hypoperfusion does not impact on spatial short and long 
term memory recall  
 
Spatial short- and long- term memory recall were challenged respectively at 10min and 3h 
after an animal had reached the learning criterion on each of the five spatial tasks (Chapter 
2, section 2.3.3.2.2.2.; Chen et al., 2000; Coltman et al., 2011). Indications of an intact 
memory recall of the spatial location of the hidden platform were considered to be the 




Figure 3.2.: Group performance on a serial spatial learning and memory water 
maze task 
(group mean ± SE) 
Spatial memory flexibility (A), learning capacity (B), short (C) and long (D) term 
memory recall were preserved in hypoperfused mice. Two- way repeated measures 
ANOVA demonstrated an absence of significant differences in the average number of 
trials to criterion (A), the average percentage of  time spent swimming in the training 
quadrant during the 10min (C) and 3h (D) PT between chronically hypoperfused 
(n=10) and sham (n=11)  mice (p>0.05). Both sham and chronically hypoperfused 
mice performed above chance level (25%) on the 10min and 3h PT (p>0.05) (C, D). 
The t- test analysis failed to show significant group differences in the average number 




the platform was situated during the training procedure). The statistical analysis was 
performed using two- way repeated measures ANOVA (Chapter 3, section 3.2.3.1.2; Chen 
et al., 2000; Coltman et al., 2011). The statistical analysis on the trials to criterion across 
the first five platform locations revealed no significant main effects of task (F(4, 76) = 
1.566, p = 0.19), or group (F(1, 19) = 0.035, p = 0.85) and no significant group x day 
interaction (F(4, 76) = 0.524, p = 0.72) (figure 3.2. C, D). These results were confirmed by 
the statistical analysis of alternative behavioural measures, namely the average number of 
virtual platform crossings, latency to platform and swimming speed to platform (once the 
platform reappeared during the last 30 sec of each PT) obtained from the 10 min and 3h 
PT (p>0.05) (table S.3.1- appendices I). One- way ANOVA statistical analysis showed 
that the percentage of time the animals from the two experimental groups spent searching 
for the hidden platform in the training quadrant during the first 60 sec for the five spatial 
tasks was significantly higher than chance (25%) for both the 10min and 3 h PT (p<.05) 
except for the 10min PT for task 1 and the 3h PT for task 5 where no difference from 
chance performance was evidenced (p>0.05). 
3.3.3. Effects of chronic cerebral hypoperfusion on white and grey matter integrity, 
inflammation  
 
3.3.3.1. Chronic cerebral hypoperfusion leads to a significant axonal injury in white 
and grey matter 
 
 Axonal integrity was examined by amyloid precursor protein (APP) 
immunohistochemistry in white and grey matter ROIs at the completion of the behavioural 
testing in sham and hypoperfused mice. APP is considered to be a sensitive biomarker of 
axonal integrity (Stephenson et al., 1992; Selkoe, 1994). Under normal physiological 
conditions this protein is immunodetected in the neural cell bodies where it is synthesized 
(Forloni et al., 1992; Palacios et al., 1992). The protein is transported to the axonal 
terminal via fast axonal transport. APP accumulates in clusters if there is pathological 




Figure 3.3.: White matter integrity and inflammation in sham and hypoperfused 
mice  
Representative images of immunohistochemically stained axons (A-A2), myelin (B-B2) 
and microglia (C-C2) from the OT of sham (A- C) and chronically hypoperfused mice 
tested on a radial arm maze (A1- C1) and a water maze (A2- C2) paradigms.  Axonal 
injury was detected by APP immunoreactivity in swollen and bulbous axons in 
hypoperfused mice (arrows in A1, A2). MAG immunostaining revealed myelin 
abnormalities such as disorganized myelin fibers, vacuoles formations and myelin debris 
in the two hypoperfused cohorts (arrows in B1, B2). Inflammatory levels were increased 
after chronic cerebral hypoperfusion (arrows in C1, C2). Normal axonal (A) and myelin 
(B) integrity, inflammatory levels (C) were evident in sham animals tested on both the 
radial arm maze and the water maze paradigms.  
Scale bar represents 20µm (magnification x40). 
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APP immunoreactivity was restricted to cell bodies in all sham operated animals (figure 
3.3. A). However, after chronic cerebral hypoperfusion APP was also immunodetected as 
small dark clusters in swollen/ bulbous axons- an indicative of axonal injury (figure 3.3. 
A1.A2.- black arrows). The observed hypoperfusion- induced axonal pathology was 
widespread among examined grey and white matter regions. The statistical analysis 
comparing the regional and total group pathological grades of axonal integrity was 
performed using Man- Whitney nonparametric test (Chapter 3, section 3.2.3.2.). 
 
In the radial arm maze experiment, axonal injury with a varying degree of severity was 
evidenced in 90% (9/10) of the hypoperfused animals (figure 3.3. A1). In this experiment, 
axonal integrity was significantly compromised in all examined white and grey matter 
ROIs: the CC (U= 15.000, p= 0.002), EC (U= 10.000, p= 0.001), IC (U= 15.000, p= 
0.002), OT (U= 10.000, p<0.0001), Fx (U= 15.000, p= 0.002), hippocampus (U= 10.000, 
p= 0.001) and Cx (U= 20.000, p= 0.005), (table 3.1.1.; figure S.3.4.1. A- E, G- H 
appendices I).  
Similarly, axonal injury was also evident in 90% (9/10) of the hypoperfused mice tested 
on a water maze paradigm (figure 3.3. A2). However, in this particular study, significant 
hypoperfusion- induced axonal pathology was only observed in the OT (U= 33.000, p= 
0.023) and the hippocampus (U= 33.000, p= 0.023) (table 3.1.2.; figure S.3.4.2. D, G, 
appendices I). There was no significant group difference in the axonal integrity in any of 
the other examined white and grey matter ROIs: the CC (U= 55.000, p= 1.000), EC (U= 
55.000, p= 1.000), IC (U= 49.500, p= 0.294), Fx (U= 49.500, p= 0.294), and Cx (U= 
44.000, p= 0.128) (table 3.1.2.;figure S.3.4.2. A-C, E, H, appendices I).  
 
The regional pathological grades of axonal integrity for each individual mouse are given 
in tables S.3.2.1. and S.3.2.2., appendices I. The total scores of axonal integrity and the 







Biomarker Regions of Sham (n=10) Hypoperfused (n=10)
interest (median) (median)
APP Corpus callosum (CC) 0.0      1.0 **
Axonal integrity External capsule (EC) 0.0        1.0 ***
Internal capsule (IC) 0.0      1.5 **
Optic tract (OT) 0.0        3.0 ***
Fimbria fornix (Fx) 0.0      1.0 **
Hippocampus 0.0        1.5 ***
Cortex (Cx) 0.0     1.5 **
MAG Corpus callosum (CC) 0.0     1.0 **
Myelin integrity External capsule (EC) 0.0     1.0 **
Internal capsule (IC) 0.0        2.0 ***
Optic tract (OT) 0.0        3.0 ***
Fimbria fornix (Fx) 0.0        1.5 ***
Iba1 Corpus callosum (CC) 0.0    0.0 *
Inflammation External capsule (EC) 0.0      1.0 **
Internal capsule (IC) 0.0      0.5 **
Optic tract (OT) 0.0      2.0 **
Fimbria fornix (Fx) 0.0      1.0 **
Hippocampus 0.0     0.0 *
Cortex (Cx) 0.0      1.0 **
 
  
Table 3.1.1.: Regional group median pathological grades: 
 Radial arm maze experiment 
Chronically hypoperfused mice (n=10) tested on a radial arm maze paradigm 
exhibited a significant axonal damage (APP), significant myelin abnormalities 
(MAG) and a significantly increased inflammation (Iba1) compared with sham 
animals (n=10) in the examined ROIs two months post- surgery. 
Significant group differences as given by Mann- Whitney nonparametric statistics: 
(p<0.05)*, (p<0.01)**, (p<0.001)*** 
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Biomarker Regions of Sham (n=11) Hypoperfused (n=10)
interest (median) (median)
APP Corpus callosum (CC) 0.0 0.0
Axonal integrity External capsule (EC) 0.0 0.0
Internal capsule (IC) 0.0 0.0
Optic tract (OT) 0.0    0.0 *
Fimbria fornix (Fx) 0.0 0.0
Hippocampus 0.0    0.0 *
Cortex (Cx) 0.0 0.0
MAG Corpus callosum (CC) 0.0       0.5 **
Myelin integrity External capsule (EC) 0.0      1.0 **
Internal capsule (IC) 0.0        1.0 ***
Optic tract (OT) 0.0        3.0 ***
Fimbria fornix (Fx) 0.0      0.0 **
Iba1 Corpus callosum (CC) 0.0  0.0
Inflammation External capsule (EC) 0.0       1.0 **
Internal capsule (IC) 0.0         1.5 ***
Optic tract (OT) 0.0          2.5 ***
Fimbria fornix (Fx) 0.0        0.5 **
Hippocampus 0.0   0.0



























Table 3.1.2.: Regional group median pathological grades:  
Water maze experiment 
Chronically hypoperfused mice (n=10) tested on a water maze paradigm exhibited 
minimal axonal injury (APP), a significant myelin pathology (MAG) and increased 
inflammation (Iba1) compared with sham animals (n=11) in the examined ROIs two 
months post- surgery. 
Significant group differences as given by Mann- Whitney nonparametric statistics: 
(p<0.05)*, (p<0.01)**, (p<0.001)*** 
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3.3.3.2. Chronic cerebral hypoperfusion leads to a significant myelin pathology  
 
Myelin structural integrity was evaluated in behaviourally tested sham and chronically 
hypoperfused mice by means of myelin associated glycoprotein (MAG) 
immunochemistry. MAG is known to be a sensitive biomarker for myelin abnormalities  
 (vacuole formations, fiber disorganization, debris) occurring under mild hypoxic- 
ischemic conditions (Aboul- Enein et al., 2003).  
 
MAG stained myelin fibers were tightly organized and formed well defined bundle- like 
structures (tracts), easily detectable in white matter regions of all sham operated animals 
(figure 3.3. B). However, myelin structural abnormalities with a different degree of 
severity were evident in white matter regions of all hypoperfused mice (figure 3.3. B1, 
B2). These white matter pathological changes consisted of vacuole formations in the 
myelin sheath, deposition of MAG debris (figure 3.3. B1, B2- black arrows). The 
statistical analysis comparing the regional and total group pathological grades of myelin 
integrity was performed using Man- Whitney nonparametric test (Chapter 3, section 
3.2.3.2.). 
 
In the radial arm maze experiment, hypoperfused mice showed significant myelin 
abnormalities in all examined white matter ROIs: the CC (U= 20.000, p= 0.004), EC (U= 
20.000, p= 0.004), IC (U= 5.000, p<0.0001), OT (U= 5.000, p<0.0001), and Fx (U= 
5.000, p<0.0001) (figure 3.3. B1) (table 3.1.1.; figure S.3.4.3. A- E, appendices I).   
 
Similar results were observed for the water maze experiment where significant 
hypoperfusion- induced myelin pathology was observed in the CC (U= 27.500, p= 0.009), 
EC (U= 22.000, p= 0.003), IC (U= 5.500, p<0.0001), OT (U= 0.000, p<0.0001), and Fx 
(U= 33.000, p= 0.023) (figure 3.3. B2) (table 3.1.2.; figure S.3.4.4. A- E, appendices I).  
 
The regional pathological grades of myelin integrity for each individual mouse are given 
in table S.3.2.3. and S.3.2.4. appendices I. The total scores of myelin integrity and the 
associated statistical analysis are given in table S.3.3.1., S.3.3.2. S.3.3.3.- appendices I. 
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3.3.3.3. Chronic cerebral hypoperfusion leads to a significantly increased 
inflammation  
 
In the present study, an ionized calcium binding adaptor protein 1 (Iba1) antibody targeted 
to inflammatory microglia (Ito et al., 1998) was applied to investigate inflammatory 
processes in white and grey matter ROIs in behaviourally tested sham and hypoperfused 
mice. 
 
Normal inflammatory levels were evidenced in all sham- operated mice where a few, 
resident Iba1 positive microglial cells were immunodetected in examined white and grey 
matter areas (figure 3.3. C). Chronic cerebral hypoperfusion was associated with an 
increase of Iba1 immunoreactivity in examined grey and white matter ROIs- an indicative 
of an increased inflammatory activity (figure 3.3. C1, C2- black arrows). The statistical 
analysis comparing the regional and total group pathological grades of axonal integrity 
was performed using Man- Whitney nonparametric test (Chapter 3, section 3.2.3.2.). 
 
In the radial arm maze experiment, increased inflammation was observed in 80% (8/10) of 
the hypoperfused mice (figure 3.3. C1). In this experiment, significant differences in 
inflammatory levels between sham and chronically hypoperfused mice were reported for 
all examined ROIs: the CC (U= 30.000, p= 0.030), EC (U= 20.000, p= 0.005), IC (U= 
25.000, p= 0.013), OT (U= 20.000, p= 0.005), Fx (U= 15.000, p= 0.002), hippocampus 
(U= 30.000, p= 0.030) and Cx (U= 20.000, p= 0.005)  (table 3.1.1.; figure S.3.4.5. A-E, G, 
H,  appendices I).  
 
In the water maze experiment, increased inflammatory levels were observed in 90% (9/10) 
of hypoperfused mice (figure 3.3. C2). However, in this particular study, significant group 
differences in the inflammatory levels were statistically evidenced only for the EC (U= 
22.000, p= 0.003), IC (U= 5.500, p<0.0001), OT (U= 5.500, p<0.0001), Fx (U= 27.500, 
p= 0.009). In the CC, inflammatory levels did not change significantly with hypoperfusion 
(U= 49.000, p= 0.294) (table 3.1.2.; figure S.3.4.6. A- E, appendices I). In this behavioural 




Figure 3.4.: Grey matter integrity in sham and hypoperfused mice 
Representative images of H&E staining from the striatum (A-A2) and CA1 region of the 
hippocampus (B-B2) of sham (A, B) and chronically hypoperfused mice tested on a radial 
arm maze (A1, B1) and water maze (B1, B2) paradigms. Neuronal perykaria ischemic 
injury was observed in examined grey matter areas of hypoperfused mice (arrow in A1, B1, 
B2). Grey matter structural integrity was preserved in all sham mice (A-B)  
Scale bar represents 15µm (magnification x40) (A-A2), 20µm (magnification x60) (B-B2). 
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observed for any of the grey matter ROIs- the hippocampus (U= 49.500, p= 0.294) and Cx 
(U= 44.000, p= 0.128) (table 3.1.2.; figure S.3.4.6. G, H appendices I).  
 
The regional pathological grades of inflammation for each individual mouse are given in 
tables S.3.2.5. and S.3.2.6. appendices I. The total scores of inflammation and the associated 
statistical analysis are given in table S.3.3.1., S.3.3.2. S.3.3.3.- appendices I. 
3.3.3.4. Chronic cerebral hypoperfusion leads to neuronal ischemic damage 
Previously published studies on chronically hypoperfused mice reported an absence of 
overt grey matter abnormalities in this animal model (Shibata et al., 2004, Shibata et al., 
2007). The present study aimed at independently examining the presence of neuronal 
ischemic injury in behaviourally tested sham and chronically hypoperfused mice by using 
a standard H&E histological staining.  
 
In the present study, all sham- operated mice exhibited a healthy neuronal morphology 
characterized by a large blue nucleus and a light blue cytoplasm observed in cortical (the 
Cx) and subcortical (the hippocampus, the striatum) areas (figure 3.4. A, B). The overall 
brain morphology following sham surgery was well preserved and the different brain 
regions were easily distinguishable on the basis of their specific cellular morphology and 
layer organization (figure 3.4. A, B).  
 
Unexpectedly, cortical and subcortical grey matter ischemic injury was observed in 70% 
(7/ 10) of the hypoperfused mice tested on  the radial arm maze task and in 28.5% (4/14) 
of the hypoperfused mice tested on the water maze paradigm (figure 3.4. A1, A2, B1, B2). 
Ischemic neurons presented a small, shrunken, dark blue, and triangular cellular 
morphology (figure 3.4. A1, B1- black arrow). In some of the injured cells there was an 
absence of a clear differentiation between the nucleus and the cytoplasm. “Ghost neuron” 
formations characterized by the physical disappearance of ischemic neurons were 
observed among cellular layers as light pink areas (figure 3.4. B1- white arrow). Pallor 
and vacuolation of the neuropil were also observed in areas of ischemic damage (figure 
S.3.4., appendices I). The predominantly affected grey matter areas in hypoperfused mice 
99 
were regions known for their susceptibility to blood flow alterations: the CA1 area of the 
hippocampus, the Cx and the striatum. However, as the pathological analysis was 
performed relatively late after the induction of chronic cerebral hypoperfusion (~ 2 
months after the microcoils application), glial scar formations were observed in the 
majority of the ischemic areas, thus rendering difficult any attempt to quantitatively 
evaluate the severity of the observed pathological changes (e.g. cell counting was 
impossible) (figure S.3.4., appendices I). Therefore, in the present study the neuronal 
ischemic injury was reported only as present/ absent.  
 
At the examined brain levels, an absence of overt neuronal ischemic injury, a preserved 
grey matter structural integrity and brain morphology were evidenced in only 30% (3/10) 
of the hypoperfused mice tested on the radial arm maze paradigm and in 71.5 % (10/14) of 
the hypoperfused mice tested in the water maze experiment. 
 
3.3.4. Inflammation in white matter correlates significantly with working memory, 
but not executive function in hypoperfused mice. 
 
In order to investigate potential associations between hypoperfusion- induced white matter 
pathology and behavioural parameters in mice, a Spearman`s correlation analysis was 
performed between the overall assessment of axonal, myelin integrity, inflammation 
(tables S.3.3.1 and S.3.3.2- appendices I) in each mouse  and their behavioural assessment 
of working memory (the number of revisiting errors on a radial arm maze paradigm) and 
executive function (the number of trials to criterion on a water maze task) (Chapter 3, 
section 3.2.3.3.). The results demonstrated significant associations between working 
memory and inflammation in white matter (r= 0.70, p= 0.03), but not between working 
memory and axonal (r=0.40, p= 0.25), myelin (r=-0.19, p= 0.58) integrity in white matter 
(figure 3.5. A, C, E). An absence of significant associations was evident between 
executive function (memory flexibility) and all examined white matter components: 
axonal (r=0.35, p= 0.31), myelin (r=-0.18, p= 0.61) integrity and inflammation (r=-0.01, 








Figure 3.5.: Correlation analysis between white matter cellular components and 
behavioural parameters of working memory and executive function in 
hypoperfused mice 
The Spearman`s correlation analysis demonstrated significant associations between 
working memory (revisiting errors) and inflammation in white matter (E) (p<0.05), in 
the absence of significant associations between working memory and axonal (A)/ 
myelin (C) integrity (p>0.05). No significant associations were evident between 
executive function (trials to criterion) and any of examined white matter cellular 




Building on previous work, the experiments presented in Chapter 3 sought to test the 
hypothesis that hypoperfusion- induced white matter pathology might be associated with 
spatial working memory and executive function deficits in mice. In accordance with the 
existing literature on this animal model, the behavioural data confirmed the existence of 
spatial working memory impairment in the absence of spatial memory flexibility, learning, 
short- and long- term memory recall deficits in hypoperfused mice. In contradiction with 
previously published work on this animal model, a spectrum of white and grey matter 
abnormalities accompanied by an increased inflammation were evident in behaviourally 
tested hypoperfused mice. Although there was a significant association only between 
hypoperfusion- induced inflammation in white matter and performance on a working 
memory radial arm maze task, the present pathological findings suggest that white matter 
abnormalities, neuronal ischemia and increased inflammation might be at the basis of 
hypoperfusion- induced cognitive impairment in mice.  
3.4.1. Cognition and memory in chronically hypoperfused mice 
3.4.1.1. Spatial working memory impairment in chronically hypoperfused mice 
In accordance with previous findings on this animal model (Shibata et al., 2007; Nishio et 
al., 2010), the present behavioural results confirmed the occurrence of spatial working 
memory impairment in chronically hypoperfused mice (Coltman et al., 2011). Executive 
function (memory flexibility), learning capacity, short and long- term memory recall were 
preserved in hypoperfused mice (Coltman et al., 2011). The absence of visual impairment 
in the behaviourally tested cohorts suggests that the observed cognitive deficits were due 
to hypoperfusion- induced neuropathology rather than visual disturbances (data presented 
in S.3.1.1., S.3.3. appendices I).  
 
The present behavioural data and published work on this animal model suggest that 
chronic cerebral hypoperfusion results in working memory impairment in mice at early 
post- surgery time points. 
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Interestingly, there seem to be species differences in the onset of cognitive impairment 
following chronic cerebral hypoperfusion in rodents. In rats, chronic cerebral 
hypoperfusion leads to an initial spatial reference memory impairment on a water maze 
task (7 days post- surgery) followed by long- term spatial reference and working memory 
deficits on a radial arm maze task (63 days post surgery) (Pappas et al., 1996; Sopala and 
Danysz, 2001). In contrast, hypoperfused mice exhibit an early spatial working memory 
impairment on a radial arm maze task in the absence of spatial reference memory or 
executive function deficits taxed on radial arm maze and water maze paradigms (Shibata 
et al., 2007; Coltman et al., 2011).  In chronically hypoperfused mice a spatial reference 
memory deficit is observed 6 months post- surgery (Nishio et al., 2010). The reported 
differences in the behavioural performance of hypoperfused rats and mice might be due to 
overall methodological as well as species differences in the response to hypoperfusion. 
Specifically, in hypoperfused rats, the common carotid arteries are completely ligated 
leading to severe cerebral blood flow reductions. In hypoperfused mice, the common 
carotids are only partially obstructed and the cerebral blood flow is modestly reduced. 
However, at the difference from the majority of rat strains, the C57Bl6J mice have 
underdeveloped posterior communicating arteries leading to poorer cerebrovascular 
compensations and a more severe pathological/ functional outcome following 
cerebrovascular challenges (e.g. cerebral ischemia) in this mouse strain (Yang et al., 1997; 
Kitagawa et al., 1998). Therefore, it is possible that differences inherent to the surgical 
procedure and the underlying cerebrovasculature might differentially impact on the spatio- 
temporal onset of neuropathology in hypoperfused rats and mice resulting in differential 
temporal onset of cognitive impairment in these animal models. However, in both 
hypoperfused mice and rats the severity of cognitive deficits seems to increase overtime in 
consistency with the chronic nature of the surgical intervention.  
 
In the alternative gerbil model of chronic cerebral hypoperfusion impaired learning 
capacity was evidence on a fear- conditioning task (Kudo et al., 1990). These behavioural 
data were also confirmed in hypoperfused rats which exhibited a learning impairment on a 
similar paradigm- the passive avoidance step task one month post- surgery (Kumaran et 
al., 2008). However, at the same post- surgical time point chronically hypoperfused mice 
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performed a fear- conditioning task as well as sham- operated counterparts (Shibata et al., 
2007; Nishio et al., 2010). It is unknown whether working memory and executive function 
are impaired in hypoperfused gerbils and whether the observed learning deficits worsen 
proportionally with the post- surgery time point in this animal model of chronic cerebral 
hypoperfusion. This is due to the fact that it is difficult to train this rodent species on 
standard behavioural paradigms such as the water maze and the radial arm maze.  
 
Overall, the behavioural data from the existing rodent models indicate the existence of 
certain species differences in the functional outcome following chronic cerebral 
hypoperfusion. This is important for preclinical (animal) data interpretation and 
extrapolation to humans. Specifically, when working with animal models one should  be 
aware of the fact that animal models do not replicate the human condition in its entire 
complexity, but do mimic some of its pathophysiological, neuropathological and 
functional aspects and therefore by their nature they do present certain limitations 
(Hainsworth and Markus, 2008; Jiwa et al., 2010). 
 
The present animal data support clinical findings on elderly people with artery stenosis 
exhibiting working memory impairment (Derdeyn et al., 1994; Mathiesen et al., 2004; 
Ruitenberg et al., 2005). However, at the difference from elderly people, chronically 
hypoperfused mice have preserved executive function (memory flexibility) at least at early 
post- surgery time points (1-2 months after surgery). Future behavioural experiments on 
this animal model would allow to investigate alternative memory and cognitive processes 
such as for instance processing speed (reaction time) which are known to be impaired in 
“healthy” elderly (Kennedy and Raz, 2009; Madden et al., 2009; Sullivan et al., 2010). 
From a methodological point of view this could be achieved by comparing the 
performance of sham and hypoperfused mice on existing behavioural paradigms such as 
operant and serial choice paradigms (Moore et al., 1992; Young et al., 2010). Further 
detailed time- course behavioural studies would allow to examine the temporal evolution 
of cognitive impairment in this chronic animal model (discussed in section 3.4.4.3.). 
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3.4.2. Spectrum of white and grey matter pathology in chronically hypoperfused 
mice  
3.4.2.1. Axonal injury in white and grey matter of chronically hypoperfused mice 
Pathological damage to axons is associated with a disruption of axonal cytoarchitecture 
and disturbances of fast axonal transport. Following axonal damage, the anterogradely 
transported APP accumulates proximal to the disrupted segment in swollen and bulbous 
axons forming immunodetectable protein clusters occurring before conventional 
morphological evidence of axonal damage (e.g. in the form of axonal end bulbs) 
(Stephenson et al., 1992). Therefore, APP immunochemistry is considered to be more 
sensitive technique than routinely used histological methods for detecting axonal damage 
such as for example Bodian or Bielschowsky’s silver impregnation (Switzer, 2000). 
 
The results from the present study demonstrated that axonal integrity was intact in sham- 
operated mice as evidenced by restricted APP immunoreactivity to cell bodies in white 
and grey matter areas. However, axonal injury with a varying degree of severity was 
observed in white and grey matter regions of behaviourally tested, chronically 
hypoperfused mice. Specifically, in the radial arm maze experiment, a significant 
widespread axonal damage was evidenced in white matter tracts (CC, EC, IC, Fx, and 
OT), cortical (Cx) and subcortical (hippocampus) grey matter regions of the hypoperfused 
brain. In the water maze experiment, chronic cerebral hypoperfusion was associated with 
relatively preserved axonal integrity in the majority of the examined white matter areas 
(CC, EC, IC, Fx) and the Cx. In this particular experiment, a significant hypoperfusion- 
induced axonal injury was observed only in the OT and hippocampus. The more 
widespread axonal injury observed in the hypoperfused cohort tested on a radial arm maze 
paradigm is in consistency with the more pronounced grey matter pathology in these 
animals (discussed in section 3.4.2.3.).  
 
The present pathological findings are in contradiction with previous studies on 
hypoperfused mice suggesting the existence of selective white matter pathology with 
minimal axonal injury in this animal model (Holland et al., 2011; Reimer et al., 2011).  
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In particular, two recent publications from our group have demonstrated using scanning- 
confocal and electron microscopy (Reimer et al., 2011) as well as in vivo MRI (Holland et 
al., 2011) an absence of and/ or a minimal axonal injury in ad libitum fed and non- 
behaviourally tested chronically hypoperfused mice at both early (3 days) and late (1 
month) post- surgery time points. The observed discrepancies with the present 
pathological findings could be explained by differences in the applied methodological 
approach. From a technical point of view, both Holland et al., 2011 and Reimer et al., 
2011 used much more sophisticated imaging tools allowing quantification of the observed 
axonal pathology, which could not be achieved by means of the presently applied semi- 
quantitative grading scale used to differentiate among variations in APP 
immunoreactivity. Further, at the difference from the present study, in Holland et al., 
2011, Reimer et al., 2011, the animals were not food deprived and/ or behaviourally tested 
(discussed in section 3.4.4.). Also, the time point used for the pathological analysis was 1 
month post- surgery for Holland et al., 2011, Reimer et al., 2011, whereas in the present 
study the pathology was examined ~2 months post- surgery (discussed in section 3.4.4.).  
 
The presently observed significant axonal injury in white and grey matter areas of 
chronically hypoperfused mice is substantiated by animal and human studies. Specifically, 
hypoperfusion- induced axonal injury was reported in chronically hypoperfused rats and 
gerbils even in the absence of behavioural training (Kurumatani et al., 1998; Wakita et al., 
2002). In the rat model of chronic cerebral hypoperfusion APP clusters were 
immunodetected in white and grey matter areas as soon as 14 days post- surgery and the 
severity of the observed axonal pathology was reported to increase gradually from 1 to 30 
days after artery ligation (Wakita et al., 2002). In chronically hypoperfused gerbils, 
significant changes in axonal cytoarchitecture were evidenced by applying a Western blot 
analysis to one of the major axonal neurofilaments- neurofilament H, two months after 
chronic cerebral hypoperfusion (Kurumatani et al., 1998). In the present experiments on 
chronically hypoperfused mice, axonal neurofilaments and microtubules were not 
examined, but future studies should aim at gaining a better understanding of the precise 
hypoperfusion- induced alterations in axonal cytoarchitecture in relation to other white/ 
grey matter cellular components (neurons, glia, myelin) by using a combined 
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immunochemical and biomolecular (e.g. Western blot and/ or (q)PCR) approach to 
visualize as well as to quantitatively detect protein levels and/ or mRNA expression of 
neurofilaments, microtubules, synaptic terminals.  
 
Clinical studies demonstrated axonal pathology in “healthy” and demented elderly on 
MRI/ DTI scans (e.g. reductions in axial diffusivity) and post- mortem as 
immunochemically- evident axonal swellings and bulbs (Syde et al., 2005; Gunning- 
Dixon et al., 2009; Madden et al., 2009; Salehi et al., 2009). In regards to the overall 
literature on white matter pathology, it seems that axonal abnormalities are more likely to 
be “the rule” than “the exception”. For instance, an extensive axonal loss has been 
reported in grey and white matter areas of multiple sclerosis patients and animal models of 
this condition (Davie et al., 1995; Trapp et al., 1998; Bitsch et al., 2000; Mancardi et al., 
2001; Lassmann, 2003; Craner et al., 2004; Fischer et al., 2009). These findings are 
interesting as multiple sclerosis is primarily regarded as an autoimmune, demyelinating 
disorder. Axonal injury is also a common pathological hallmark in spinal cord and 
traumatic brain injury (Park et al., 2004; Buki and Povlishok, 2006; Yi and Hazell, 2006). 
It is believed that axonal injury is at the basis of functional impairment (cognitive, 
memory and motor deficits) associated with white matter damage in different 
neurological/ neurodegenerative conditions as well as in elderly (Medana and Esiri, 2003). 
This is not surprising considering the fact that axonal degeneration could lead to synaptic 
loss, dendritic abnormalties and disruption of broad neural connections (Medana and Esiri,  
2003; Buki and Povlishok, 2006; Fields, 2008).   
Although, there are discrepancies between the present findings of axonal injury in 
chronically hypoperfused mice and already published work on this model (Holland et al., 
2011; Reimer et al., 2011), the overall existing literature supports the existence of axonal 






3.4.2.2. Myelin pathology in chronically hypoperfused mice 
In the present study, myelin associated glycoprotein (MAG) immunochemistry was 
applied for the pathological evaluation of myelin structural integrity in behaviourally 
tested sham and chronically hypoperfused mice.  
MAG is a minor myelin protein (2% of total myelin protein) with periaxonal localization 
(Quarles, 2007). Functionally, MAG is involved in axon- glial interactions and it is a well 
established molecular factor inhibiting axonal regeneration following brain injury by its 
involvement in the NOGO signaling system (Liu et al., 2002; Quarles, 2007).  
 
MAG has been shown to be preferentially lost under hypoxic- ischemic like conditions 
such as stroke (Aboul- Enein et al., 2003). Therefore, MAG immunohistochemistry is 
considered to be a sensitive pathological tool for the detection of mild structural 
abnormalities in the myelin sheath such as fibers disorganizations, vacuoles and 
accumulations of MAG debris which could not be detected using standard histological 
tools such as Kluver- Barrera and Luxol fast blue staining (Kluver and Barrera, 1953; 
Goto, 1987). This immunohistochemical approach has been previously applied by our 
group and has been shown to be sensitive to myelin abnormalities in chronically 
hypoperfused mice (Coltman et al., 2011; Holland et al., 2011; Reimer et al., 2011).  
In the present experiments, all sham- operated mice exhibited preserved myelin integrity 
in examined white matter areas. In accordance with previous findings in this model 
(Shibata et al., 2004, Shibata et al., 2007; Nishio et al., 2010; Coltman et al., 2011; 
Holland et al., 2011; Reimer et al., 2011), myelin abnormalities such as fibers 
disorganizations, vacuole formations and an accumulation of myelin debris in examined 
white matter tracts (the CC, EC, IC, OT, Fx) were evidenced in all hypoperfused animals 
tested on both the radial arm maze and the water maze tasks. These data suggest that 
myelin pathology assessed by MAG immunoreactivity is inherent to the hypoperfused 
condition regardless of any additional environmental factors (e.g. behavioural paradigm, 
food deprivation). 
In regards to previous findings on this animal model, it seems that pathological changes in 
MAG and the associated axon- glial interactions might be an early pathological 
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phenomenon occurring as soon as 3 days following microcoils surgery (Reimer et al., 
2011). These myelin abnormalities increase in severity proportionally with the post- 
surgery time period indicating cumulative pathological changes in the myelin sheath of 
chronically hypoperfused mice (Reimer et al., 2011). Interestingly, MAG protein levels 
remain intact in white matter areas of the chronically hypoperfused mouse brain at both 
early (3 days) and late (1 month) post- surgery time points. The reason(s) for the steady 
protein levels are unknown, but they might be related to preserved oligodendroglial 
protein synthesis as demonstrated by an absence of oligodendroglial apoptosis in this 
animal model (Reimer et al., 2011; Chapter 5). However, in MAG null mice, 
oligodendroglial apoptosis is reported to occur with chronological aging suggesting that 
following MAG loss in chronically hypoperfused mice, oligodendroglial apoptosis could 
occur at later post- surgical time points (Weiss et al., 2000). These in vivo results are 
supported by in vitro findings showing increased survival rate and myelin production by 
oligodendrocytes cultured in MAG supplemented media suggesting that MAG signaling is 
important for oligodendroglial biology (Gard et al.1996). Future long- term studies on 
chronically hypoperfused mice would allow to determine oligodendroglial fate in relation 
to MAG. Alternatively, it would be interesting to apply the microcoils surgery on MAG 
null mutants in order to determine the effects of deficient MAG signaling on 
oligodendroglia and myelin integrity in this model. Since MAG is involved in axon- glial 
interactions, one could suppose that an absence of MAG might also impact on the severity 
of axonal injury following chronic cerebral hypoperfusion. This hypothesis is supported 
by the existence of late- onset axonopathy in aging MAG null mutants characterized by 
axonal swellings, spheroids, as well as decreases in neurofilaments associated with nerve 
conduction abnormalities (Weiss et al., 2001; Loers et al. 2004). Further, compact myelin 
was reported to remain intact in chronically hypoperfused mice as shown by preserved 
MBP immunohistochemical distribution and protein levels between 3 days and 1 month 
post- surgery (Reimer et al., 2011). These observations are in accordance with findings in 
MAG null mutants where the absence of MAG does not affect compact myelin (PLP and 
MBP) protein levels (Weiss et al. 2000). However, in chronically hypoperfused rats, 
significant MBP decreases were evidenced by means of immunohistochemical analysis 
and protein assays (Farkas et al., 2004). Using a specific MBP isoform- degraded MBP 
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(dMBP) which selectively labels degraded myelin (Matsuo et al., 1997), myelin pathology 
was evidenced in various white matter regions of the hypoperfused mouse brain 1- 2 
months post- surgery using a standard immunohistochemical approach (Coltman et al., 
2011; Holland et al., 2011). These data were confirmed in the presence (Coltman et al., 
2011) and absence (Holland et al., 2011) of behavioural training suggesting that myelin 
pathology is an inherent pathological hallmark of the hypoperfused mouse brain. In 
addition to changes at the peri-axonal space evidenced by MAG immunohistochemistry, 
Reimer et al., 2011 demonstrated concomitant changes at the paranodes by Caspr- 
Neurofascin (Nfasc155) immunoreactivity. Caspr is located at the axonal paranode, and 
Nfasc155 is contained at the opposing paranodal loops of the myelin sheath. These 
proteins function as a diffusion barrier for the nodal Nav1.6. channels and are essential for 
the integrity of nodes of Ranvier. With hypoperfusion, there were significant reductions in 
Nfasc155 immunoreactivity suggesting paranodal abnormalities. It is unknown whether 
and/ or how MAG abnormalities might influence on the occurrence of paranodal 
pathology following chronic cerebral hypoperfusion and future studies should elucidate 
this question.  
Overall, the experimental data so far suggest the occurrence of paranodal- peri-axonal 
abnormalities in chronically hypoperfused mice at least at early post- surgery time points 
(1- 2 months following microcoils application).  
 
Chronological age is associated with pathological changes in myelin structure such as 
vacuole formations, cytoplasm- filled ballons, fibers disorganization and accumulation of 
myelin debris in white matter areas accompanied by alterations in myelin lipid and protein 
content (Knox et al., 1989; Tang et al., 1997; Peters et al., 2000; Peters and Sethares, 
2002; Bartzokis, 2004). These myelin abnormalities are observed in elderly humans, aged 
rats, and non- human primates and they are supposed to contribute to age- related 
cognitive decline (Knox et al., 1989; Tang et al., 1997; Peters et al., 2000; Peters and 
Sethares, 2002; Bartzokis, 2004). Additionally, MAG pathology is evidenced in several 
central nervous system disorders such as schizophrenia (Aberg et al. 2006; Mcinnes and 
Lauruat 2006), multiple sclerosis (Johnson et al. 1986; Rodriguez and Scheithauer 1994), 
cuprizone toxicity (Ludwin and Johnson 1981), progressive multifocal 
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leukoencephalopathy (Itoyama et al. 1982), hypoxic- ischemic conditions (Aboul- Enein 
et al., 2003). However, the functional implication of MAG abnormalities in humans 
remains unknown. In mice, MAG null mutantion is not associated with any major 
functional deficits (at least during early and mid- adulthood) when compared with aged 
matched WT controls (Montag et al., 1994). These animal data suggest that MAG 
abnormalities might not be crucial for sustaining normal cognitive and motor function.  
 3.4.2.3. Neuronal ischemic injury in chronically hypoperfused mice 
 
In the present experiments, a standard histological H&E staining was used to investigate 
the overall brain morphology and detect potential neuronal ischemic injury in the 
examined behavioural cohorts. Similar to other histological techniques, H&E is a crude 
method of pathological evaluation and lacks a sufficient sensitivity as to the mechanisms 
leading to neuronal cell death (apoptosis vs. necrosis), the damaged cellular compartments 
(dendrites, axons, soma, axonal terminals, synapses), the functional changes (protein 
synthesis, neurotransmission, gene expression, neuronal action potential firing) as well as 
the phenotype of the injured neurons. 
 
In the present experiments, an extensive neuronal ischemic loss was evidenced in 
examined cortical (the Cx) and subcrotical (the striatum, the hippocampus) grey matter 
areas of hypoperfused mice. The observed grey matter pathology was characterized by 
areas of pyknotic neural cells accompanied by regional disorganizations of structural layer 
morphology, pallor of neuropil. These pathological changes were primarily observed in 
food- deprived hypoperfused animals tested on a radial arm maze paradigm. The same 
results were observed for the replica of the radial arm maze experiment presented in 
appendices I confirming the presence of neuronal ischemic injury in the majority of 
hypoperfused mice (~70%) following behavioural training on a radial arm maze task. 
 
The present findings of neuronal ischemic injury in chronically hypoperfused mice tested 
on a radial arm maze task were surprising in regards to a previously published work on 
this model suggesting an absence of overt grey matter abnormalities at early post- surgery 
time points (1- 2 months post- coiling) (Shibata et al., 2004; Shibata et al., 2007; Coltman 
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et al., 2011; Holland et al, 2011). Specifically, Shibata et al. 2007 tested spatial working 
memory in chronically hypoperfused mice one month after surgery using the same 
behavioural paradigm (the radial arm maze task). However, this group never examined the 
pathological profile of the behaviourally tested cohort reporting no overt grey matter 
ischemic injury on the basis of pathological data from a simultaneously examined non- 
behaviourally challenged and ad libitum fed cohort of hypoperfused mice. Therefore, it is 
possible that grey matter ischemia was not detected by Shibata et al., 2007 as the 
neuropathology was not examined in the behaviourally tested chronically hypoperfused 
mice.  
 
Neuronal ischemic injury as well as morphological changes in neurons have been reported 
to occur in chronically hypoperfused rats and gerbils (Kudo et al., 1993; Ni et al., 1995; 
Pappas et al., 1996; Kim et al., 2008). Specifically, changes in MAP-2- a cytoskeletal 
phosphoprotein associated with dendritic microtubules and synaptophysin- a marker of 
synaptic vesicles, have been shown to decrease in both hypoperfused rats and gerbils 
(Kudo et al., 1993; Kurumatani et al., 1998; Liu et al., 2005). MAP-2 is regarded as a 
sensitive marker for ischemic brain injury and MAP- 2 mRNA and protein concentrations 
are significantly decreased at both early (1 month) and late (5 months) time points in the 
hypoperfused rat brain, indicating dendritic loss with hypoperfusion. Further, using an 
ethanolic phosphotungstic acid electron microscopy Hai et al., 2012 demonstrated a 
significant increase in the post- synaptic density proteins in the rat model of chronic 
cerebral hypoperfusion three months after surgery. In the same study, Western blot 
analysis identified significant changes in the protein levels of various kinases involved in 
signal transduction pathways Ca2+-calmodulin-dependent protein kinase II (CaMKII), 
phospho-CaMKII (p-CaMKII), phospho-extracellular regulated kinase (p-ERK),  in the 
CA1 region of the hypoperfused hippocampus.  
 
The present data showing neuronal ischemia in chronically hypoperfused mice as well as 
data from alternative animal models indicates the existence of important cellular and 
molecular changes occurring in grey matter areas following hypoperfusion and supports to 
a certain extent the validity of the alternative to the present hypothesis suggesting a role of 
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grey matter pathology in cognitive deficits associated with chronic cerebral hypoperfusion 
in mice (discussed in section 3.4.3.). 
 
In humans, neuronal loss is evidenced in various neurological conditions. Specifically, 
neuronal injury following cerebrovascular challenge is observed in patients with ischemic 
stroke, vascular dementia, cerebral amyloid angiopathy observed in Alzheimer`s disease, 
CADASIL (Garcia et al., 1996; Kalaria, 1996; Grinberg and Thal, 2010). Interestingly, to 
a lesser extent, grey matter pathology (neuronal cell loss) is also observed in different 
white matter conditions (Liu et al., 1997; Clark et al., 2000; Volpe, 2001; Dutta and Trapp, 
2007; Fischer et al., 2009; Geurts and Barkhof, 2008). Clinical and preclinical studies 
have demonstrated the presence of neuronal loss in multiple sclerosis patients and animal 
models of this condition (Meyer et al., 2001; Dutta and Trapp, 2007; Fischer et al., 2009; 
Geurts and Barkhof, 2008). In multiple sclerosis, grey matter pathology is believed to 
contribute to the occurrence of permanent disability (Meyer et al., 2001; Dutta and Trapp, 
2007). 
 
3.4.2.4. Increased inflammation in white and grey matter of chronically 
hypoperfused mice 
Previous findings on chronically hypoperfused rats, gerbils and mice (Kudo et al., 1990; 
Pappas et al., 1996; Tomimoto et al., 2003; Shibata et al., 2004; Coltman et al., 2011; 
Holland et al, 2011; Kitamura et al., 2012) suggest increased inflammatory levels in these 
animal models. Recently using a microarray analysis, Reimer et al., 2011, demonstrated 
significant alterations in inflammation associated genes following chronic cerebral 
hypoperfusion in mice. The present results support these previous data by demonstrating 
significant hypoperfusion- induced increases in Iba1 immunoreactivity in major white 
matter tracts (EC, IC, OT and Fx) in behaviourally tested mice. In consistency with the 
overall more severe pathological profile, only the hypoperfused animals tested on the 
radial arm maze paradigm presented significantly increased inflammation in the CC, Cx 
and hippocampus. Inflammatory levels in examined white and grey matter areas were 
considered normal in all sham- operated mice. 
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From a mechanistic point of view, microglia might have contributed to the development 
and severity of both white and grey matter pathology observed in the present experiments 
on chronically hypoperfused mice. Previous studies on hypoperfused mice and rats 
showed selective white matter- related increases in microglial cells/ inflammatory agents 
associated with the predominant white matter injury in these animal models (Tomimoto et 
al., 2003; Farkas et al., 2004; Shibata et al., 2004; Coltman et al., 2011; Holland et al., 
2011). These data are substantiated by in vitro, animal and clinical studies demonstrating 
that the myelin- producing oligodendroglial cells are particularly vulnerable to 
inflammation (Otero and Merrill, 1994; McLaurin et al., 1995; Vartanian et al., 1995; 
Merrill and Scolding, 1999). This is due to the fact that oligodendroglial cells express 
receptors for IL, cytokines and chemokines- inflammatory factors known to play an 
important role during oligodendroglial maturation, proliferation, migration and axonal 
myelination during neurodevelopment (Otero and Merrill, 1994; Dopp et al., 1997; 
Diemel et al., 1998; Vela et al., 2002). However, these signaling molecules could also be 
harmful to oligodendrocytes when synthesized in relatively high quantities as in the case 
of various neurodegenerative conditions (e.g. multiple sclerosis). For instance, in vitro 
studies have demonstrated that high concentrations of TNFα, IL-2 and IFNγ are lethal to 
oligodendroglia (Otero and Merrill, 1994; McLaurin et al., 1995; Vartanian et al., 1995). 
In transgenic mice overexpressing TNFα there are chronic inflammatory demyelination 
and degeneration of oligodendroglia. Further, TNFα levels have been shown to increase in 
chronically hypoperfused rats (Tomimoto et al., 2003) and to be associated with 
oligodendroglial apoptosis suggesting a role of this inflammatory factor in the 
development of hypoperfusion- induced neuropathology. In order to test the effects of the 
potential involvement of TNFα in the development of neuropathology following chronic 
cerebral hypoperfusion in mice, one could apply the microcoil surgery in TNFα mutants 
(Pasparakis et al., 1996) and compare axonal structure, myelin integrity in white and grey 
matter areas.  
 
The inflammatory response associated with hypoperfusion is sustained, occurring during 
the early post- surgery time points and detected up to 13 weeks after hypoperfusion in rats 
(Tomimoto et al., 2003; Farkas et al., 2004). However, little is known about the dynamics 
114 
of the inflammatory reaction following hypoperfusion in mice and how the observed 
spatio- temporal microglial activity might be associated with the development of 
neuropathology. Therefore, future studies should examine microglia at different post- 
surgery time points and determine the potential contribution of these cells to the observed 
pathological changes in chronically hypoperfused mice. These future experiments might 
be useful for the identification of cellular and molecular mechanisms involved in the 
development of neuropathology following chronic cerebral hypoperfusion (discussed in 
Chapter 6, section 6.1.3.). 
 
Microglia release free radicals such as NO which are known to be harmful to cellular 
mitochondrias. Damage to mitochondrias is associated with an increased synthesis of pro- 
apoptotic signals (caspase- 3, cytochrom- c) initiating molecular pathways leading to 
cellular death (Kroemer et al., 1998; Ricci et al., 2004). NO concentration increases 
substantially in chronically hypoperfused rats 2 weeks after artery ligation (de la Torre et 
al., 2003). Elevated NO levels following hypoxic- ischemic events in vivo have been 
related to neuronal and glial cell loss (Eliasson et al., 1999; Haynes et al., 2003). In vitro 
studies have confirmed these data by demonstrating that microglia secreted NO leads to 
neuronal and glial apoptosis (Kim and Kim, 1991; Boje and Arora, 1992; Chao et al., 
1992; Cazevieille et al., 1993; Mitrovic et al., 1995). These data suggest that microglia 
activity following chronic cerebral hypoperfusion in mice might be impacting on the 
development of both white and grey matter injury. This is not surprising in regards to the 
existing literature. For instance, neuronal cells loss is observed in multiple sclerosis 
patients presenting elevated microglial activity accompanied by increased inflammatory 
and oxidative levels (Fischer et al., 2009). Further, microglia obtained from brain autopsy 
material of vascular or Alzheimer`s dementia patients were immunoreactive to major 
histocompatibility complex class I and II MHC-II, matrix metalloprotease-3 (MMP-3), 
and pro- inflammatory cytokines suggesting a role of these signaling cues in the 
development of age- related neuropathology (Wakita et al., 1994 ; de Groot et al., 2001; 
Lue et al., 2001). In order to investigate the role of microglia in the development of white 
and grey matter injury following chronic cerebral hypoperfusion in mice one could use 
different approaches (discussed in Chapter 6, section 6.1.3.3.). For instance, the 
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application of adriamycin- a known chemotherapeutic drug (Neuwelt et al., 1981) has 
been shown to inhibit microglial activation/ proliferation (Graeber et al., 1989). Future in 
vivo experiments might consider blocking microglial proliferation by intraventricular 
administration of adriamycin in sham and chronically hypoperfused mice at different post- 
surgery time points to determine the effects of microglia and the associated inflammatory 
agents on neuropathology and functional impairment in this animal model. However, this 
experiment would require the performance of two surgical procedures on the same animal- 
intraventricular cannulae implantation for the adriamycin as this drug does not normally 
diffuse through the blood brain barrier and the microcoils surgery to induce hypoperfusion 
which might be problematic from an ethical and regulatory point of view in the UK. 
Therefore, one could consider applying the microcoils surgery on microglia mutants 
(Gowing et al., 2008) where these cells are genetically ablated and then study the effects 
of this mutation on the neuropathological and functional outcome following 
hypoperfusion in mice. 
 
Further the astrocytic response following hypoperfusion was not examined in the present 
experiments. Astrocytes are known to be important cellular players during the processes of 
neurodegeneration/ neuroregeneration secreting pro- inflammatory agents and growth 
factors, buffering extracellular glutamate and participating in concert with microglia in the 
formation of glial scars (Volterra and Meldolesi, 2005). Previous studies on chronically 
hypoperfused rats, gerbils and mice demonstrated increased numbers of astroglial cells 
suggesting an important role of astrocytes in the cellular and molecular processes 
following experimental chronic cerebral hypoperfusion (Pappas et al., 1996; Kurumatani 
et al., 1998; Farkas et al., 2004; Shibata et al., 2004; Farkas et al., 2007). 
 
In humans, increased inflammatory levels were associated with grey and white matter 
pathology in multiple sclerosis patients (Fischer et al., 2009). Further increased 
inflammation seems to accompany the development of neuropathology in elderly people, 
aged nonhuman primates and rodents (Sloane et al., 1999; Ye and Johnson, 1999; 
Abraham and Lazar, 2000; Rosenberg et al., 2001; Fernando et al., 2006; Gold et al., 
2007; Ihara et al., 2010). 
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Overall, the observed increases in inflammatory microglia in both white and grey matter 
areas of the chronically hypoperfused mouse brain rise again the question of the validity 
of the main hypothesis under test. The observed inflammation affected both white and 
grey matter suggesting a spectrum of complex hypoperfusion- induced cellular and 
molecular disturbances affecting various cortical, subcortical regions and white matter 
tracts potentially contributing in concert to the observed cognitive deficits in chronically 
hypoperfused mice. 
 
3.4.3. Is hypoperfusion- induced white matter pathology associated with cognitive 
impairment in mice? An unresolved question. 
The present experiments sought to test the hypothesis suggesting that hypoperfusion- 
induced white matter pathology may impact on working memory and executive function 
in mice. This hypothesis was based on data from clinical and preclinical studies 
suggesting that white matter abnormalities with cerebrovascular origin are related to 
working memory and executive function impairment (O`Sullivan et al., 2001; Charlton et 
al., 2006; Cook et al., 2007; Grieve et al., 2007; Shibata et al., 2007; Wright, et al., 2008; 
Kennedy and Raz, 2009; Nishio et al., 2010; Coltman et al., 2011).  
 
To investigate this, a potential association was tested between white matter cellular 
components (axonal, myelin integrity, inflammation) and behavioural parameters of 
working memory (the number of revisiting errors) and executive function (the number of 
trials to criterion) in hypoperfused mice (section 3.2.3.3.). Since in the present study, the 
pathological analysis was limited to certain neuroanatomical levels, it was difficult to 
estimate the overall extent and severity of pathology throughout the brain, but the 
cumulative score represented an overall estimation of the observed axonal, myelin 
pathology, inflammation across the examined white matter areas (Coltman et al., 2011; 
Holland et al., 2011). The total pathological score was considered more appropriate for the 
correlation analysis as it gives larger numerical scale for potential variations than the 
regional pathological grades which were numerical restricted between 0- 3. The number of 
revisiting errors and trials to criterion were chosen for behavioural co- variates as they are 
suggested to be robust measures of working memory and executive function on a radial 
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arm maze and a water maze paradigm, respectively (Olton and Samuelson, 1976; Morris, 
1984; Chen et al., 2000; D`Hooge and De Deyn, 2001; Shibata et al., 2007; Nishio et al., 
2010; Coltman et al., 2011). 
 
A significant positive association was evident between the severity of inflammation in 
white matter and working memory deficits, but not executive function in hypoperfused 
mice. This is in consistency with the observed working memory deficits in hypoperfused 
animals. Executive function (memory flexibility) remained intact following hypoperfusion 
in mice at least at the examined post- surgery time point. The present data are supported 
by animal and human reports demonstrating the existence of significant associations 
between inflammatory levels and cognitive deficits. Specifically, increases in GFAP 
positive cells in the hippocampus of hypoperfused rats correlated significantly with the 
number of revisiting errors (working memory) on a radial arm maze task, but not with 
spatial learning capacity taxed on a water maze paradigm (Pappas et al., 1996). LPS- 
treated aged mice presented significant correlations between mRNA expression of 
cytokines (IL-1b, IL-6, and TNFa) in grey matter (e.g. hippocampus) and working 
memory assessed on a radial arm maze task (Chen et al., 2008) and a T- maze paradigm 
(Murray et al., 2012). One of the major methodological differences between the present 
study and these previous reports relies in the brain areas where inflammation was 
examined. The present associations were focused on hypoperfusion- induced 
inflammation across white matter areas. However, significant hypoperfusion- induced 
inflammation was also evident in grey matter regions, especially in mice tested on a radial 
arm maze paradigm (discussed in section 3.4.2.4.). Therefore, it is possible that 
inflammation in grey matter might have contributed to the observed working memory 
impairment in hypoperfused mice. In elderly people, peripheral inflammation (e.g. 
cytokines) was found to be associated with the occurrence of cognitive deficits (Marsland 
et al., 2006; Wright et al., 2006) and dementia (Trollor et al., 2010).  
 
Previous clinical reports suggest the existence of significant associations between age- 
related axonal pathology in white matter and cognitive deficits in the elderly (Morris and 
Price, 2001; Chalrton et al., 2006). However, in the present study an absence of significant 
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associations was observed between axonal integrity in white matter and working memory/ 
executive function in hypoperfused mice. This is surprising with regards to the observed 
widespread hypoperfusion- induced axonal pathology suggesting the existence of 
important neural disconnections among various cortico- cortical, cortical subcortical areas 
supporting working memory and executive function. Similarly, myelin integrity did not 
correlate significantly with cognitive function following hypoperfusion in mice. These 
findings are supported by previous reports on MAG null mutants showing an absence of 
functional impairment in the absence of MAG (at least during early and mid- adulthood) 
(Montag et al., 1994). MAG might not be crucial for sustaining normal cognitive and 
motor function and compact myelin proteins (e.g. MBP, PLP) might compensate for MAG 
deficiency in the rodent brain supporting cognition and memory. However, the present 
data is in contradiction with the existing literature on elderly people and aged nonhuman 
primates. Specifically, Bartzokis, 2004 suggested that age- related myelin breakdown is 
the major neurobiological determinant of cognitive decline and dementia in humans. 
Significant reductions of MBP protein were observed post- mortem in “healthy” and 
demented elderly and they correlated significantly with performance scores on cognitive 
and memory tests (Wang et al., 2004). Similarly, Peters and Sethares, 2002 observed 
significant associations between myelin pathology and cognitive dysfunction in aged 
macaque monkeys.  
 
Alternatively, it is possible that pathological damage to axons and myelin affecting 
specific white and grey matter regions might have contributed to the occurrence of 
cognitive deficits in hypoperfused mice, but these regional associations remained 
undetected by the presently applied analysis which focused on the overall scores of axonal 
and myelin integrity in white matter. For instance, age- related white matter abnormalities 
in the CC were associated with working memory and executive function impairment in 
both elderly humans and aged non- human primates (Clarke and Zaidel, 1994; Peters and 
Sethares, 2002; Meguro et al., 2003; Teipel et al., 2003; Jokinen et al., 2007; Paul et al., 
2007; Sullivan et al., 2010). Additionally, lesions to the IC and EC have been associated 
with working memory, executive function, reaction time and processing speed deficits in 
elderly people (Kenedy and Raz, 2009).  
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Since the correlation analysis was underpowered (focused on the hypoperfused group- 
n=10), it is possible that significant associations between axonal, myelin integrity in white 
matter and behavioural parameters in hypoperfused mice existed, but remained presently 
undetected. It was impossible to perform a separate correlation analysis for the sham 
group due to the limited numerical pathological variation for this experimental group (all 
grades were equal 0) (section 3.2.3.3.). 
 
Further, hypoperfusion- induced damage to specific grey matter areas, namely major 
neuroanatomical components of the working memory circuit (e.g. the striatum, thalamus, 
hippocampus and prefrontal cortex) might have contributed to the occurrence of cognitive 
deficits in hypoperfused mice  (Herrero et al., 2002, Ergorul and Eichenbaum, 2004). 
However, in the absence of any quantification/ categorization of the severity of grey 
matter pathology in hypoperfused mice, it was difficult to perform any association 
analysis between grey matter integrity and behavioural performance. This is an important 
methodological drawback as it prevents experimental test of the alternative to the main 
study hypothesis suggesting neuronal involvement in hypoperfusion- induced cognitive 
deficits in mice. This alternative hypothesis is supported by previous findings in animal 
models of chronic cerebral hypoperfusion where changes in synaptic (synaptophysin) and 
dendritic (MAP2) protein levels correlated significantly with spatial memory recall on a 
water maze task (Liu et al., 2005). These results suggest that even subtle abnormalities in 
neuronal cytoarchitecture could impact on cognitive function under hypoperfused 
conditions.  
 
Overall, the evidence of neuronal ischemic injury (grey matter loss) in hypoperfused mice 
challenges the validity of the main study hypothesis. The presently observed pathological 
profile in hypoperfused mice suggests that widespread neuropathology affecting both 
white and grey matter areas might be at the basis of cognitive deficits in this animal 
model. In addition, nonexamined brain processes such as blood brain barrier integrity, 
neurotransmission might have been affected by the microcoils surgery and might have 
contributed to the observed pathology and cognitive deficits in hypoperfused mice 
(discussed in Chapter 6, section 6.1.1.). 
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Only future experimental work with an improved methodological design and increased 
experimental groups (n) would allow to make any firm conclusions on the role of 
hypoperfusion- induced neuropathology on cognition and memory in mice (discussed in 
section 3.4.4.3.).  
 
At the completion of the experimental work presented in this thesis a new rat model of 
chronic cerebral hypoperfusion has been developed by Kitamura et al., 2012. This new 
model consists of the bilateral application of an ameroid constrictor device to the common 
carotids allowing regulated blood flow reductions associated with the development of 
white matter pathology in the absence of grey matter ischemia. Chronically hypoperfused 
rats exhibited a spatial working memory impairment one- month post- surgery. In the 
future, one could consider using this new animal model to experimentally study the effects 
of hypoperfusion- induced white matter pathology on cognition and memory. However, 
although, this new model represents an inventive experimental tool, due to its recent 
development, it requires a more detailed behavioural and pathological characterization. 
Addtionally, the presently limited availability of transgenic rat lines prevents the wide 
application of the ameroid constrictor device surgery on a variety of genetically modified 
animals. This is not the case for the microcoils surgery which has been specifically 
optimized on C57Bl6J mice- the mouse strain on which the majority of currently available 
genetically modified mice are backcrossed to. 
 
3.4.4. Methodological strengths, limitations and future behavioural and pathological 
experiments on chronically hypoperfused mice 
3.4.4.1. Strengths of the applied behavioural and pathological approach 
In the present study spatial working memory and executive function were evaluated using 
two of the most widely employed behavioural paradigms, namely the radial arm maze and 
the water maze tasks (Olton and Samuelson, 1976; Morris, 1984; Chen et al., 2000; 
D`Hooge and De Deyn, 2001; de Wilde et al., 2002; Shibata et al., 2007; Nishio et al., 
2010; Coltman et al., 2011). These behavioural paradigms provide a good estimation of 
cognition and memory in rodents. and they have been largely employed to evaluate the 
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functional outcome in chronically hypoperfused rats and mice (Pappas et al., 1996; Sopala 
and Danysz, 2001; de Wilde et al., 2002; Shibata et al., 2007; Nishio et al., 2010; Coltman 
et al., 2011). This allowed to confirm and expand previous behavioural findings on 
chronically hypoprefused mice as well as to compare the present results with existing data 
from alternative animal models (rats). 
The strengths of the present pathological analysis relate to the sensitivity of the applied 
immunochemical procedure to specific white matter cellular components- axons (APP), 
myelin (MAG) and inflammatory microglia (Iba1). This represents an important 
advantage considering that previously white matter abnormalities in hypoperfused mice 
were described using basic histological techniques (e.g. Kluver- Barrera) (Shibata et al., 
2004; Shibata et al., 2007; Nishio et al., 2010). The present pathological data provide a 
more detailed characterization of the cellular changes underlying hypoperfusion- induced 
white matter pathology in mice. In contrast to previous reports on this animal model, the 
present study examined for the first time grey matter integrity by means of a standard 
H&E histological staining which gives a good, overall indication of brain morphology and 
allows to identify neuronal ischemic injury. 
Lastly, the applied systematic evaluation of behaviour and pathology in the same cohorts 
of chronically hypoperfused mice allowed to reveale a previously undetected spectrum of 
white and grey matter pathology in this animal model. 
3.4.4.2. Limitations of the applied behavioural and pathological approach  
The present study also presented certain limitations in its experimental design which 
constituted an important drawback for hypothesis test.  
Performing behavioural training in rodents using available paradigms (e.g. radial arm 
maze and water maze) involves stress- related, aversive factors such as: 1) handling and 
daily contact with humans; 2) food- deprivation, swimming (particularly aversive for mice 
who are not natural swimmers); 3) extra- cage physical and exploratory activity.  These, 
additional to the microcoils surgery factors, might have contributed to the overall 
functional and pathological profile of chronically hypoperfused mice. In the present study 
a poorer physiological post- surgery outcome was observed in the food- deprived 
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hypoperfused cohort tested on a radial arm maze paradigm. These animals exhibited 
pronounced post- surgical neurological dysfunction such as seizing activity, sickness and 
even death leading to an important loss of experimental (n) numbers in this hypoperfused 
group. The remaining hypoperfused animals exhibited a spectrum of white and grey 
matter abnormalities accompanied by an increased inflammation. At the functional level, 
these animals presented impaired working memory. The hypoperfused mice tested on a 
water maze task recovered relatively well after surgery and exhibited predominant white 
matter pathology. At the functional level, this hypoperfused cohort presented intact 
cognition and memory (memory flexibility, learning, short and long term memory recall). 
It is unknown whether and/ or to what extent the behavioural procedure impacted on the 
functional outcome in the two cohorts of hypoperfused mice and future studies should 
examine the effects of the behavioural procedure and its associated factors on both 
neuropathology and functional outcome in this animal model (discussed in section 
3.4.4.3). 
The applied pathological approach presented important limitations, namely related to the 
restricted number of examined brain levels/ regions, the limited number of applied 
biomarkers, the nonquantitative nature of the obtained data (pathological grades) and the 
specific time- point when the pathological changes were examined. This limited spatio- 
temporal and biomarker analysis might have omitted pathological changes as 1) they 
might have been present on non- examined brain levels/ areas and/ or 2) not detected by 
the applied antibody, and/ or 3) occurring at later post- surgery time points especially in 
regards to the chronic nature of the cerebrovascular challenge and the cumulative severity 
of the observed neuropathology and cognitive impairment in chronically hypoperfused 
mice (Nishio et al 2010; Reimer et al., 2011). Further, the observed pathology was not 
quantitatively measured in the experimental cohorts limiting all observations in a 
restricted numerical range from 0- 3. This semi- quantitative pathological approach could 
not account for potentially subtle inter- individual differences in the severity of the 
pathological profile. Further, the non- quantitative nature of the obtained results presented 
certain limitations in regards to the experimental test of the main and alternative study 
hypotheses (discussed in section 3.4.3.).   
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A good scientific practice usually requires the application of more than one 
methodological strategies to support any given result. In the present experiment, white and 
grey matter integrity, inflammation were examined only be means of standard histology/ 
immunohistochemistry in the absence of any additional biomolecular (e.g. protein levels, 
gene expression) and/ or structural analysis (e.g. electron microscopy). 
3.4.4.3. Future behavioural and pathological studies on chronically hypoperfused 
mice 
 
With regards to the limitations of the present methodology discussed in the previous 
section, future behavioural and pathological experiments on chronically hypoperfused 
mice should apply an improve experimental design to address the study hypothesis as well 
as to determine the specific effects of factors which were presently suspected to affect on 
neuropathology and functional outcome in this animal model. 
 
Future experiments on chronically hypoperfused mice should systematically evaluate 
white and grey matter integrity as well as alternative brain processes (e.g. 
cerebrovasculature, neurotransmission- discussed in Chapter 6, section 6.3.1.) in 
behaviourally tested chronically hypoperfused mice using a combination of experimental 
techniques This would allow to obtain a detailed spatio- temporal characterization of 
neuropathology and the associated behavioural deficits in chronically hypoperfused mice. 
Further, a quantitative pathological assessment would allow to account for potentially 
subtle inter- individual pathological differences which could not be detected by the 
presently applied semi- quantitative approach. The obtained quantitative pathological data 
would be more suitable for correlational analyses with behavioural parameters in this 
animal model due to the larger spectrum of numerical inter- individual pathological 
variations necessary to more accurately address the present study hypothesis (discussed in 
section 3.4.3.). 
Depending on the scientific question(s) neuropathology could be examined and/ or 
measured using different in vitro and in vivo strategies. For instance, by using double/ 
triple immunochemistry with compatible, fluorescent antibody probes one could study on 
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the same brain samples axonal (e.g. APP, SMI312R), myelin (e.g. MAG, MBP, PLP) 
integrity in relation to neuronal (e.g. NeuN, MAP-2)/ glial (e.g. MBP, PLP, MAG, GFAP) 
cells. The subsequent confocal (or immunofluorescence detecting) microscopy would 
allow to quantitatively measure the respective biomarker fluorescence levels. 
Alternatively, one could examine structural white matter integrity using electron 
microscopy on semi- thin toluidine blue stained brain sections. Additionally, modern 
neuroimaging approaches such as MRI- DTI exist and allow to quantify both in vivo as 
well as in vitro (brain samples) changes in white matter integrity (Chapter 4). Axons and 
myelin could be quantitatively evaluated by analyzing axial (axons) and radial (myelin) 
diffusivity respectively on MRI- DTI scans. Western blot (protein levels) and/ or (q)PCR 
(mRNA expression) analysis would allow to quantitatively determine potential 
biomolecular changes occurring in white and grey matter areas of the chronically 
hypoperfused mouse brain. One could also consider developing in vitro procedures 
mimicking the hypoperfused conditions, by culturing brain slices under low glucose and 
oxygen levels allowing to reduce the number of experimental animals.  However, this in 
vitro approach presents certain limitations such as an absence of active circulation which 
might impact on neuropathology. Further, although functional experiments (e.g. action 
potential propagation) could be performed in vitro, it is impossible to test specific 
alterations in cognitive and memory function (e.g. processing speed, working memory, 
memory flexibility, attention, memory recall). 
In the present study, the behavioural and pathological evaluation of sham and 
hypoperfused mice was performed at a relatively short post- surgery time point (1- 2 
months post- surgery). A recent study suggests more severe behavioural deficits (both 
spatial working and reference memory impairment) and pathological pattern (white and 
grey matter injury) in hypoperfused mice 6 months after microcoils application (Nishio et 
al. 2010). Future detailed timecourse behavioural and pathological analyses of this animal 
model would allow to better assess the temporal dynamics of hypoperfusion- induced 
neurobiological alterations and the associated functional impairment in mice (Nishio et al., 
2010). For instance, future behavioural experiments could examine working memory and/ 
or references memory in the same cohorts of sham and chronically hypoperfused mice at 
different time points after surgery using a radial arm maze and/ or water maze paradigm 
125 
and/ or alterantive behavioural paradigms (e.g. as reaction time and serial choice tasks). 
However, this longitudinal approach presents the drawback of cumulative effects of the 
repeated training on the performance of both sham and chronically hypoperfused animals 
and could also affect on neuropathology. An alternative experimental strategy, would 
consists of applying a cross- group approach, comparing simultaneously the performance 
of experimental cohorts at a different post- surgery time points- e.g. 1 month vs. 6 months 
post- surgery and their pathological profile. The cross- group approach would allow to 
control for the cumulative effects of training on cognition and neuropathology associated 
with the above mentioned longitudinal approach. However, the cross- group approach 
would not allow to determine the progression of cognitive impairment and neuropathology 
within the same cohorts of animals.  
 
In the present study, environmental factors associated with the behavioural training such 
as  the feeding pattern (food deprivation vs. ad libitum) seem to have impacted on the 
pathological and functional outcome following hypoperfusion in behaviourally tested, 
young, adult mice. It is unknown whether and/ or how the feeding pattern interacted with 
the behavioural training and whether the resulting pathological and behavioural profile 
was due to the effects of a single factor and/ or a combination of factors. It is important 
that future experiments try to determine the individual as well as combined effects of the 
three major experimental factors in the present study: 1) surgical procedure (sham vs, 
hypoperfused), 2) feeding pattern (food deprivation vs. ad libitum), and 3) behavioural 
training (absence vs. presence of behavioural training) in order to gain a better 
understanding of the etiological causes associated with neuropathology and functional 
outcome in hypoperfused mice. This could be done by simply comparing sham vs. 
chronically hypoperfused mice under different experimental conditions (mentioned above) 
allowing to evaluate the individual as well as interactive effects of the above mentioned 3 
experimental factors on the pathological profile as well as behavioural performance of 
sham and chronically hypoperfused mice.  
 
Inter- individual differences could exist among experimental animals as well as batches of 
animals which may account for the presently observed pathological and functional 
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differences between the two hypoperfused cohorts. In the present study, the cerebral blood 
flow was not measured in the behaviourally tested animals. It is possible that differences 
in the perfusion rate existed between the two behaviourally tested hypoperfused cohorts 
due to variations in the artery size, the exact placement of the microcoils, the skills of the 
surgeon, the used anesthetic leading to the observed pathological and functional 
differences. It is important, that future studies using this animal model measure the 
perfusion rates in all experimental animals. This could be done, in vivo, non- invasively 
by means of Laser- Doppler flowmetry or by means of PET imaging for rodents. 
However, introducing these additional experimental factors could also aversively (e.g. 
stress- related) affect the functional as well as pathological outcome. Alternatively, one 
could measure the cerebral blood flow and metabolism post- mortem by means of 
autoradiographic techniques employing I-iodo-antipyrine and "C-deoxyglucose (Mies et 
al., 1981). 
Further, the present study did not examine alternative brain processes (e.g. cerebral 
metabolism, cerebrovasculature, neurotransmission) that could be affected in the 
chronically hypoperfused brain and by consequence could impact on both the 
neuropathological and functional outcome in this model (discussed in Chapter 6, section 
6.1.1.). 
Additionally, the present experiments, at the exception of inflammation, did not address 
the pathophysiological mechanisms (e.g. excitotoxicity, oxidative stress) underlying the 
development of neuropathology and cognitive impairment in chronically hypoperfused 
mice. Therefore, it is important that future mechanistic studies address this question as 
discussed  in Chapter 6, sections 6.1.3.. 
Lastly, in regards to the relevance of this animal model to the aging process in humans, it 
is necessary that future experimental work addresses the effects of chronic cerebral 
hypoperfusion on neuropathology and cognition in the context of  aging (discussed in 
Chapter 6, section 6.1.2.). 
Future research directions on chronically hypoperfused mice are discussed in details in 
Chapter 6. 
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 3.4.5. Implications of the new mouse model of chronic cerebral hypoperfusion and 
future directions 
 
The major interest of the new mouse model of chronic cerebral hypoperfusion is that it 
allows to study in isolation the effects of chronic cerebral hypoperfusion on 
neuropathology and cognitive function in mice. As previously discussed in the present 
thesis, in clinical settings it is extremely difficult to examine in isolation the effects of 
single etiological entities on neuropathology and cognitive function due to ethical issues 
and the presence of comorbidities in the elderly.  
Further development and characterization of the new mouse model of chronic cerebral 
hypoperfusion would allow the future application of the microcoils surgery on genetically 
modified rodents. This would allow to investigate the individual and combined effects of 
cerebrovascular (e.g. hypoperfusion) and molecular (e.g. APOE) factors on the 
development of neuropathology and cognitive deficits in experimental settings (Chapter4; 
Chapter 6, section 6.1.5.). Further analysis of the underlying pathophysiological 
mechanisms (e.g. excitotoxicity, oxidation) in this animal model would potentially reveal 
new biological targets for the future pre- clinical development of therapeutic strategies for 
the treatment of age- related neuropathology and cognitive decline (Chapter 6, section 
6.1.3.). 
However, this animal model also presents certain limitations. Specifically, the observed 
pathological profile in chronically hypoperfused mice is heterogeneous- certain 
hypoperfused mice exhibit predominant white matter pathology whereas others present a 
spectrum of grey and white matter abnormalities. Therefore, in order to obtain meaningful 
conclusions on potential associations between a certain pathological profile (e.g. white 
matter pathology) and functional impairment in chronically hypoperfused mice, for future 






The present study confirmed the existence of white matter pathology, increased 
inflammation and spatial working memory impairment in hypoperfused mice. However, at 
the difference from previous findings on this model, grey matter ischemic injury was 
evidenced in the majority of the hypoperfused animals tested on a radial arm maze 
paradigm. Due to the observed spectrum of white and grey matter pathology as well as to 
certain methodological limitations it was difficult to accurately test the main study 
hypothesis suggesting that hypoperfusion- induced white matter pathology is associated 









































Effects of APOE on white matter integrity under 
normal physiological and chronically 
hypoperfused conditions in mice 
 
 
4.1. Introduction and aims 
MRI techniques developed for the noninvasive investigation of white matter integrity are 
largely employed in clinical settings. These neuroimaging techniques revealed the 
prevalence of white matter abnormalities associated with chronic cerebral hypoperfusion 
in the elderly (Farkas and Luitent, 2001; O`Sullivan et al., 2001; Deary et al., 2003; 
Charlton et al., 2006; Fernando et al., 2006; Grieve et al., 2007; Kennedy and Raz, 2009; 
Penke et al., 2010)  FA and MTR are MRI parameters accounting for white matter 
structural integrity and reductions in their values are indicative for white matter pathology 
(Moseley et al., 1990; Wolff and Balaban, 1989; Basser, 1995; Beaulieu, 2002; Harsan et 
al., 2006; Blezer et al., 2007; Holland et al., 2011). Both FA and MTR have been shown to 
decrease with increasing age in humans (O` Sullivan et al., 2001; Deary et al., 2003; ; 
Charlton et al., 2006; Grieve et al., 2007; Kennedy and Raz, 2009; Bastin et al., 2009; 
Penke et al., 2010). The broad application of MRI for clinical diagnosis and the existing 
uncertainty in regards to its underlying biological substrates have urged the validation and 
further development of neuroimaging techniques using animal models (Benveniste and 
Blackband, 2002). Recently, our group demonstrated the sensitivity of in vivo MRI to 
detect widespread white matter pathology occurring in chronically hypoperfused mice 
(Holland et al., 2011).  
Recent clinical studies suggest that human APOE allelic variation differentially impacts 
on white matter integrity and cerebrovasculature in cognitively intact adults- the APOE4 
allele being associated with white matter pathology and cerebrovascular abnormalities 
(Kalmijn et al., 1996; Skoog et al., 1998; Reiman et al., 1996; Reiman et al., 2004; 
Bartzokis et al., 2007; Filippini et al., 2009; Heise et al., 2010; Ryan et al., 2011).  
Human APOE allelic variation also differentially affects grey matter integrity. 
Specifically, the APOE4 allele is the major, known genetic risk factor for the development 
of age- related neurodegeneration and dementia (e.g. Alzheimer`s disease)  (Saunders et 
al., 1993; Schuff et al., 2009b). Additionally, APOE4 carriers show poorer pathological 
and functional outcome following injury to the central nervous system compared with 
non- APOE4 carriers (Nicoll et al., 1995; Gromadzka et al., 2007; Wagle et al., 2009). 
Similarly, APOE deficient and human APOE4 transgenic mice exhibit an early onset 
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neurodegeneration, cerebrovascular pathology and poor outcome following injury to the 
brain when compared with WT and APOE3 counterparts (Piedrahita et al. 1992; Gordon 
et al., 1995; Masliah et al., 1995; Masliah et al., 1997; Sheng et al., 1998; Buttini et al., 
1999; Sheng et al., 1999; Buttini et al., 2000; Fullerton et al., 2001; Methia et al., 2001; 
Kitagawa et al., 2002;  Hafezi- Moghadam et al., 2006). APOE effects on grey matter 
integrity have been largely studied and characterized in both clinical and preclinical 
settings (Saunders et al., 1993; Gordon et al., 1995; Masliah et al., 1995; Masliah et al., 
1997; Buttini et al., 1999; Sheng et al., 1998; Sheng et al., 1999; Buttini et al., 2000; 
Schuff et al., 2009b).  
However, little is known about APOE effects on white matter It is possible that APOE 
affects on white matter integrity under both normal physiological and pathological 
conditions (e.g. chronic cerebral hypoperfusion) via an impaired turnover of myelin lipids 
and cholesterol, increased inflammation, lipid peroxidation, protein oxidation and 
excitotoxicity (Van Ree et al., 1994; Laskowitz et al., 1997a; Laskowitz et al., 1998; 
Horsburgh et al., 2000a;  Laskowitz et al., 2000; Ramassamy et al., 2001; Aono et al., 
2002; Han et al., 2003; Horsburgh et al., 2003; Choi et al., 2004; Champagne et al., 2005; 
Bartzokis et al., 2006).  
Further, little is known about the concomitant effects of genetic (APOE) and 
cerebrovascular (chronic cerebral hypoperfusion) mechanisms on white matter integrity. 
This question is particularly important especially with regards to the multifactorial 
etiology of white matter pathology in elderly people. 
Building on previous work, the present study sought to test the hypothesis that APOE 
deficiency might be associated with white matter anomalies under normal physiological 
conditions and the development of more severe hypoperfusion- induced white matter 
pathology in mice. 
Mouse APOE deficiency was also expected to impact on grey matter integrity and/ or  the 
cerebrovasculature under both normal physiological and chronically hypoperfused 
conditions as previously demonstrated in this animal model (Piedrahita et al. 1992; 
Gordon et al., 1995; Masliah et al., 1995; Masliah et al., 1997; Laskowitz et al., 1997; 
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Hosrburgh et al., 1999; Sheng et al., 1999; Fullerton et al., 2001; Methia et al., 2001; 
Kitagawa et al., 2002;  Hafezi- Moghadam et al., 2006). 
To detect potentially subtle genetic differences in white matter integrity, an ex vivo MRI 
was applied to compare regional MRI parameters of white matter integrity (FA and MTR) 
between age and sex- matched WT and APOEKO mice subjected to sham surgery or 
hypoperfusion. Ex vivo MRI allows longer imaging times in the absence of physiological 
artifacts and the generation of images with a very good spatial resolution. The sensitivity 
of ex vivo MRI to detect white matter integrity was verified at the microstructural level 
using a standard immunohistochemistry with antibodies targeted to the neuronal axons 
(APP) and myelin sheath (MAG, dMBP). With regards to previously reported early 
occurring neurodegeneration and more severe neuropathology (e..g infarctions) following 
cerebrovascular challenge in APOEKO mice (Gordon et al., 1995; Masliah et al., 1995; 
Masliah et al., 1997; Laskowitz et al., 1997; Hosrburgh et al., 1999; Sheng et al., 1999; 
Buttini et al., 2000; Kitagawa et al., 2002), in addition to white matter, grey matter 
integrity was also examined on T2- weighted scans and corresponding H&E stained brain 
sections in all experimental animals. Inflammation was evaluated by Iba1 
immunochemistry as 1) APOE is known to exert immunomodulatory function (Laskowitz 
et al., 1997a; Laskowitz et al., 2000; Champagne et al., 2005), 2) inflammation increases 
after chronic cerebral hypoperfusion (Shibata et al., 2004; Coltman et al., 2011), 3) 
inflammation could impact on MRI metrics (Blezer et al., 2007; Wu et al., 2008). To 
control for any naturally occurring cerebrovascular abnormalities (e.g. atherosclerosis) in 
APOEKO mice which could affect on the perfusion rate in these animals, relatively young 







The major aim of the present thesis chapter was to: 
 
 Determine the effects of APOE on white and grey matter integrity, inflammation 
under normal physiological conditions as well as one month after chronic cerebral 




















4.2. Materials and methods 
4.2.1. Animals and surgery 
Five months old male C57Bl6J (WT) (n= 19) (31±3gr) and APOE deficient (APOEKO) 
(n= 18) (30±4gr) mice were used for the experimental purposes of Chapter 4 (Chapter 2, 
section, 2.1.1.; section 2.1.2.). The animals from both genotypes were randomly allocated 
to a sham or a microcoils surgery. Eleven WT and 10 APOEKO mice were subjected to 
chronic cerebral hypoperfusion. The rest of the WT (n= 8) and APOEKO (n= 8) mice 
underwent sham surgery. The surgical procedure is described in details in Chapter 2, 
section 2.2. Food and water were provided ad libitum during the whole experimental 
period. All animals were sacrificed a month after surgery for ex vivo MRI and 
immunohistological analysis. Animals not surviving the entire experimental period were 
excluded from any further analysis. 
4.2.2. Ex vivo MRI procedure 
Ex vivo MRI was performed on perfusion- fixed WT and APOEKO mouse brains one 
month after microcoils or sham surgery as described in Chapter 2, section 2.9. The 
generated ex vivo MRI images had a good spatial resolution allowing the delineation of 
ROIs on T2- weighted scans with a minimal contamination by adjacent brain regions 
(figure 4.1. A, B, C). Regional FA and MTR analysis were used to examine white matter 
integrity in selected ROIs (the CC, EC, IC, OT) (Chapter 2, section 2.9.4.). Additionally, 
FA and MTR were examined in the hippocampus which was selected as a control grey 
matter region.  The overall brain morphology and grey matter structural integrity were 
visually examined on four T2- weighted MRI scans from the following neuroanatomical 
levels: 0.74 mm, 0.38 mm, -0.94 mm, -2.12 mm bregma (Franklin and Paxinos, 1997). 
Grey matter pathology usually appears as dark hypointense regions on T2- weighted 
scans. The grey matter ROIs were cortical (the Cx) and subcortical (the striatum and the 
hippocampus) regions known to be susceptible to cerebral blood flow alterations 
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Figure 4.1.: Representative ex vivo MRI generated T2- weighted, FA, and MTR scans 
MRI images with a good spatial resolution were generated using a new ex vivo MRI 
procedure for multiple brains imaging. In (A) is presented a T2-weighted scan with the 
examined ROIs delineated in colour on the left hemisphere: CC (brown), EC (blue), IC 
(yellow), OT (green), hippocampus (pink). In (B) is shown a representative FA scan with an 
example of a MTR map presented in (C). All images are representative of the same 
neuroanatomical level from the same WT sham animal. 
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4.2.3. Pathological assessment  
The pathological assessment of white and grey matter integrity, inflammation was 
performed at the completion of the ex vivo MRI procedure (one month after surgery) 
using standard histological and immunohistochemical procedures (Chapter 2, section 2.5., 
section 2.6.1.). 
Axonal (APP) and myelin (MAG, dMBP) integrity, inflammation (Iba1) were examined 
on 6µm thin coronal brain sections from -2.12mm bregma neuroanatomical level (Franklin 
and Paxinos, 1997) using a standard immunohistochemical procedure (Chapter 2, section 
2.6.1.). The applied biomarkers were studied in the same white matter ROIs as those 
examined for the MRI analysis, namely the CC, EC, IC, and OT. Additionally, axonal 
integrity (APP), degraded myelin (dMBP), and inflammatory activity (Iba1) were also 
examined in the hippocampus. The severity of the observed pathological changes was 
semi- quantitatively evaluated by means of a pathological grading scale (Chapter 2, 
section 2.7.4.; Coltman et al., 2011; Holland et al., 2011). 
The overall grey matter integrity and the presence of neuronal ischemic injury were 
examined on 6µm H&E stained coronal brain sections from neuroanatomical levels 0.74 
mm; 0.38 mm;  -0.94 mm; -2.12 mm bregma (Franklin and Paxinos, 1997) corresponding 
to each of the four T2- weighted scans (figure S.4.3.- appendices II ). The grey matter 
ROIs were cortical (the Cx) and subcortical (the striatum, the hippocampus) regions 
known to be susceptible to blood flow alterations. 
4.2.4. Statistics 
The experimental group (n) numbers included in the statistical analysis were: 8 WT sham, 
8 APOEKO sham, 10 WT hypoperfused and 8 APOEKO hypoperfused animals. 
4.2.4.1. Statistical analysis of the ex vivo MRI (FA and MTR) data 
The regional average MRI biomarkers (FA and MTR) were statistically compared among 
the four experimental groups using two- way multifactorial analysis of variance 
(MANOVA, Hotelling`s trace multivariate test) with the regional MRI data (FA and MTR 
in the CC, EC, IC, OT and hippocampus) as the dependent variable and genotype (WT vs. 
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APOEKO) and surgery (sham vs. hypoperfusion) as the experimental factors. The surgery 
x genotype interaction was simultaneously analyzed. MANOVA is used for data analysis 
in neuroimaging studies to correct for the issue of multiple intercorrelated MRI voxels, 
thus minimizing the risk of committing type I statistical error (Madden et al., 2007; de 
Weijer et al., 2011; Holland et al., 2011). Multiple intercorrelated voxels, or 
multicollinearity, can arise as the MRI biomarkers are related (e.g. changes in FA could 
affect MTR as measured on the same biological samples). Furthermore, it is possible that 
adjacent voxels (e.g. regional FA and MTR voxels in the CC and EC) may influence each 
other due to averaging across the spatial resolution. The Hotelling`s trace multivariate test 
was selected for the present MANOVA analysis as it is considered to be appropriate for 
group comparisons when the experimental (n) numbers are relatively small and/ or 
uneven. In the case of significant differences indicated by MANOVA, group differences 
for each dependent variable (regional FA and MTR) were tested using Tukey`s post- hoc 
analysis. 
 
Significance was accepted for p < 0.05. 
 
4.2.4.2. Statistical analysis of the pathological data 
 
Kruskal-Wallis nonparametric statistics followed by Dunn`s multiple comparisons post- 
hoc analysis were applied for the statistical comparison of the regional group median 
pathological grades of axonal (APP), myelin (MAG, dMBP) integrity and inflammation 
(Iba1). The Kruskal- Wallis nonparametric statistics were applied as the pathological data 
was not a quantitative measure (semi- quantitative grades). The group differences were 







4.3.1. Post- surgery recovery and physiological status  
All sham animals from both genotypes recovered well after the surgical procedure. One of 
the 11 WT (0.09%) and 2 of the 10 APOEKO (20%) hypoperfused animals did not 
survive the post- surgery recovery period and were excluded from the subsequent MRI 
and pathological analysis.  The remaining 99.1% WT (10/11) and 80% APOEKO (8/10) 
hypoperfused mice recovered well after surgery and did not show any overt signs of 
neurological dysfunction. In the final analysis were included: 8 WT sham, 8 APOEKO 
sham, 10 WT hypoperfused and 8 APOEKO hypoperfused animals (figure S.4.1.- 
appendices II). 
4.3.1. Ex vivo MRI results 
4.3.1.1. APOE deficiency and chronic cerebral hypoperfusion impact on MRI 
parameters of white matter integrity 
The regional average MRI biomarker values (FA and MTR)  were statistically compared 
among the four experimental groups using two- way MANOVA, Hotelling`s trace 
multivariate test (Chapter 4, section 4.2.4.2.; Madden et al., 2007; de Weijer et al., 2011; 
Holland et al., 2011). The Hotelling's Trace multivariate test of overall differences among 
groups for FA and MTR was statistically significant for the CC, EC and IC (p<0.05) 
where there was a significant effect of genotype (CC, F(3, 26)= 5.264, p=0.006; EC, F(3, 26)= 
3.597, p=0.028; IC F(3, 26)= 5.844,  p=0.004) and surgery (CC, F(3, 26)= 61.750, p=0.000; 
EC, F(3, 26)= 59.343, p=0.000; IC, F(3, 26)= 69.409,  p=0.000) as well as a significant 
interaction between surgery x genotype (CC, F(3, 26)= 6.804, p=0.002; EC, F(3, 26)= 5.315,  
p=0.006; IC, F(3, 24)= 4.440,  p=0.013). In the OT and the hippocampus there was a 
significant effect of surgery (OT, F(3, 26)= 31.286,  p=0.000; hippocampus, F(3, 26)= 11.105,   
p=0.000), but an absence of significant effect of genotype (OT, F(3, 26)= 0.729,  p=0.545; 
hippocampus, F(3, 26)= 3.022,   p=0.05) or interaction between surgery and genotype (OT, 
F(3, 26)= 0.507,  p=0.681; hippocampus, F(3, 26)= 1.896,  p= 0.157).  
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4.3.1.1.1. APOE deficiency is associated with significant FA reductions in white, but 
not grey matter after chronic cerebral hypoperfusion 
FA is an MRI- DTI parameter of white matter integrity (Basser, 1995; Beaulieu, 2002) 
and a decrease in FA is associated with white matter pathology (Harsan et al., 2006; 
Holland et al., 2011). Significant group differences in FA were evident in the CC (F(3, 26)= 
35.71, p= 0.000), EC (F(3, 26)= 29.56, p= 0.000),  IC (F(3, 26)=  33.91, p= 0.000) and OT (F(3, 
26)= 15.40, p= 0.000). An absence of significant group difference in FA was observed in 
the control grey matter ROI- the hippocampus (F₍₃‚₂6₎= 1.94, p= 0.147). The post- hoc 
Tukey`s analysis showed that WT and APOEKO hypoperfused animals had a significantly 
reduced FA in the CC, EC, IC, and OT in comparison with WT and APOEKO sham 
groups (p<0.05) (table 4.1., figure S.4.2.1- A-D- appendices II). Interestingly, APOEKO 
hypoperfused mice presented a significantly decreased FA in the CC, EC and IC when 
compared with WT hypoperfused group (p<0.05) (table 4.1., figure S.4.2.1. A-C- 
appendices II). FA did not differ significantly in any of the ROIs between WT and 
APOEKO sham mice (p>0.05) (table 4.1.; figure S.4.2.1. A-E- appendices II). 
4.3.1.1.2. APOE deficiency is associated with significant MTR reductions in white, 
but not grey matter after chronic cerebral hypoperfusion 
MTR accounts for changes in white matter integrity by measuring the alterations in energy 
transfer between the free and the macromolecules (lipids)- bound pools of water 
molecules in the brain (Wolff and Balaban, 1989). MTR was significantly different among 
the groups in all examined white matter ROIs: the CC (F(3, 26)=  47.99, p= 0.000), EC (F(3, 
26)=  55.29, p=0.000), IC (F(3, 26)= 36.48, p= 0.000), and OT (F(3, 26)= 22.14, p= 0.000). 
Significant group differences in MTR were also observed in the control grey matter ROI- 
the hippocampus (F(3, 26)=  13.53, p= 0.000). The post- hoc Tukey`s analysis revealed that 
WT and APOEKO hypoperfused mice had significantly reduced MTR values in all ROIs 
when compared with WT and APOEKO sham groups (p<0.05) (table 4.1.; figure S.4.2.2. 
A-E- appendices II). However, only in the CC was MTR found to be significantly 
decreased in APOEKO hypoperfused mice compared with WT hypoperfused animals 
(p<0.05) (table 4.1.; figure S.4.2.2. A- appendices II).  
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MRI Region of WT (n=8) WT (n=10) APOEKO (n=8) APOEKO (n=8)
parameter interest Sham Hypoperfused Sham Hypoperfused
FA CC     0.54 ± 0.01  0.45 ± 0.12
∆□
      0.56 ± 0.02    0.33 ± 0.01
∆□○
EC     0.53 ± 0.01  0.43 ± 0.02
∆□
      0.56 ± 0.02    0.32 ± 0.01
∆□○
IC     0.59 ± 0.02  0.48 ± 0.01
∆□
      0.58 ± 0.02    0.36 ± 0.02
∆□○
OT     0.76 ± 0.02   0.50 ± 0.03
∆□
      0.71 ± 0.04   0.44 ± 0.04
∆□
Hippocampus     0.33 ± 0.007         0.35 ± 0.01       0.35 ± 0.01          0.32 ±  0.005
MTR CC   57.47 ± 1.11       48.56 ± 0.83
∆□
     57.35 ± 0.87  44.20 ± 1.22
∆□○
EC   58.25 ± 0.68       48.77 ± 1.24
∆□
     58.35 ± 0.55   44.25 ± 1.07
∆□
IC   59.25 ± 1.23       49.64 ± 1.23
∆□
     58.93 ± 1.11 46.18 ± 0.90
∆□
OT   58.82 ± 1.22       45.24 ± 1.94
∆□
     58.86 ± 1.42 44.44 ± 2.36
∆□
Hippocampus   50.47 ± 0.35       46.54 ± 1.29
∆□
     49.95 ± 0.70        42.50 ± 1.26
∆□
  
Table 4.1.: Regional MRI biomarker values (group mean ± SE) 
Significant group differences in FA and MTR were evident by two- way MANOVA in 
examined white matter ROIs (p<0.05). In the hippocampus significant group differences 
were observed in MTR (p<0.05), but not FA (p>0.05). Tukey`s post- hoc analysis revealed 
significant reductions in MRI metrics (FA and MTR) in major white matter tracts with 
hypoperfusion in both WT and APOEKO mice (p<0.05). APOEKO hypoperfused mice 
exhibited significant reductions in FA and MTR in the CC when compared with WT 
hypoperfused mice (p<0.05). Additionally, following hypoperfusion FA was significantly 
reduced in the EC and IC of APOEKO mice compared with WT counterparts (p<0.05). In 
the hippocampus, although there were significant decreases in MTR with hypoperfusion 
(p<0.05), they were not associated with the APOE genotype (p>0.05). No significant 
differences in MRI metrics were evident in all examined ROIs between WT and APOEKO 
sham mice (p>0.05). 
Significant group differences as given by the Tukey`s post- hoc analsysis if p<0.05 from:  
WT sham∆, APOEKO sham□, WT hypoperfused○ 
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There was no significant difference in MTR in any of the examined ROIs between WT 
and APOEKO sham mice (p>0.05) (table 4.1.; figure S.4.2.2. A-E- appendices II). 
4.3.1.1.3. APOE deficiency does not affect grey matter structural integrity under 
normal physiological and chronically hypoperfused conditions: T2-weighted scans 
The overall brain morphology was visually examined on T2- weighted scans in all four 
experimental groups. No overt grey matter abnormalities and preserved brain morphology 
were evident in examined cortical and subcortical areas of all experimental animals (figure 
S.4.3.- appendices II). 
4.3.2. Pathological data 
4.3.2.1. APOE deficiency does not impact on axonal integrity under normal 
physiological and chronically hypoperfused conditions 
In the present study, axonal integrity was studied by means of APP immunohistochemistry 
(Chapter 2, section 2.7.4.1.; Coltman et al., 2011; Holland et al., 2011). APP is localized 
to cell bodies under normal physiological conditions, but it accumulates in injured axons 
(Forloni et al., 1992; Palacios et al., 1992; Stephenson et al., 1992; Selkoe, 1994). 
Axonal integrity was preserved in all WT (8/8) and APOEKO (8/8) sham mice where APP 
immunoreactivity was restricted to cellular somas (figure 4.2. A1, A3). However, APP 
clusters- inducative of axonal injury were evident in 7 WT hypoperfused (7/10) and in 7 
APOEKO hypoperfused (7/8) mice (figure 4.2. A2, A4).  
The Kruskal- Wallis nonparametric analysis demonstrated significant group differences in 
axonal integrity in all white matter ROIs: the CC (χ²= 14.42, p= 0.0061), EC (χ²= 14.42, 
p= 0.0061), IC (χ²= 14.53, p= 0.0023), and OT (χ² = 17.20, p= 0.0006), but not in the 
control grey matter region- the hippocampus (χ² = 6.58, p= 0.0866) (table 4.2., figure 
S.4.3.1. A- E- appendices II). The subsequent  Dunn`s post- hoc analysis showed that for 
all white matter ROIs (the CC, EC, IC, and OT) only APOEKO hypoperfused mice 
(p<0.05), but not WT hypoperfused animals (p>0.05) presented a significantly more 
severe axonal injury in comparison with WT and APOEKO sham groups (table 4.2.,  
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Figure 4.2.: White matter integrity in WT and APOEKO sham and hypoperfused 
mice 
Representative images of immunohistochemically stained axons (A1- A4), myelin (B1- 
B4), degraded myelin (C1- C4), and microglia (D1- D4) from the IC of WT sham (A1- 
D1), WT hypoperfused (A2-D2), APOEKO sham (A3-D3), APOEKO hypoperfused 
mice (A4-D4).  Myelin structural abnormalities (arrows in B2, B4), degraded myelin 
(arrows in C2, C4), increased inflammation (arrows in D2, D4) were observed in both 
WT and APOEKO hypoperfused mice one month after chronic cerebral hypoperfusion. 
Axonal, myelin integrity and inflammation were considered normal in both WT (A1- 
D1) and APOEKO (A3- D3) sham mice. 




Biomarker Region of WT (n=8) WT (n=10) APOEKO (n=8) APOEKO (n=8)
interest Sham Hypoperfused Sham Hypoperfused
APP Corpus callosum (CC) 0.0  0.5 0.0    1.0
∆□
Axonal integrity External capsule (EC) 0.0  0.5 0.0    1.0
∆□
Internal capsule (IC) 0.0  0.5 0.0    1.0
∆□
Optic tract (OT) 0.0     1.5
∆□ 0.0    1.0
∆□
Hippocampus 0.0           0.0 0.0 0.0
MAG Corpus callosum (CC) 0.0 0.0 0.0 0.0
Myelin integrity External capsule (EC) 0.0    1.0
∆□ 0.0 0.5
Internal capsule (IC) 0.0    1.5
∆□ 0.0    1.0
∆□
Optic tract (OT) 0.0    2.5
∆□ 0.0    2.5
∆□
dMBP Corpus callosum (CC) 0.0 1.0 0.0 0.5
Degraded myelin External capsule (EC) 0.0     1.0
∆□ 0.0    1.0
∆□
Internal capsule (IC) 0.0     1.0
∆□ 0.0    1.0
∆□
Optic tract (OT) 0.0  0.0 0.0    1.0
∆□
Hippocampus 0.0     1.0
∆□ 0.0    1.0
∆□
Iba1 Corpus callosum (CC) 0.0  0.0 0.0     1.0
∆□
Inflammation External capsule (EC) 0.0     1.5
∆□ 0.0              1.0
Internal capsule (IC) 0.0     2.0
∆□ 0.0     1.5
∆□
Optic tract (OT) 0.0     3.0
∆□ 0.0     3.0
∆□
Hippocampus 0.0     2.0




Table 4.2.: Regional group median pathological grades 
Chronic cerebral hypoperfusion led to a significant axonal and myelin pathology, an 
increased inflammation in both WT and APOEKO hypoperfused mice (p<0.05). 
Only APOEKO hypoperfused mice showed a significantly more severe axonal injury 
in white matter regions than the two sham groups (p<0.05). There was no difference 
in the pathological profile between WT and APOEKO sham as well as between WT 
and APOEKO hypoperfused mice (p>0.05). 
The post hoc Dunn`s analysis is indicated to be significantly different (p<0.05) from: 
WT sham∆, APOEKO sham□ 
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figure S.4.3.1. A- D- appendices II). There was no significant difference in the axonal 
integrity in any of the ROIs between WT and APOEKO sham as well as between WT and 
APOEKO hypoperfused mice (p>0.05) (table 4.2., figure S.4.3.1.- A- E- appendices II). 
The individual pathological grades of axonal integrity for each mouse are given in table 
S.4.1.1., appendices II.   
4.3.2.2. APOE deficiency does not impact on myelin integrity under normal 
physiological and chronically hypoperfused conditions 
Myelin integrity was examined using MAG immunohistochemistry which is a sensitive 
biomarker to hypoxia- ischemia- induced myelin pathology (Chapter 2, section 2.7.4.2.; 
Aboul- Enein et al., 2003; Coltman et al., 2011; Holland et al., 2011).  
The pathological analysis demonstrated that myelin integrity was preserved in all WT 
(8/8) and all APOEKO (8/8) sham mice where myelin fibers were tightly organized in 
bundles forming the white matter ROIs (the CC, EC, IC, and OT) (figure 4.2. B1, B3). 
Myelin pathology consisting of disorganized myelin fibers, vacuole formations, and 
myelin debris was pathologically evidenced in all WT (10/10) and all APOEKO (8/8) 
hypoperfused animals (figure 4.2. B2, B4).  
The nonparametric Kruskal- Wallis analysis demonstrated significant group differences in 
myelin integrity in the EC (χ² = 12.15, p= 0.0069) where the Dunn`s post- hoc analysis 
indicated that WT hypoperfused mice (p< 0.05), but not APOEKO hypoperfused (p> 
0.05) mice presented significantly more severe myelin abnormalities in comparison with 
WT and APOEKO sham animals (table 4.2., figure S.4.3.2. B- appendices II). Significant 
group differences in myelin integrity were also observed in the IC (χ² = 21.12, p<0.0001) 
and OT (χ² = 24.14, p<0.0001) where both WT and APOEKO hypoperfused mice showed 
significant myelin abnormalities when compared with WT and APOEKO sham groups 
(p<0.05) (table 4.2., figure S.4.3.2.C, D- appendices II). Myelin integrity did not differ 
significantly in any of the ROIs between WT and APOEKO sham mice as well as between 
WT and APOEKO hypoperfused mice (p> 0.05) (table 4.2., figure 4.3.2. A-D- appendices 
II). There was no significant group difference in myelin integrity in the CC (χ² = 24.14, p= 
0.1118) (table 4.2., figure S.4.3.2. A- appendices II).  
144 
The individual pathological grades of myelin structural integrity (MAG) for each mouse 
are given in table S.4.1.2., appendices II.  
4.3.2.3. APOE deficiency does not impact on myelin degradation under normal 
physiological and chronically hypoperfused conditions 
In addition to MAG immunochemistry in the present experiment, myelin pathology was 
also examined by using an alternative immunostaining for degraded myelin basic protein 
(dMBP). dMBP is a MBP isoform expressed only under pathological conditions and it is 
associated with myelin abnormalities (Matsuo et al., 1997). dMBP is usually not 
immunodetected under normal physiological conditions. 
The pathological analysis demonstrated an absence of dMBP immunoreactivity in WT and 
APOEKO sham- operated animals in all examined ROIs (figure 4.3. C1, C3). Degraded 
myelin was immunodetected in 9 WT (9/10) and in all APOEKO (8/8) hypoperfused 
animals (figure 4.2. C2, C4). 
The Kruskal- Wallis nonparametric analysis demonstrated significant group differences in 
the extent of degraded myelin in the EC (χ² = 19.96, p= 0.0002), IC (χ² = 20.36, p= 
0.0001), OT (χ² = 11.68, p= 0.0086) and hippocampus (χ² = 17.31, p= 0.0006) (table 4.2., 
figure S.4.3.3. B- E- appendices II). The post- hoc analysis showed that both WT and 
APOEKO hypoperfused animals presented a significant myelin degradation in the EC, IC 
and hippocampus than WT and APOEKO sham mice (p< 0.05) (table 4.2., figure S.4.3.3. 
B, C- appendices II). In the OT, only WT hypoperfused mice (p< 0.05), but not APOEKO 
hypoperfused (p> 0.05) animals showed significantly more degraded myelin than the two 
sham groups (table 4.2., figure S.4.3.3. D- appendices II). The extent of degraded myelin 
did not differ significantly in any of the ROIs between WT and APOEKO sham mice as 
well as between WT and APOEKO hypoperfused groups (p> 0.05) (table 4.2., figure 
S.4.3.3. A-_ E- appendices II). In the CC, although there was an overall significant group 
difference in the extent of degraded myelin (χ² = 11.94, p= 0.0076), the post- hoc analysis 
failed to show any significant differences among the four experimental groups (p>0.05) 
(table 4.2. figure S.4.3.3. A- appendices II).  
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The individual pathological grades of myelin structural integrity (dMBP) for each mouse 
are given in table S.4.1.3., appendices II.   
4.3.2.4. APOE deficiency does not impact on inflammatory levels under normal 
physiological and chronically hypoperfused conditions 
Inflammatory activity was examined by means of an Iba1 immunohistochemistry (Ito et 
al.,1998).  
The inflammatory levels were considered normal in both WT (8/ 8) and APOEKO (8/ 8) 
sham mice where only a few Iba1 immunopositive microglia were evidenced in examined 
white and grey matter areas (figure 4.2. D1, D3).  Increased levels of inflammation 
translated by an increase in Iba1 positive microglia were observed in 9 WT hypoperfused 
animals (9/ 10) and in 7 APOEKO hypoperfused mice (7/ 8) (figure 4.2. D2, B4).  
The Kruskal- Wallis nonparametric analysis demonstrated significant group differences in 
inflammatory activity in all examined ROIs: the CC (χ² = 13.92, p= 0.0030), EC (χ² = 
13.43, p= 0.0038), IC (χ² = 17.03, p= 0.0007), OT (χ² = 21.69, p<0.0001), and 
hippocampus (χ² = 15.23, p= 0.0016) (table 4.2., figure S.4.3.4. A_ E- appendices II). The 
post- hoc Dunn`s analysis showed that in the CC, only APOEKO hypoperfused (p<0.05), 
but not WT hypoperfused (p>0.05) mice presented a significantly increased inflammation 
compared with WT and APOEKO shams (table 4.2., figure S.4.3.4. A- appendices II). In 
contrast, in the EC, WT hypoperfused (p<0.05), but not APOEKO hypoperfused (p>0.05) 
animals had a significantly increased microglial response compared with the two sham 
groups (table 4.2., figure S.4.3.4. B- appendices II). In the IC, OT and hippocampus both 
WT and APOEKO hypoperfused animals showed a significantly more severe 
inflammation than WT and APOEKO sham mice (p<0.05) (table 4.2., figure S.4.3.4. C, 
D- appendices II). The inflammatory levels did not differ significantly in any of the ROIs 
between WT and APOEKO sham mice as well as between WT and APOEKO 
hypoperfused groups (p>0.05) (table 4.2., figure S.4.3.4. A- E- appendices II)  
The individual pathological grades of inflammation for each mouse are given in table 
S.4.1.4., appendices II.  
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Figure 4.3.: Grey matter integrity in WT and APOEKO sham and hypoperfused 
mice 
Representative H&E images of the Cx (A1- A4), the striatum (B1- B4), and the CA1 
region of the hippocampus (C1- C4) of WT sham (A1- C1), WT hypoperfused (A2-C2), 
APOEKO sham (A3- C3), and APOEKO hypoperfused animals (A4- C4). The visual 
analysis revealed an absence of overt neuronal perikarya ischemic injury and preserved 
grey matter integrity in all experimental groups. 
Scale bar represents 15µm (magnification x60). 
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4.3.2.5. APOE deficiency does not affect grey matter integrity under normal 
physiological and chronically hypoperfused conditions 
Grey matter integrity was study in selected cortical (the Cx) and subcortical (the 
hippocampus, striatum) brain areas of WT and APOEKO mice in the presence and 
absence of experimentally induced chronic cerebral hypoperfusion.  
The pathological examination of grey matter integrity and neuronal perikarya showed an 
absence of overt neuronal ischemic damage and grey matter infarctions in all experimental 
animals at least in the examined brain regions. In the present experiment, the neuronal 
cells in cortical and subcortical areas in the four experimental groups presented healthy 
cellular morphology consisting of light blue stained cytoplasm and well distinguishable 


















The study presented in Chapter 4 sought to test the hypothesis that mouse APOE 
deficiency might be associated with white matter anomalies under normal physiological 
conditions and the development of more severe hypoperfusion- induced white matter 
pathology. In an attempt to translate this research to human subjects, a combined ex vivo 
neuroimaging/ histological approach was applied to compare white and grey matter 
integrity between WT and APOEKO mice under normal physiological conditions as well 
as one month after hypoperfusion. The ex vivo MRI findings, but not the 
immunohistochemical analysis partially validated the main study hypothesis suggesting a 
role of APOE in the development of hypoperfusion- induced white matter pathology in 
mice. Further, the present neuroimaging and pathological findings suggest that mouse 
APOE deficiency might not impact on grey matter integrity and inflammation under 
normal physiological and chronically hypoperfused conditions. 
4.4.1. APOE effects on white matter integrity under normal physiological and 
chronically hypoperfused conditions in mice 
4.4.1.1. APOE does not affect white matter integrity under normal physiological 
conditions in mice 
The ex vivo MRI results demonstrated that under normal physiological conditions white 
matter was preserved in the absence of endogenous mouse APOE. Specifically, no 
significant differences in FA and MTR values in major white matter tracts- the CC, EC, 
IC, OT were evident between WT and APOEKO sham groups. The neuroimaging findings 
were confirmed at the microstructural level where intact myelin and neuronal axons were 
immunochemically revealed in examined white matter regions of APOEKO sham animals.  
In contrast to the main study hypothesis, the present neuroimaging and 
immunohistochemical data suggest that mouse APOE may not be essential for the 
maintenance of white matter integrity under normal physiological conditions. 
These results are surprising with regards to clinical data suggesting the existence of white 
matter abnormalities in cognitively intact APOE4 carriers (Bartzokis et al., 2006; 
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Bartzokis et al., 2007). The myelin sheath is particularly enriched in lipids and cholesterol 
composing~75% of its total dry mass (de Vries and Hoekstra, 2000; Dietschy et al., 2001). 
Previous studies on naïve APOEKO mice demonstrated an impaired cholesterol 
metabolism, an increased lipid peroxidation, a deficient phospholipids and sulfatides 
content in this animal model (Piedrihta et al., 1992; Van Ree et al., 1994; Montine et al., 
1999; Han et al., 2003; Elosua et al., 2004).  
Taken together the existing literature suggests a potential APOE involvement in regulating 
myelin lipid content in white matter. It is possible that genotype differences in white 
matter lipids existed between the two sham groups, but they were not examined in the 
present study (discussed in section 4.4.6.2.3). 
In the absence of concomitant pathology, it is possible that alternative mechanisms of lipid 
turnover such as APOA-I or APOA- J compensate for APOE deficiency in the brain and 
are sufficient to maintain myelin lipid homeostasis. For instance, the myelin- producing 
oligodendrocytes express the liver- X receptor- a nuclear oxysterol receptor activated by 
both APOE and APOA-I (Nelissen et al., 2012). Exogenous treatment of oligodendrocytes 
with the liver- X- receptor agonist T0901317 induces an enhanced cholesterol efflux in the 
presence of APOA-I or high-density lipoprotein particles. These data suggest the existence 
of alternative pathways which may sustain cholesterol levels in APOE deficient 
oligodendrocytes necessary for myelin production. 
Although MAG and dMBP are sensitive biomarkers to myelin pathology occurring 
following mild hypoxic- ischemic events (Matsuo et al., 1997; Aboul- Enein et al., 2003; 
Coltman et al., 2011; Holland et al., 2011; Reimer et al., 2011), they might not be sensitive 
to potentially subtle genotype differences in myelin integrity affecting for instance, other 
myelin proteins (e.g. PLP, CNPase). This hypothesis is substantiated by previous studies 
on naive APOEKO mice demonstrating the existence of an increased grey matter protein 
oxidation in this animal model (Ramassamy et al., 2001; Choi et al., 2004). It is unknown 
whether APOE affects white matter (myelin) protein content. Future experiments 
following previously established protocols for myelin proteins purification (Bellini et al., 
1986; Heape et al., 1999) and identification of oxidized proteins (Ramassamy et al., 2001; 
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Choi et al., 2004) would allow to determine the levels of protein oxidation in white matter 
areas of APOEKO mice (discussed in section 4.4.6.2.3).  
In contradiction with the present pathological findings, previous studies on naïve 
APOEKO mice have demonstrated the early occurrence of axonal pathology in this animal 
model characterized by decreases in α and β tubulin (Masliah et al., 1995). In the present 
study, the immunochemical analysis revealed preserved axonal integrity and APP 
transport in WT and APOEKO sham mice. This might be partially explained by the 
preservation of kinesin microtubules in APOEKO animals (Masliah et al., 1995) and their 
support of the fast axonal APP transport. It is important that future experiments examine 
in details axonal cytoarchitecture in APOEKO mice as changes in microtubules, 
neurofilaments might have existed in these animals, but remained undetected by the 
presently applied APP immunochemistry (discussed in section 4.4.6.2.3.).  
Additionally, it is possible that the ex vivo MRI procedure was unable to detect subtle 
genotype differences in white matter integrity. To selectively assess axonal and myelin 
integrity on the same biological sample, one should consider applying more sophisticated 
neuroimaging analysis taking into consideration the axial (λ‖; axonal integrity) and radial 
(λ┴; myelin integrity) diffusivity (discussed in sections 4.4.4., 4.4.6.1.3).  
Further, it is possible that APOEKO sham animals were too young (5 months) to exhibit 
white matter pathology which might occur later during their lifespan (discussed in section 
4.4.6.3.).  
4.4.1.2. APOE affects hypoperfusion- induced white matter pathology in mice 
Chronic cerebral hypoperfusion was associated with significant reductions in MRI metrics 
of white matter integrity (FA and MTR) in the CC, EC, IC, OT of both WT and APOEKO 
hypoperfused mice one month after surgery. Additionally, the MTR analysis demonstrated 
significant hypoperfusion- induced abnormalities in the control grey matter region- the 
hippocampus. APOEKO hypoperfused mice exhibited more severe white matter 
abnormalities in the CC where both FA and MTR were significantly reduced when 
compared with WT hypoperfused mice. In the IC and EC, FA, but not MTR was also 
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significantly decreased in APOEKO hypoperfused compared with WT hypoperfused 
animals.  
 
The present neuroimaging findings partially confirmed the main study hypothesis that 
APOE deficiency may impact on the severity of hypoperfusion- induced white matter 
abnormalities in mice.  
 
These results are not surprising in regards to previous experimental work suggesting a role 
of APOE in the endogeneous processes of myelination/ remyeliantion (Boyles et al., 1989; 
Stoll et al., 1989; Zhao et al., 2007; Chaerkady et al., 2011; Gan et al., 2011). Specifically, 
APOE has been identified as one of the molecular factors controlling adult and embryonic 
neural stem cells survival and differentiation towards the oligodendroglial lineage in vitro 
(Chaerkady et al., 2011; Gan et al., 2011). Experimental findings from an in vivo model of 
optic nerve injury suggest that oligodendroglial cells, but not astrocytes upregulate APOE 
after injury which may be associated with the processes of cholesterol synthesis and 
remyelination (Stoll et al., 1989). APOE levels increase significantly with a peak at the 
time of active remyelination in a rat model of sciatic nerve injury (Boyles et al., 1989). It 
has been shown that APOE plays an important role in the delivery of newly synthesized 
cholesterol to damaged cells and actively participates in the clearance of cellular debris 
promoting neuroregeneration and remyelination. On the basis of these in vitro and in vivo 
findings one could hypothesize that APOE deficiency may impact on oligodendroglial 
number, survival, functionality (e.g. cholesterol synthesis, myelin production) and 
indirectly may influence the processes of remyelination by 1) an impaired production of 
sterols and fatty acids by mature oligodendrocytes necessary for remyelination of 
demyelinated axons and/ or 2) a deficient differentiation of the endogenous neural stem 
cells pool towards the oligodendroglial lineage following hypoperfusion in mice. Future 
experiments should examine oligodendroglial cell differentiation, survival and 
functionality in relation to APOE under normal physiological as well as chronically 
hypoperfused conditions in mice (discussed in section 4.4.6.3).  
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APOE may influence the severity of neuropathology via alternative pathways such as 
modulation of excitotoxicity, oxidative stress and inflammation (Laskowitz et al., 1998; 
Horsburgh et al., 2000b; Horsburgh et al., 2003). For instance, in vitro exposure of 
primary neural culture and a neuronal cell line to a human recombinant APOE prior to 
NMDA- induced excitotoxic challenge partially reduces cell death (Aono et al., 2002). In 
vivo, intracerebral infusion of recombinant APOE in APOE deficient mice significantly 
reduces free radical levels following global ischemia (Horsburgh et al., 2000a). In vitro, 
recombinant APOE and APOE conditioned media prevent peroxide free radical induced 
cytotoxicity (Miyata and Smith, 1996). These in vivo and in vitro findings suggest that 
APOE deficiency might lead to the presently MRI- evidenced more severe white matter 
pathology in APOEKO hypoperfused mice via an impaired anti- excitotoxic and anti- 
oxidative function (discussed in section 4.4.6.3.). Further APOE deficiency might mediate 
its effects on white matter integrity in hypoperfused mice via an impaired 
immunomodulation (discussed in section 4.4.3.).  
 
Additionally, previous studies have demonstrated that APOE affects the integrity of the 
blood brain barrier under both normal physiological as well as pathological conditions and 
it is associated with the formation of atherosclerotic plaques (Piedrihta et al., 1992; 
Nakashima et al., 1994; Van Ree et al., 1994; Fullerton et al., 2001; Methia et al., 2001; 
Meir and Leitersdorf, 2004 Hafezi- Moghadam et al., 2006). It is possible that 
cerebrovascular anomalies in APOEKO hypoperfused mice might have impacted on their 
neuropathological profile (discussed in section 4.4.6.3.). 
 
The present neuroimaging findings are in consistency with clinical data demonstrating the 
existence of white matter pathology in APOE4 adults (Persson et al., 2006; Filippini et al., 
2009; Smith et al., 2010; Heise et al., 2010; Ryan et al., 2011).. These white matter 
abnormalities occur relatively early during lifespan and they are not directly associated 
with cognitive impairment. However, it is possible that APOE associated white matter 
abnormalities increase the risk of age- related neurodegeneration and the occurrence of 
dementia in APOE4 carriers (Strittmatter et al., 1993). Further, cognitively intact APOE4 
adults exhibit impaired cerebrovasculature and cerebral metabolism suggesting that 
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cerebrovascular factors might contribute to the development of white matter pathology in 
these individuals (Kalmijn et al., 1996; Skoog et al., 1998; Reiman et al., 1996; Reiman et 
al., 2004). 
 
At the microstructural level axonal and myelin pathology was evidenced in both WT and 
APOEKO hypoperfused mice in consistency with previous findings on the hypoperfused 
model (Coltman et al., 2011; Holland et al., 2011; Reimer et al., 2011). However, in the 
present study, the neuroimaging findings suggesting significant APOE differences in 
hypoperfusion- induced white matter pathology were not supported by the pathological 
data. Specifically, the semi-quantitative pathological grading scale was unable to detect 
significant genotype differences in the severity of hypoperfusion- induced axonal and 
myelin abnormalities. The observed discrepancy between the ex vivo MRI data and the 
pathological analysis could be partially explained by differences in the sensitivity of the 
two techniques (discussed in section 4.4.5).  
 
Overall, the pathological analysis failed to confirm the neuroimaging findings rising 
questions as to validity of the main study hypothesis. 
 
4.4.2. APOE effects on grey matter integrity under normal physiological and 
chronically hypoperfused conditions in mice 
An absence of mouse APOE effects on grey matter integrity was observed in sham and 
hypoperfused mice using T2- weighted neuroimaging and H&E histological analysis.  
These findings are in consistency with previous studies on chronically hypoperfused mice 
suggesting an absence of overt grey matter pathology in this animal model (Shibata et al., 
2004; Shibata et al., 2007; Nishio et al., 2010; Coltman et al., 2011; Holland et al., 2011).  
However, the present results are in controversy with data from alternative animal models 
where grey and white matter abnormalities develop following artery ligation (Kudo et al., 
1993; Ni et al., 1995; Pappas et al., 1996; Kim et al., 2008). 
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Further, naïve APOEKO mice have been shown to exhibit synapto- dendritic 
abnormalities and an early onset neurodegeneration (Gordon et al., 1995; Masliah et al., 
1995; Masliah et al., 1997; Sheng et al., 1999; Buttini et al., 2000). In addition, following 
experimental global and focal ischemia, APOEKO mice develop more severe 
neuropathology (e.g. infarctions) compared with WT counterparts (Laskowitz et al., 1997; 
Hosrburgh et al., 1999; Sheng et al., 1999; Kitagawa et al., 2002).  
In humans, the APOE4 allele is associated with the development of age- related 
neurodegeneration and dementia (Saunders et al., 1993; Moffat et al., 2000; Cohen et al., 
2001; Schuff et al., 2009b). Human APOE4 carriers show poorer recovery after stroke 
exhibiting more severe infarctions than APOE3 carriers (Gromadzka et al., 2007; Wagle et 
al., 2009).  
The observed discrepancy between the present pathological data on APOEKO 
hypoperfused mice and the existing human and animal literature on APOE might be 
partially explained by cerebrovascular and methodological differences. For instance, 
during focal and global ischemia the cerebral blood flow reductions are severe leading to 
the development of neuronal ischemic injury (infarctions) and white matter pathology, 
whereas during chronic cerebral hypoperfusion, the cerebral blood flow is mildly but 
chronically reduced leading to the development of predominant white matter pathology (at 
least in non- food deprived and behaviourally tested mice). Further, it is possible that the 
applied pathological approach, namely the visual examination of T2- weighted scans and 
H&E stained brain samples was not sensitive to detect subtle grey matter abnormalities 
(e.g. dendritic/ synaptic loss). Interestingly, in the present study significant MTR 
reductions were evident in the hypoperfused hippocampus in the absence of significant 
APOE effects. Pathologically, significant dMBP accumulations were observed in the 
hippocampus of both WT and APOEKO hypoperfused mice. 
On the basis of the present findings and the existing literature, one could suppose the 
existence of presently non- detected grey matter abnormalities on T2- weighted scans and 
H&E stained brain sections in APOEKO sham and hypoperfused animals (Gordon et al., 
1995; Masliah et al., 1995; Laskowitz et al., 1997; Masliah et al., 1997; Hosrburgh et al., 
1999; Sheng et al., 1999; Buttini et al., 2000; Kitagawa et al., 2002). Additionally, it is 
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possible that WT hypoperfused mice also exhibited grey matter pathology, especially with 
regards to the pathological findings presented in Chapter 3 and data from alternative 
animal models (Kudo et al., 1993; Ni et al., 1995; Pappas et al., 1996; Kim et al., 2008). 
4.4.3. APOE effects on inflammation under normal physiological and chronically 
hypoperfused conditions in mice 
In contrast to previous findings on naïve APOE deficient mice (Laskowitz et al., 2000; 
Lynch et al., 2001), the present pathological analysis revealed that the baseline 
inflammatory levels were similar in WT and APOEKO sham mice. The inflammatory 
activity increased significantly after chronic cerebral hypoperfusion as previously shown 
in this animal model (Shibata et al., 2004; Coltman et al., 2011; Holland et al., 2011). 
However, the APOE genotype was not related to the severity of the observed 
inflammatory response in white and grey matter areas of hypoperfused mice.  
These results are in contradiction with previous reports showing an impaired immune 
response in APOEKO mice under different pathological conditions (Ophir et al., 2003; 
Champagne et al., 2005). In a previous in vivo study on APOE deficient mice, a 
stereological quantification of GFAP positive astrocytes demonstrated APOE genotype 
differences in the astroglial response following experimental entorhinal cortex lesion 
(Champagne et al., 2005). Similar results were evidenced after LPS treatment where 
APOEKO and human APOE4 transgenic mice exhibited an impaired astroglial and 
microglial activation associated with the development of more pronounced white matter 
pathology in these animals compared with WT and APOE3 counterparts (Ophir et al., 
2003). In this particular study, inflammatory levels were examined by means of a standard 
immunohistochemical procedure followed by a quantitative, stereological assessment of 
GFAP- positive astroglial processes length and the number of F4/80- positive microglia. 
Further, by using an immunohistochemical approach for interleukins (IL-6; IL-1β; IL-18) 
and CD45 (marker of inflammatory cells) accompanied by a subsequent cell counting 
procedure, Rahman et al., 2005 demonstrated increased inflammatory levels in APOE 
deficient mice maintained on a high cholesterol diet.  
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With regards to the observed discrepancy between the present pathological findings 
suggesting an absence of APOE differences in the immune response following chronic 
cerebral hypoperfusion and previously published work demonstrating APOE 
immunomodulatory role following injury to the brain (Ophir et al., 2003; Champagne et 
al., 2005; Rahman et al., 2005), one should consider applying quantitative pathological 
techniques (similar to the ones presented in peer- reviewed publications) in order to verify 
the present findings. Further, astrocytes are glial cells constituting the blood brain barrier 
and exerting various physiological functions in the central nervous system (e.g. secretion 
of neurotrophic factors, buffering of extracellular glutamate, immunomodulation) (Hertz 
and Zielke, 2004; Hawkins and Davis, 2005; Volterra and Meldolesi, 2005; Magistretti, 
2006). APOEKO mice have been shown to exhibit blood brain barrier abnormalities under 
normal physiological conditions and increases in blood brain barrier permeability in the 
presence of neuropathology (Fullerton et al., 2001; Methia et al., 2001; Hafezi- 
Moghadam et al., 2006). To gain a better understanding of the cellular and molecular 
mechanisms mediating APOE effects on neuropathology, it would be interesting to 
examine the astroglial response in APOEKO mice under normal physiological and 
chronically hypoperfused conditions compared with WT counterparts. From a 
methodological point of view, this could be achieved by the application of astroglial 
specific biomarkers such as GFAP for immunohistochemical and/ or Western blot analysis 
(previously discussed experimental strategies are given in Chapter 3 sections 3.4.2.4., 
3.4.4.3.) 
In humans, significantly increased inflammatory levels are evidenced in APOE4 carriers 
with Alzheimer`s dementia corresponding with the accelerated disease progression in 
these individuals compared with non- APOE4 demented adults (Fazekas et al., 2005).  
4.4.4. Sensitivity of ex vivo MRI to white matter integrity 
Postmortem MRI was previously used to study white matter integrity in human, primate 
and rodent brain under normal physiological and pathological conditions (Nagara et al., 
1987; Grafton et al., 1991; Bronge et al., 2002; Guilfoyle et al., 2003; Sun et al., 2003; 
Song et al., 2003; Englund et al., 2004; Larsson et al., 2004; Pfefferbaum et al., 2004; 
Schmierer et al, 2004; Song et al., 2005; Sun et al., 2005; Dhenain et al., 2006; Harms et 
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al., 2006; Sun et al., 2006b;  Blezer et al., 2007; D`Arceuil et al., 2007; Ou et al., 2009; 
Augustinack et al., 2010).  
Ex vivo MRI differs from in vivo MRI as the tissue samples are drained from the 
circulating blood, their temperature is below the normal body temperature of the living 
animal/ human and a fixative reagent is usually applied to ensure the perseveration of 
protein connections and sample morphology. All this could alter MRI measures as the 
procedure relies on the temperature driven diffusion of water molecules in the brain and 
applying MRI on postmortem samples has to overcome certain issues. This is done by 
adjusting the ex vivo imaging protocol by applying stronger magnet gradients and 
excitation frequencies to the sample (Larsson et al., 2004; Pfefferbaum et al., 2004). Some 
groups also use additional sample treatments with enhancing contrast agents (Blezer et al., 
2007; D`Arceuil et al., 2007; Augustinack et al., 2010) or agar embedding (Bronge et al., 
2002; Pfefferbaum et al., 2004; Dhenain et al., 2006) to improve image quality.  
Ex vivo MRI presents some obvious advantages compared to in vivo MRI procedure. Ex 
vivo MRI allows longer imaging times in the absence of anesthesia and physiological 
artifacts inherent to all in vivo MRI, the application of stronger magnets gradients and the 
subsequent generation of high quality images which are valuable tool for the detailed 
study of neuroanatomy. Furthermore, in contrast to in vivo MRI where only one animal 
(one brain) is scanned per imaging session, ex vivo MRI allows the simultaneous scanning 
of multiple samples (3- 4 brains in the present study) per imaging session thus leading to 
significant reductions in the experimental cost related to the MRI procedure. Although 
tissue fixation prior to ex vivo MRI has been shown to decrease the apparent water 
diffusivity, it does not affect the overall anisotropy compared with in vivo imaging 
procedures (Guilfoyle et al., 2003; Sun et al., 2003; Sun et al., 2005). Up to 10h after 
death in fixative solution the anisotropy values in the brain have been shown to remain the 
same as in the living animal (Kim et al., 2007). To avoid any potential bias related to an 
overfixation of the tissue material and/ or long postmortem delays, in the present study, ex 
vivo MRI was performed relatively shortly after death (~24h) in the absence of additional 
enhancing contrast agents and embedding substances.  
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From a neurobiological perspective, FA is determined by both myelin and axonal integrity 
(Basser, 1995; Beaulieu, 2002). Pathological damage to one or both of these white matter 
components leads to a reduction in FA measured using both in vivo (Filippi et al., 2001; 
Bozzali et al., 2002; Deary et al., 2003; Harsan et al., 2006; Penke et al., 2010; Holland et 
al., 2011) as well as ex vivo (Song et al., 2003; Song et al., 2005; Dhenain et al., 2006; 
Harms et al., 2006; Sun et al., 2006a; Gouw et al., 2008) MRI settings.  
MTR has slightly different neurobiological basis (Wolff and Balaban, 1989; Grossman et 
al., 1994), but damage to the myelin sheath and/ or the neuronal axons can impact on the 
pool of bound water molecules in the brain and therefore could lead to reductions in MTR 
(McGowan et al., 1999; Blezer et al., 2007; Ou et al., 2009; Holland et al., 2011).  
Interestingly, in the present study, although FA and MTR detected with the same 
sensitivity pathological changes in white matter tracts, they differed in their sensitivity to 
detect subtle white matter changes in grey matter. In the hippocampus, only MTR 
decreased significantly after chronic cerebral hypoperfusion and correlated with myelin 
(dMBP), but not axonal pathology (S.4.1.- appendices II). This is in accordance with 
previous findings showing that MTR is particularly sensitive to myelin pathology as in the 
case of multiple sclerosis (Schmierer et al., 2004; Blezer et al., 2007). Although there were 
no APOE genotype differences in MRI parameters in the hippocampus, the correlation 
data suggest that MTR, but not FA is sensitive to pathological changes affecting both grey 
and white matter (S.4.1.- appendices II).  
To distinguish between axonal and myelin pathology using MRI- DTI (Beaulieu, 2002), it 
is necessary to apply more sophisticated DTI analysis focused on the axial (λ‖; axons) and 
radial (λ┴; myelin) diffusivities (discussed in section 4.4.6.1.3.). 
 In vivo DTI has been shown to differentiate between axonal and myelin pathology in a 
cuprizone mouse model of demyelination (Sun et al., 2006a) and in mice with retinal 
ischemia (Song et al., 2003) where increases in radial diffusivity were associated with 
myelin loss and reductions in axial diffusivity were indicative of axonal injury.  
Similar results were obtained using ex vivo MRI in mice with middle cerebral carotid 
artery occlusion (Sun et al., 2005), on cuprizone- treated mice (Song et al., 2005) and on 
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mice with induced retinal ischemia (Sun et al., 2006b). Furthermore, Sun et al., 2006b 
showed differential sensitivity of in vivo and ex vivo MRI to axonal and myelin pathology 
in mice with retinal ischemia. Although DTI sensitivity to myelin pathology was similar 
for in vivo and ex vivo MRI settings, ex vivo DTI failed to detect axonal pathology 
observed in vivo, pointing to the necessity of a further development and validation of ex 
vivo DTI techniques. In the present ex vivo MRI study, λ‖ and λ┴ were not measured and 
future in vivo and ex vivo experiments on the same hypoperfused mice should elucidate 
the respective contribution of axonal and myelin pathology to the observed white matter 
structural changes observed on MRI scans (discussed in section 4.4.6.1.3.).  
Using an in vivo MRI approach on chronically hypoperfused mice, our group previously 
reported that both FA and MTR are sensitive metrics of diffuse white matter abnormalities 
occurring in this animal model (Holland et al., 2011). In vivo, FA decreased significantly 
following hypoperfusion in the CC and EC, whereas MTR reductions were evidenced in 
all white matter ROIs (the CC, IC, OT, Fx). In the present ex vivo MRI study, both FA 
and MTR detected with the same sensitivity white matter integrity (the CC, EC, IC, OT)  
and were able to account for significant genotype differences in hypoperfusion- induced 
white matter pathology (the CC). The hippocampal (grey matter) FA and MTR in vivo did 
not change significantly in chronically hypoperfused mice. However, in the present ex 
vivo MRI experiment on the same animal model, MTR was found to be significantly 
reduced in the hypoperfused hippocampus in the absence of significant APOE effects. 
4.4.5. Differential sensitivity of ex vivo MRI and immunohistochemistry to APOE 
genotype differences in white matter integrity in mice 
In the present study ex vivo MRI was found to be more sensitive to APOE genotype 
differences in white matter integrity than a standard immunohistochemistry. This 
discrepancy could be explained by differences in the nature of the two techniques as well 
as in the total volume of examined brain tissue. FA and MTR quantitatively measured 
alterations in white matter structural integrity occurring in tracts throughout the brain 
(section thickness 0.5mm), whereas axonal and myelin integrity was semi- quantitatively 
categorized on brain sections from only one neuroanatomical level (-2.12mm bregma, 
Franklin and Paxinos, 1997) (section thickness 6µm). Similar results showing differences 
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in the sensitivity of ex vivo MRI and histology in detecting white matter pathology were 
reported by other groups. Ex vivo MRI was found to be either more
 
(Grafton et al., 1991) 
or less (Bronge et al., 2002) sensitive than standard histological techniques in identifying 
white matter abnormalities. This discrepancy in the existing literature is most likely due to 
differences in the employed MRI and histological techniques, the strength of the MRI 
magnet, the total imaging time, the type of fixative and the postmortem delay. However, 
similar to the present study, Grafton et al., 1991 found ex vivo MRI to be more sensitive 
to white matter pathology in human brains than a semi- quantitative pathological grading 
scale. In the present study, the microstructural changes in white matter integrity were 
evaluated by means of a semi- quantitative grading scale because of 1) its shown 
sensitivity to detect white matter pathology in chronically hypoperfused mice (Coltman et 
al., 2011; Holland et al., 2011) and 2) its broad application in human neuropathological 
studies (Grafton et al., 1991; Dickson et al., 1991; Curtis et al., 2003). Further 
development and characterization of ex vivo MRI might be of particular interest for the 
elucidation of the microstructural basis of diffuse white matter pathology evidenced in 
different neuropathological conditions and associated with cognitive impairment. Ex vivo 
MRI might become a useful complementary tool to basic histological techniques allowing 
a detailed whole brain anatomy examination which otherwise would be an expensive 
histological venture.  
4.4.6. Strengths and limitations of the applied methodology and future experimental 
work  
4.4.6.1. Strengths and limitations of ex vivo MRI and future experiments to further 
develop and characterize this newly developed neuroimaging procedure 
4.4.6.1.1. Strengths of the ex vivo MRI procedure  
One of the major advantages of the newly developed ex vivo MRI procedure consists of 
the important reductions of the experimental costs associated with neuroimaging. In 
contrast to in vivo MRI, ex vivo MRI allows to image more than 1 biological sample per 
imaging session which leads to ~1 /4 reductions in the cost of performing pre- clinical 
neuroimaging studies (discussed in section 4.4.4.). 
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Further, ex vivo MRI allows longer imaging times in the absence of anesthetic agents, 
movement and physiological artifacts leading to the generation of images with a very good 
spatial resolution facilitating the subsequent regional image analysis (discussed in section 
4.4.4.). In the present study, a significant technical achievement was accomplished by 
optimizing ex vivo MRI without applying any additional contrast agents/ embedding 
substances which could impact on the subsequent pathological analysis by changing the 
tissue morphology. 
Another interest of the ex vivo neuroimaging approach relies in its translational nature to 
clinics and the extrapolation of experimental (animal) findings to humans. 
Lastly, the applied ex vivo MRI analysis allows to quantitatively assess white matter 
integrity throughout the mouse brain. This would be difficult to achieve by using standard 
immunohistochemical procedures, especially in regards to the implicated costs associated 
with whole brain immunostaining. 
4.4.6.1.2. Limitations of the ex vivo MRI procedure  
In the present study, the neuroimaging procedure was performed post- mortem in 
conditions which were different from the natural, physiological environment of the living 
animal (discussed in section 4.4.4.). For instance, there are important differences in the 
brain sample temperature in vivo (~37°C) compared with ex vivo (~20°C) which might 
impact on the water molecule diffusivity and by consequence on the MRI metrics (Sun et 
al., 2003). Additionally, at the difference from the living animal the perfused brain is 
characterized by an absence of active circulation and neurotransmission. It is unknown 
whether and/ or to what extent the present ex vivo MRI findings recapitulated the actual 
pathology in the living animal (discussed in section 4.4.6.1.3.).  
In addition, the ex vivo MRI procedure was associated with a prolonged samples 
conservation in fixative solution (> 24h) under an increased ambient temperature (>4°C). 
This might have overfixed the tissue material and by consequence impacted on the 
immunohistochemical analysis. Previous studies demonstrated that up to 10h after death in 
fixative solution does not affect anisotropy in ex vivo MRI samples (Kim et al., 2007) 
(discussed in 4.4.4.). However, the effects of prolonged tissue fixation (>24h) on mean 
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diffusivity, anisotropy and neuropathology are unknown. Potential artifectual alterations in 
ex vivo MRI parameters due to tissue overfixation might have led to wrong study 
conclusions (e.g. not detected group differences in white matter integrity when present or 
vice- versa) (discussed in section 4.4.6.1.3.). 
Another limitation of the presently applied ex vivo MRI procedure relates to the obtained 
data and its subsequent analysis. Specifically, although the applied FA and MTR analysis 
is sensitive to overall pathological changes in white matter integrity, it does not allow to 
distinguish between axonal and myelin pathology. Therefore, this neuroimaging analysis 
does not provide any information on the cellular (microstructural) determinants of the 
MRI- evidenced white matter abnormalities in WT and APOEKO hypoperfused mice. 
Further, the present MRI analysis might not have been sensitive to subtle white matter 
abnormalities in APOEKO sham mice (discussed in sections 4.4.1.1.).  
In the present study, grey matter integrity was not quantitatively measured on T2- 
weighted scans. The MRI scans are designed to detect white matter integrity and they are 
not suited to grey matter. Therefore, although, the visual examination of T2- weighted 
scans allows to determine the potential presence/ absence of overt grey matter pathology it 
does not provide quantitative assessment of grey matter integrity. This nonquantitative 
approach risks of omitting important pathological changes in grey matter potentially 
present in some of the experimental animals (Chapter 3; Gordon et al., 1995; Masliah et 
al., 1995; Laskowitz et al., 1997; Masliah et al., 1997; Hosrburgh et al., 1999; Sheng et al., 
1999; Buttini et al., 2000; Kitagawa et al., 2002) (discussed in section 4.4.2.). 
4.4.6.1.3. Future experiments to further develop and characterize ex vivo MRI 
To test the sensitivity and biological significance of post- mortem MRI, it is important to 
measure FA and MTR in vivo and subsequently perform the same measures ex vivo in the 
same sham and hypoperfused mice in order to determine the existence of any potential in 
vivo/ ex vivo “within” and “between” group differences in the regional FA and MTR 
values. The results from this analysis would allow to validate and further refine the 
sensitivity of ex vivo MRI. 
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To determine the effects of the prolonged time in fixative under an increased ambient 
temperature inherent to post- mortem MRI, future experiments should compare MRI/ 
immunochemical data from the living animal with the same measures in brain samples 
kept for different periods in fixative (e.g. 0h vs. 12h vs. 24h. vs. > 24h). This would allow 
to determine whether the prolonged time in fixative solution (>24h) affects on MRI 
measures and neuropathology. 
To selectively detect axonal and myelin integrity using MRI, one should consider applying  
more sophisticated neuroimaging analyses such as assessment of axial (λ‖; axonal 
integrity) and radial (λ┴; myelin integrity) diffusivity (Song et al., 2003; Song et al., 2005; 
Sun et al., 2006a; Sun et al., 2006b; Blezer et al., 2007). Under normal physiological 
conditions, the water molecules in the brain diffuse preferentially along the neuronal 
axons and this physical phenomenon is translated into an increased axial diffusivity. In the 
absence of pathology, the water molecules could hardly diffuse perpendicular to the 
neuronal axons being hindered by the myelin sheath and the axonal cytoarchitecture (e.g. 
microtubules, neurofilaments). Therefore, under normal physiological conditions, the 
radial diffusivity is low. Axonal pathology results in decreases in axial diffusivity. 
Inversely, pathological damage to the myelin sheath results in an increased radial 
diffusivity. Thus, by measuring axial and radial diffusivity one could get a better 
understanding of the cellular determinants of white matter integrity on MRI scans. 
Further, it is important to compare axial and radial diffusivity in vivo vs. ex vivo as 
previous studies on a mouse model of retinal ischemia suggest that ex vivo MRI might not 
be sensitive to in vivo MRI evidenced axonal pathology (Sun et al., 2006b). Future 
combined in vivo and ex vivo MRI analysis of axial and radial diffusivity in sham and 
hypoperfused animals would allow to determine whether the newly developed ex vivo 
MRI procedure is sensitive to pathological changes in axonal and myelin integrity and 
whether the ex vivo MRI metrics are comparable with in vivo findings in the same groups 
of animals. This would allow to further refine and develop neuroimaging approaches for 
both pre- clinical and clinical application. 
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4.4.6.2. Strengths and limitations of the immunochemical pathological approach and 
future experiments 
4.4.6.2.1. Strengths of the immunochemical approach 
The strengths of the immunohistochemical procedure are discussed in details in Chapter 3, 
section 3.4.4.1 Briefly, the major advantage of this approach relates to the selective 
examination of specific white matter cellular components by the application of antibody 
probes targeted to the neuronal axons (APP), myelin sheath (dMBP, MAG) and 
inflammatory microglia (Iba1) allowing more detailed characterization of white matter 
abnormalities in this animal model. The applied H&E histological staining gives a good 
overall indication of grey matter morphology and the existence of neuronal ischemic 
injury. 
4.4.6.2.2. Limitations of the immunohistochemical approach 
The major drawbacks of the applied immunohistochemical approach are discussed in 
details in Chapter 3, section 3.4.4.2. Briefly, the limitations of the pathological analysis 
are associated with the limited number of applied white and grey matter- specific 
biomarkers, the single brain level pathological analysis, as well as the semi- quantitative 
nature of the obtained data. Overall, this pathological approach risks of omitting 
neuropathology affecting alternative white and grey matter cellular components not 
immunodetected by the applied antibodies and/ or present on non- examined brain levels. 
This is of particular importance especially in regards to the presently observed 
discrepancy between the immunohistochemical and ex vivo MRI findings (discussed in 
section 4.4.5.).  
4.4.6.2.3. Future pathological studies 
Future experiments should perform a quantitative pathological characterization in this 
animal model especially with regards to the presently observed discrepancy between the 
immunochemical (single brain level) and ex vivo (whole brain) MRI analysis (discussed 
in section 4.4.5.). This could be achieved by 1) the application of a wider range of white 
and grey matter specific biomarkers, 2) the examination of additional neuroanatomical 
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levels (corresponding to the MRI- DTI analysis) and 3) the application of laboratory 
techniques allowing quantitative neuropathological evaluation (discussed in Chapter 3, 
section 3.4.4.3.). Additionally, an electron microscopy structural analysis would allow to 
better characterize APOE effects on white matter integrity in the presence and absence of 
chronic cerebral hypoperfusion in mice. 
In regards to 1) the important role of APOE in regulating brain cholesterol and lipid 
homeostasis (Mahley and Innerarity, 1983; Han et al., 2003; Bartzokis et al., 2003; 
Bartzokis et al., 2007), 2) the high lipid and cholesterol content of the myelin sheath 
(~75% of its dry mass) (de Vries and Hoekstra, 2000; Dietschy et al., 2001) as well as 3) 
previously demonstrated impaired cholesterol metabolism, increased lipid peroxidation, 
deficient phospholipids and sulfatides content in naïve APOEKO mice (Piedrihta et al., 
1992; Van Ree et al., 1994; Montine et al., 1999; Han et al., 2003; Elosua et al., 2004), 
future experiments should examine the individual and combined effects of the surgical 
procedure (sham vs. hypoperfused) and genotype (APOEKO vs.WT) on myelin 
cholesterol and lipid levels using for example HPLC (e.g. myelin lipids) and/ or Western 
blot analysis (e.g. myelin proteins).  
4.4.6.3. Other methodological limitations and future experiments to examine APOE 
effects on white matter integrity under normal physiological and hypoperfused 
conditions in mice 
The present study presented other methodological limitations not directly related to the ex 
vivo MRI and immunohistochemical procedures.  
All pathological analysis was performed one- month post- surgery. It is unknown whether 
APOE- associated differences in white and grey matter integrity occur or not at later post- 
surgery time points. Future experiments should examine white and grey matter integrity at 
different post- surgery time points in APOEKO and WT animals in the presence and 
absence of chronic cerebral hypoperfusion. This is important in regards to 1) previously 
demonstrated cumulative pathology in chronically hypoperfused animals (Farkas et al., 
2007; Nishio et al., 2010; Reimer et al., 2011) and 2) the natural effects of aging on 
neuropathology (Arnsten and Goldman- Rakic, 1985; Olendorf, 1987; de Jong et al., 1990; 
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Miguez et al., 1990; McEntee and Crook, 1991; Ni et al.,1995; Kondo et al., 1996; 
Egashira et al., 1996; Tanaka et al., 1996; Tang et al., 1997; Ouchi et al., 1998; Bimonte et 
al., 2003; Blesch, 2006; Choy et al., 2006; Farkas et al., 2006; Fernando et al., 2006; Gold 
et al., 2007) which might impact on their neuropathological profile.  On the basis of these 
previous data, it is possible that a more severe neuropathology develops at later post- 
surgery time points and these pathological changes might be more pronounced in 
APOEKO hypoperfused animals.  
Further, the cerebral blood flow was not measured in the experimental groups. This is an 
important methodological drawback especially in regards to previously reported naturally 
occurring cerebrovascular anomalies (e.g. atherosclerosis, blood brain barrier leakage) in 
APOE deficient mice (Piedrihta et al., 1992; Nakashima et al., 1994; Van Ree et al., 1994; 
Fullerton et al., 2001; Methia et al., 2001; Meir and Leitersdorf, 2004; Hafezi- Moghadam 
et al., 2006). These pathological changes are exacerbated in the presence of 
neuropathology (Methia et al., 2001). Although, in the present study, an attempt was made 
to limit these effects by using relatively young adult mice, it is possible that early 
atherosclerotic plaques existed in the APOEKO mice impacting on the overall perfusion 
rates in these animals. Future experiments on APOEKO mice should take into 
consideration the existence of potential differences in the hypoperfusion rates between 
APOEKO and WT mice which might impact on neuropathology and functional outcome. 
Methodological strategies to measure the cerebral blood flow are discussed in Chapter 3, 
section 3.4.4.3. 
The present study focused on relatively young, adult WT and APOEKO mice. However, 
in regards to the relevance of the hypoperfused model and APOE to the aging process in 
humans, it is important to examine the individual and combined effects of surgery (sham 
vs. hypoperfusion) and genotype (APOEKO vs. WT) on neuropathology and functional 
outcome in the context of aging (Chapter 6, section 6.1.2.). 
Although the present study provides an interesting insight into APOE effects on white 
matter integrity following chronic cerebral hypoperfusion, it does not inform on the 
functional significance of the observed genotype differences in white matter integrity. 
Previous studies on APOEKO deficient mice with experimentally induced injury to the 
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central nervous system have reported more severe pathological and functional outcome in 
these animals in comparison with WT counterparts (Chen et al., 1997; Laskowitz et al., 
1997a; Lomnitski et al., 1997; Horsburgh et al., 1999; Lomnitski et al., 1999; Sheng et al., 
1999; Lynch et al., 2002; Kitagawa et al., 2002; Champagne et al., 2005). These findings 
suggest that APOEKO mice might exhibit more severe neuropathology associated with 
more pronounced functional impairment following chronic cerebral hypoperfusion. Future 
experiments should examine the individual and combined effects of surgery (sham vs. 
hypoperfusion) and genotype (APOEKO vs. WT) on cognition and memory using 
behavioural paradigms. In vitro experimental strategies would allow to determine whether 
these experimental factors affect on action potential propagation using electrophysiology 
(e.g. action potential propagation measured in brain slice preparation) These functional 
experiments would allow to determine whether the presently MRI- evidenced APOE 
differences in hypoperfusion- induced white matter pathology are relevant at the 
functional level. 
Further, at the exception of inflammation, the exact molecular and/ or cellular 
mechanism(s) via which APOE might modulate the development of hypoperfusion- 
induced white matter pathology in mice remain(s) unknown. Future experiments should 
examine possible pathophysiological pathways (e.g. impaired lipid and cholesterol 
metabolism, excitotoxic levels, oxidation, pre- existing cerebrovascular abnormalities) 
associated with hypoperfusion- induced neuropathology in APOEKO mice using 
experimental strategies discussed in Chapter 6, section 6.1.3.. Briefly, the application of 
anti- excitotoxic, anti- oxidative, anti- inflammatory agents would allow to determine 
whether these pathways influence on the development of white matter pathology and 
whether and/ or how they are modulated by APOE. Alternative strategy would consist of 
the intracerebral infusion of synthetic APOE vs. control (saline) into APOEKO sham and 
hypoperfused mice and their respective controls followed by a subsequent evaluation of 
excitotoxic levels, oxidative stress and inflammation in these animals (discussed in 
Chapter 6, section 6.1.4.2.).  
Future studies would allow to determine the potential cellular substrates of the MRI- 
evidenced APOE genotype differences in the severity of hypoperfusion- induced white 
168 
matter pathology. Recent experiments suggest that APOE might impact on the myelin 
producing oligodendroglia and by consequence could affect the endogenous processes of 
remyelination (Chaerkady et al., 2011; Gan et al., 2011; Nelissen et al., 2012) (discussed 
in section 4.4.1.2.). Methodologically this question could be addressed by comparing the 
proportions of mature oligodendrocytes (e.g. MBP, PLP) and OPC (e.g. NG2, O4) (DAPI 
for cell nuclei) in WT and APOEKO sham and hypoperfused mice using for instance a 
combined immunochemical/ confocal imaging approach. 
Another major methodological limitation of the present study relates to the small group 
(n) numbers on which the analyses were based. This was due to a slow breeding in the 
APOEKO colony and the difficulty to gather simultaneously sufficient numbers of sex, 
age, and genotype- matched animals. The alternative commercial purchase of large 
numbers of genetically modified animals involved important costs. However, with regards 
to the heterogeneous nature of the hypoperfused model one should consider using larger 
groups of WT and APOEKO hypoperfused animals as this would allow 1) a more precise 
pathological evaluation, 2) an increased statistical power and by consequence 3) firmer 
study conclusions. 
In an attempt to approach the human condition and an additional step towards translation 
of this research, future experiments should also investigate the effects of the human APOE 
isoforms (APOE 3 vs. APOE4) on neuropathology (white matter integrity) and functional 
outcome comparing human APOE3 vs. APOE4 transgenic mice under normal 
physiological and chronically hypoperfused conditions. 
4.4.7. Implications of the study and future directions 
The present study provides a preclinical insight into the individual and combined effects 
of genetic (APOE) and cerebrovascular (chronic cerebral hypoperfusion) factors on the 
development of neuropathology. This question has a direct relevance to clinics where 
human APOE allelic variation and chronic cerebral hypoperfusion have been associated 
with the development of age- related white matter pathology (Kalaria, 1996; Tang et al., 
1997; de Leeuw et al., 2000; Farkas et al., 2006; Gold et al., 2007; Bartzokis et al., 2007; 
Filippini et al., 2009; Heise et al., 2010; Ryan et al., 2011). 
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The present neuroimaging findings suggest that APOE may not be essential for the 
maintenance of white matter integrity under normal physiological conditions, but it may 
impact on the severity of hypoperfusion- induced white matter pathology at least in the 
mouse. 
Although a substantial future development of the ex vivo MRI procedure,  
immunochemical evaluation and overall study design is required, the present data are 
interesting and would serve as a basis for future research into the pathophysiological 
mechanism(s) underlying APOE effects on hypoperfusion- induced white matter 
pathology. This future work would potentially lead to the identification of biological 
targets for the pre- clinical development of therapeutic strategies for the treatment of age- 
related cognitive decline in APOE4 carriers who are at a higher risk of dementia. 
Future experiments on human APOE3 and APOE4 transgenic mice would allow to better 
approach the human condition and would facilitate the translation of the obtained pre- 
clinical findings to clinics.  
4.5. Summary 
The neuroimaging findings presented in Chapter 4 suggest that mouse APOE deficiency 
may not impact on white matter integrity under normal physiological conditions, but it 
may be associated with the development of more severe hypoperfusion- induced white 
matter abnormalities. However, these neuroimaing findings were not supported by the 
applied immunochemical (microstructural) analysis showing an absence of APOE 
differences in the severity of axonal and myelin integrity in examined hypoperfused white 
matter tracts. An absence of APOE effects on grey matter and inflammation were 


































Characterization of methylation and 
hydroxymethylation in white matter under normal 
physiological and chronically hypoperfused 
conditions in mice 
5.1. Introduction and aims 
5- Methylcytosine (5mC) is a major form of epigenetic DNA modification involving 
methylation of the 5’ carbon of cytosine in a CpG dinucleotide context in gene promoters 
(Bird, 2002). Methylation is associated with regulation of gene expression (e.g. 
transcriptional silencing) modulating cellular function during lifespan and disease. 
With aging there are dynamic global and gene-specific changes in 5mC distribution in 
cortical and subcortical grey matter regions of the mammalian brain which are associated 
with neurodegeneration and cognitive impairment (West et al., 1995; Mehler, 2008; Zawai 
et al., 2009; Chouliaras et al., 2010; Penner et al., 2010). Several mechanisms have been 
proposed to impact on DNA methylation with increasing age including cerebrovascular 
conditions (e.g. stroke, chronic cerebral hypoperfusion) and the resulting hypoxic- 
ischemic environment accompanied by increased excitotoxicity, oxidative stress, 
inflammation (Endres et al., 2000;  Westberry et al., 2008). Severe reductions of cerebral 
blood flow as a result of experimental stroke and focal ischemia are known to reduce brain 
genomic methylation (Endres et al., 2000; Westberry et al., 2008).  
This is particularly relevant with regard to a newly discovered oxygen- dependent 
modification of 5mC- 5- hydroxymethylcytosine (5hmC) catalyzed by the Ten- eleven 
translocation proteins (TET1, TET2, TET3) (Kriaucionis and Heintz., 2009; Tahiliani et 
al., 2009; Ito et al., 2010). 5hmC is detected in a range of mammalian tissues at different 
developmental stages, but it is particularly enriched in the early mammalian embryo as 
well as in the developing and adult brain where it is abundant in neurons (Kriaucionis and 
Heintz., 2009; Li and Liu, 2011; Ruzov et al.., 2011).  From a functional perspective, 
recent genome- wide studies using human brain tissue (Jin et al., 2011) and mouse 
embryonic stem cells (Ficz et al., 2011) have demonstrated that in contrast to 5mC which 
is predominantly located at heterochromatic regions, 5hmC is abundant in euchromatin 
suggesting that this epigenetic DNA modification is most likely to be involved in 
facilitating gene expression. In the adult mouse cerebellum, increases in intragenic 5hmC 
have been associated with age- related neuropathology (Song et al., 2010). However, the 
exact functional significance of 5hmC in the healthy and diseased central nervous system 
remains unclear.  
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White matter abnormalities linked to hypoxic environment occurring with cerebrovascular 
disease (e.g. chronic cerebral hypoperfusion) are suggested to contribute to cognitive 
decline in “healthy” elderly (Farkas and Luiten, 2001; O`Sullivan et al., 2001; Roman et 
al., 2002; Deary et al., 2003; Charlton et al., 2006; Fernando et al., 2006; Grieve et al., 
2007; Kennedy and Raz, 2009; Ihara et al., 2010; Penke et al., 2010).  
At the outset of this thesis, there was minimal information on methylation and 
hydroxymethylation dynamics in white matter under normal physiological and chronically 
hypoperfused conditions. Although, more than 90% of the existing age- related 
neuropathologies are not inherited (absence of DNA alterations), changes in gene 
expression are known to occur in the aging brain most likely due to epigenetic 
dysregulations (Penner et al., 2010; Marques et al., 2011). Using a microarray analysis, 
Reimer et al., 2011, demonstrated alterations in the expression of 129 genes in white 
matter following chronic cerebral hypoperfusion in mice of which some were associated 
with oxidative stress. 
The present study aimed at investigating methylation and hydroxymethylation in white 
matter using the mouse model of chronic cerebral hypoperfusion outlined in previous 
chapters within the thesis.  On the basis of previous studies on alternative animal models 
(Endres et al., 2000; Westberry et al., 2008) and clinical conditions in which TETs 
mutations were associated with perturbations in hydroxy/ methylation (myeloid cancer- 
Ko et al., 2010), the initial study predictions were that chronic cerebral hypoperfusion 
might impact on 5hmC in the brain either as a direct consequence of hypoperfusion- 
induced perturbations in 5mC and/ or via an impaired TETs enzymatic activity. Since the 
major pathological changes in this animal model occur in white matte tracts, the 
expectations at the outset of this study were that epigenetic alterations might appear in 
hypoperfused white matter areas. 
The study hypothesis was that in mice, chronic cerebral hypoperfusion and the resulting 
mild reductions of the cerebral blood flow might impact on the oxidative production of 
5hmC in white matter by modification of brain methylation dynamics and/ or the 
disruption of TETs machinery responsible for the oxidation of 5mC.   
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However, since little was known about the cellular distribution and functional significance 
of 5hmC in the brain at the outset of this experiment, the alternative hypothesis that 5hmC 
might not be altered with chronic cerebral hypoperfusion was also considered. 
Alternatively, with regards to grey matter abnormalities observed in some hypoperfused 
mice in this thesis (Chapter 3) as well as in alternative animal models (Kudo et al., 1993; 
Ni et al., 1995; Pappas et al., 1996; Kim et al., 2008), epigenetic alterations were also 
expected to occur in grey matter areas following chronic cerebral hypoperfusion. 
Therefore, in the present study 5mC, 5hmC and one of the TETs members- TET2 were 
also examined in cortical and subcortical grey matter areas.  
In order to experimentally address the present study hypothesis, methylation, 
hydroxymethylation and TET2 were investigated by a standard immunohistochemistry in 
white and grey matter areas under normal physiological conditions compared with one 
month after chronic cerebral hypoperfusion in mice. To account for observed specific 
hypoperfusion- induced hydroxymethylation increases in white matter, 5hmC was studied 
in relation to 5mC and TET2 in vivo. To determine the potential cellular basis of 5hmC in 
white matter, 5hmC was examined in relation to mature and progenitor oligodendroglia 
(OPC) in vivo. Based on previous findings suggesting that 5hmC is high in progenitor 
cells and neurons (Kriaucionis and Heintz., 2009; Li and Liu, 2011; Ruzov et al.., 2011)  
the initial study predictions were that 5hmC would be high in all neural cells at different 
stages of maturation. Additionally, since inflammatory cells increase in white matter tracts 
of chronically hypoperfused mice (Shibata et al., 2004; Coltman et al., 2011) and 
inflammatory agents have been shown to affect methylation under different pathological 
conditions (Zhang et al., 2007; Wilson, 2008; Backdahl et al., 2009), hydroxymethylation 
in white matter was studied in relation to inflammatory microglia in vivo. To verify the in 
vivo findings and further examine hydroxymethylation in relation to glia, 5hmC 
immunochemical distribution was examined using in vitro systems of oligodendroglial 




The aims of the present thesis chapter were to: 
 
 Investigate methylation, hydroxymethylation and TET2 in white and grey matter 
areas of the adult mouse brain under normal physiological conditions compared 
with one month after chronic cerebral hypoperfusion in mice. 
 
 In the event of significant group differences in epigenetic dynamics in the brain, 
determine potential associations between epigenetic marks (5hmC, 5mC and 
TET2). 
 
 In the event of significant group differences in epigenetic dynamics in the brain, 














5.2. Materials and methods 
5.2.1. Animals and surgery 
For the experimental purposes of the present Chapter 5, I used the remaining brain tissue 
material from 8 WT (C57Bl6J) sham and 9 WT (C57Bl6J) hypoperfused mice that were 
previously used for the experiment presented in Chapter 4. One of the original 10 WT 
hypoperfused mice (mouse number 800940) from Chapter 4 was not included in the 
present study due to a lack of sufficient number of brain sections. 
5.2.2. In vivo evaluation of the proportion of 5mC, 5hmC and TET2 immunopositive 
cells in the mouse brain under normal physiological and chronically hypoperfused 
conditions 
5mC, 5hmC and TET2 immunoreactivity was examined on semi- adjacent coronal brain 
sections from -2.12mm bregma neuroanatomical level (Franklin and Paxinos, 1997) in 
white (the CC, IC, EC) and grey matter regions (the CA1 and Cx) of sham and chronically 
hypoperfused mice one month after surgery. 5mC, 5hmC, TET2 positive cells as well as 
ssDNA positive cells (for the 5hmC and 5mC immunostaining), DAPI stained cells (for 
the TET2 immunostaining) were manually counted on five random fields imaged from 
each ROI. The regional proportion of 5mC, 5hmC, TET2 positive cells was calculated as 
described in the materials and methods (Chapter 2, section 2.8.).   
5.2.3. In vivo evaluation of the proportion of CC1, NG2, Iba1 immunopositive cells in 
the mouse brain under normal physiological and chronically hypoperfused 
conditions  
CC1, NG2, Iba1 immunoreactivity was examined on semi- adjacent coronal brain sections 
from -2.12mm bregma neuroanatomical level (Franklin and Paxinos, 1997) in sham and 
chronically hypoperfused mice one month after surgery. CC1, NG2, Iba1 positive cells 
were studied in major white matter tracts (the CC, EC, IC). CC1, NG2, Iba1 positive cells 
were manually counted on five random fields imaged from a given ROI as well as the total 
number of cells (DAPI stained cells for CC1 and NG2; haemotoxylin stained cells for 
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Iba1). The regional proportion of CC1, NG2, and Iba1 positive cells was calculated as 
described in Chapter 2, section 2.8. 
5.2.4. In vitro evaluation of 5hmC immunochemical distribution in oligodendroglial 
cells at different stages of maturation (0, 2, 6 DIV), in IFNγ/ LPS activated and 
nonactivated microglia in vitro 
5hmC immunoreactivity was studied using an in vitro system of oligodendroglial 
maturation (Chapter 2, section 2.10.). Oligodendroglial cells at 0, 2, 6 DIV were 
immunocytochemically stained for 5hmC. Additionally, in vitro, 5hmC immunoreactivity 
was studied in IFNγ and LPS activated and nonactivated microglia cells (Chapter 2, 
section 2.11.). These in vitro experiments were performed in triplicates. 
5.2.5. Statistics 
5.2.5.1. Statistical analysis of the regional group proportions of biomarker positive 
cells 
The group average regional proportion of 5mC, 5hmC, TET2, CC1, NG2, and Iba1 
positive cells were statistically compared using an unpaired t- test.  
Significant group differences were reported for p<0.05. 
5.2.5.2. Correlation analyses 
Due to the relatively small (n) group numbers the correlation analyses were performed on 
data from both sham and chronically hypoperfused mice. In order to avoid performing 
multiple correlations among epigenetic marks as well as between epigenetic marks and 
glia across brain regions inevitably leading to meeting the set criterion of significance 
(p<0.05) purely by chance, the analysis was focused on relevant epigenetic and cellular 
markers in a major white matter tract (the CC) where hypoperfusion- induced changes in 




5.2.5.2.1. Correlation analysis among epigenetic marks (5mC, 5hmC and TET2) 
To account for specific hypoperfusion- induced variations in 5hmC observed in the CC 
and to address the main study hypothesis, the regional proportions of 5hmC positive cells 
were correlated with the regional proportions of 5mC and TET2 positive cells in the CC 
using a parametric Pearson`s correlation analysis. A separate Pearson`s correlation 
analysis was performed between each pair of epigenetic marks (e.g. 5hmC/ 5mC, 5hmC/ 
TET2). 
5.2.5.2.2. Correlation analysis between hydroxymethylation and cells composing the 
cerebral white matter 
To determine the potential cellular basis underlying the presently observed 5hmC 
dynamics in white matter, the proportion of 5hmC positive cells in the CC was correlated 
with the proportion of mature oligodendrocytes (CC1), OPC (NG2), and microglia (Iba1) 
in the same white matter tract by using a parametric Pearson`s correlation analysis. A 
separate correlation analysis was performed between 5hmC and each glial marker (e.g. 
5hmC/ CC1, 5hmC/ NG2, 5hmC/ Iba1). 













5.3.1. Chronic cerebral hypoperfusion leads to the development of white matter 
pathology  
Significant axonal (APP) and myelin (MAG, dMBP) pathology was evident in examined 
white matter tracts in chronically hypoperfused mice, but not sham- operated animals a 
month after surgery. An absence of overt grey matter abnormalities in cortical and 
subcortical areas was observed in all experimental animals. These results are presented in 
S.5.1.- appendices III. 
5.3.2. Chronic cerebral hypoperfusion does not affect brain 5mC distribution 
The proportion of 5mC positive cells was identified by means of a double 5mC/ ssDNA 
nuclear immunoreactivity in grey and white matter regions of the brain. Under both 
normal physiological and chronically hypoperfused conditions, 5mC was identified in cell 
nuclei as evidenced by its co- localization with ssDNA in all cells composing white and 
grey matter areas (figure 5.1. A- A1; figure S.5.2.1. appendices III). The t- test statistical 
analysis demonstrated that chronic cerebral hypoperfusion did not affect the regional 
distribution of 5mC in the brain  as shown by the absence of significant group differences 
in the proportion of 5mC/ ssDNA positive cells in examined white and grey matter ROIs:  
the CC (t= 0.68, p= 0.51), EC (t= 0.12, p= 0.90), IC (t= 0.01, p= 0.99), CA1 (t= 0.31, p= 
0.76), and Cx (t= 0.15, p= 0.88) (table 5.1.). Further, there was an absence of significant 
group differences in the number of 5mC positive cells and the total number of ssDNA 
positive cells in all examined brain areas (p>0.05) (table S.5.2.- appendices III). 
5.3.3. Chronic cerebral hypoperfusion leads to significant white matter tract- specific 
changes in brain 5hmC distribution 
The proportion of 5hmC positive cells was identified by means of a double 5hmC/ ssDNA 
nuclear immunoreactivity in grey and white matter regions of the brain. Under both 
normal physiological and chronically hypoperfused conditions, 5mC was identified in cell 
nuclei as evidenced by its co- localization with ssDNA in cells composing white  
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Figure 5.1.: Methylation, hydroxymethylation and TET2 immunochemically 
evidenced distribution in the CC of sham and chronically hypoperfused mice 
Representative images of 5mC (A-A1), 5hmC (B-B1) and TET2 (C-C1) 
immunoreactivity in the CC of sham (A-C) and chronically hypoperfused (A1-C1) mice. 
Under both normal physiological and chronically hypoperfused conditions, 5mC (A-A1) 
and 5hmC (B-B1) were evidenced in the nuclei of cells situated in the CC (predominantly 
glia) as evidenced by immunochemical co- localization of these biomarkers with ssDNA 
(A1-B1). TET2 immunoreactivity was evidenced in both the cellular nuclei and cytoplasm 
of cells composing the cerebral white matter (predominantly glia) in sham and chronically 
hypoperfused mice (C-C1). Chronic cerebral hypoperfusion did not impact on 5mC (A1) 
and TET2 (C1) immunochemical distribution in white matter, but led to significant 
increases in the proportion of 5hmC immunopositive cells in the CC (B1). 
Scale bar represents 20µm (magnification x40). 
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Biomarker Region of interest
Sham (n=8) Hypoperfused (n=9)
5mC Corpus callosum (CC) 0.78 ± 0.1 0.83 ± 0.0
External capsule (EC) 0.77 ± 0.1 0.76 ± 0.1
Internal capsule (IC) 0.88 ± 0.1 0.84 ± 0.0
CA1 0.96 ± 0.0 0.99 ± 0.0
Cortex (Cx) 0.91 ± 0.0 0.90 ± 0.0
5hmC Corpus callosum (CC) 0.50 ± 0.1   0.84 ± 0.0*
External capsule (EC) 0.51 ± 0.1 0.60 ± 0.1
Internal capsule (IC) 0.86 ± 0.1 0.74 ± 0.1
CA1 0.79 ± 0.1 0.89 ± 0.1
Cortex (Cx) 0.89 ± 0.0 0.92 ± 0.0
TET2 Corpus callosum (CC) 0.31 ± 0.1 0.31 ± 0.1
External capsule (EC) 0.29 ± 0.1 0.28 ± 0.1
Internal capsule (IC) 0.49 ± 0.1 0.46 ± 0.1
CA1 0.58 ± 0.0 0.57 ± 0.0
Cortex (Cx) 0.30 ± 0.0   0.40 ± 0.0*




Table 5.1.: Regional mean proportions of 5mC, 5hmC, TET2 
immunopositive cells 
(group mean ±SE) 
Chronic cerebral hypoperfusion did not impact on the regional distribution of 
5mC and TET2 in the CC (p>0.05), but was associated with a significant 
increase in the proportion of 5hmC immunopisitive cells in the CC (p<0.05). 
The proportion of TET2 immunopositive cells was significantly increased in 
the hypoperfused Cx. In the rest of the examined white and grey matter areas, 
no significant group differences in the proportion of biomarker positive cells 
(5mC, 5hmC, TET2) were evidenced by the t- test statistical analysis for all 
biomarkers (p>0.05). 
Significant group differences as given by the t- test statistical analysis: 
(p<0.05)* 
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and grey matter areas (figure 5.1. B- B1; figure S.5.2.2.- appendices III). Interestingly, 
under normal physiological conditions, not all cells in white matter were 5hmC 
immunopositive (figure S.5.2.2. A, D- appendices III).  There was a significant increase in 
the proportion of 5hmC/ ssDNA positive cells in the hypoperfused CC (t= 2.21, p= 0.04) 
(figure 5.1. B; figure S.5.2.2. A1, D1- appendices III). The majority of cells in the 
hypoperfused CC were 5hmC immunoreactive (figure 5.1. B1; figure S.5.2.2. A1, D1, 
appendices III). There were no statistically significant alterations in the proportion of 
5hmC/ ssDNA positive cells in any of the other ROIs: the IC (t= 1.31, p= 0.21), EC (t= 
0.23, p= 0.82), CA1 (t= 1.15, p= 0.27), Cx (t= 1.48, p= 0.16) (table 5.1.). Additionally, 
there was also an absence of significant group differences in the number of 5hmC positive 
cells and the total number of ssDNA positive cells in all examined brain areas (p>0.05) 
(table S.5.2.- appendices III). 
5.3.4. Chronic cerebral hypoperfusion leads to significant grey matter- specific 
changes in TET2 distribution 
The proportion of TET2 positive cells was identified by double TET2/ DAPI staining in 
grey and white matter regions. TET2 immunoreactivity showed a differential cellular 
localization in cells situated in grey and white matter areas under both normal 
physiological and chronically hypoperfused conditions. Specifically, in grey matter cells 
(predominantly neurons), TET2 immunoreactivity was restricted to the cellular cytoplasm, 
whereas TET2 was immunodetected in both the cytoplasm and the nucleus of white matter 
cells (predominantly glia) (figure 5.1. C- C1; figure S.5.2.3- appendices III). The cellular 
identity of TET2 immunopositive cells was determined on the basis of their regional 
localization (grey matter regions or white matter tracts) as well as on the relative size of 
their nucleus. There were no significant differences in the proportion of TET2/ DAPI 
positive cells between hypoperfused and sham mice in any of the examined white matter 
tracts- the CC (t= 0.07, p= 0.94), EC (t= 0.08, p= 0.93), IC (t= 0.44, p= 0.66) as well as in 
the CA1 region (t= 0.23, p= 0.82) (table 5.1). However, the proportion of TET2/ DAPI 
positive cells increased significantly in the Cx of chronically hypoperfused mice in 
comparison with sham animals (t= 2.190, p= 0.04) (table 5.1.; figure S.5.2.3. C-C1, F-F1- 
appendices III). There was an absence of significant group differences in the 
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  Figure 5.2.: Hydroxymethylation does not correlate significantly with 
methylation and TET2 in the CC 
The Pearson`s correlation analysis demonstrated an absence of significant 
associations between the proportion of 5hmC/ ssDNA positive cells with the 
proportion of 5mC/ ssDNA as well as TET2/ DAPI positive cells in the CC 
(p>0.05) 
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 number of TET2 positive cells and the total number of DAPI positive cells in all 
examined brain areas (p>0.05) (table S.5.2.- appendices III). 
5.3.5. Hydroxymethylation does not correlate significantly with methylation and 
TET2 in white matter (the CC)  
In order to account for the observed hypoperfusion- induced significant increases in 5hmC 
in the CC and to determine the existence of potential association(s) between 
hydroxymethylation and methylation, TET2 in white matter of the adult mouse brain (the 
main study hypothesis), the regional proportions of these epigenetic biomarkers in the CC 
were correlated using Pearson`s statistical analysis (Chapter 5, section 5.2.5.2.1.). There 
was no significant correlation between hydroxymethylation and methylation (R
2
= 0.42, p= 
0.08) as well as between hydroxymethylation and TET2 (R
2
= 0.08, p= 0.75) in the CC 
(figure 5.2. A, B).  
5.3.6. Chronic cerebral hypoperfusion does not affect the proportion of mature 
oligodendrocytes 
The proportion of mature oligodendroglia was revealed by double CC1/ DAPI staining 
restricted to white matter tracts in the brain (figure 5.3. A-A1). There was not a significant 
difference in the proportion of mature oligodendrocytes between hypoperfused and sham 
mice in any of the examined white matter tracts: the CC (t= 1.35, p= 0.19), EC (t= 0.51, 
p= 0.62), IC (t= 1.55, p= 0.14) (table 5.2., figure 5.3. A-A1). Further, there was an absence 
of significant group differences in the number of  CC1 positive mature oligodendroglia 
and the total number of DAPI positive cells in all ROIs (p>0.05) (table S.5.3.- appendices 
III). 
5.3.7. Chronic cerebral hypoperfusion is associated with a significant increase in the 
proportion of OPC 
The proportion of OPC was identified by double NG2/ DAPI staining in white matter 
ROIs (figure 5.3. B-B1). A significant increase in the proportion of OPC was evident in 
the CC (t= 3.22, p= 0.006) and the IC (t= 2.19, p= 0.04) of hypoperfused mice compared 




Figure 5.3.: Mature oligodendrocytes (CC1), OPC (NG2) and microglia (Iba1)  
immunoreactivity in the CC of sham and chronically hypoperfused mice 
Representative images of mature oligodendrocytes (CC1) (A- A1), OPC (NG2) (B- 
B1) and microglia (Iba1) (C-C1) in the CC of sham (A-C) and chronically 
hypoperfused (A1-C1) mice. Cellular nuclei were counterstained with DAPI for  
CC1 and NG2 immuoreactive cells (A-A1; B-B1). Haemotoxylin was used to 
counterstain cellular nuclei for Iba1 immunoreactive cells (C-C1). Chronic cerebral 
hypoperfusion did not affect the proportion of mature oligodendrocytes in the CC 
(A1), but led to significant increases in the proportions of OPC and microglia in the 
same white matter tract (B1, C1). 
Scale bar represents 20µm (magnification x40). 
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Biomarker Region of interest
Sham (n=8) Hypoperfused (n=9)
CC1 Corpus callosum (CC) 0.68 ± 0.1 0.51 ± 0.1
External capsule (EC) 0.55 ± 0.1 0.49 ± 0.1
Internal capsule (IC) 0.74 ± 0.0 0.61 ± 0.1
NG2 Corpus callosum (CC) 0.16 ± 0.1     0.42 ± 0.1**
External capsule (EC) 0.42 ± 0.1 0.57 ± 0.1
Internal capsule (IC) 0.19 ± 0.1  0.37 ± 0.1*
Iba1 Corpus callosum (CC) 0.08 ± 0.0 0.14 ± 0.0*
External capsule (EC) 0.08 ± 0.0 0.09 ± 0.0
Internal capsule (IC) 0.06 ± 0.0  0.12 ± 0.0*
Proportion of biomarker positive cells
(mean ± SE)  
  
Table 5.2.: Regional mean proportions of mature oligodendrocytes 
(CC1), OPC (NG2), and microglia (Iba1)  
(group mean ±SE) 
No significant hypoperfusion- induced changes were evidenced in the 
proportion of CC1 positive mature oligodendroglia in all examined white 
matter tracts (p>0.05). The proportion of NG2 positive OPC and Iba1 positive 
microglia increased significantly in the CC and IC (p<0.05), but not in the EC 
(p<0.05) as shown by the t- test statistical analysis. 
Significant group differences as given by the t- test statistical analysis: 
(p<0.05)*, (p<0.01)** 
185 
no significant group differences in the proportion of OPC (table 5.2.). Further, there were 
significant group differences in the number of NG2 positive OPC (p<0.05) in the absence 
of significant group differences in the regional total number of DAPI positive cells 
(p>0.05) in all examined white matter areas (table S.5.3.- appendices III). 
5.3.8. Chronic cerebral hypoperfusion leads to a significant increase in the 
proportion of microglia 
The proportion of microglia was revealed by Iba1 immunoreactivity with haemotoxylin 
counterstaining for identification of cellular nuclei and the regional total number of cells 
(figure 5.3. C-C1). There was a significant increase in the proportion of microglia in the 
CC (t= 2.54, p= 0.02) and the IC (t= 2.83, p= 0.013) of hypoperfused mice compared with 
sham animals (table 5.2., figure 5.3. C-C1). In the EC (t= 0.57, p= 0.58) there were no 
significant group differences in the proportion of inflammatory cells (table 5.2.). There 
were significant group differences in the number of Iba1 positive microglia in the CC and 
the IC (p<0.05), but not in the rest of the ROIs. Further, there were no significant group 
differences in the regional total number of cells (p>0.05) (table S.5.3.- appendices III). 
5.3.9. Hydroxymethylation significantly correlates with microglia in the CC 
In order to determine the potential cellular basis of 5hmC in white matter, the proportion 
of 5hmC positive cells was correlated with the proportion of mature oligodendroglia 
(CC1), OPC (NG2), and microglia (Iba1)  in the CC using Pearson`s analysis (Chapter 5, 
section 5.2.5.2.2.). The results demonstrated that hydroxymethylation correlated 
significantly with inflammatory microglia (R
2
= 0.60, p= 0.01), but not with mature 
oligodendroglia (R
2
= -0.17, p= 0.52) and OPC (R
2




Figure 5.4.: Hydroxymethylation correlates significantly with inflammatory microglia, 
but not with mature and progenitor oligodendroglia in the adult mouse CC 
The Pearson`s correlation analysis demonstrated the existence of a significant association 
between the proportions of 5hmC/ ssDNA positive cells and Iba1/ H&E positive microglia  
in the adult mouse CC (p<0.05) (A). No significant associations were evidenced between 
the proportions of 5hmC/ ssDNA positive cells and CC1/ DAPI positive mature 




5.3.10. In vitro 5hmC immunochemical distribution decreases with oligodendroglial 
maturation and it is abundant in both activated and non activated microglia 
To verify the in vivo findings and further examine hydroxymethylation in relation to glia, 
5hmC immunochemical distribution was studied using in vitro systems of 
oligodendroglial maturation and microglial activation. 5hmC immunoreactivity was found 
to decrease with oligodendroglial maturation in vitro. High 5hmC immunoreactivity was 
observed in the oligodendroglial cell preparations at 0 DIV and it subsequently decreased 
progressively with the in vitro maturation of these cells from 2 to 6 DIV (figure 5.5. A- 
A2). Both nonactivated and IFNγ/ LPS activated microglial cells were strongly 5hmC 


































Figure 5.5.: In vitro 5hmC immunochemical distribution in oligodendroglia at 
different stages of maturation (0-6DIV), in IFNγ/ LPS activated and nonactivated 
microglia 
Representative images of 5hmC immunochemical distribution in oligodendroglia cultures 
at different stages of maturation (A-A2) and in vitro nonactivated and IFNγ/ LPS 
activated microglia (B-B1). In vitro, 5hmC decreased with oligodendroglia maturation 
from 0- 6DIV (A-A2). 5hmC was high in both activated and nonactivated microglia (B-
B1).  




The experimental work presented in Chapter 5 sought to test the hypothesis that chronic 
cerebral hypoperfusion might affect the oxidative production of 5hmC in white matter by 
modification of methylation dynamics and/ or by disruption of TETs enzymatic 
machinery. 5mC, 5hmC and one of the TETs members- TET2 were immunochemically 
examined in white and grey matter areas of the adult mouse brain under normal 
physiological conditions compared with one month after chronic cerebral hypoperfusion. 
In contrast to the main study hypothesis, the results demonstrated significant alterations in 
5hmC in the absence of changes in 5mC and TET2 in the hypoperfused CC (white 
matter). These data and a subsequent correlation analysis suggest that hydroxymethylation 
might be an epigenetic mechanism occurring independently from 5mC and TET2 in white 
matter. In vivo and in vitro investigation of the cellular determinants of 5hmC in white 
matter points to a potential role of microglia in the processes of hydroxymethylation. In 
regards to the alternative hypothesis suggesting epigenetic perturbations in grey matter 
following cerebrovascular challenge, in the present study significant increases in TET2 
were observed in the hypoperfused Cx in the absence of hypoperfusion- induced 
alterations in 5mC and 5hmC in any of the examined grey matter areas. 
5.4.1. Methylation dynamics in white and grey matter under normal physiological 
conditions and one month after chronic cerebral hypoperfusion in mice 
Under both normal physiological and chronically hypoperfused conditions 5mC was 
found to be restricted to cell nuclei in white and grey matter areas as demonstrated by an 
immunochemical co- localization of this epigenetic mark with single stranded DNA 
(ssDNA). Methylation was found to be abundant in all cells composing white and grey 
matter areas in both sham and chronically hypoperfused mice. 
In contrast to the main study hypothesis, chronic cerebral hypoperfusion did not impact on 
5mC distribution in white matter areas (the CC, EC, and IC) in mice. These findings 
suggest that methylation might be a stable epigenetic mechanism in white matter and 
subtle alterations in the cerebral blood supply such as those occurring with hypoperfusion 
might not affect the distribution of this epigenetic mark in the mouse brain. 
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In contradiction with the alternative prediction suggesting potential hypoperfusion- 
induced alterations in 5mC in grey matter, in the present study methylation was found to 
remain unchanged in the hypoperfused Cx and hippocampus (the CA1). This alternative 
prediction was based on clinical and pre- clinical work. In alternative animal models of 
focal ischemia brain methylation dynamics are significantly altered via increased 
oxidative stress, free radicals and excitotoxicity in grey matter. In mice, focal ischemia 
was associated with a global brain hypermethylation (Endres et al., 2000). Experimental 
stroke in rats significantly altered methylation of the ERα in the brain (Westberry et al., 
2008). The differences in the observed methylation patterns in experimental focal 
ischemia (stroke) and chronic cerebral hypoperfusion might be partially explained by the 
severity of the cerebrovascular challenge. During focal ischemia the blood flow reductions 
are temporary, but severe leading to the occurrence of both grey and white matter 
ischemic injury (Mao et al., 1999), whereas during chronic cerebral hypoperfusion the 
blood flow is only partially, but permanently restricted leading to very mild cerebral 
perfusion  and the development of a predominant white matter pathology (Shibata et al., 
2004; Shibata et al 2007; Nishio et al., 2010; Coltman et al., 2011, Holland et al., 2011; 
Reimer et al., 2011). It is also possible that during mild hypoperfusion, damaged DNA is 
efficiently repaired by alternative mechanisms such as hydroxymethylation (Surani and 
Hajkova, 2010). Therefore, no changes in methylation are observed in hypoperfused mice.  
The present results are also in contradiction with human data. For instance clinical studies 
on monozygous twins with discordant Alzheimer`s disease showed a significantly 
decreased 5mC immunoreactivity in grey matter areas of the affected twin compared with 
the cognitively intact twin brother (Mastroeni et al., 2009). Similar results were reported 
in Alzheimer`s patients exhibiting a significant global DNA hypomethylation in 
subcortical grey matter areas (e.g. entorhinal cortex) in comparison with healthy controls 
(Mastroeni et al., 2010). These findings suggest that changes in methylation dynamics 
might play a role in the development of age- related neuropathology. The discrepancies 
with the present preclinical data on chronically hypoperfused mice might be due to a 
variety of factors such as species differences in epigenetic marks, etiological differences 
(e.g. cerebrovascular challenge vs. age- related neurodegeneration), age (elderly people 
(>70 years) vs. young adult mice (3 months)) and others (e.g. environmental factors).  
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Little is known about methylation dynamics in elderly people exhibiting white matter 
abnormalities with cerberovascular etiology. On the basis of the present pre- clinical 
findings showing an absence of hypoperfusion- induced 5mC alterations in white matter, it 
is possible that this epigenetic mark may not be involved in the development of white 
matter pathology in the elderly. However, in regards to the limitations of animal models 
no firm conclusions based on data extrapolations could be made at the present time. 
Alternatively, it is possible that changes in methylation occur in the hypoperfused brain, 
but following a different spatio- temporal dynamics. Specifically, alterations in 
methylation might occur in presently non- examined brain areas as well as at earlier and/ 
or later post- surgical time points and these methylation dynamics might be differentially 
associated with neuropathology. This is particularly true in regards to the chronic nature of 
the cerebrovascular challenge in this animal model and the cumulative hypoperfusion- 
induced neuropathology (Nishio et al, 2010; Reimer et al., 2011) (discussed in sections 
5.4.6.2., 5.4.6.3.). 
Further, it is also possible that the applied immunochemistry could not detect potentially 
subtle changes in genomic methylation occurring in the hypoperfused mouse brain. Future 
applications of quantitative techniques for genomic 5mC detection such as bisulfite DNA 
sequencing might be more sensitive to subtle changes in brain methylation occurring with 
hypoperfusion in mice (discussed in section 5.4.6.2.). 
The recent discovery of 5hmC- an oxygen dependent modification of 5mC particularly 
enriched in the central nervous system, initiated a debate as to the sensitivity of the 
currently applied techniques to selectively assess brain methylation and 
hydroxymethylation. Specifically, the majority of the standard molecular techniques 
cannot distinguish 5mC from its oxidative derivative- 5hmC (Nestor et a., 2010). By 
consequence, there is a current reappraisal of previous publications on methylation and a 
necessity to clarify whether and/ or to what extent these studies account for actual 
methylation and not hydroxymethylation dynamics. 
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5.4.2. Hydroxymethylation in white and grey matter under normal physiological 
conditions and one month after chronic cerebral hypoperfusion in mice 
Similar to 5mC, 5hmC was found to be restricted to cellular nuclei in both white and grey 
matter as demonstrated by an immunochemical co- localization of this epigenetic mark 
with ssDNA under normal physiological as well as hypoperfused conditions in mice. 
Interestingly, under normal physiological conditions, not all cells in white matter were 
5hmC immunopositive (discussed in section 5.4.3.) 
Chronic cerebral hypoperfusion was associated with white matter tract- specific changes 
in 5hmC. Specifically, a significant 5hmC up- regulation was observed in the 
hypoperfused CC where most cells were found to be 5hmC immunoreactive. In the rest of 
the examined white and grey matter ROIs, 5hmC distribution was not altered by chronic 
cerebral hypoperfusion. The reasons for this differential regional regulation of 5hmC after 
chronic cerebral hypoperfusion remain unknown. However, from a cerebrovascular and 
neuroanatomical perspective, the CC is situated just beneath the highly vascularized Cx 
having much higher oxygen supply necessary for oxidation of 5mC in comparison with 
subcortical white matter tracts characterized by a very limited cerebrovascular irrigation 
and low oxygen levels even under normal physiological conditions (Nonaka et al., 2003).  
 
The present findings are partially in accordance with the study predictions suggesting 
5hmC alterations in white matter following chronic cerebral hypoperfusion in mice. 
However, in contrast to the initial study hypothesis these hypoperfusion- induced changes 
in 5hmC in white matter occurred independently from alterations in 5mC and TET2 
(discussed in section 5.4.5.).  
 
Interestingly, changes in 5hmC dynamics were only observed in white matter regions 
where the major pathological abnormalities occur in the hypoperfused model (at least in 
the absence of food deprivation and behavioural training) (the pathological data is 
presented in S.5.1.- appendices III; Chapter 4). These findings suggest a potential role for 
5hmC in the development of neuropathology in chronically hypoperfused mice. This idea 
is supported by a recently published work suggesting intragenic 5hmC increases in the 
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brain under different conditions including Alzheimer`s disease, hypoxia and chronological 
aging (Song et al., 2010; Chen et al., 2012).  
The exact molecular mechanism(s) via which 5hmC up- regulation might impact on 
neuropathology are unknown, but a recent review suggests a role of 5hmC in the processes 
of DNA repair and more particularly in base excision mechanisms via a specific 5hmC 
DNA glycosylase activity (Cannon et al., 1988; Surani and Hajkova, 2010). It is possible 
that during pathological events an increase in damaging oxidative, inflammatory, and 
excitotoxic agents affects DNA integrity and 5hmC up- regulation might help rescuing the 
genetic material and by consequence modulate the pathological outcome. With regards to 
the euchromatic genomic 5hmC localization, it is also possible that this epigenetic mark 
promotes the transcription of genes necessary for cell survival such as growth factors and 
natural anti- oxidants (Jin et al., 2011).  
 
However, due to the semi- quantitative immunochemical evaluation of 5hmC and the 
relatively small (n) numbers on which the statistical analysis was based as well as the 
observed absence of significant group differences in the proportion of 5hmC positive cells 
in the rest of the examined ROIs, one should consider the alternative explanation for the 
present findings, namely that the observed statistically significant group differences in 
5hmC in this particular white matter tract (the CC) might not represent actual biological 
phenomena, but instead were due to chance. Only future studies applying quantitative 
techniques (e.g. deep- genome sequencing) to assess the regional 5hmC content in the 
brain under normal physiological and chronically hypoperfused conditions in mice would 
allow to verify the present immunochemical findings suggesting significant 5hmC 
increases in the hypoperfused CC. Further future experiments would allow to  gain a better 
understanding of the biological significance of this newly discovered epigenetic mark, its 
involvement in neuropathology, as well as the underlying molecular and cellular 
mechanisms associated with hydroxymethylation in the brain (discussed in sections 
5.4.6.2., 5.4.6.3.). 
 
In relation to humans, it is difficult to speculate on any particular role of 5hmC in age- 
related neuropathology and functional impairment based on the present preclinical 
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findings. However, the present results are interesting and they could potentially constitute 
the basis for a future experimental and clinical work focused on 5hmC in the context of 
“healthy” and pathological aging. 
 
5.4.3. In search of the cellular basis of 5hmC in white matter. An unresolved 
question. 
In order to account for specific 5hmC dynamics observed in white matter following 
hypoperfusion in mice, hydroxymethylation was examined in relation to some of the cells 
composing the cerebral white matter, namely mature oligodendroglia, OPC and 
inflammatory microglia in a series of in vivo and in vitro experiments. Given that it was 
technically impossible to perform double immunochemistry on 5hmC stained biological 
samples (discussed in section 5.4.6.2.), separate immunochemical analyses were 
performed for mature oligodendroglia (CC1), OPC (NG2) and microglia (Iba1) in sham 
and chronically hypoperfused mice on semi- adjacent brain sections. Subsequently, the 
obtained regional proportions of these cells were correlated with the proportion of 5hmC 
positive cells in the CC. The CC was selected for a white matter tract of interest for the 
correlation analysis as 1) clinical and preclinical studies suggest important age- related 
neuropathology in this white matter region associated with cognitive and memory deficits 
(Clarke and Zaidel, 1994; Peters and Sethares, 2002; Meguro et al., 2003; Teipel et al., 
2003; Jokinen et al., 2007; Paul et al., 2007; Sullivan et al., 2010), 2) hypoperfusion- 
induced abnormalities have been evidenced in the CC in mice (Shibata et al., 2004; 
Shibata et al., 2007; Nishio et al., 2010; Holland et al., 2011; Reimer et al., 2011), 3) in the 
present study a significant hydroxymethylation upregulation was evident in the 
hypoperfused CC. The data from all sham and hypoperfused animals were included in the 
correlation analysis due to the limited n numbers per experimental group and the potential 
bias due to a loss of statistical power if the correlation were to be performed separately for 
the two experimental groups (Chapter 5, sections 5.2.5.2.; 5.2.5.2.2.).  
The in vivo experiments revealed that chronic cerebral hypoperfusion did not affect the 
proportion of mature oligodendroglia, but led to significant increases in the proportion of 
NG2 positive OPC in the CC and IC.  
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The presently observed absence of changes in the proportion of mature oligodendroglia 
one month after hypoperfusion is in accordance with recent observations of an absence of 
significant caspase- 3 immunoreactivity in white matter areas of chronically hypoperfused 
mice (Reimer et al., 2011). 
Significant increases in OPC are observed in various white matter disorders where these 
cells are believed to contribute to the endogenous brain repair mechanisms by replacing 
injured/ dying oligodendrocytes and/ or by contributing to the remyelination of 
demyelinated axons (Chang et al., 2000; Reynolds et al., 2002).  
The applied parametric correlation analysis failed to demonstrate significant associations 
between 5hmC and oligodendroglia at different stages of maturation in vivo which might 
be related to the nature of the used data (proportions of cells counted on semi- adjacent 
sections) (discussed in section 5.4.6.2.). 
To overcome some of the limitations associated with the in vivo analysis, 5hmC 
immunoreactivity was further examined using in vitro systems of oligodendroglial 
maturation.  
The results demonstrated that 5hmC immunoreactivity decreased with the in vitro 
maturation of oligodendroglia. The present in vitro findings showing high 5hmC content 
in OPC are supported by previous studies from our and other laboratories suggesting that 
this epigenetic mark is particularly enriched in embryonic stem cells and multipotent 
progenitors, but it is low in most of the differentiated somatic cells (Ito et al., 2010; Ficz et 
al., 2011; Jin et al., 2011; Li and Liu, 2011; Kinney et al., 2011; Ruzov et al. 2011). In 
contrast to a previously demonstrated high 5hmC distribution in mature neurons, the 
present in vitro immunochemical analysis suggests that 5hmC is low in mature 
oligodendroglia (Kriaucionis and Heintz., 2009; Li and Liu, 2011; Ruzov et al.., 2011). 
These in vitro findings support the present in vivo data showing that not all cells in white 
matter are 5hmC immunopositive under normal physiological conditions. It is possible 
that in the absence of pathology, mature oligodendroglia are 5hmC negative in vivo. 
However, it is also possible that, in the living animal, under pathological conditions (e.g. 
chronic cerebral hypoperfusion), the mature oligodendrocytes up- regulate 5hmC as part 
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of their endogenous cell survival program, namely repair of damaged DNA thus 
contributing to the presently observed significant increases in 5hmC in the hypoperfused 
CC.  
The differential 5hmC dynamics observed in oligodendroglia at different maturational 
stages might be related to the ability of these cells to produce and maintain myelin 
(myelinating and non- myelinating oligodendrocytes). Additionally, the observed 5hmC 
differences between mature and progenitor oligodendroglia might be associated with a 
differential activity of other epigenetic mechanisms such as HDAC1 and methylation 
regulating gene expression in these cells. For instance, it is known that histone 
deacetylation (HDAC1), a marker of gene silencing is highly increased in mature 
oligodendrocytes, but not in other neural cells (e.g. progenitors, neurons) (Martin- 
Husstege et al., 2002; Liu et al., 2007). Further, a differential methylation pattern of the 
GFAP promoter determines neural stem cells differentiation towards neuronal vs. glial 
phenotype. Specifically, hypermethylation of the GFAP promoter is associated with 
predominantly neuronal cell fate, whereas hypomethylation of the GFAP promoter 
triggers glial differentiation (Okada et al., 2008). On the basis of these previous findings, 
one could hypothesize that decreases in 5hmC might be necessary for supporting 
alternative epigenetic mechanisms differentiating OPC form their mature derivatives 
expressing genes associated with myelin production (e.g. MBP, PLP). 
In the present study, 5hmC was also examined in relation to inflammation as 
inflammatory activity has been shown to impact on epigenetic marks such as methylation 
(Zhang et al., 2007; Wilson, 2008; Backdahl et al., 2009) and to increase after chronic 
cerebral hypoperfusion (Shibata et al., 2004; Coltman et al., 2011). The results confirmed 
previous findings on the hypoperfused model showing a significant increase in the 
proportion of inflammatory cells in white matter one month after chronic cerebral 
hypoperfusion in mice (Shibata et al., 2004; Coltman et al., 2011). Interestingly, a 
significant correlation between the proportion of inflammatory cells and the proportion of 
5hmC positive cells was evidenced in the CC, suggesting a role of inflammatory processes 
in 5hmC up- regulation in white matter after chronic cerebral hypoperfusion.  
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The in vivo results were confirmed using an in vitro system where both IFNγ/ LPS 
activated and nonactivated microglia were found to be highly 5hmC immunopositive. 
On the basis of these in vivo and in vitro findings, it is possible that inflammatory 
microglia modulate the production of 5hmC from 5mC in white matter. These findings are 
not surprising in regards to the existing literature demonstrating a role of inflammation in 
epigenetic regulation under various pathological conditions (Zhang et al., 2007; Wilson, 
2008; Backdahl et al., 2009). Recently, using a microarray analysis, Reimer et al., 2011 
reported significant alterations in the expression of 129 genes in white matter areas of 
chronically hypoperfused mice. Subsequent analysis indicated alterations in biological 
pathways, including inflammatory responses and cytokine- cytokine receptor interactions. 
It is possible that the presently observed associations between hydroxymethylation and 
microglia in white matter account for the previously observed hypoperfusion- induced 
alterations in inflammatory gene expression. Therefore, it would be interesting to further 
examine the exact associations between 5hmC and inflammatory microglia in vivo. For 
instance, one could examine hydroxymethylation dynamics under normal physiological 
and chronically hypoperfused conditions in microglia mutant mice compared with WT 
controls (Gowing et al., 2008). The obtained data would help understanding whether 
5hmC is regulated by inflammatory microglia in vivo as well as whether the 5hmC- 
inflammatory pathway have any biological significance at the neuropathological and 
functional levels. 
In regards to the present in vivo results, it is difficult to assume that microglia are the only 
cell type up- regulating 5hmC in the hypoperfused CC due to obvious differences in the 
proportion of microglia (0.14) and 5hmC (0.84) positive cells in this white matter tract. It 
is possible that other cells (e.g. OPC and/ or astrocytes) contribute to hydroxymethylation 
in white matter. 
The present study did not address 5hmC distribution in astrocytes in the experimental 
groups. Astrocytes contribute to the inflammatory response following injury to the central 
nervous system and participate in the processes of neurodegeneration/ neuroregeneration 
(Hertz and Zielke, 2004; Hawkins and Davis, 2005; Volterra and Meldolesi, 2005; 
Magistretti, 2006). Future experiments should therefore examine 5hmC distribution in 
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astroglia under normal physiological and chronically hypoperfused conditions in mice 
using a combination of experimental techniques such as for instance immunochemistry 
and a deep genome sequencing. 
5.4.4. TET2 in white and grey matter under normal physiological conditions and one 
month after chronic cerebral hypoperfusion in mice 
TET2 immunoreactivity exhibited a differential cellular localization in white and grey 
matter areas under normal physiological and chronically hypoperfused conditions in mice. 
TET2 was abundant in the cytoplasm of cortical and subcortical cells (predominantly 
neurons), but was essentially absent from their nuclei. In white matter regions, TET2 
immunoreactivity was evident in both the cytoplasm and nucleus of cells (predominantly 
glia) (figure S.5.2.3.- appendices III). These data suggest that TET2 might fulfill 
differential gene regulatory function in white and grey matter.  
Chronic cerebral hypoperfusion did not impact significantly on TET2 distribution in 
subcortical (the CA1) and white matter (the CC, EC, and IC) regions. Interestingly, a 
significant increase in TET2 was evidenced in the Cx of hypoperfused mice.  
These findings support the study initial predictions suggesting possible alterations in 
TET2 dynamics in the brain following chronic cerebral hypoperfusion in mice. However, 
in contrast to the study hypothesis, these changes were not directly related to 
hypoperfusion- induced alterations in 5hmC (discussed in section 5.4.5.). 
The molecular mechanism(s) and functional significance of TET2 upregulation in the 
hypoperfused Cx remain unknown. However, limited or no cortical damage is usually 
observed in ad libitum fed and non- behaviourally tested hypoperfused mice at early post- 
surgery time points (Shibata et al., 2004; Holland et al., 2011; Reimer et al., 2011). It is 
possible that TET2 up- regulation is necessary for the survival program of neurons under 
hypoxic conditions protecting these cells from harmful agents. Due to the cytoplasmic 
localization of this protein in cells composing grey matter areas (predominantly neurons), 
its function is most likely trophic and/ or antioxidative rather than gene regulatory.  
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Alternatively, similar to the present 5hmC findings, it is possible that the observed 
hypoperfusion- induced alterations in cortical TET2 do not have any particular functional 
(biological) significance and these significant results could be explained by chance 
(discussed in section 5.4.2.). 
It has been shown that each TET member has a tissue specific spatial and temporal pattern 
of expression, TET2 being most widely expressed in mouse tissues (Langemeijer et al., 
2009). This suggests that TET proteins might fulfill different biological functions in 
distinct somatic contexts. Recently, our and other groups discovered that 5hmC is 
differentially distributed among adult organs, essentially 5hmC was absent or very low in 
the majority of examined adult tissues except in the brain and bone marrow where 5hmC 
was highly enriched (Globisch et al., 2010; Li and Liu, 2011; Kinney et al., 2011; Ruzov 
et al., 2011). As TET proteins are involved in the production of 5hmC, it is possible that 
they follow similar tissue distribution patterns in adult mammalian organisms. Using an in 
vitro system for neural differentiation of human embryonic stem cells, TET1, TET2, and 
TET3 were detected in neural progenitor cells at least at the mRNA level (Ruzov et al., 
2011). However, so far, the biological significance of TET members especially in regards 
to neural cells and 5hmC production during neurodevelopment as well as in the healthy 
and diseased adult brain remains to be elucidated (discussed in sections, 5.4.6.2, 5.4.6.3.).  
5.4.5. Is hydroxymethylation associated with methylation and TET2 in white matter?  
The present study sought to test the hypothesis that chronic cerebral hypoperfusion might 
affect the oxidative production of 5hmC in white matter by modification of brain 
methylation dynamics and/ or by disruption of TETs machinery.  This hypothesis was 
based on previous studies demonstrating that cerebral blood flow reductions are associated 
with alterations in methylation patterns in the brain (Endres et al., 2000; Westberry et al., 
2008). Further, a pathological disruption of the TETs enzymatic pathway might affect 
5mC oxidation processes especially in the case of reduced oxygen levels to the brain (e.g. 
chronic cerebral hypoperfusion) and by consequence might impact indirectly on 5hmC. 
This was recently demonstrated in the case of myeloid cancers where TET2 mutation was 
found to reduce the hydroxylation of 5mC (Ko et al., 2010). In order to account for any 
potential associations between hydroxymethylation and 5mC, TET2 in white matter, a non 
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parametric correlation analysis was performed between the proportion of 5hmC positive 
cells and the proportion of 5mC, TET2 positive cells in the CC, respectively (Chapter 5, 
sections 5.2.5.2.; 5.2.5.2.1.; 5.4.3.).  
The results demonstrated an absence of significant associations between 5mC and 5hmC 
in the CC. These data suggest that either 1) brain methylation and hydroxymethylation are 
two independent epigenetic phenomena and changes in hydroxymethylation occur as a 
distinct regulatory mechanism and/ or 2) the employed immunochemical approach lacked 
sufficient sensitivity to accurately determine 5mC and 5hmC levels and therefore the 
subsequent correlation analysis failed to show any links between these two epigenetic 
marks in the adult mouse CC and/ or 3) nondetected associations existed between these 
two epigenetic marks in nonexamined brain areas and/ or occurred at different post- 
surgical time points.  
However, it is difficult to assume that methylation and hydroxymethylation would be 
exclusively independent processes in the brain at least in regards to findings in the early 
mammalian embryo. Recently, our and other groups reported that the process of active 
demethylation of the paternal pronucleus of the zygote constitutes an active 
hydroxymethylation (Iqbal et al., 2011; Ruzov et al., 2011; Wossidlo et al., 2011). 
Alternatively, it is also possible that in the adult organism these two epigenetic processes 
are less interdependent and 5hmC might represent a separate epigenetic mechanism 
fulfilling an entirely different function from what is known in the zygote. This is 
supported by a recent study on aged animals showing significant increases in 
hydroxymethylation in grey matter in the absence of alterations in methylation and TETs 
mRNA expression (Chen et al., 2012). From a functional perspective, this is not surprising 
since 5mC and 5hmC exhibit differential genomic localization suggesting that these two 
epigenetic marks might antagonistically regulate gene silencing/ transcription (Bird, 2002; 
Ficz et al., 2011; Jin et al., 2011) Furthermore, it has been recently shown that 
transcriptional repressors known to bind methylated DNA such as MeCP2, MBD1, 
MBD2, and MBD4 do not recognize 5hmC (Jin et al., 2010). Future studies should 
determine the respective functional roles of 5mC and 5hmC in the brain (e.g. white 
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matter) as well as the potential interplay between these two epigenetic phenomena in 
health and disease (discussed in sections 5.4.6.2., 5.4.6.3.). 
Methylation and hydroxymethylation should also be examined in relation to other 
epigenetic marks such as histone acetylation (HAT) and deacetylation (HDAC) as possible 
interactions among these mechanisms might regulate gene expression in the normal and 
diseased brain (Wu and Zhang, 2010). In regards to published studies suggesting an 
important role of HDAC in oligodendrocytes and remyelination following experimental 
demyelination of the CC in the aging brain (Shen et al., 2008), it would be interesting to 
examine potential associations between histone deacetylation and hydroxy/methylation 
dynamics in white matter areas of hypoperfused mice. This is important as to the presently 
observed specific 5hmC increases in the hypoperfused CC and the differential distribution 
of this epigenetic mark in glial cells (discussed in sections 5.4.6.2., 5.4.6.3.). 
In the present study, hydroxymethylation was also examined in relation to TET2 in the 
CC. The correlation analysis failed to show any significant links between TET2 and 
hydroxymethylation in this white matter tract. These results suggest that TET2 may not be 
directly involved in the production of 5hmC from 5mC in the adult mouse brain which is 
in consistency with its cytoplasmic localization at least in cells composing the cerebral 
grey matter (predominantly neurons). However, in cells located in white matter tracts 
(predominantly glia) TET2 immunoreactivity was also detected in nuclei suggesting a 
potential involvement of TET2 in gene regulatory processes. Alternatively, it is possible 
that TET1 and/ or TET3 (presently non- examined), but not TET2 catalyze the 
hydroxylation of 5mC in the brain under normal physiological and chronically 
hypoperfused conditions (discussed in sections 5.4.6.2., 5.4.6.3.).  
Overall, in relation to the main study hypothesis the present results suggest that 
hypoperfusion induces selective alterations in 5hmC in white matter (the CC), but these 




5.4.6. Methodological strengths, limitations and future epigenetic experiments in 
chronically hypoperfused mice 
5.4.6.1. Strengths of the applied methodology to examine epigenetic marks in the 
mouse brain under normal physiological and chronically hypoperfused conditions 
The methodological strengths of the present study relate to the immunochemical 
visualization of 5mC, 5hmC, TET2 cellular localization in white and grey matter areas of 
the adult mouse brain under normal physiological and chronically hypoperfused 
conditions using previously validated, sensitive antibody probes (Ruzov et al., 2011). This 
could not be achieved by means of standard biomolecular techniques such as for example, 
bisulfite DNA sequencing unable to differentiate methylation from its oxidative 
derivative- hydroxymethylation (Nestor et al., 2010).  
5.4.6.2. Limitations of the applied methodology to examine epigenetic marks in the 
mouse brain under normal physiological and chronically hypoperfused conditions  
The major methodological drawback of the present study relates to the technical difficulty 
to perform a double/ triple immunochemistry on 5mC, 5hmC stained samples due to the 
severe HCL treatment required for nuclear DNA immunostaining. This methodological 
limitation prevented the direct immunochemical co- localization among epigenetic marks 
(5mC, 5hmC and TET2) and glial specific biomarkers. By consequence, the exact cellular 
identity of these epigenetic marks in white matter remains unclear. The in vitro 
experiments using relatively pure oligodendroglia and microglia cell preparations were 
also methodologically limited. The absence of immunocolocalization between epigenetic 
and glial specific biomarkers did not rule out the presence of fibrobalsts and astrocytes 
known to be frequent contaminators in neural preparations. Further, the in vitro 
environment does not recapitulate the cellular and molecular complexity of the in vivo 
central nervous system which is an important drawback in regards to the sensitivity of 
epigenetic phenomena to environmental factors (e.g. inflammation, free radicals) (Cerda 
and Weitzan, 1997; Duan et al., 2002; Kruman et al., 2002; Zhang et al., 2007; Wilson, 
2008; Backdahl et al., 2009). Thus, it is difficult to extrapolate without certain reservations 
the in vitro findings to the in vivo situation. 
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In the present study, the immunohistochemical analysis was performed at a specific post- 
surgery time point (1 month after surgery) as well as on a single brain level due to the 
expenses associated with a whole brain immunohistochemistry. By consequence, all 
conclusions on the regional distribution of 5mC, 5hmC, TET2 as well as CC1, NG2 and 
Iba1 positive cells in sham and hypoperfused mice are spatio- temporally limited. 
Pathological and epigenetic alterations might have occurred at earlier/ later post- surgery 
time points and/ or might have been present on non- examined brain areas/ levels.  
The present immunochemical evaluation was not supported by any additional 
biomolecular, quantitative analysis (e.g. deep genome sequencing (5mC and 5hmC) and 
Western blot analysis (TETs protein levels)). By consequence, it is possible that the 
observed group differences in 5hmC did not represent the actual, whole brain 5hmC 
genomic content in the CC. Further, the functional significance of the examined epigenetic 
processes remains largely unknown. 
The present study examined only TET2 immunoreactivity and it did not address the 
cellular distribution of other TET family members (TET1 and TET3) due to the absence of 
available antibody probes at the time when the experiments were performed. It is possible 
that TET1 and TET3 in the brain present a differential cellular localization and fulfill 
different function under normal physiological and chronically hypoperfused conditions 
when compared with TET2. This hypothesis is based on recent findings suggesting 
differential distribution of these proteins in somatic tissues where each TET member 
exhibits a tissue specific spatial and temporal pattern of expression (Langemeijer et al., 
2009). In regards to the presently observed absence of significant associations between 
TET2 and hydroxymethylation in white matter it is possible that hydroxymethylation in 
the brain is catalyzed by TET1 and/ or TET3 (discussed in section 5.4.5.). 
With the exception of methylation, TET2, and inflammatory microglia the present study 
did not examine any other potential pathways which might impact on 5hmC content in the 
brain following hypoperfusion in mice. Therefore, it is unknown whether and/ or how 
hydroxy/ methylation dynamics relate to alternative epigenetic marks (e.g. TET1 and 
TET3; HDAC)  as well as whether/ how 5mC and 5hmC are modulated by 
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pathophysiological mechanisms (e.g. excitotoxicity, oxidative stress, inflammation) in the 
adult mammalian brain (discussed in section 5.4.6.3.). 
5.4.6.3. Future experiments to examine epigenetic mechanism in the mouse brain 
under normal physiological and chronically hypoperfused conditions 
Although, a significant progress has been made in optimizing double 5mC and 5hmC 
immunochemistry after the completion of this thesis, further optimization is still required 
for the performance of 5mC/ 5hmC immunochemistry with neural specific biomarkers on 
the same biological sample. The major methodological difficulty relies in the currently 
used HCL treatment required for nuclear DNA immunostaining (e.g. 5mC, 5hmC). 
Methodologically, one could reduce the incubation time in HCL, currently performed at 
37°C for 30min which might allow a  better preservation of membrane epitopes. 
Since little is known about TETs in the central nervous system (discussed in section 5.4.4., 
5.4.6.2.), future molecular studies should examine these proteins in white and grey matter 
areas of sham compared with hypoperfused mice using for instance a combination of 
laboratory techniques such as immunochemistry, (q)PCR and/ or Western blot analysis. 
Further, to determine the potential TETs functional significance in the brain, one could 
proceed by a selective genetic ablation or pharmacological inhibition of one (or a 
combination) of TETs followed by a subsequent examination of brain hydroxy/ 
methylation dynamics, neuropathology and functional outcome in sham compared with 
hypoperfused mice. 
To test potential (presently undetected) associations between brain hydroxymethylation 
and methylation, one could investigate the effects of perturbation in methylation patterns 
on brain hydroxymethylation in the presence and absence of chronic cerebral 
hypoperfusion. Methodologically, one could use DNMT deficient mice exhibiting 
perturbed methylation dynamics (Okano et al., 1998; Bird and Wolffe, 1999; Okano et al., 
1999) and their respective WT controls to compare the regional brain 5hmC content in the 
presence and absence of chronic cerebral hypoperfusion. A subsequent investigation of 
neuropathology and functional outcome in this animal model would allow to determine 
the potential biological importance of these epigenetic marks. 
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With regards to published studies suggesting an important role of HDAC in 
oligodendroglial biology and the implication of this epigenetic mark in the processes of 
remyelination following experimental demyelination of the CC in the aging brain (Shen et 
al., 2008), it would be interesting to examine potential associations between histone 
deacetylation and hydroxymethylation dynamics in the hypoperfused white matter. From a 
methodological point of view, this could be achieved by comparing 5hmC content in 
white matter of sham and chronically hypoperfused mice treated with valporic acid 
(HDAC antagonist) vs. saline (control). This study would allow to determine whether an 
absence of active histone deacetylation impacts on hydroxymethylation in white matter in 
the presence and absence of chronic cerebral hypoperfusion and what the potential 
functional consequence (e.g. neuropathological and functional outcome) might be. 
Additionally, methylation and hydroxymethylation dynamics might be modulated by 
environmental factors such as for example increased excitotoxicity, oxidative stress and 
inflammation under hypoperfused conditions (Cerda and Weitzan, 1997; Duan et al., 
2002; Kruman et al., 2002; Zhang et al., 2007; Wilson, 2008; Backdahl et al., 2009).  
Future mechanistic studies examining for instance the effects of pharmacological 
inhibition of these pathophysiological mechanisms in chronically hypoperfused mice 
(discussed in Chapter 6, section 6.1.3., 6.1.4.3.) would allow to determine whether they 
affect on epigenetic marks in the presence and absence of chronic cerebral hypoperfusion 
and what the potential neuropathological and functional consequences might be. 
It is known that epigenetic patterns are not stable and they vary under different 
physiological conditions as well as naturally during lifespan (Bird, 2002; Mehler, 2008; 
Penner et al., 2010; Song et al., 2010; Hernandez et al., 2011; Chen et al., 2012; Dzitoyeva 
et al., 2012; Szulwach et al., 2012). Therefore, with regards to the chronic nature of the 
hypoperfused mouse model, future time- course studies should examine methylation and 
hydroxymethylation dynamics at different post- surgery time points in sham and 
hypoperfused mice. These experiments would allow to determine the associations of 
potential temporal and regional variations in brain methylaiton and hydroxymethylation 
with the observed neuropathological and functional outcome in this animal model.  
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Further in regards to the relevance of the hypoperfused model to the aging processes in 
humans, it would be interesting to compare epigenetic marks in the brains of aged vs. 
young animals in the presence vs. absence of chronic cerebral hypoperfusion (discussed in 
Chapter 6, section 6.1.2.) 
5.4.7. Implications of the study and future directions 
The major implication of the present study relies in the experimental investigation of 
emerging epigenetic phenomena such as methylation and hydroxymethylation in the 
normal and diseased (e.g. chronic cerebral hypoperfusion) mammalian brain. Both 
methylation and hydroxymethylation have been associated with age- related 
neuropathology (Post et al., 1999; Tohgi et al., 1999; Wang et al., 2008; Kriaucionis and 
Heintz., 2009; Mastroeni et al., 2009; Mastroeni et al., 2010; Song et al., 2010; Szulwach 
et al., 2011; Chen et al., 2012). However, little is known about 1) the specific distribution 
of methylation and hydroxymethylation in cells composing the cerebral white and grey 
matter, 2) the dynamics of these epigenetic phenomena in the central nervous system 
under normal physiological and pathological conditions, 3) the association between 
methylation and hydroxymethylation as well as their relations to other epigenetic marks, 
4) whether and/ or how changes in 5mC and 5hmC dynamics under pathological 
conditions might impact on neuropathology and functional outcome, 5) whether the TET 
proteins are important regulators of hydroxylation of 5mC in the brain and whether/ how 
pathological alterations in TETs- associated pathways could impact on 5mC and 5hmC 
distribution in the brain. 
The present study addressed some of the above mentioned questions. Specifically, it 1) 
provided the first detailed, immunochemical characterization of methylation, 
hydroxymethylation and TET2 in white and grey matter areas of the adult mouse brain 
under normal physiological conditions and one month after chronic cerebral 
hypoperfusion, 2) examined potential associations between these epigenetic marks in 
white matter (5mC, 5hmC, TET2), 3) attempted to determine the cellular basis of 5hmC  
in white matter using in vivo and in vitro strategies. 
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The present findings would potentially constitute the basis for future studies examining 
the molecular and functional significance of epigenetic mechanisms in the development of 
age- related neuropathology and cognitive decline. Understanding the functional 
significance of distinct epigenetic marks in the brain, their interplay and how they could 
be exogenously regulated would potentially allow the identification of new molecular 
targets for the treatment of age- related neuropathology and cognitive decline.  
5.5. Summary 
The experimental findings presented in Chapter 5 suggest that chronic cerebral 
hypoperfusion alters significantly hydroxymethylation in the CC in the absence of changes 
in methylation and TET2 in white matter. Significant TET2 alterations were evidenced in 
the hypoperfused Cx. A subsequent correlation analysis demonstrated that 
hydroxymethylation in white matter might occur independently from 5mC and TET2. 
Further in vivo and in vitro investigation of the potential cellular basis of 5hmC suggests 







































In the present thesis a new mouse model of chronic cerebral hypoperfusion was further 
developed and characterized. The obtained data would potentially constitute the basis for 
future research leading to the pre- clinical identification of new biological targets for the 
development of therapies for age- related cognitive decline. 
 
6.1. Future research directions using the new mouse model of chronic cerebral 
hypoperfusion 
 
6.1.1. Effects of chronic cerebral hypoperfusion on alternative (non- examined) brain 
processes in mice  
Chronic cerebral hypoperfusion might affect presently non- examined brain processes 
potentially contributing to the pathological and behavioural profile in this animal model.  
 
6.1.1.1. Effects of chronic cerebral hypoperfusion on the cerebral metabolism in mice 
 
Age- related alterations in the cerebral hemodynamics are associated with carotid stenosis 
(e.g. chronic cerebral hypoperfusion) and cognitive impairment (Derdeyn et al., 1994; 
Ogawa et al., 1996; Pardo et al., 2007).  
 
Hypoperfusion- induced alterations in the cerebral hemodynamics might impact on the 
cerebral metabolism in mice by affecting the glucose turnover, the ATPase activity, the 
ATP and lactate concentrations as shown in alternative animal models (Plaschke et al., 
2005; Shang et al., 2005). Specifically, in chronically hypoperfused rats a sudden ATP 
depletion is observed in the minutes following artery ligation (5-10 mins post- surgery) 
(Plaschke et al., 2005). These ATP reductions persist for two weeks and ATP 
concentrations are restored to normal (baseline level) 8 weeks post- surgery. (Plaschke et 
al., 2005). Importantly, the ATPase activity was found to be decreased, whereas the lactate 
concentrations and utilization were 2.5 fold increased in grey matter areas (the Cx and 
hippocampus) in chronically hypoperfused rats (Shang et al., 2005). By using 18F-
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fluorodeoxyglucose positron emission tomography (PET), which measures cerebral 
glucose transport across the blood- brain barrier, Nishio et al., 2010 demonstrated that the 
glucose utilization in the hippocampus of chronically hypoperfused mice remains 
impaired 6 months post- surgery. Similar findings were observed in clinical studies on 
elderly people using the same experimental approach (18F-fluorodeoxyglucose PET). In 
particular, reductions in the cerebral glucose uptake were evident in individuals with mild 
cognitive impairment or probable and possible Alzheimer`s disease (Drzezga et al., 2003; 
Hunt et al., 2007). A longitudinal FDG-PET study revealed hippocampal reductions in 
glucose uptake during normal aging (Mosconi et al., 2006; Samuraki et al., 2007). Further, 
by using the same neuroimaging technique, Reiman et al., 1996 and Reiman et al., 2004 
demonstrated low rates of glucose metabolism in young and middle aged, cognitively 
intact APOE4 carriers in the same regions of the brain where such metabolic abnormalities 
are usually evident in Alzheimer`s patients (e.g. prefrontal, parietal, temporal and 
posterior cingulate regions). Taken together these clinical data suggest that decreases in 
the cerebral metabolism might be a predictive factor of neurodegeneration and cognitive 
decline with increasing age. 
 
Further, the discussed animal and human data are important considering the more 
pronounced neuronal ischemic injury observed in the food deprived, behaviourally tested 
hypoperfused cohorts in the present thesis (Chapter 3). It is possible that undetected 
hypoglycaemia due to the experimental diet led to more pronounced metabolic 
perturbations in the brains of food deprived hypoperfused animals impacting on neuronal 
function and survival. 
 
However, the cerebral blood metabolism was not examined in any of the studies in the 
present thesis. Future experiments measuring the cerebral metabolism (e.g. ATP, ATPase 
activity, glucose, lactate) at different post- surgery time points under different 
experimental conditions (e.g. presence vs. absence of behavioural training; food diet vs. 
ad libitum feeding or a combination of these) comparing sham and chronically 
hypoperfused mice would help to get a better understanding of the effects of potential 
hypoperfusion- induced cerebral hemodynamic changes on the neuropathological and 
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functional outcome in this model over time. Additionally, one could suspect that 
hypoperfusion- induced metabolic abnormalities might be more pronounced in APOEKO 
deficient and human APOE4 transgenic mice due to naturally occurring cerebrovascular 
abnormalities in these animals (Piedrahita et al. 1992; Buttini et al., 1999; Sheng et al., 
1999; Buttini et al., 2000; Fullerton et al., 2001; Methia et al., 2001; Kitagawa et al., 2002; 
Fryer et al., 2005 Hafezi- Moghadam et al., 2006). 
 
6.1.1.2. Effects of chronic cerebral hypoperfusion on the cerebrovasculature in mice 
 
The observed cerebral blood flow restoration in all animal models of chronic cerebral 
hypoperfusion suggests the existence of compensatory mechanisms occurring overtime 
following surgery. Compensatory blood flow might be provided through artery dilation, 
nonperfused capillaries and veins, angiogenesis. This idea is supported by existing data 
from chronically hypoperfused rats and recent findings on chronically hypoperfused mice. 
In the rat model of chronic cerebral hypoperfusion compensatory mechanisms such as 
enlargement of the posterior arteries at the base of the brain and the arteries emanating 
from the circle of Willis were evident between 4- 6 months after artery ligation. Further, in 
this model, an increased capillary diameter, neovascularization, and an increase in 
vascular endothelial growth factor (VEGF) were found in grey matter areas after 4 weeks 
of artery stenosis (de Wilde et al., 2002; Ohtaki et al., 2006). A recent microarray study in 
chronically hypoperfused mice revealed alterations in blood vessels development genes in 
white matter (Reimer et al., 2011). These data are suggestive of potential cerebrovascular, 
compensatory mechanisms taking place in the hypoperfused mouse brain.  
 
Further, microcerebrovascular pathology (e.g. small arteries and arterioles abnormalities) 
is observed in both elderly people and hypoperfused rats (Olendorf, 1987; Tang et al., 
1997; de Jong et al., 1999; Choy et al., 2006; Farkas et al., 2006; Fernando et al., 2006; 
Gold et al., 2007). Therefore, microcerebrovascular pathology might contribute to the 
pathological and behavioural profile following hypoperfusion in mice.  
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Future experiments on chronically hypoperfused mice should examine the morphology of 
cerebral blood vessels and angiogenesis in this animal model using a standard histological 
approach (e.g. H&E) and/ or sensitive biomarkers targeted to endothelial cells (e.g. 
BMEC), pericytes (e.g. CD31), pericytes progenitors (e.g. Angiopoietin-1), VEGF. 
Further these future experiments should take into consideration the potential effects of 
additional factors such as APOE which might affect the microcerebrovascular integrity 
under both normal physiological and chronically hypoperfused conditions. Specifically, 
APOE deficient mice exhibit reduced VEGF expression and impaired collateral vessel 
development following experimental ischemic injury which impacts negatively on 
pathology and functional outcome (Couffinhal et al., 1999). Human APOE4 carriers with 
Alzheimer`s disease exhibit more severe microvascular pathology consisting of Aβ 
accumulation in the cerebral blood vessels and small vessels artheriosclerosis in white and 
grey matter areas of the brain (Premkumar et al., 1996; Yip et al.,2005). 
 
The blood brain barrier plays an important role in protecting the brain from potentially 
harmful molecules coming from the peripheral circulation. The blood brain barrier is 
particularly vulnerable to hypoxic- ischemic events and its rupture could exacerbate both 
the observed pathological and functional outcome (Lenzser et al., 2005; Preston and 
Foster, 1997). Morphological abnormalities in the blood brain barrier such as basement 
membrane thickening, fibrous collagen deposit have been reported to occur in both 
“healthy” and demented elderly potentially affecting the normal transport of nutrients to 
the brain (Farkas and Luiten, 2001; Bell and Zlokovic, 2009). In accordance with these 
human findings, naive aged rats (30 months) exhibit capillary basement membrane 
pathology (de Jong et al., 1990). The possible associations between the observed blood 
brain barrier abnormalities in elderly people and aged rats were tested in chronically 
hypoperfused adult rats. In this animal model, microvascular basement membrane 
thickening and collagen deposits similar to those observed in clinical studies were 
reported 14 months after artery ligation (de Jong et al., 1999). These experimental data 
suggest a role of chronic cerebral hypoperfusion in the occurrence of blood brain barrier 
abnormalities in the aging mammalian brain.  
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At the present time, little is known about the blood brain barrier integrity in chronically 
hypoperfused mice and whether and/ or how potential blood brain barrier abnormalities 
could affect the pathological and functional outcome in this animal model. This is 
important as to the future identification of pathophysiological mechanisms influencing the 
development of neuropathology and cognitive deficits in chronically hypoperfused mice 
(discussed in section 6.1.3.).Future experiments should focus on examining the blood 
brain barrier integrity in this animal model for instance, by using previously described 
methods such as venous administration of Evans blue dye that does not cross the blood 
brain barrier under normal physiological conditions, but accumulates in the brain 
parenchyma when the blood brain barrier is pathologically disrupted. Investigation of 
Evans blue in the brain parenchyma of sham compared with chronically hypoperfused 
mice would allow to determine the potential existence of blood brain barrier abnormalities 
in this animal model (Fullerton et al., 2001).  Further, it is unknown how potential 
hypoperfusion- induced blood brain barrier abnormalities could be modulated by 
additional molecular factors such as APOE. Previous studies demonstrated the existence 
of blood brain barrier abnormalities in naïve APOEKO mice which increase in severity in 
the presence of pathology (Fullerton et al., 2001; Methia et al., 2001; Hafezi- Moghadam 
et al., 2006) suggesting that blood brain barrier integrity might be modulated by the APOE 
genotype in the presence of chronic cerebral hypoperfusion. 
 
6.1.1.3. Effects of chronic cerebral hypoperfusion on neurotransmission in mice 
 
Impaired neurotransmission, namely disturbances in the cholinergic system are one of the 
hallmarks of dementia (Minger et al., 2000; Fong et al., 2011). Age- related 
cerebrovascular abnormalities have been proposed to play a role in the occurrence of 
cholinergic dysfunction and associated cognitive impairment in patients with Alzheimer`s 
and vascular dementia (Roman and Kalaria, 2006). A recent clinical study suggests a 
potential association between a state of chronic cerebral hypoperfusion and an impaired 
cholinergic function in Alzheimer`s patients (Fong et al., 2011) exhibiting significantly 
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more pronounced losses of choline acetyltransferase (ChAT) activity in the presence of 
the APOE4 allele (Lai et al., 2006). 
 
Experimental cerebral hypoperfusion, in a similar way, leads to memory impairment with 
alterations in the cholinergic parameters such as muscarinic, nicotinic receptors, ChAT 
and decreased acetylcholine levels in the hippocampus of chronically hypoperfused rats 
(Ni et al., 1995; Kondo et al., 1996; Egashira et al., 1996; Tanaka et al., 1996; Ouchi et al., 
1998). In chronically hypoperfused mice a recent study by Nishio et al., 2010 suggested 
reduced levels of acetylcholine esterase in cortical and subcortical grey matter areas. Both 
clinical and experimental studies have proven that a cholinergic agonist based therapy 
mitigates memory dysfunctions in Alzheimer`s patients and hypoperfused rats (Nanri et 
al., 1998; Murakami et al., 2000). In regards to the important role of the cholinergic 
system in mediating learning and memory processes as well as in the development of 
dementia (Van der Zee et al., 2011), future studies in chronically hypoperfused mice 
should determine to what extent hypoperfusion- induced alterations in the acetylcholine 
levels could impact on cognitive and memory function in mice. 
 
Disturbances in the cholinergic system are often accompanied by alterations in other 
neurotransmitter systems (e.g. catecholamines) and future studies should also get a better 
understanding of the effects of the microcoils surgery on catecholamines, gabaergic and 
glutamatergic synthesis in mice. Little is known about the effects of hypoperfusion on 
catecholamines in both humans and animal models of chronic cerebral hypoperfusion. 
Catecholamines are known to play a role in the modulation of prefrontal executive 
function, in particular the dopamine system (Arnsten, 1998). Experimental evidence from 
aged rats, nonhuman primates and elderly people suggests a role of the catecholamine 
(e.g. dopamine and serotonine) and noradrenaline systems in age- related cognitive decline 
(Adolfsson et al., 1979; Arnsten and Goldman- Rakic, 1985; Miguez et al., 1990; McEntee 
and Crook, 1991; Reeves et al., 2002).   
 
Future experiments on chronically hypoperfused mice should determine if there are any 
alterations in the brain neurotransmitter systems and if they impact on the pathological and 
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functional outcome in this animal model. Methodologically, one could use HPLC and/ or a 
standard immunohistochemical approach to measure neurotransmitters in the brains of 
behaviourally tested sham compared with chronically hypoperfused mice. Subsequent 
association analysis between neurotransmitter levels (e.g. acetylcholine) with 
neuropathological and behavioural measures would allow to determine whether potential 
hypoperfusion- induced alterations in neurotransmission are functionally relevant. Further, 
one should consider the effects of additional factors such as APOE that could potentiate 
the effects of hypoperfusion on neurotransmission. For instance, naïve APOE deficient 
mice exhibit reduced numbers in muscarinic acetylcholine receptors in grey matter (the 
hippocampus) and impaired performance on a 5-choice serial reaction time tasks 
(executive function) (Siegel et al., 2011). Therefore, potential hypoperfusion- induced 
alterations in neurotransmitters systems might be more pronounced in APOEKO mice. 
 
6.1.2. Effects of chronic cerebral hypoperfusion on neuropathology and cognitive 
impairment in the context of aging 
Reduced neurotrophic levels, neuronal abnormalities (e.g. synaptic/ dendritic loss and 
dysfunction), impaired neurotransmission, cerebrovascular pathology occur with 
chronological age and may impact on the pathological and functional profile of aged sham 
and hypoperfused animals compared with young treatment- matched counterparts 
(Arnsten and Goldman- Rakic, 1985; Olendorf, 1987; de Jong et al., 1990; Miguez et al., 
1990; McEntee and Crook, 1991; Ni et al.,1995; Kondo et al., 1996; Egashira et al., 1996; 
Tanaka et al., 1996; Tang et al., 1997;  Ouchi et al., 1998; Bimonte et al., 2003; Blesch, 
2006; Choy et al., 2006; Farkas et al., 2006; Fernando et al., 2006; Gold et al., 2007).  
 
Aged rodents, dogs and nonhuman primates exhibit cognitive deficits even in the absence 
of surgical/ phramacological intervention when compared with young counterparts. For 
instance, relative to young controls, aged dogs exhibit worse cognitive scores in object 
recognition, reversal learning and spatial learning tasks (Head et al. 1995; Cummings et al. 
1996). Similar results are observed in aged monkeys presenting memory flexibility, 
working memory and processing speed deficits when compared with young counterparts 
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(Herndon et al., 1997; Luebke et al., 2004). However, some behavioural studies on aged 
animals suggest differential effects of aging on cognition and memory. Specifically, an 
inter- animal variability in the severity of age- related cognitive impairment exists among 
aged rodents. Some aged animals present intact cognitive and memory function, whereas 
others exhibit an age- related deterioration in cognition and memory (Matzel et al., 2008).   
 
In regards to the relevance of the hypoperfused model to the aging process in humans, 
future experiments comparing aged vs. young cohorts of sham vs. chronically 
hypoperfused mice would allow to determine the effects of aging alone as well as in 
combination with experimentally induced cerebrovascular challenge (e.g. chronic 
hypoperfusion) on the development of cognitive decline and neuropathology. However, 
for these particular studies one should consider the above mentioned inter- animal 
variability in cognitive function in naïve aged mice.  
 
Age- related pathological alterations seem to be more pronounced in APOE4 human 
carriers, APOE deficient mice and human APOE 4 transgenic animals (Piedrihta et al., 
1992; Van Ree et al., 1994; Gordon et al., 1995; Masliah et al, 1995; Premkumar et al., 
1996; Reiman et al., 1996; Masliah et al., 1997; Sheng et al., 1999; Buttini et al., 2000; 
Fullerton et al., 2001; Methia et al., 2001; Han et al., 2003;  Reiman et al., 2004; Hafezi- 
Moghadam et al., 2006; Beeri et al., 2006; Persson et al., 2006; Filippini et al., 2009; 
Smith et al., 2010; Heise et al., 2010; Ryan et al., 2011). In the present thesis APOE 
deficiency was found to impact on the development of hypoperfusion- induced white 
matter pathology on MRI scans of relatively young, adult mice (Chapter 4). It is possible 
that white matter abnormalities develop naturally, at a later time point during the lifespan 
of APOEKO mice even under normal physiological conditions due to previously 
demonstrated increased lipid peroxidaiton, protein oxidation and impaired cholesterol 
transport, cerebrovascular abnormalitites in this animal model leading to the development 
of more severe neuropathology following chronic cerebral hypoperfusion in aged 
APOEKO mice (Piedrahita et al. 1992; Van Ree et al., 1994; Fullerton et al., 2001; Methia 
et al., 2001; Ramassamy et al., 2001; Han et al., 2003; Choi et al., 2004; Hafezi- 
Moghadam et al., 2006). Future experiments should examine the individual and combined 
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effects of the surgical procedure (sham vs. hypoperfusion), genotype (WT vs. APOEKO; 
APOE3 vs. APOE4) and age (young vs. old) on neuropathology and functional 
impairment in this animal model. 
Previous reports suggest age- related epigenetic alterations associated with 
neuropathology and cognitive decline (Post et al., 1999; Tohgi et al., 1999; Wang et al., 
2008; Kriaucionis and Heintz., 2009; Mastroeni et al., 2009; Mastroeni et al., 2010; Song 
et al., 2010; Szulwach et al., 2011; Chen et al., 2012). In the present thesis methylation 
and hydroxymethylation dynamics were investigate under normal physiological and 
hypoperfused conditions in white and grey matter areas of relatively young adult mice. 
Hypoperfusion was found to increase significantly 5hmC, but not 5mC in white matter, 
most likely related to increases in inflammatory microglia (Chapter 5). It is possible that 
age- related changes in the brain microenvironment such as increases in inflammation, 
excitotoxicity, oxidative stress, neurodegeneration could impact on the processes of 
hydroxylation of 5mC (Arnsten and Goldman- Rakic, 1985; Olendorf, 1987; de Jong et 
al., 1990; Miguez et al., 1990; McEntee and Crook, 1991; Ni et al.,1995; Kondo et al., 
1996; Egashira et al., 1996; Tanaka et al., 1996; Tang et al., 1997; Ouchi et al., 1998; 
Bimonte et al., 2003; Blesch, 2006; Choy et al., 2006; Farkas et al., 2006; Fernando et al., 
2006; Gold et al., 2007; Baltan et al., 2008). Future experimental work should investigate 
using sensitive techniques methylation and hydroxymethylaiton dynamics in the brains of 
aged sham vs. chronically hypoperfused mice compared with treatment- matched young 
counterparts. Subsequent associations of epigenetic marks with neuropathology and 
functional outcome under normal physiological and chronically hypoperfused conditions 
in young vs. aged animals would allow to reveal the potential biological significance of 
these molecular mechanisms in the central nervous system during lifespan and disease. 
6.1.3. Pathophysiological mechanisms in chronically hypoperfused mice 
Although in the present thesis the inflammatory response was partially examined in 
chronically hypoperfused mice, the pathophysiological mechanism(s) in this animal model 
remain(s) largely unknown. It is important that future research identifies cellular and 
molecular pathways underlying hypoperfusion- induced neuropathology and functional 
impairment in mice. Considering the chronic nature of the cerebrovascular challenge, it is 
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possible that at different post- surgery time points, different pathophysiological 
mechanisms modulate neuropathology and functional impairment in hypoperfused mice. 
These mechanistic studies would potentially constitute the basis for future pre- clinical 
development of therapeutic strategies for age- related cognitive decline. As previously 
discussed in this thesis (Chapter 1, section 1.6.) APOE could modulate excicotoxic, 
oxidative and inflammatory levels therefore determining the pathophysiological 
environment in the hypoperfused mouse brain. 
6.1.3.1. A role of excitotoxicity in hypoperfusion- induced neuropathology and 
cognitive deficits in mice? 
Excitotoxic brain injury is associated with disturbances in brain ionic homeostasis 
occurring following excessive glutamate synthesis under pathological conditions such as 
hypoxic- ischemic events (Hazell, 2007; Tekkok et al., 2007). Excitotoxicity is associated 
with an overactivation of glutamatergic receptors present on glia and neurons leading to 
the occurrence of white and grey matter pathology (Choi, 1990; Sattler and Tymianski, 
2001; Karadottir and Attwell, 2007; Bakiri et al., 2009). 
 
Nonselective Na+ channels blockers such as tetrodoxin (TTX), lidocaine and flecainide as 
well as glutamatergic receptor antagonists (e.g. NBQX) reduce pathological damage to 
white and grey matter in experimental models of hypoxia- ischemia (e.g. stroke, 
periventricular leukomalacia), multiple sclerosis, spinal cord and traumatic brain injury 
(Zafonte et al., 1999; Schwartz and Fehlings, 2001; Bechtold et al., 2004; Follet et al., 
2004; Sfaello et al., 2005; Waxman, 2006). For instance, BW61 9C89, a blocker of 
voltage- gated Na+ receptors inhibits glutamate release in a rat model of middle cerebral 
artery occlusion and exerts neuroprotection (Graham et al., 1994). Intraperitoneal 
administration of riluzole, a Na+ blocker is associated with an improved neuropathology 
and functional outcome following spinal cord injury in the rat (Schwartz and Fehlings, 
2001). Intracerebral infusion of topiramate, reduces excitotoxic white matter injury 
following intracerebral administration of ibotanate- a glutamatergic agonist acting via the 
NMDA, AMPA receptors, in newborn mice (Sfaello et al., 2005). 
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Pathological changes at the paranodal structure and the nodes of Ranvier have been 
reported to occur in white matter as soon as 3 days following chronic cerebral 
hypoperfusion in mice and these morphological abnormalities seem to increase in severity 
overtime (Reimer et al., 2011). Specifically, progressive paranodal breakdown and 
increases in the length of the nodes of Ranvier characterized by spreading of Nav1.6.  
channels along the axolemma were evident in white matter tracts of hypoperfused mice 
between 3 days and 1 month after surgery. Nav1.6. is the major Na+ channel at the nodes 
of Ranvier (Caldwell et al., 2000) and these receptors might be essential molecular players 
mediating excitotoxic damage to white matter (Stys, 1998; Stys, 2005). Nav1.6. receptors 
are also present on neuronal dendrites and synapses (Caldwell et al., 2000). In alternative 
animal models of chronic cerebral hypoperfusion significant alterations in synapses and 
dendrites are reported to occur in hypoperfused grey matter areas (Kudo et al., 1993; 
Kurumatani et al., 1998; Liu et al., 2005). Changes in the paranodal structure of the 
axolemma have been reported to occur in both aged animals and humans. For instance, 
Sugiyama et al., (2002) reported age-dependent alterations in the paranodal structure, 
illustrating paranodal loops that fail to reach the axon in white matter of 31 month old rats. 
An increase in paranodal profiles and the presence of short, thin internodal lengths of 
myelin in cortical areas 17 and 46 have been evident in aged rhesus monkey (Peters and 
Sethares, 2003). In humans, changes in the axolemma at the nodal regions seem to occur 
with chronological age (Lasiene et al., 2009).   
 
It is possible that excitotoxic mechanisms mediate the development of both white and grey 
matter pathology in chronically hypoperfused mice via Nav1.6. receptors. From a 
methodological point of view, it might be challenging to test this hypothesis due to the 
current lack of specific Nav1.6 blockers. However, Nav1.6.KO mouse line exists (Levin 
and Meisler, 2004) and the microcoils surgery could be applied on Nav1.6. KO and WT 
control mice to test the effects of Nav1.6. receptors on neuropathology and functional 
outcome in this animal model. The absence of Nav1.6. receptors might be associated with 
a better neuropathological and functional outcome following hypoperfusion in mice due to 
limited excitotoxicity. Alternatively, to reduce the cost of using genetically modified 
animals, one could intracerebrally administer Na+ blockers (e.g. TTX) or glutamatergic 
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antagonists (e.g. NBQX) vs. saline in C57BlJ6 hypoperfused mice and compare the effects 
of these treatments on neuropathology and functional outcome. However, there are a few 
considerations concerning this pharmacological approach. The cerebrovascular challenge 
in this animal model is chronic and it is necessary to determine when to apply Na+/ 
glutamatergic blockers in hypoperfused mice. The long- term administration of 
pharmacological inhibitors of Na+/ glutamatergic- dependent cellular activity risks of 
perturbing non- affected neural circuits leading to additional neuropathology and 
functional deficits. 
6.1.3.2. A role of oxidative stress in hypoperfusion- induced neuropathology and 
cognitive deficits in mice? 
Oxidative stress has been reported to occur in various neuropathological conditions, 
characterized by increased excitotoxic and inflammatory levels (e.g. hypoxic- ischemic 
insults) (Auten and Davis, 2009). Oxidative stress is defined as a disturbance in the pro-
oxidant- antioxidant balance in favour of the former, leading to cellular injury, molecular 
dysfunction, cell death (Auten and Davis, 2009). Excitotoxic and inflammatory processes 
might influence the development of neuropathology following chronic cerebral 
hypoperfusion in mice and their effects might be potentiated and/ or partially mediated via 
the formation of reactive oxygen species such as NO. For instance, hypoxia- ischemia 
increases the expression of NO synthases- the enzymes catalyzing the production of NO 
during the initial hours following the insult (Iadecola et al., 1997). NO concentration has 
been shown to increase 2 weeks following artery ligation in chronically hypoperfused rats 
(de la Torre et al., 2003). An excess of NO is known to be harmful to cellular 
mitochondrias initiating the release of pro- apoptotic signals such as cytochrome- C and 
caspase- 3 resulting in an increased cell death and neuropathology (Kroemer et al., 1998; 
Ricci et al., 2004). Elevated NO levels following hypoxic- ischemic events in vivo have 
been shown to cause neuronal and glial cell death (Eliasson et al., 1999; Haynes et al., 
2003). In vitro studies have confirmed these data by demonstrating that microglia secreted 
NO leads to neuronal and glial apoptosis (Kim and Kim, 1991; Boje and Arora, 1992; 
Chao et al., 1992; Cazevieille et al., 1993; Mitrovic et al., 1995). It is possible that 
hypoperfusion- induced increases in reactive oxygen species contribute to the 
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development of white and grey matter pathology in this animal model (Chapter 3, section 
3.4.2.4.). Previous experimental work has demonstrated beneficial effects of anti- 
oxidative agents on neuropathological and functional outcome in different central nervous 
system disorders. For instance, the antioxidants N-acetyl-cysteine, a-lipoic acid, and a-
tocopherol (vitamin E) prevent axonal degeneration in a mouse model of x- 
adrenoleukodystrophy (Lopez- Erauskin et al., 2011). Intaperitoneal injection of the anti- 
oxidant peroxiredoxin 5 is neuroprotective in new born mice with experimentally- induced 
excitotoxic brain lesions (Plaisant et al., 2003). In a rat model of middle cerebral artery 
occulusion, oral administration of the anti- oxidant ebselen reduces significantly the 
volume of brain infarcts (Takagaso et al., 1997). 
 
Future experimental work on chronically hypoperfused mice could examine the potential 
effects of anti-oxidative agents (e.g. N-acetyl-cysteine, a-lipoic acid, a-tocopherol vitamin 
A, C, and/ or E, peroxiredoxin 5) on neuropathology and functional outcome in this 
animal model potentially revealing new molecular targets for the preclinical development 
of therapeutic strategies for age- related cognitive decline. Similar to the discussed in the 
previous section, experimental modulation of brain oxidative levels in chronically 
hypoperfused mice should overcome certain issues associated with the chronic nature of 
the cerebrovascular challenge in this animal and potentially adverse effects associated 
with nonselective modulation of reactive oxygen species in the brain. Specifically, 
previous studies have demonstrated that although high concentrations of oxidative species 
are harmful to neuronal and glial cells, reactive oxygen species also play an important role 
in modulating cellular function. For instance, NO promotes vasodilatation, inhibition of 
platelet aggregation, modulation of neurotransmission, promotion of synaptogenesis, 
synaptic remodelling, and exerts antimicrobial toxicity- all important for neuroprotection 
and functional recovery following hypoxic- ischemic injury to the brain (Love, 1999). 
 
6.1.3.3. A role of inflammation in hypoperfusion- induced neuropathology and 
cognitive deficits in mice? 
As previously discussed within the present thesis increased inflammatory levels following 
chronic cerebral hypoperfusion could impact on the development of white and grey matter 
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abnormalities observed in this animal model. Inflammatory cells such as microglia and 
astrocytes play an important role during the endogenous processes of brain repair by 
buffering extracellular glutamate, secreting neurotrophic factors (e.g. BDNF, IGF-1), pro- 
inflammatory agents (e.g. cytokines, chemokines, matrix metalloproteinase), interleukins 
(IL1- 10) and oxidative species (e.g. NO) (Lakhan et al., 2009). The balance among these 
glial- produced molecular factors could modulate the severity of neuropathology and 
functional outcome following injury to the central nervous system.  
To test the effects of immunomodulatory interventions on neuropathology and functional 
impairment in chronically hypoperfused mice one could consider different experimental 
strategies (some experimental strategies were previously discussed within the thesis). For 
instance, a potential inhibition of presently observed hypoperfusion- induced microglial 
activation in mice, could be achieved by the application of naloxone- a nonselective 
antagonist of the G-protein linked opioid receptors that are widely expressed on cells of 
the central nervous system (CNS) (Liu and Hong, 2003). Previous in vitro studies 
demonstrated that naloxone was capable of reducing the LPS-stimulated production of 
cytokines and NO in glial cultures (Das et al., 1995; Kong et al., 1997). In vivo naloxone 
exerts neuroprotective effects in LPS animal models of Parkison`s disease by inhibiting 
microglial secretion of pro- inflammatory substances (Liu et al., 2000, Lu et al., 2000). 
Further, corticosteroids have recognized anti- inflammatory properties in different 
pathological conditions with a certain effect on neuropathology and functional recovery 
such as in the case of spinal cord and traumatic brain injury, stroke, multiple sclerosis 
(Limbourg et al., 2002; He et al., 2004; Kwon et al., 2004; Garay et al., 2008). 
Alternatively, nonsteroidal drugs such as aspirin have been suggested to modulate the 
inflammatory response under pathological conditions and exert neuroprotective function 
by inhibiting glial secreted proinflammatory cyclooxygenase enzymes, which have been 
implicated in neurodegenerative pathways (Wahner et al., 2007). These nonsteroidal 
compounds seem to be particularly promising for future clinical application as most of 




Future research work on chronically hypoperfused mice could consider examining the 
effects of the above mentioned immunomodulatory substances on neuropathology and 
functional outcome in this animal model.  
 
6.1.4. Preclinical development of therapeutic strategies for the treatment of age- 
related cognitive decline using chronically hypoperfused mice 
In addition to modulation of potential hypoperfusion- associated pathophysiological 
mechanisms, future experimental work could consider developing alternative therapeutic 
strategies in this animal model. 
6.1.4.1. Cerebral reperfusion 
Since hypoperfusion- induced neuropathology and cognitive impairment in mice are 
associated with microcoils- mediated partial obstruction of the common carotids resulting 
in mild cerebral hypoprefusion, a potential strategy to restore brain structure- function in 
this animal model might consist of the surgical removal of the microcoils followed by 
restoration of cerebral blood flow (e.g. reperfusion). In alternative cerebrovascular models 
(e.g. focal ischemia) and human patients with stroke, the processes of cerebral perfusion- 
reperfusion involve complex cellular and molecular pathways persisting even after the 
reperfusion phase (D`Ambrosio et al., 2001; Fiehler et al., 2004). However, with the 
restoration of cerebral irrigation, there is a progressive normalization of the cerebral 
microenvironment (e.g. decreases in inflammation) followed by a long- term restoration of 
function by neuroregeneration of injured areas and/ or by compensatory brain mechanisms 
(Hossmann, 2008). The immediate hours (up to 6 hours) following reperfusion have been 
shown to represent a therapeutic window to reduce brain damage and improve functional 
outcome after hypoxic- ischemic events (Baron et al., 1995; Molina and Saver, 2005).  
It is unclear whether the removal of the microcoils in chronically hypoperfused mice 
would be beneficial (e.g. improvement of working memory). Although, technically 
challenging (e.g. risk of potential arterial damage; a second surgical intervention on the 
same animal), future experimental work should address this question by characterizing the 
processes of cerebral perfusion- reperfusion in hypoperfused mice at both the 
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neuropathological and functional levels. Due to the chronic nature of the cerebrovascular 
challenge in this animal model, this future work would require the identification of the 
optimal post- surgery time point for reperfusion (e.g. microcoils removal) associated with 
any beneficial pathological and/ or functional outcome. This intervention (e.g. removal of 
microcoils) might be less efficient at later post- hypoperfusion time points characterized 
by more severe neurodegeneration and cognitive impairment in mice (Nishio et al., 2010; 
Reimer et al., 2011).  
6.1.4.2. APOE modulation 
Human APOE allelic polymorphism has been shown to modulate the person`s 
susceptibility to recover following injury to the brain as well as to develop dementia and 
cerebrovascular pathology with increasing age (Saunders et al., 1993; Kalmijn et al., 1996; 
Skoog et al., 1998; Reiman et al., 1996; Reiman et al., 2004; Schuff et al., 2009b; Nicoll et 
al., 1995; Gromadzka et al., 2007; Wagle et al., 2009). Recent clinical reports associated 
the APOE4 allele with the occurrence of white matter abnormalities in cognitively intact 
adults which at a higher risk of dementia (Bartzokis et al., 2007; Filippini et al., 2009; 
Heise et al., 2010; Ryan et al., 2011).  
 
In the present thesis, ex vivo MRI analysis revealed that APOE may impact on the 
severity of hypoperfusion- induced white matter pathology in mice. Specifically, an 
absence of endogenous APOE was associated with more severe reductions in MRI 
parameters of white matter integrity in APOEKO hypoperfused mice compared with WT 
hypoperfused counterparts (Chapter 4). Although, the neuroimaging data were not 
supported by the applied pathological analysis (discussed in Chapter 4, section 4.4.5.), 
they are interesting and if confirmed in the future, they could constitute the basis for future 
investigation of APOE effects on neuropathology and functional outcome in this animal 
model. Results from previous studies suggest that restoring and/or increasing APOE levels 
can promote neuroprotection in the injured brain. For instance, an amelioration of 
neurological and pathological deficits in APOE deficient mice was achieved by 
intracerebral administration of recombinant APOE. Infusion of human recombinant 
APOE3 and APOE4 reversed cognitive deficits and participated in restoration of neuronal 
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structure in APOEKO mice (Masliah et al., 1997). The neuroprotective effects of APOE 
were also observed in WT mice following global ischemia (Horsburgh et al., 2000c). 
Increasing APOE levels in the brain would therefore appear to be a tempting therapeutic 
strategy to pursue in chronically hypoperfused mice. Several approaches could be used to 
augment endogenous APOE levels in the brain: (1) direct intrathecal administration of 
APOE in lipid-conjugated form (Horsburgh et al., 2000c)  (2) intrathecal or systemic 
administration of APOE mimetic peptides (that could cross the blood-brain barrier) (Aono 
et al., 2003); (3) administration of agents that can increase APOE expression levels. A key 
consideration of any approach, however, would be the potential systemic side effects of 
increasing APOE levels given the fundamental role of APOE in lipid and cholesterol 
homeostasis, especially in the periphery. In this regard, restricting increased APOE 
expression to the brain would be an important advantage. Since there is no clear evidence 
that APOE crosses the blood-brain barrier, direct intrathecal administration/viral vector-
mediated delivery of APOE could achieve brain-specific increases in APOE. However, 
even with these approaches, blood-brain barrier disruption in the injured brain could result 
in leakage of APOE into the systemic circulation. Another key issue, especially in regards 
to translation of this research to clinics relates to human APOE polymorphism. Although 
the precise mechanism(s) responsible for APOE genotype dependent responses to brain 
injury are not fully understood, there is evidence that differences may be due to beneficial 
properties of the APOE3 (and APOE2) isoform (that are absent in the APOE4 isoform) 
but also to direct toxic properties of APOE4 (Marques et al., 1997). In regards to clinics, 
these divergent effects of human APOE isoforms could preclude development of a single 
drug that would benefit patients with chronic cerebral hypoperfusion of all APOE 
genotypes. For example, a drug that indiscriminately enhances APOE expression in the 
brain may be beneficial in APOE3 (and APOE2) carriers (promotes beneficial APOE3/E2 
effects), but have mixed effects in APOE4 carriers (compensates for effects due to APOE4 
deficiency but also promotes toxic APOE4 effects). In view of the above 
pharmacogenomic issues, specifically enhancing APOE3 effects could be advantageous. A 
third consideration with an APOE-based therapeutic approach would be the duration of 
APOE expression that could be achieved. The ability to mediate prolonged APOE 
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expression in the brain under chronic conditions (e.g. chronic cerebral hypoperfusion) 
might provide more long-term benefits than a transient period of expression.  
 
Future experiments on this animal model should therefore examine the effects of APOE- 
based therapy in mice taking into account the above mentioned considerations. 
6.1.4.3. Epigenetic modulation  
Modulation of epigenetic mechanisms might constitute a promising new therapeutic 
alternative for age- related cognitive decline. The sporadic nature of 90% of dementia 
cases, the differential susceptibility to and course of the illness, as well as the relatively 
late onset of functional impairment suggest that epigenetic and environmental components 
play a role in the pathogenesis of age- related cognitive decline (Mehler, 2008; Zawai et 
al., 2009; Chouliaras et al., 2010; Penner et al., 2010). This idea is supported by clinical 
studies on monozygotic twins where both genomic 5mC content and the acetylation levels 
of histone 3 (H3) and H4 were significantly different in each twin and these epigenetic 
differences were more pronounced with increasing age (Fraga et al., 2005). Additionally, 
studies on monozygous twins with discordant Alzheimer`s disease demonstrated decreases 
in grey matter methylation in the affected twin compared with the cognitively intact twin 
brother (Mastroeni et al., 2009).  In recent years, it has become increasingly clear that, 
besides stochastic changes in the epigenome that occur throughout life, environmental 
factors such as nutrition, diet, drugs, hormones, and infections modulate a person’s 
phenotype and susceptibility to dementia via epigenetic mechanisms (Abdolmaleky et al., 
2004; Poulsen et al., 2007; Liu et al., 2008). For instance, epigenetic changes occur 
following cerebrovascular challenge most likely induced by increases in excitotoxicity, 
oxidative stress and inflammation (Endres et al., 2000; Westberry et al., 2008). Epigenetic 
changes might be associated with the occurrence of white matter abnormalities with 
cerebrovascular etiology in elderly people (Farkas and Luiten, 2001; O`Sullivan et al., 
2001; Roman et al., 2002; Deary et al., 2003; Charlton et al., 2006; Fernando et al., 2006; 
Grieve et al., 2007; Kennedy and Raz, 2009; Ihara et al., 2010; Penke et al., 2010).  
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The results from this thesis suggest significant hypoperfusion- induced alterations in 
5hmC in white matter in the absence of 5mC alterations in mice. Significant increases in 
cortical TET2- one of the enzymes catalyzing the hydroxylation of 5mC were also evident 
in hypoperfused mice (Chapter 5). The functional significance of these epigenetic 
alterations in the hypoperfused mouse brain remains unclear. If, in the future, the present 
results are confirmed, modulation of epigenetic phenomena in hypoperfused mice should 
be considered as a potential therapeutic strategy in this animal model. 
 
Currently, there is an absence of identified compounds which specifically modulate 5hmC 
due to the recent discovery of this epigenetic mark (Kriaucionis and Heintz., 2009; 
Tahiliani et al., 2009; Ito et al., 2010). Hydroxymethylation could be targeted via 
alternative molecular pathways such as methylation, TETs and potentially HDAC which 
might influence neuropathology and functional outcome in hypoperfused mice. One of the 
major considerations of exogenous (e.g. pharmacological) epigenetic modulation  relies in 
the high inter- dependence among epigenetic mechanisms and the possibility of undesired 
alterations in associated epigenetic marks having deleterious rather than beneficial effects 
on neuropathology and functional outcome such as in the case of cancer (Ptak and 
Petronis, 2008). The majority of currently applied compounds for epigenetic modulation 
are nonspecific and by consequence not always safe for clinical application. However, 
experimental studies have demonstrated that pharmacological modulation of methylation 
and HDAC in animal models of stroke could be neuroprotective. For instance, 
intracerebroventricular administration of a methyltransferase inhibitor (5-aza-29- 
deoxycytidine) and a deacetylation inhibitor (trichostatin A) increased gene expression 
and conferred neuroprotection in WT mice following focal ischemia (Enders et al., 2000). 
Intraperitoneal administration of suberoylanilide hydroxamic acid- an HDAC inhibitor 
induced an increased expression of the neuroprotective proteins Hsp70 and Bcl-2 within 
the ischemic mouse parenchyma (Faraco et al., 2006). 
 
Alternatively, there are currently marketed compounds shown to modulate epigenetic 
marks in the brain. For instance, the psychotropic valporate induces gene expression via 
inhibition of HDACs and its ability to perform DNA demethylation (Milutinovic et al., 
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2007). The antidepressant fluoxetine, a selective serotonin reuptake inhibitor, induces 
expression of genes encoding MeCP2 and MBD1 (proteins associated with maintenance 
of methylation- Chapter 1, section 1.7.1.) by continuously activating the serotonergic 
system in the adult rat brain suggesting that fluoxetine might affect on methylation 
dynamics (Cassel et al., 2006). 
 
Future experimental work on chronically hypoperfused mice could investigate the effects 
of compounds known to modulate epigenetic mechanisms on hypoperfusion- induced 
neuropathology and functional outcome. However, it is important to take into 
consideration the fact that these substances are not selective to the examined molecular 
mechanisms and their application could be potentially associated with disturbances in 
alternative brain processes (e.g. neurotransmission) impacting on neuropathology and 
cognition in hypoperfused mice. 
 
Since hydroxymethylation results from the oxidation of 5mC catalyzed by the TETs- 
another strategy to modulate 5hmC in the brain would potentially reside in modifying 
TETs activity. Although, in the present thesis, a correlation analysis suggested an absence 
of associations between 5hmC and TET2 in white matter, it is unknown whether/ how the 
other TET members- TET1 and TET3 regulate hydroxylation of 5mC in the brain under 
normal physiological and chronically hypoperfused conditions (Chapter 5, sections 5.4.5., 
5.4.6.3.). Future experimental work should investigate the catalysis of hydroxymethylation 
in the brain. If, as shown in stem, cancer cells and the early mammalian embryo (Tahiliani 
et al., 2009; Ito et al., 2010; Ko et al., 2010; Ficz et al., 2011; Ruzov et al., 2011), TETs 
participate in this molecular pathway, then one could modulate 5hmC in the brain via 
modulation of TETs activity. Methodologically, this could be achieved by comparing the 
effects of exogenously administered pharmacological agents (TETs inhibitors/ agonists) 
and/ or infusion of synthetic TETs (one or a combinations of these proteins) in the brains 
of hypoperfused mice and compare the effects of this experimental intervention with 
saline treatment on 5hmC, neuropathology and functional outcome (other strategies to 
study TETs in the brain are discussed in Chapter 5 section 5.4.6.3.). 
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6.1.4.4. Alternative therapeutic interventions 
There is evidence that alternative compounds could be neuroprotective and promote 
functional recovery following hypoperfusion in clinical and preclinical settings. For 
instance, Choto-san, a Kampo (traditional medicine of Japan) formula was shown to 
improve cognitive impairment in stroke patients and spatial learning deficits in chronically 
hypoperfused rats via stimulation of muscarinic receptor M1 (Terasawa et al., 1997; 
Murakami et al., 2005). High fish consumption (a source of long chain n- 3 
polyunsaturated fatty acids) has been associated with a reduced risk of cognitive decline in 
elderly people (Kalmijn et al., 1997; Terano et al., 1999). In hypoperfused rats n- 3 
polyunsaturated fatty acids supplemented diet compared with three other diets (i.c. normal 
chow) improved behavioural performance on a water maze paradigm and better preserved 
blood brain barrier integrity via decreases in the number of endothelial mitochondria, as 
well as the ratio of microvessels with degenerative pericytes (de Wilde et al., 2002).  
These alternative therapeutic strategies are interesting to explore in chronically 
hypoperfused mice especially in regards to their relatively easy adaptation to humans. 
6.1.4.5. Cellular therapies 
In principle stem cells constitute a promising resource for the development of allogeneic 
cellular therapies for incurable diseases characterized by the loss of one or more cell type 
owing to their broad capacity for growth and to be specified into functional derivatives. In 
practice, this potential has already been demonstrated in animal models of 
neuropathological conditions, such as spinal cord injury, stroke, periventricular 
leukomlalacia and many others (Lindvall et al., 2004; Keirstead et al., 2005; England et 
al., 2009; Titomanlio et al., 2011; Abe et al., 2012).  However, the broad clinical 
application of exogenous stem- cells based therapies is still restricted in Europe and North 
America due to safety (e.g. tumorigenesis), ethical (e.g. human embryonic stem cells) and 
regulatory issues. Furthermore, there are important considerations concerning 1) the type 
of the cellular implant (e.g. embryonic/ fetal/ adult/ induced stem cells, in vitro 
predifferentiated, nondifferentiated progenitors), 2) the time for the intervention  (e.g. 
early or late post- injury time point), 3) the route of administration (e.g. venously vs. 
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intracerebrally), 4) the location (e.g. near vs. far from the lesion- this is particularly 
challenging in the case of widespread pathologies such as multiple sclerosis), 5) the 
promotion of the graft survival especially under pathological conditions, 6) the time when 
a certain outcome should be expected (e.g. neuroregeneraion, functional recovery). 
An interesting alternative to allogenic cellular therapies for neuropathological conditions 
may reside in the stimulation of the endogenous neural stem cell pool in the brain 
promoting neuroregeneration and functional recovery (Lie et al., 2004). This could be 
achieved by exogenous administration of substances (e.g. growth factors- BDNF, EGF, 
PDGF) known to play a role in neural stem cells proliferation, survival and differentiation 
during neurodevelopment and under pathological conditions (Picard- Riera et al., 2004; 
Calza et al., 2010; Guerra- Crespo et al., 2012) 
The present thesis as well as a recently published work by Reimer et al., 2011 suggest 
significant increases in OPC in white matter areas of hypoperfused mice- an indicative of 
active cellular proliferation in this animal model. However, neuropathology and cognitive 
deficits occur in hypoperfused mice suggesting that the endogenous brain repair 
mechanisms are insufficient to prevent brain injury and promote functional recovery (e.g. 
working memory impairment).  
In the future, it would be interesting to examine the effects of exogenous stimulation of 
neural repair in this animal model by infusion of compounds stimulating the endogenous 
neural stem cell pool or by implantation of exogenous progenitors.  
However, there are important considerations to take into account before developing a 
cellular therapy in chronically hypoperfused mice. 
Specifically, the first challenge resides in the chronic nature of the model raising questions 
as to when to intervene (e.g. immediately after the microcoils surgery or at later post- 
surgery time points). To determine the most beneficial time point for the application of 
cellular therapy in chronically hypoperfused mice, an initial strategy might involve the 
comparison of the therapeutic efficacy (e.g. brain repair, functional recovery) at different 
time- points following microcoils implication. Second, the pathology in this animal model 
is widespread affecting both white and grey matter areas. This raises questions as to what 
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type of progenitors to administer/ what type of substances to infuse. An administration of 
nondifferentiate neural progenitors might be a better strategy than application of pre- 
differentitated oligodendrocytes/ neurons. Further, the alternative pharmacological 
simulation of progenitors would require a cocktail of substances promoting differentiation 
towards multiple neural lineages. In addition, the widespread nature of the observed 
pathology in this animal model might constitute a problem as to the location of the 
implant/ infusion of substances. In regards to the literature in this case, the lateral 
ventricles are in general the preferred location for exogenous cellular application/ 
pharmacological intervention (Lindvall et al., 2004). Third, under chronically 
hypoperfused conditions there are increases in inflammation, oxidative species and 
excicotoxicity which might compromise the survival of the cellular implant or counteract 
the effects of the applied substances. This could be overcome by treating chronically 
hypoperfused mice with anti- inflammatory, anti- oxidative and/ or anti- excitotoxic 
agents prior to any other intervention (e.g. cellular graph/ pharmacological stimulation of 
endogenous stem cells). However, blocking these molecular processes, might impact on 
the proliferation capacity of both exogenously applied and endogenous progenitor cells as 
inflammatory, oxidative and neutrotransmitter signals have been shown to regulate neural 
migration and differentiation during neurodevelopment as well as in the presence of 
pathology. 
Fourth, there are inter- individual differences in the observed pathological profile in 
chronically hypoperfused mice. For this type of heterogenous pathology, it is particularly 
challenging to develop universal cellular therapies and a patient- specific approach might 
be more appropriate. 
Therefore, although promising, cellular therapies might be difficult to optimize and apply 
in this animal model as well as in human patients with chronic cerebral hypoperfusion at 
least in the near future. 
6.1.5. Future application of the microcoils surgery on genetically modified mice 
One of the major advantages of the new mouse model of chronic cerebral hypoperfusion 
compared with the alternative rat and gerbil models consists of the potential application of 
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the microcoils surgery on genetically modified animals allowing to address in pre- clinical 
settings the individual and combined effects of cerebrovasculr (e.g. chronic cerebral 
hypoperfusion) and molecular (e.g. APOE) factors on neuropathology and functional 
outcome. 
There is increasing evidence suggesting the presence of cerebrovascular pathology in 
Alzheimer`s dementia (Iadecola, 2010). The neurovascular hypothesis of Alzheimer`s 
disease (Zlokovic, 2005; Roman and Kalaria, 2006; Bell and Zlokovic, 2009) suggests that 
faulty clearance of Aβ across the blood brain barrier, aberrant angiogenesis and 
senescence of the cerebrovascular system could initiate neurovascular uncoupling, vessel 
regression, brain hypoperfusion and neurovascular inflammation. Ultimately, this would 
lead to blood brain barrier disruption accompanied by chemical imbalance in the neuronal 
environment and to synaptic and neuronal dysfunction, injury and loss.  
A few groups have recently applied the microcoils surgery on APP transgenic mice to 
address the role of cerebral hypoperfusion in familial Alzheimer`s dementia. Kitaguchi et 
al., 2009 demonstrated that chronic cerebral hypoperfusion accelerates the deposition of 
Aβ in APP transgenic mice bearing both the Swedish and Indiana familial human APP 
mutations. In these mice, Yamada et al., 2011 showed that the microcoils surgery impairs 
performance on a Barnes maze and is associated with impaired Aβ metabolism. Taken 
together these animal findings suggest that chronic cerebral hypoperfusion might 
accelerate the development of familial Alzheimer`s disease in humans. However, future 
research is required to further characterize the molecular and cellular pathways leading to 
the observed neuropathology and functional impairment in this animal model of dementia. 
As previously discussed in this thesis, human APOE allelic polymorphism is the major 
known genetic risk factor for the occurrence of age- related neurodegeneration, 
cerebrovascular pathology and cognitive impairment (Saunders et al., 1993; Kalmijn et al., 
1996; Skoog et al., 1998; Reiman et al., 1996; Reiman et al., 2004; Schuff et al., 2009b; 
Nicoll et al., 1995; Gromadzka et al., 2007; Wagle et al., 2009). The present thesis 
partially addressed APOE effects on neuropathology following chronic cerebral 
hypoperfusion in mice (Chapter 4). However, in order to better approach the human 
condition, future research should focus on comparing the effects of human APOE3 and 
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APOE4 isoforms on neuropathology and functional outcome under normal physiological 
and chronically hypoperfused conditions in transgenic mice (Sheng et al., 1998; Buttini et 
al., 1999; Buttini et al., 2000; Fryer et al., 2005). Based on previous reports, the initial 
expectations are that the presence of the human APOE4 allele would be associated with 
the development of more severe neuropathology and cognitive deficits in hypoperfused 
mice (Sheng et al., 1998; Buttini et al., 2000; Fryer et al., 2005).  
Further, cerebral blood flow reductions and white matter pathology are also evident in 
other non age- related neurodegenerative and psychiatric disorders (e.g. Huntington` s 
disease, schizophrenia) (Goldberg et al., 1990; Lim et al., 1999; Rosas et al., 2006) and the 
microcoils surgery could be applied on existing mouse models of these conditions in order 
to examine the effects of hypoperfusion on neuropathology and functional outcome. 
6.2. Summary 
The present thesis provided a behavioural, neuropathological, genetic and epigenetic 
characterization of a new mouse model of chronic cerebral hypoperfusion opening novel 
directions for future experimental work leading to the potential development of 
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S.3.1. Additional behavioural analysis from the radial arm maze study presented in 
the main thesis body 
 
S.3.1.1. Chronic cerebral hypoperfusion does not affect the visual abilities in mice 
 
As previous pilot studies from our group had demonstrated the occurrence of axonal and 
myelin damage to the optic tract following hypoperfusion in mice, in the present radial 
arm maze experiment, the visual abilities of sham and hypoperfused animals trained on 
the radial arm maze spatial working memory task were tested by means of an optokinetic 
drum (Thaung et al., 2002) at three different time points (Chapter 2 section 2.3.1.):  
 
1) 3 days prior to surgery (control baseline level),  
2) 6 days before the behavioural testing (24 days after surgery),  
3) at the end of the behavioural testing (50 days after surgery).  
 
On the pre- surgery screening session (3 days prior to surgery), only 10% (1/10) of the 
initially included sham and 20% (4/20) of the initially included hypoperfused animals did 
not show a visual response to the first visual stimulation, but responded to the second 
visual stimulation. On the first post- surgery testing session (24 days after surgery), only 
16.7% (2/15) of the hypoperfused animals did not respond to the first visual stimulation, 
but showed a visual response on the second trial. All sham animals (10/10) showed a 
visual response on the first stimulation trial. At the end of the behavioural testing (50 days 
after surgery), 20% (2/10) of the hypoperfused mice did not respond to the first, but 
showed a visual response to the second visual stimulation. All sham mice (10/10) showed 
a visual response to the first stimulation (figure S.3.1.1.). 
The results from this visual test subsequently helped to clarify whether the spatial working 
memory impairment observed in chronically hypoperfused mice was due to actual 
neuroanatomical changes or alternatively, to a visual deficit following hypoperfusion- 







Figure S.3.1.1.: Visual abilities of sham and hypoperfused mice 
The visual abilities of sham and chronically hypoperfused mice included in the 
radial arm maze study were tested at three different time points. Although 
chronic cerebral hypoperfusion induced a significant white matter pathology in 
the OT of hypoperfused mice, this did not impact on their visual abilities as 
demonstrated by an intact head movement response to a visual stimulation 24 




Figure S.3.1.2.: Physiological status of sham and hypoperfused mice 
In the radial arm maze study, from the initially included hypoperfused animals 25% 
were procedure terminated (dead or culled) due to a poor post- surgery recovery,  25% 
exhibited seizure- like activity, 50% recovered well (healthy) from surgery (A).  
In the water maze, from the initially included hypoperfused animals 22.8.% were 
procedure terminated (dead or culled), 0.07% showed seizure- like activity and 77.8% 
recovered  well (healthy) from surgery (B).   
Sham animals from both studies showed a good post- surgery recovery (A, B). 
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S.3.1.2. Chronic cerebral hypoperfusion leads to significant spatial working memory 
impairment on a radial arm maze paradigm 
 
S.3.1.2.1. Results: total number of arm entries and trial duration 
Two- way repeated measures ANOVA showed that hypoperfused animals (n=10) entered 
in total significantly more arms (F(1, 18)= 26.535, p<0.0001) and completed the task for a 
significantly longer time (trial duration) (F(1, 18)= 11.682, p= 0.003) than sham mice (n= 
10) (figure S.3.1. A, B). There was a significant effect of the training day for both the total 
number of arm entries (F(1,18)=  115.724, p<0.0001) and the trial duration (F(1,18)=  49. 189, 
p<0.0001). An absence of a significant training day x group interaction was evidenced for 
all behavioural measures: the total number of arm entries (F(1,18)=  0.184, p=0.673) and the 
trial duration (F(1,18)=  3. 828, p= 0.660). The Tukey`s post- hoc analysis demonstrated that 
hypoperfused mice entered significantly more arms in total on training day 2 (p=0.001), 
day 5 (p= 0.0013), day 6 (p=0.010), day 7 (p= 0.003), and day 8 (p=0.031). Significant 
group differences in the trial duration were observed for training day 2 (p=0.028), day 6 































Figure S.3.1.3.: Group performance on a spatial working memory radial arm 
maze task 
(group mean ± SE) 
Spatial working memory was significantly impaired in hypoperfused mice. Two- way 
repeated measures ANOVA demonstrated that chronically hypoperfused mice (n=10) 
visited significantly more arms in total (A) and completed the task for a significantly 
longer time (B) than sham mice (n=10) (p<0.05).  




S.3.2. Replica of the radial arm maze study (not presented in the main thesis body) 
S.3.2.1 Materials and methods 
S.3.2.1.1. Animals and surgery 
Three months old C57Bl6/J male mice weighting 25±5gr (Chapter 2, section 2.1.1.; 
Coltman et al., 2011) were used for the replica of the radial arm maze experiment 
presented in Chapter 3. The animals were randomly allocated to a sham (n=17) and 
microcoils (n= 24) surgery performed as described in Chapter 2, section 2.2. All mice 
were subjected to a food deprivation procedure in order to reduce their body weight to 85-
90% from their original one. Only the animals surviving the whole experimental period 
were included in the final behavioural and pathological analysis.  
S.3.2.1.2. Behavioural testing 
Spatial working memory was tested one month after surgery using a radial arm maze 
paradigm (Chapter 2, section 2.3.2.; Shibata et al., 2007; Nishio et al., 2010; Coltman et 
al., 2011). At the completion of the behavioural procedure (~2 months post- surgery) the 
animals were perfusion- fixed (Chapter 2, section 2.4.) and their brains were processed for 
histology and immunohistochemistry (Chapter 2, section 2.5.). 
S.3.2.1.3. Pathological assessment 
The pathological assessment of grey and white matter integrity for this behavioural study 
was performed by Dr Karen Horsburgh and therefore the pathological results are not 
presented in this thesis. The pathological analysis is reported in Coltman et al., 2011. 
S.3.2.1.4. Statistical analysis of the behavioral performance  
The statistical comparisons were performed on the average of two blocked trials 
representing the average performance of the animals on two consecutive days of training 
for each behavioural measure (Shibata et al., 2007; Nishio et al., 2010; Coltman et al., 
2011). 
For the replica of the radial arm maze experiment only the behavioural performance of 
hypoperfused animals with white matter pathology (without neuronal ischemic injury at 
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least at the examined neuroanatomical levels) (n= 7) was statistically compared to the 
performance of sham animals (n= 17). Group comparisons were performed using a two- 
way repeated measures ANOVA as described for the first radial arm maze experiment 
(Chapter 3, section  3.2.4.2.1.).  When significant main effects of trial block of group x 
block interactions (p<0.05) were indicated by ANOVA, a Tukey`s post- hoc analysis was 
applied to determine the exact training day(s) when significant group differences in the 
behavioural performance between sham and hypoperfused mice occurred.  
Significant group differences were reported for p values (p<0.05).  
S.3.2.2. Results 
S.3.2.2.1. Post- surgery recovery and physiological status of the animals 
In the replica radial arm maze experiment 0.04% (1/24) of the hypoperfused mice died 
soon after surgery and 20.0% (5/24) of the hypoperfused mice showed a moderate seizure- 
like activity during the behavioural testing. The remaining 18 hypoperfused mice (79.0%) 
and all sham animals (n= 17) recovered well after surgery in the absence of any overt 





























Figure S.3.2.1.: Physiological status of sham and hypoperfused tested on a 
radial arm maze (replica) 
In the replica of the radial arm maze study, from the hypoperfused animals 
0.04% were procedure terminated due to a poor post- surgery recovery, 20%  
exhibited sezure- like activity, 75% recovered well  after surgery (healthy). All 
sham mice showed a good post- surgery recovery. 
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S.3.2.2.2. Chronic cerebral hypoperfusion leads to spatial working memory 
impairment in mice 
As the major focus of this experimental chapter was on the effects of hypoperfusion- 
induced white matter pathology on cognitive abilities of mice, the radial arm maze 
experiment was conducted twice in order to increase the experimental numbers of 
hypoperfused animals with predominant white matter pathology. For this purpose, for the 
replica of the radial arm maze experiment only the performance of the hypoperfused 
animals with white matter pathology (n=7) was statistically compared to sham mice 
(n=17). The obtained results confirmed the data from the first radial arm maze experiment. 
Again, hypoperfused mice (n= 7) committed significantly more revisiting errors (F(1, 22)= 
8.057, p= 0.010), visited significantly fewer new arms in the first 8 arm entries (F(1, 22)= 
5.619, p= 0.027),  and they entered significantly more arms in total (F(1, 22)= 6.741, p= 
0.016) than sham mice (n= 17) (figure S.3.2.2. A, B, C). There were no significant group 
differences in the trial duration (F(1, 22)= 0.425, p= 0.521) (figure S.3.2.2. D). The post- hoc 
Tukey`s analysis demonstrated that hypoperfused mice committed significantly more 
revisiting errors on training day 6 (p=0.008), day 7 (p= 0.014) (figure S.3.2.2. A). They 
also visited significantly fewer novel arms in the first 8 arm choices on training day 7 
(p=0.017) (figure S.3.2.2. B). Hypoperfused mice entered significantly more arms in total 



























Figure S.3.2.2.:  Group performance on a spatial working memory radial arm maze 
task (replica) 
(group mean ± SE) 
Hypoperfused mice (n=7) committed significantly more revisiting errors, visited 
significantly fewer new arms in the first 8 arm choices and entered significantly more arms 
in total than sham animals (n=17) (p<0.05) (A, B, C). There was no significant group 
difference in the trial duration (p>0.05) (D). 
Significant group differences as given by the Tukey`s post- hoc analysis: ns (nonsignficant) 
(p>0.05), (p<0.05)*, (p<0.01)**, (p<0.0001)*** 
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S.3.3. Additional behavioural data from the water maze experiment presented in the 
main thesis body 
 
S.3.3.1. Chronic cerebral hypoperfusion does not impact on a cue task performance 
Since mice are not natural swimmers, their ability to swim and perform a water maze task 
was tested a day prior to surgery as well as four days before the start of the serial spatial 
learning and memory task (three weeks after surgery) using a cue task water maze 
protocol (Chapter 2, section 2.3.3.2.1.). The behavioural performance on this task relies on 
the ability of mice to remember the spatial association between a hidden escape platform 
and a landmark cue in the absence of extramaze cues. It also requires intact visual abilities 
allowing the animals to perceive the landmark indicating the spatial location of the hidden 
platform.  
In the present experiment, the cue task performance prior to surgery allowed to exclude 
mice exhibiting floating behavior from the subsequent surgical procedure and behavioural 
testing. The statistical analysis for the pre- surgery data (training day 1) was performed 
using an unpaired t- test comparing the group mean escape latency to platform. The 
statistical analysis for the post- surgery data (training day 2- 5) was analyzed using two- 
way repeated measures ANOVA comparing the group mean escape latency to platform 
overtime (Chen et al., 2000, Coltman et al., 2011). Significant differences were reported 
for p<0.05. 
The analysis showed that prior to the surgical procedure (baseline level), there was no 
significant difference in the ability of hypoperfused (n=10) and sham (n= 11) mice to 
perform the cue task (t= 0.689, p= 0.49). Similarly, the statistical analysis of the post-
surgery performance on the same water maze task demonstrated an absence of significant 





























Figure S.3.3.: Cue task performance on a water maze paradigm 
(group mean ± SE) 
Chronically hypoperfused mice (n=10) performed as well as sham 
animals (n=11) on a cue task water maze paradigm both prior to and 3 
weeks after surgery (ns, p>0.05). 
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Behavioural measure
Percentage of time spent 
swimming in training quadrant
Swimming speed
Percentage of time spent
swimming near the walls
(thigmotaxis)
Number of platform crossings
Latency to platform
F(1, 18)= 1.183, p= 0.29
F(1, 18)= 0.064, p= 0.80 F(1, 18)= 0.266, p= 0.61
F(1, 18)= 0.437, p= 0.52
Group statistics
PT 10min PT3h
F(1, 18)= 0.018, p= 0.89 F(1, 18)= 0.151, p= 0.70
F(1, 18)= 2.021, p= 0.17 F(1, 18)= 3.056, p= 0.09
F(1, 18)= 2.787, p= 0.11

















Table S.3.1.: Short and long term memory recall in sham and hypoperfused mice: 
additional group statistical analysis 
There were no significant group differences in the behavioural performance on the short 
(10min) and long (3h) term PTs on all five tasks as shown by two- way ANOVA for the 
average  percentage of time spent swimming in the training quadrant during the first 60 
sec of each PT, the average swimming speed,  the average percentage of time  spent 
swimming near the walls of the pool, the average number of platform crossing during the 
first 60sec of each PT and the average  latency to platform (p>0.05). 
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Animal Group
number Corpus External Internal Optic Fimbria Hippocampus Cortex
callosum capsule capsule tract fornix
1 sham 0 0 0 0 0 0 0
4 sham 0 0 0 0 0 0 0
7 sham 0 0 0 0 0 0 0
9 sham 0 0 0 0 0 0 0
11 sham 0 0 0 0 0 0 0
13 sham 0 0 0 0 0 0 0
15 sham 0 0 0 0 0 0 0
18 sham 0 0 0 0 0 0 0
20 sham 0 0 0 0 0 0 0
22 sham 0 0 0 0 0 0 0
2 hypo 1 1 1 3 3 3 0
3 hypo 3 3 3 3 1 3 3
6 hypo 0 1 0 3 1 2 2
8 hypo 0 0 0 0 0 0 0
10 hypo 0 0 0 0 0 3 0
12 hypo 1 1 3 3 1 1 2
14 hypo 2 1 2 3 0 0 0
16 hypo 1 1 3 3 3 1 2
17 hypo 1 2 3 2 1 1 2








Table S.3.2.1.: Individual regional pathological grades of axonal (APP) integrity of 
sham and hypoperfused mice tested on a radial arm maze paradigm 
The animal numbers are the coded experimental numbers used to identify blindly to 
their treatment the animals during the behavioural and pathological evaluation. In red 
are indicated the hypoperfused animals without neuronal ischemic injury at the 
examined brain levels (8, 12, 16). In black are presented all the other animals. 
313 
Animal Group
number Corpus External Internal Optic Fimbria Hippocampus Cortex
callosum capsule capsule tract fornix
800727 sham 0 0 0 0 0 0 0
800729 sham 0 0 0 0 0 0 0
800732 sham 0 0 0 0 0 0 0
800739 sham 0 0 0 0 0 0 0
800743 sham 0 0 0 0 0 0 0
800744 sham 0 0 0 0 0 0 0
800747 sham 0 0 0 0 0 0 0
800752 sham 0 0 0 0 0 0 0
800758 sham 0 0 0 0 0 0 0
800759 sham 0 0 0 0 0 0 0
800760 sham 0 0 0 0 0 0 0
800726 hypo 0 0 0 1 0 0 0
800728 hypo 0 0 0 0 0 0 1
800733 hypo 0 0 0 0 0 1 0
800738 hypo 0 0 0 0 0 1 1
800746 hypo 0 0 0 1 0 0 0
800749 hypo 0 0 0 0 0 1 0
800753 hypo 0 0 0 2 0 0 0
800754 hypo 0 0 0 1 0 0 0
800755 hypo 0 0 0 0 0 0 0




Table S.3.2.2.: Individual regional pathological grades of axonal (APP) integrity 
of sham and hypoperfused mice tested on a water maze paradigm 
The animal numbers are the coded experimental numbers used to identify blindly to 
their treatment the animals during the behavioural and pathological evaluation. All 
hypoperfused animals included in final data analysis of the water arm maze study 
presented white matter pathology in the absence of grey matter abnormalities (at least 




number Corpus External Internal Optic Fimbria
callosum capsule capsule tract fornix
1 sham 0 0 0 0 0
4 sham 0 0 0 0 0
7 sham 0 0 0 0 0
9 sham 0 0 0 0 0
11 sham 0 0 0 0 0
13 sham 0 0 0 0 0
15 sham 0 0 0 0 0
18 sham 0 0 0 0 0
20 sham 0 0 0 0 0
22 sham 0 0 0 0 0
2 hypo 1 1 1 3 3
3 hypo 1 0 1 3 3
6 hypo 0 0 2 3 2
8 hypo 0 0 0 3 1
10 hypo 1 1 2 0 1
12 hypo 0 0 2 0 2
14 hypo 1 1 2 3 1
16 hypo 1 1 3 3 0
17 hypo 1 1 2 3 3




Table S.3.2.3.: Individual regional pathological grades of myelin (MAG) integrity 
of sham and hypoperfused mice tested on a radial arm maze paradigm 
The animal numbers are the coded experimental numbers used to identify blindly to 
their treatment the animals during the behavioural and pathological evaluation. In red 
are indicated the hypoperfused animals without neuronal ischemic injury at the 




number Corpus External Internal Optic Fimbria
callosum capsule capsule tract fornix
800727 sham 0 0 0 0 0
800729 sham 0 0 0 0 0
800732 sham 0 0 0 0 0
800739 sham 0 0 0 0 0
800743 sham 0 0 0 0 0
800744 sham 0 0 0 0 0
800747 sham 0 0 0 0 0
800752 sham 0 0 0 0 0
800758 sham 0 0 0 0 0
800759 sham 0 0 0 0 0
800760 sham 0 0 0 0 0
800726 hypo 1 1 2 3 0
800728 hypo 0 0 1 3 0
800733 hypo 0 0 1 1 0
800738 hypo 1 1 1 3 1
800746 hypo 1 1 1 3 1
800749 hypo 1 1 1 3 0
800753 hypo 0 0 1 3 0
800754 hypo 0 1 2 3 1
800755 hypo 1 1 1 3 1
800757 hypo 0 0 0 3 0
Region of interest 
  
Table S.3.2.4.: Individual regional pathological grades of myelin (MAG) 
integrity of sham and hypoperfused mice tested on a water maze paradigm 
The animal numbers are the coded experimental numbers used to identify blindly to 
their treatment the animals during the behavioural and pathological evaluation. All 
hypoperfused animals included in final data analysis of the water arm maze study 
presented white matter pathology in the absence of grey matter abnormalities (at 




number Corpus External Internal Optic Fimbria Hippocampus Cortex
callosum capsule capsule tract fornix
1 sham 0 0 0 0 0 0 0
4 sham 0 0 0 0 0 0 0
7 sham 0 0 0 0 0 0 0
9 sham 0 0 0 0 0 0 0
11 sham 0 0 0 0 0 0 0
13 sham 0 0 0 0 0 0 0
15 sham 0 0 0 0 0 0 0
18 sham 0 0 0 0 0 0 0
20 sham 0 0 0 0 0 0 0
22 sham 0 0 0 0 0 0 0
2 hypo 0 1 2 3 3 3 2
3 hypo 3 3 3 3 1 3 3
6 hypo 0 1 1 2 1 0 1
8 hypo 1 1 0 2 1 0 0
10 hypo 0 0 0 0 1 0 0
12 hypo 0 0 0 0 0 1 2
14 hypo 1 1 2 3 1 0 1
16 hypo 0 0 0 0 0 0 0
17 hypo 0 0 0 0 0 0 0




Table S.3.2.5.: Individual regional pathological grades of inflammation (Iba1) of 
sham and hypoperfused mice tested on a radial arm maze paradigm 
The animal numbers are the coded experimental numbers used to identify blindly to 
their treatment the animals during the behavioural and pathological evaluation. In red 
are indicated the hypoperfused animals without neuronal ischemic injury at the 




number Corpus External Internal Optic Fimbria Hippocampus Cortex
callosum capsule capsule tract fornix
800727 sham 0 0 0 0 0 0 0
800729 sham 0 0 0 0 0 0 0
800732 sham 0 0 0 0 0 0 0
800739 sham 0 0 0 0 0 0 0
800743 sham 0 0 0 0 0 0 0
800744 sham 0 0 0 0 0 0 0
800747 sham 0 0 0 0 0 0 0
800752 sham 0 0 0 0 0 0 0
800758 sham 0 0 0 0 0 0 0
800759 sham 0 0 0 0 0 0 0
800760 sham 0 0 0 0 0 0 0
800726 hypo 0 1 1 3 0 0 0
800728 hypo 0 0 1 3 1 0 0
800733 hypo 0 0 0 0 0 0 0
800738 hypo 0 0 1 2 0 0 0
800746 hypo 0 1 2 2 0 0 0
800749 hypo 0 0 2 3 1 0 0
800753 hypo 0 1 2 3 1 0 0
800754 hypo 0 1 1 2 1 0 0
800755 hypo 1 3 3 3 1 0 1




Table S.3.2.6.: Individual regional pathological grades of inflammation (Iba1) of 
sham and hypoperfused mice tested on a water maze paradigm 
The animal numbers are the coded experimental numbers used to identify blindly to 
their treatment the animals during the behavioural and pathological evaluation. All 
hypoperfused animals included in final data analysis of the water arm maze study 
presented white matter pathology in the absence of grey matter abnormalities (at least 





Figure S.3.4.1. A-E: White matter regional group median pathological grades of axonal 
integrity (the radial arm maze experiment) 
Hypoperfused mice (n=10) showed a significantly impaired axonal integrity in all examined  
white matter ROIs when compared  with sham animals (n=10) (p<0.05) (A-E). In red are 
indicated hypoperfused mice with without neuronal ischemic injury (at least at the examined 
brain levels). 
Significant group differences as given by Mann- Whitney nonparametric statistics: 




Figure S.3.4.1. F-G: Grey matter regional group median pathological grades of axonal 
integrity (the radial arm maze experiment) 
Hypoperfused mice (n=10) showed a significantly impaired axonal integrity in all grey 
matter ROIs when compared with sham animals (n=10) (p<0.05) (F, G). In red are 
indicated hypoperfused mice with without neuronal ischemic injury (at least at the 
examined brain levels). 






Figure S.3.4.2. A-E: White matter regional group median pathological grades of 
axonal integrity (the water maze experiment) 
Hypoperfused mice (n=10) showed a significantly impaired axonal integrity in the OT (D) 
(p<0.05), but not in the rest of the examined ROIs (A-C, E) (p>0.05) when compared with 
sham animals (n=11). All hypoperfused mice tested on the water maze paradigm did not 
exhibit grey matter ischemic injury (at least at the examined brain levels). 
Significant group differences as given by Mann- Whitney nonparametric statistics: 




Figure S.3.4.2. F-G: Grey matter regional group median pathological grades of axonal 
integrity (the water maze experiment) 
Hypoperfused mice (n=10) showed a significantly impaired axonal integrity in the 
hippocampus (F), but not in the Cx (G) when compared with sham animals (n=11) (p<0.05). 
All hypoperfused mice tested on the water maze paradigm did not exhibit grey matter 
ischemic injury (at least at the examined brain levels). 
Significant group differences as given by Mann- Whitney nonparametric statistics: 





Figure S.3.4.3.:  Regional group median pathological grades of myelin integrity 
(the radial arm maze experiment) 
Hypoperfused mice (n=10) exhibited a significant myelin pathology in all examined white 
matter ROIs when compared  with sham animals (n=10) (p<0.05) (A-E). In red are indicated 
hypoperfused mice with without neuronal ischemic injury (at least at the examined brain 
levels). 
Significant group differences as given by Mann- Whitney nonparametric statistics: 





Figure S.3.4.4.A-E: Regional group median pathological grades of myelin integrity 
(the water maze experiment) 
Hypoperfused mice (n=10) showed a significantly impaired myelin integrity in all examine 
white matter ROIs when compared with sham animals (n=11) (p<0.05). All hypoperfused 
mice tested on the water maze paradigm did not exhibit grey matter ischemic injury (at least 
at the examined brain levels). 







Figure S.3.4.5. A-E: White matter regional group median pathological grades of 
axonal integrity (the radial arm maze experiment) 
Hypoperfused mice (n=10) showed a significantly increased inflammation in all examined  
white matter ROIs when compared  with sham animals (n=10) (p<0.05) (A-E). In red are 
indicated hypoperfused mice with without neuronal ischemic injury (at least at the 
examined brain levels). 
Significant group differences as given by Mann- Whitney nonparametric statistics: 




Figure S.3.4.5. F-G: Grey matter regional group median pathological grades of 
inflammation (the radial arm maze experiment) 
Hypoperfused mice (n=10) showed a significantly increased inflammation in grey 
matter ROIs when compared with sham animals (n=10) (p<0.05) (F-G). In red are 
indicated hypoperfused mice with without neuronal ischemic injury (at least at the 
examined brain levels). 






Figure S.3.4.6. A-E: White matter regional group median pathological grades of 
inflammation (the water maze experiment) 
Hypoperfused mice (n=10) showed a significantly increased inflammation in white 
matter tracts (B-E) (p<0.05) except in the CC (A) (p>0.05) when compared with sham 
animals (n=11). All hypoperfused mice tested on the water maze paradigm did not 
exhibit grey matter ischemic injury (at least at the examined brain levels). 
Significant group differences as given by Mann- Whitney nonparametric statistics: 



















Figure S.3.4.6. F-G: Grey matter regional group median pathological grades of 
inflammation (the water maze experiment) 
Hypoperfused mice (n=10) did not show significantly increased inflammation when 
compared with sham animals (n=11) in any of the examined grey matter ROIs (F-G) 
(p>0.05). All hypoperfused mice tested on the water maze paradigm did not exhibit 
grey matter ischemic injury (at least at the examined brain levels). 
Significant group differences as given by Mann- Whitney nonparametric statistics: 






1 sham 0 0 0
4 sham 0 0 0
7 sham 0 0 0
9 sham 0 0 0
11 sham 0 0 0
13 sham 0 0 0
15 sham 0 0 0
18 sham 0 0 0
20 sham 0 0 0
22 sham 0 0 0
2 hypo 9 9 9
3 hypo 13 8 13
6 hypo 5 7 5
8 hypo 0 4 5
10 hypo 0 5 1
12 hypo 9 4 0
14 hypo 8 8 8
16 hypo 11 8 0
17 hypo 9 10 0
19 hypo 7 6 15


























Table S.3.3.1.: Total individual pathological scores across white matter ROIs of 
sham and hypoperfused mice tested on a radial arm maze paradigm 
The total pathological scores of axonal (APP), myelin (MAG) integrity, inflammation 
(Iba1) were calculated as described in Chapter 2, section 2.7.4., Coltman et al., 2011, 
Holland et al., 2011. 
The animal numbers are the coded experimental numbers used to identify blindly to 
their treatment the animals during the behavioural and pathological evaluation. In red 
are indicated the hypoperfused animals without neuronal ischemic injury at the 






800727 sham 0 0 0
800729 sham 0 0 0
800732 sham 0 0 0
800739 sham 0 0 0
800743 sham 0 0 0
800744 sham 0 0 0
800747 sham 0 0 0
800752 sham 0 0 0
800758 sham 0 0 0
800759 sham 0 0 0
800760 sham 0 0 0
800726 hypo 1 7 5
800728 hypo 0 4 5
800733 hypo 0 2 0
800738 hypo 0 7 3
800746 hypo 1 7 5
800749 hypo 0 6 6
800753 hypo 2 4 7
800754 hypo 1 7 5
800755 hypo 0 7 11
800757 hypo 2 3 4


























Table S.3.3.2.: Total individual pathological scores across white matter 
ROIs of sham and hypoperfused mice tested on a water maze paradigm 
The total pathological scores of axonal (APP), myelin (MAG) integrity, 
inflammation (Iba1) were calculated as described in Chapter 2, section 2.7.4., 
Coltman et al., 2011, Holland et al., 2011. 
The animal numbers are the coded experimental numbers used to identify 
blindly to their treatment the animals during the behavioural and pathological 
evaluation. All hypoperfused animals included in final data analysis of the 
water arm maze study presented white matter pathology in the absence of grey 




Experiment Biomarker Total group median Total group median Group statistics
pathological score across pathological score across (Mann- Whitney test)
examined white matter ROIs examined white matter ROIs
Sham (n=10) Hypoperfused (n=10)
Radial arm maze APP 0       8.5*** U= 10.000, p= 0.0007
MAG 0        7.5 *** U=0.000, p<0.0001
Iba1 0       5.0*** U= 15.000, p= 0.002
APP 0   0.5* U= 27.500, p= 0.01
Water maze MAG 0       6.5*** U=0.000, p<0.0001






















Table S.3.3.3.: Total group median pathological scores across white matter ROIs of sham 
and hypoperfused mice tested on a radial arm maze and water maze paradigm and group 
statistics 
Statistical group comparisons were performed using Mann- Whitney statistics as described in 
Chapter 3, section 3.2.3.2. 
Chronically hypoperfused mice tested on both a radial arm maze and water maze paradigm 
exhibited significantly more severe total axonal, myelin pathology and increased inflammation 
in white matter when compared with sham mice. 

























Corpus External Internal Optic Hippocampus
callosum capsule capsule tract
900835 WT sham 0 0 0 0 0
900837 WT sham 0 0 0 0 0
900838 WT sham 0 0 0 0 0
900843 WT sham 0 0 0 0 0
900844 WT sham 0 0 0 0 0
900845 WT sham 0 0 0 0 0
900846 WT sham 0 0 0 0 0
900849 WT sham 0 0 0 0 0
900832 WT hypo 0 0 0 0 0
900833 WT hypo 1 2 2 2 2
900834 WT hypo 0 1 0 2 0
900836 WT hypo 1 1 1 2 0
900839 WT hypo 1 1 2 2 2
900840 WT hypo 0 0 0 1 0
900841 WT hypo 1 0 1 2 1
900847 WT hypo 0 0 0 0 0
900848 WT hypo 0 0 0 0 0
900850 WT hypo 2 1 2 1 1
900869 APOEKO sham 0 0 0 0 0
900870 APOEKO sham 0 0 0 0 0
900875 APOEKO sham 0 0 0 0 0
900873 APOEKO sham 0 0 0 0 0
900874 APOEKO sham 0 0 0 0 0
900879 APOEKO sham 0 0 0 0 0
900880 APOEKO sham 0 0 0 0 0
900878 APOEKO sham 0 0 0 0 0
900871 APOEKO hypo 1 2 1 1 0
900872 APOEKO hypo 0 0 1 0 0
900877 APOEKO hypo 0 0 0 2 0
900881 APOEKO hypo 0 0 0 0 0
900882 APOEKO hypo 2 2 3 2 3
900885 APOEKO hypo 2 1 3 2 2
900883 APOEKO hypo 1 1 1 1 0






Table S.4.1.1.: Individual regional grades of axonal (APP) integrity in WT and 
APOKO sham and hypoperfused mice 
The animal numbers are the coded experimental numbers used to identify blindly to 
their treatment the animals during the pathological evaluation. Mouse number 




Corpus External Internal Optic
callosum capsule capsule tract
900835 WT sham 0 0 0 0
900837 WT sham 0 0 0 0
900838 WT sham 0 0 0 0
900843 WT sham 0 0 0 0
900844 WT sham 0 0 0 0
900845 WT sham 0 0 0 0
900846 WT sham 0 0 0 0
900849 WT sham 0 0 0 0
900832 WT hypo 2 2 2 2
900833 WT hypo 0 2 3 3
900834 WT hypo 0 0 0 1
900836 WT hypo 0 1 1 3
900839 WT hypo 0 1 2 3
900840 WT hypo 0 0 0 3
900841 WT hypo 0 0 1 3
900847 WT hypo 0 1 1 2
900848 WT hypo 0 0 2 2
900850 WT hypo 1 2 2 2
900869 APOEKO sham 0 0 0 0
900870 APOEKO sham 0 0 0 0
900875 APOEKO sham 0 0 0 0
900873 APOEKO sham 0 0 0 0
900874 APOEKO sham 0 0 0 0
900879 APOEKO sham 0 0 0 0
900880 APOEKO sham 0 0 0 0
900878 APOEKO sham 0 0 0 0
900871 APOEKO hypo 0 0 1 3
900872 APOEKO hypo 1 0 0 0
900877 APOEKO hypo 0 0 2 3
900881 APOEKO hypo 0 1 3 2
900882 APOEKO hypo 2 3 1 3
900885 APOEKO hypo 1 1 2 3
900883 APOEKO hypo 0 1 1 1






Table S.4.1.2.: Individual regional grades of myelin (MAG) integrity in WT and 
APOKO sham and hypoperfused mice 
The animal numbers are the coded experimental numbers used to identify blindly to 
their treatment the animals during the pathological evaluation. Mouse number 900840 




Corpus External Internal Optic Hippocampus
callosum capsule capsule tract
900835 WT sham 0 0 0 0 0
900837 WT sham 0 0 0 0 0
900838 WT sham 0 0 0 0 0
900843 WT sham 0 0 0 0 0
900844 WT sham 0 0 0 0 0
900845 WT sham 0 0 0 0 0
900846 WT sham 0 0 0 0 0
900849 WT sham 0 0 0 0 0
900832 WT hypo 1 1 1 0 0
900833 WT hypo 1 1 1 1 1
900834 WT hypo 0 0 0 0 0
900836 WT hypo 1 2 2 1 3
900839 WT hypo 2 2 1 0 1
900840 WT hypo 0 1 0 1 1
900841 WT hypo 0 0 1 0 3
900847 WT hypo 1 1 1 0 1
900848 WT hypo 0 1 0 0 1
900850 WT hypo 1 0 1 1 0
900869 APOEKO sham 0 0 0 0 0
900870 APOEKO sham 0 0 0 0 0
900875 APOEKO sham 0 0 0 0 0
900873 APOEKO sham 0 0 0 0 0
900874 APOEKO sham 0 0 0 0 0
900879 APOEKO sham 0 0 0 0 0
900880 APOEKO sham 0 0 0 0 0
900878 APOEKO sham 0 0 0 0 0
900871 APOEKO hypo 1 1 1 1 1
900872 APOEKO hypo 0 1 0 0 1
900877 APOEKO hypo 0 1 1 1 0
900881 APOEKO hypo 2 2 2 1 0
900882 APOEKO hypo 3 3 1 1 2
900885 APOEKO hypo 0 1 1 1 3
900883 APOEKO hypo 1 1 1 0 1






Table S.4.1.3.: Individual regional grades of myelin (dMBP) integrity in WT and 
APOKO sham and hypoperfused mice 
The animal numbers are the coded experimental numbers used to identify blindly to 
their treatment the animals during the pathological evaluation. Mouse number 900840 




Corpus External Internal Optic Hippocampus
callosum capsule capsule tract
900835 WT sham 0 0 0 0 0
900837 WT sham 0 0 0 0 0
900838 WT sham 0 0 0 0 0
900843 WT sham 0 0 0 0 0
900844 WT sham 0 0 0 0 0
900845 WT sham 0 0 0 0 0
900846 WT sham 0 0 0 0 0
900849 WT sham 0 0 0 0 0
900832 WT hypo 0 0 0 0 0
900833 WT hypo 2 3 3 3 3
900834 WT hypo 0 1 0 2 0
900836 WT hypo 1 2 2 3 2
900839 WT hypo 0 3 3 3 3
900840 WT hypo 2 2 2 3 2
900841 WT hypo 0 0 2 3 1
900847 WT hypo 0 0 1 0 0
900848 WT hypo 0 0 0 3 2
900850 WT hypo 2 3 3 2 3
900869 APOEKO sham 0 0 0 0 0
900870 APOEKO sham 0 0 0 0 0
900875 APOEKO sham 0 0 0 0 0
900873 APOEKO sham 0 0 0 0 0
900874 APOEKO sham 0 0 0 0 0
900879 APOEKO sham 0 0 0 0 0
900880 APOEKO sham 0 0 0 0 0
900878 APOEKO sham 0 0 0 0 0
900871 APOEKO hypo 1 0 3 3 3
900872 APOEKO hypo 3 2 3 2 2
900877 APOEKO hypo 0 0 0 3 0
900881 APOEKO hypo 0 0 0 0 0
900882 APOEKO hypo 3 3 3 3 3
900885 APOEKO hypo 1 3 2 3 3
900883 APOEKO hypo 1 1 1 3 1






Table S.4.1.4.: Individual regional grades of inflammation (Iba1) in WT and 
APOKO sham and hypoperfused mice 
The animal numbers are the coded experimental numbers used to identify blindly to 
their treatment the animals during the pathological evaluation. Mouse number 





















Figure S.4.1.: Physiological status of WT and APOE sham and hypoperfused mice 
WT (99.1%) and APOEKO (80%) hypoperfused mice showed a good post- surgery 
recovery (healthy) at the exception of 0.09% WT and 20% APOEKO hypoperfused 
mice that were procedure terminated due to a severe sickness. All sham animals from 
































































































































































Figure S.4.2.1.: Regional FA parameters 
(group mean ± SE) 
Significant group differences in FA were evidenced by two- way MANOVA in the CC, 
EC, IC, and OT (p<0.0001), but not in the hippocampus (p= 0.147) (A-E). These 
significant changes were significantly more pronounced in APOEKO hypoperfused mice 
when compared with WT hypoperfused counterparts in the CC, EC and IC (p<0.01) (A, B, 
C). There was an absence of significant differences in the regional FA values between WT 
and APOEKO sham animals in all examined ROIs (p>0.01) (A-E). Significant group 



































































































































































Figure S.4.2.2.: Regional MTR parameters 
(group mean ± SE) 
Significant group differences in MTR were evidenced by two- way MANOVA in the CC, 
EC, IC, OT and hippocampus (p<0.0001) (A-E). These significant changes were 
significantly more pronounced in APOEKO hypoperfused mice when compared with WT 
hypoperfused counterparts in the CC (p<0.01) (A, B, E). There was an absence of 
significant differences in the regional MTR values between WT and APOEKO sham 
animals in all examined ROIs (p>0.01) (A-E). Significant group differences as given by 






















p= 0.0023 p= 0.0006 
p= 0.0866 
Figure S.4.3.1.: Regional group median pathological grades of axonal integrity  
APOEKO hypoperfused mice (n=8) (p<0.05), but not WT hypoperfused mice (n=10)  
(p>0.05) developed significantly more severe axonal pathology than WT (n=8) and APOEKO 
(n=8) sham in the CC, EC, IC (A, B, C). In the OT both APOEKO and WT hypoperfused 
mice exhibited significant axonal injury compared with the two sham group (D) (p<0.05). In 
the hippocampus there was no significant group difference in axonal integrity (E) (p>0.05). 
There was no significant difference in axonal integrity between WT and APOEKO sham as 
well as between WT and APOEKO hypoperfused in any of the ROIs (p>0.05) (A-E). 
Significant group differences as given by Dunn multiple comparisons`s post- hoc analysis: 



















p=0.1118 p= 0.0069 
p< 0.0001 
p< 0.0001 
Figure S.4.3.2.:  Regional group median pathological grades of myelin integrity (MAG) 
Both WT (n= 10) and APOEKO (n=8) hypoperfused mice exhibited significantly impaired 
myelin integrity when compared with the two sham groups in the IC and OT (C, D) (p<0.05). 
In the CC, there was no significant difference in myelin integrity between the four groups (A) 
(p>0.05). In the EC, only WT hypoperfused mice (p<0.05), but not APOEKO hypoperfused 
mice (p>0.05) showed significantly impaired myelin integrity when compared with sham mice 
from both genotypes (B). There was no difference in myelin integrity between WT and 
APOEKO sham as well as between WT and APOEKO hypoperfused mice in any of the 
examined ROIs (p<0.05) (A-D). Significant group differences as given by Dunn multiple 

























Figure S.4.3.3.: Regional group median pathological grades of degraded myelin (dMBP) 
Hypoperfused mice from both genotypes exhibited significantly more degraded myelin in the 
EC, IC, and hippocampus than the two sham groups (B, C) (p<0.05). In the OT, only 
APOEKO hypoperfused group (n=8) (p<0.05), but not WT hypoperfused mice (n=10) 
(p>0.05) showed significantly more degraded myelin than the two sham groups. In the CC, 
there was no significant group difference in dMBP immunoreactivity (A) (p>0.05). There was 
no difference in myelin integrity between WT and APOEKO sham as well as between WT and 
APOEKO hypoperfused mice in any of the examined ROIs (A-E) (p>0.05). Significant group 
differences as given by Dunn multiple comparisons`s post- hoc analysis: (p<0.05)*, 
























Figure S.4.3.4.: Regional group median pathological grades of inflammation 
APOEKO (n=8) and WT (n=10) hypoperfused mice showed significantly increased 
inflammation in the EC, IC, OT, and hippocampus than the two sham groups (B-D, E) (p<0.05). 
In the CC, only APOEKO hypoperfused (p<0.05), but not WT hypoperfused (p>0.05) mice 
exhibited significantly increased inflammation than the two sham groups (A). There was no 
difference in inflammatory levels between WT and APOEKO sham as well as between WT and 
APOEKO hypoperfused mice in any of the examined ROIs (p>0.05) (A-E). Significant group 












Figure S.4.4.: Grey matter structural integrity on T2- weighted scans of WT and 
APOEKO sham and hypoperfused mice 
Grey matter structural integrity was examined on four consecutive T2- weighted scans 
corresponding to the following neuroanatomical levels:  0.74mm bregma (A1- A4), 0.38mm 
bregma (B1- B4), -0.94mm bregma (C1- C4), -2.12mm bregma (D1- D4). 
 An absence of overt grey matter abnormalities were observed in all experimental animals. 
343 
S.4.1. Correlation analysis between regional MRI metrics and pathological grades  
 
S.4.1.1. Statistics 
Non-parametric Spearman`s test was applied for the correlation analysis of the regional 
FA and MTR values and the regional median grades of white matter integrity (APP, 




White matter abnormalities related to chronic cerebral hypoperfusion and APOE genotype 
were revealed by using a combined ex vivo MRI and standard immunohistochemical 
approach. In order to verify the sensitivity of the developed ex vivo MRI technique to 
detect changes in white matter integrity in perfusion- fixed brain samples, the regional FA 
and MTR were correlated with the regional pathological grades of axonal (APP), myelin 
(MAG) integrity, degraded myelin (dMBP), and inflammation (Iba1). 
A significant negative correlation was evidenced between the regional FA and MTR 
parameters and the corresponding pathological grades of axonal (APP) and myelin 
(dMBP, MAG) integrity as well as with the grades of inflammatory activity (Iba1) for all 
white matter ROIs (p<0.05). In the control grey matter region- the hippocampus, FA did 
not correlate significantly with any of the biomarkers (p> 0.05). However, MTR showed a 
significant negative correlation with myelin (dMBP) integrity and inflammatory levels (p< 
0.05), but not with axonal pathology (p> 0.05). A summary of the correlation statistical 
analysis is provided in table S.4.2. This result suggests that a decrease in both FA and 
MTR correlates with an increase in the severity of the observed axonal damage, myelin 







parameter interest APP MAG dMBP Iba1
Axonal integrity Myelin integrity Degraded myelin Inflammation
FA Corpus callosum (CC) r= -0.4966, p= 0.0028 r= -0.4656, p= 0.0055 r= -0.4666,  p=0.0054 r= -0.5491, p= 0.0008 
External capsule (EC) r= -0.5169, p= 0.0017 r= -0.4635, p= 0.0058 r=-0.6219,  p< 0.0001 r= -0.4815, p= 0.0039 
Internal capsule (IC) r= -0.7016, p< 0.0001 r= -0.7488, p< 0.0001 r= -0.7477, p< 0.0001 r= -0.6817, p< 0.0001
Optic tract (OT) r= -0.6290, p< 0.0001 r= -0.7411, p< 0.0001 r= -0.5810, p= 0.0003 r= -0.6040, p= 0.0002 
Hippocampus r= -0.0790, p= 0.6567 r= -0.1497, p= 0.3981 r= -0.2321, p= 0.1865
MTR Corpus callosum (CC) r= -0.6314, p= 0.0002 r= -0.4889, p= 0.0061 r= -0.5549, p= 0.0015 r= -0.6130, p= 0.0003 
External capsule (EC) r= -0.5991, p= 0.0005 r= -0.5320, p= 0.0025 r= -0.6132, p= 0.0003 r= -0.5852, p= 0.0007 
Internal capsule (IC) r= -0.6699, p< 0.0001 r= -0.6438, p= 0.0001 r= -0.6937, p< 0.0001 r= -0.6459, p= 0.0001 
Optic tract (OT) r= -0.6478, p= 0.0001 r= -0.7270, p< 0.0001 r= -0.6009, p= 0.0004 r= -0.6642, p< 0.0001






















Table S.4.2.: Correlation analysis of MRI parameters and pathological grades of 
axonal (APP), myelin (MAG) integrity, degraded myelin (dMBP), and 
inflammation (Iba1) 
 Spearman`s correlation analysis showed a significant negative correlation between 
MRI (FA and MTR) parameters of white matter integrity and pathological grades of 
axonal (APP), myelin (dMBP) integrity and inflammation (Iba1) in examined white 
matter ROIs. In the hippocampus, only MTR, but not FA values correlated 
significantly with axonal integrity, degraded myelin and inflammation. 








S.5.1. Pathological assessment 
S.5.1.1. Materials and methods 
The pathological profiles of the hypoperfused and sham animals used for the experimental 
purposes of the present Chapter 5 are described in Chapter 4. All analysis was performed 
one month after chronic cerebral hypoperfusion or sham controls. White matter integrity 
was examined on coronal brain sections at -2.12mm bregma neuroanatomical level 
(Franklin and Paxinos, 1997) using antibodies that allow detection of  alterations in axonal 
integrity  (APP) and the myelin sheath (dMBP and MAG), in the three white matter tracts 
(CC, EC, IC). White matter pathology  was evaluated by means of a semi- quantitative 
grading scale (Chapter 2, section 2.7.4.) in white and grey matter ROIs of sham and 
hypoperfused animals (Chapter 2, section 2.8.). 
The overall grey matter integrity and the presence of neuronal ischemic injury were 
examined on 6µm H&E stained coronal brain sections from neuroanatomical levels 0.74 
mm; 0.38 mm;  -0.94 mm; -2.12 mm bregma (Franklin and Paxinos, 1997) (Chapter 4, 
section 4.3.2.5.; figure, 4.3.; figure S.4.3.- appendices II ). The grey matter ROIs were 
cortical (the Cx) and subcortical (the striatum, the hippocampus) regions known to be 
susceptible to blood flow alterations 
S.5.1.2. Statistical analysis  
As only a subset of the animals from Chapter 4 (hypoperfused n= 9; sham n= 8) were used 
in the present study, the group median regional pathological grades of axonal (APP) and 
myelin (MAG and dMBP) integrity were statistically reanalyzed by a nonparametric 
Mann- Whitney test. This particular statistical test was applied for the data analysis as the 
pathological grades were nonquantitative values and therefore could not be analyzed by 
using a standard parametric t- test analysis.  






5.3.1.1. Chronic cerebral hypoperfusion affects significantly axonal integrity 
Axonal pathology was detected by APP immunoreactivity and identified as intense APP 
immunoreactivity in swollen and/ or bulbous axons. Axonal injury with a varying degree 
of severity was evidenced in 6 of the 9 hypoperfused and in none of the 8 sham animals 
(figure S.5.1. A1- A4). Hypoperfused animals showed significant axonal damage in all 
white matter ROIs when compared with sham mice: the CC (U= 16.0, p= 0.016), EC (U= 
16.0, p= 0.016), IC (U= 16.0, p= 0.016) (table S.5.1.).   
The regional pathological grades of axonal integrity for each individual experimental 
animal are given in table S.4.1.1., appendices II. 
5.3.1.2. Chronic cerebral hypoperfusion leads to significant myelin structural 
abnormalities in EC and IC, but not in CC 
Using MAG immunostaining, myelin structural abnormalities with a varying degree of 
severity were observed in all hypoperfused (9/9) and in none of the sham animals (0/8) 
(figure S.5.1. B1- B4). A significant group difference in the severity of myelin 
abnormalities was evident in the EC (U= 12.0, p= 0.007) and IC (U= 4.0, p= 0.001) (table 
S.5.1.). Interestingly, after chronic cerebral hypoperfusion the myelin structural integrity 
was relatively preserved in the CC as shown by the absence of significant group difference 
(U= 28.0, p= 0.169) (table S.5.1.). 
The regional pathological grades of myelin integrity as evaluated by MAG 
immunohistochemistry for each individual experimental animal are given in table S.4.1.2., 
appendices II. 
5.3.1.3. Chronic cerebral hypoperfusion is associated with a significant myelin 
degradation  
Degraded myelin accumulation with a varying degree of severity was detected by dMBP 
immunoreactivity in 8 hypoperfused (8/9) and none of the sham mice (0/8) (figure S.5.1. 
C1-C4).. There was a significant group difference in the severity of degraded myelin in all 
347 
white matter tracts: the CC (U= 12.0, p= 0.006), EC (U= 12.0, p= 0.006), IC (U= 8.0, p= 
0.002) (table S.5.1.). 
The regional pathological grades of myelin integrity as evaluated by dMBP 
immunohistochemistry for each individual experimental animal are given in table S.4.1.3., 
appendices II 
5.3.1.4. Chronic cerebral hypoperfusion does not affect grey matter structural 
integrity 
As described in the previous Chapter 4 there was no overt neuronal perikarya damage in 
the examined grey matter ROIs (the striatum, the hippocampus, and the cortex) in any of 



















Figure S.5.1.: White matter integrity in sham and hypoperfused mice 
Representative images of axonal (A1- A4), myelin (B1- B4) integrity and degraded 
myelin (C1-C4) in the CC (A1-A2, B1- B2, C1- C2) and the IC (A3-A4, B3-B4, C3-
C4) in sham (A1-C1, A3-C3) and hypoperfused (A2-C2, A4-C4) mice. 
Hypoperfused mice exhibited axonal pathology (arrows in A2, A4) and degraded 
myelin (arrows in C2 and C4) in both the CC (A2, C2) and the IC (A4, C4). Myelin 
structural integrity evaluated by MAG immunohistochemistry was preserved in the 
hypoperfused CC (B2), but not in the hypoperfused IC where disorganized myelin 
fibers, vacuoles and myelin debris were observed (arrow in B4).  
Scale bar represents 20µm (magnification x40). 
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Biomarker Region of interest Sham (n=8) Hypoperfused (n=9)
(median) (median)
APP Corpus callosum(CC) 0 1*
Axonal integrity External capsule (EC) 0 1*
Internal capsule (IC) 0 1*
MAG Corpus callosum(CC) 0 0
Myelin integrity External capsule(EC) 0  1*
Internal capsule(IC) 0  2*
dMBP Corpus callosum(CC) 0  1*
Degraded myelin External capsule(EC) 0  1*




















Table S.5.1.: Regional group median pathological grades 
Chronically hypoperfused mice (n=9) exhibited axonal injury (APP), myelin 
abnormalities (MAG) and increased inflammation (Iba1) in white ROIs compared 
with sham animals (n=8) a month post- surgery. 
Significant group differences as given by Mann- Whitney nonparametric statistics: 









Figure S.5.2.1.: Brain 5mC immunochemical distribution in sham and 
hypoperfused mice 
Representative images of 5mC immunoreactivity with ssDNA counterstaining in 
CC (A, A1), IC (B, B1) and Cx (C, C1) of sham (A-C) and hypoperfused mice 
(A1-C1). Under both normal physiological and chronically hypoperfused 
conditions methylation was evident in cellular nuclei as demonstrated by co- 
immunolocalization with ssDNA in white (A-A1, B-B1) and grey (C- C1) matter 
regions of the adult mouse brain. 
Scale bar represents 20µm (magnification x40). 
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  Figure S.5.2.2.: Brain 5hmC immunochemical distribution in sham and 
hypoperfused mice 
Representative images of 5hmC immunoreactivity with ssDNA counterstaining in 
CC (A, A1), IC (B, B1) and Cx (C, C1) of sham (A-C) and hypoperfused (A1-C1) 
mice. Under both normal physiological and chronically hypoperfused conditions, 
5hmC was immunodected in cellular nuclei as shown by co- immunocolocalization 
with ssDNA in white (A- A1, B- B1) and grey matter (C- C1) areas. Interestingly, 
under normal physiological conditions not all cells in white matter were 5hmC 
immunopositive. Chronic cerebral hypoperfusion led to a significant 5hmC 
upregulation in white matter (the CC- A1), but not in grey matter (C1) areas.  





Figure S.5.2.2.: A higher resolution (at the same magnification) of the images 
shown in figure S.5.2.2. A- A1 
Under normal physiological conditions 5hmC was enriched in certain cells present in 
white matter (white arrows in D) and absent in others (blue arrow in D). The exact 
phenotype of 5hmC positive and negative cells in white matter tracts remains unclear. 
Chronic cerebral hypoperfusion led to a significant increase in the proportion of 
5hmC positive cells in the CC (D1).  
















Figure S.5.2.3.: Brain TET2 immunochemical distribution in sham and 
hypoperfused mice 
Representative images of TET2 immunoreactivity with DAPI counterstaining in the 
CC (A, A1), IC (B, B1) and Cx (C, C1) of sham (A-C) and hypoperfused (A1-C1) 
mice. Under normal physiological conditions, TET2 was equally distributed among 
white (A, B) and grey (C) matter regions. Chronic cerebral hypoperfusion did not 
impact on TET2 distribution in white matter (A1, B1), but led to a significant TET2 
up- regulation in the Cx (C1). 












Figure S.5.2.3.: A higher resolution (at the same magnification) of the images 
shown in figure S.5.2.3. A, C, C1 and an additional image from the CA1 region of 
the hippocampus (E) 
Under both normal physiological and chronically hypoperfused conditions TET2 was 
found in the cytoplasm of cortical (arrow in F) and subcrotical (arrow in E) cells 
(predominantly neurons) as well as in both the cytoplasm and nuclei of cells in white 
matter (predominantly glia) (arrow in D). Chronic cerebral hypoperfusion led a 
significant increase in cortical TET2 (D1). 
Scale bar represents 20µm (magnification x40). 
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Biomarker Region of interest Group statistics Group statistics
Sham (n=8) Hypoperfused (n=9) Sham (n=8) Hypoperfused(n=9)
5mC Corpus callosum (CC)       46 ± 5.7        49 ± 5.5 t= 0.7488,   p= 0.4656      59 ± 5.3     59 ± 5.5 t= 0.3671, p= 0.7187
External capsule (EC)       31 ± 5.5        26 ± 5.1 t= 0.2383,   p= 0.8149      40 ± 5.2     34 ± 4.7 t= 0.4162, p= 0.6831
Internal capsule (IC)       78 ± 7.2        71 ± 7.4 t= 0.1943,   p= 0.8485      85 ± 4.3     84 ± 8.2 t= 0.1468, p= 0.8853
CA1       76 ± 4.0        58 ± 8.4 t= 1.616,     p= 0.1269      79 ± 3.1     59 ± 8.0 t= 1.931,   p= 0.0726
Cortex (Cx)     111 ± 8.7        97 ± 9.4 t= 1.077,     p= 0.2983    127 ± 7.2   108 ± 8.5 t= 1.410,   p= 0.1789
5hmC Corpus callosum (CC) 32 ± 11.1        51 ± 8.6 t= 1.438,     p= 0.1710      64 ± 16.7     61 ± 9.2 t= 0.1760, p= 0.8626
External capsule (EC)       18 ± 4.3        20 ± 4.1 t= 0.3289,   p= 0.7467      35 ± 6.1     33 ± 5.1 t= 0.2550, p= 0.8022
Internal capsule (IC)       70 ± 11.8        70 ± 18.3 t= 0.02759, p= 0.9784      81 ± 10.4       95 ± 15.0 t= 0.8318, p= 0.4186
CA1       57 ± 12.6        56 ± 8.5 t= 0.1133,   p= 0.9113      72 ± 6.6     63 ± 7.9 t= 1.033,   p= 0.3315
Cortex (Cx)       93 ± 10.3      111 ± 8.0 t= 1.525,     p= 0.1480     104 ± 11.0   120 ± 9.6 t= 1.213,   p= 0.2440
TET2 Corpus callosum (CC)       18 ± 4.2        20 ± 4.3 t= 0.2717,   p= 0.7895      59 ± 2.5     63 ± 2.5 t= 1.429,   p= 0.1735
External capsule (EC)         9 ± 2.0          8 ± 1.9 t= 0.5438,   p= 0.5946      31 ± 2.2     27 ± 1.0 t= 1.698,   p= 0.1101
Internal capsule (IC)       24 ± 2.6        21 ± 3.4 t= 0.6494,   p= 0.5259      50 ± 1.9     48 ± 2.5 t= 0.6578, p= 0.5206
CA1       28 ± 1.6        25 ± 1.7 t= 1.287,     p= 0.2175      48 ± 1.7     43 ± 1.5 t= 2.161,   p= 0.0572
Cortex (Cx)       21 ± 3.0        27 ± 2.1 t= 1.708      p= 0.1083      68 ± 2.6     66 ± 2.6 t= 0.3440, p= 0.7356
Number biomarker positive cells
(mean ± SE) (mean ± SE)


















Table S.5.2.: Regional number of 5mC, 5hmC, TET2 positive cells and total 
number of cells (group mean ± SE values) 
The regional number of 5mC, 5hmC, TET2 positive cells and the corresponding 
regional total number of ssDNA (for 5mC, 5hmC) or DAPI (for TET2) stained cells did 
not differ significantly between sham and hypoperfused mice in any of the examined 
ROIs as indicated by the t- test statistical analysis (p>0.05) 
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Biomarker Region of interest Group statistics Group statistics
Sham (n=8) Hypoperfused (n=9) Sham (n=8) Hypoperfused (n=9)
CC1 Corpus callosum (CC)       40 ± 5.6        32 ± 7.7 t= 0.8381, p= 0.4151      58 ± 1.9     61 ± 3.6 t= 0.6400,   p= 0.5318
External capsule (EC)       17 ± 3.7        15 ± 3.1 t= 0.3967, p= 0.6971      31 ± 2.4     31 ± 2.1 t= 0.03228, p= 0.9747
Internal capsule (IC)       42 ± 3.7        35 ± 4.8 t= 1.147,   p= 0.2693      57 ± 3.4     58 ± 3.1 t= 0.2338,   p= 0.8183
NG2 Corpus callosum (CC)       10 ± 4.1        24 ± 3.2** t= 2.981,   p= 0.0093      60 ± 1.2     59 ± 3.2 t= 0.1817,   p= 0.8583
External capsule (EC)       14 ± 2.6        20 ± 1.3* t= 2.373,   p= 0.0314      34 ± 2.6     37 ± 2.2 t= 0.9881,   p= 0.3388
Internal capsule (IC)         9 ± 2.6        19 ± 3.3* t= 2.591,   p= 0.0205      48 ± 1.6     52 ± 1.7 t= 1.967,     p= 0.0680
Iba1 Corpus callosum (CC)         4 ± 0.4          7 ± 0.8* t= 3.546  , p= 0.0029      53 ± 5.5     52 ± 2.4 t= 0.1441,   p= 0.8874
External capsule (EC)         3 ± 0.3          3 ± 0.6 t= 1.051,   p= 0.3098      31 ± 1.8     35 ± 1.0 t= 1.979,     p= 0.0665
Internal capsule (IC)         5 ± 0.3        12 ± 2.7* t= 2.292,   p= 0.0368      85 ± 4.5     89 ± 9.1 t= 0.3283,   p= 0.7472
Number biomarker positive cells Total number of cells






Table S.5.3.: Regional number of CC1, NG2, Iba1 positive cells and total number of 
cells (group mean ± SE values) 
The regional number of CC1 positive cells in white matter ROIs and the corresponding 
regional total number of  DAPI (CC1 and NG2), haemotoxylin (Iba1) positive cells for 
all biomarkers did not differ between sham and hypoperfused mice (p>0.05).  The 
number of NG2 (the CC, EC, IC) and the number of Iba1 (the CC and the IC) positive 
cells increased significantly after chronic cerebral hypoperfusion (p<0.05). Significant 
group differences as indicated by the t- test statistical analysis: (p<0.05)* 
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